data_2nmb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nmb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.92 0.39 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -66.47 -29.29 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.17 -56.65 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 1.5 p30 -58.5 -36.88 74.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.958 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 17.4 tt0 -60.19 -27.22 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.489 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 -30.5 14.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.863 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.21 -50.72 61.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 59.3 t -58.26 -38.75 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.422 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -39.9 70.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.561 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.78 1.41 55.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 65.92 78.51 0.27 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.829 0.347 . . . . 0.0 111.081 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 t 176.19 60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.2 -172.75 2.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.1 m 174.16 153.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.997 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 82' ' ' SER . 32.4 m-85 -162.1 139.78 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.422 ' N ' HD11 ' A' ' 120' ' ' LEU . 23.3 t -60.76 157.23 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.735 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 86' ' ' LYS . 7.1 p 178.67 160.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.987 0.422 . . . . 0.0 111.915 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.427 ' N ' HG23 ' A' ' 85' ' ' VAL . 1.7 mttp -111.31 71.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.636 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.479 ' CE1' ' HA2' ' A' ' 89' ' ' GLY . 41.4 t80 -55.02 107.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.996 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 6.9 mp -48.5 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.479 ' HA2' ' CE1' ' A' ' 87' ' ' TYR . . . 176.18 -133.32 2.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.419 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.95 151.14 38.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.954 0.407 . . . . 0.0 111.002 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.55 167.05 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.832 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.14 142.6 27.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 2.1 m -145.49 173.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.223 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -116.26 25.56 10.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.427 ' CB ' HG23 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -144.84 -74.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.253 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m 59.45 19.48 7.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.24 66.54 1.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.59 -161.03 27.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.344 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -36.26 3.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 111.06 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -61.58 -25.9 67.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.427 HG23 ' CB ' ' A' ' 95' ' ' GLU . 15.8 t -76.06 -30.44 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.31 -38.75 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.2 -37.72 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -88.31 -34.8 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.683 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.31 -51.31 65.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -45.52 62.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.595 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -39.12 73.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.399 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.66 -39.65 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.757 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.434 HD11 ' CB ' ' A' ' 114' ' ' ARG . 1.5 mm? -55.64 -26.26 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -86.21 -61.29 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.044 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -48.4 -33.44 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.034 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -165.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.41 42.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.434 ' CB ' HD11 ' A' ' 109' ' ' LEU . 1.7 mmp_? -93.1 70.39 4.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.825 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 133.84 19.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 71.7 Cg_endo -79.37 141.49 16.01 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.476 2.117 . . . . 0.0 112.63 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 87' ' ' TYR . 12.0 m -78.35 173.99 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.37 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -135.95 72.9 1.44 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.246 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -141.17 -130.4 2.58 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.852 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.441 ' CD2' ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -145.25 140.94 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.878 0.37 . . . . 0.0 111.433 -178.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 0.5 OUTLIER -85.68 116.22 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -81.05 84.25 6.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.968 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.445 ' CG1' ' HB3' ' A' ' 194' ' ' ALA . 38.0 t -94.89 125.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -142.82 44.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.499 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 41.35 51.91 4.42 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.949 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.428 ' CA ' HG23 ' A' ' 144' ' ' ILE . 20.9 t70 -164.94 -40.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.673 0.273 . . . . 0.0 111.072 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 144' ' ' ILE . . . -176.52 118.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.459 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -65.6 115.81 6.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.736 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -117.99 78.94 1.3 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 121' ' ' LEU . 5.8 p -68.14 132.79 32.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.081 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.31 139.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -75.95 163.05 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -103.17 15.68 28.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.327 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.03 -60.26 1.82 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.883 0.373 . . . . 0.0 110.579 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 42.9 p -82.01 -27.91 32.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.7 48.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -126.54 142.38 13.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.1 tp -69.45 132.63 46.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.745 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 87' ' ' TYR . 8.8 mt -100.63 -53.26 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.395 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.48 67.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.21 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.436 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.6 p-10 -72.97 67.59 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.51 152.57 48.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.5 m -78.71 145.06 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.69 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.485 HG12 ' CD1' ' A' ' 195' ' ' PHE . 7.0 tt -71.89 -30.71 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.897 0.38 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -75.5 -28.94 59.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.283 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -90.91 -39.23 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.368 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 144' ' ' ILE . 9.9 p -58.9 163.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.038 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 12.9 t -76.06 1.95 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.438 ' HA ' ' CE1' ' A' ' 195' ' ' PHE . 1.4 m-85 80.86 174.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.044 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.472 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 2.9 t -108.92 164.99 11.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -155.17 97.67 2.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--N 1.345 0.352 0 C-N-CA 122.256 1.971 . . . . 0.0 111.789 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 178' ' ' LEU . . . -109.87 144.97 16.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.39 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.488 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 3.5 m-85 -143.97 178.26 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.607 0.241 . . . . 0.0 110.852 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.8 m -172.26 134.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 111.554 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.577 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 98.2 m-85 -94.55 -174.31 3.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.486 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 0.9 OUTLIER -165.99 137.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.607 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.72 125.69 24.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.0 OUTLIER -76.89 87.48 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.046 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 168' ' ' THR . 23.1 t0 50.84 -90.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.234 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 165' ' ' ARG . . . 59.47 -82.35 0.01 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -140.96 25.15 2.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.481 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 170' ' ' ARG . 4.2 m -122.25 23.62 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.488 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 169' ' ' THR . 12.3 mtp180 86.74 -72.29 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.487 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -146.6 -164.33 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 0.0 111.02 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.417 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 2.0 m95 -56.01 90.17 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.429 ' HG3' ' CG2' ' A' ' 169' ' ' THR . 0.0 OUTLIER -98.07 110.74 23.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.828 -177.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -82.03 148.19 28.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.735 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 173' ' ' MET . 24.6 m-70 -128.66 158.58 38.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.857 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.63 138.53 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.845 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.577 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -153.98 115.06 4.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.178 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.432 ' CD2' ' HA2' ' A' ' 159' ' ' GLY . 0.1 OUTLIER -90.25 122.33 33.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.821 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.42 ' N ' HD11 ' A' ' 178' ' ' LEU . . . -46.1 135.44 7.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -67.08 0.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -33.3 65.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.343 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' CD1' ' A' ' 178' ' ' LEU . 1.4 m-20 63.27 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.268 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.22 28.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.863 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.43 29.22 0.22 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.23 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 186' ' ' ARG . 18.0 mt-10 -138.61 47.7 1.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.027 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.475 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -159.63 -42.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.427 ' CD2' ' HB ' ' A' ' 85' ' ' VAL . 5.9 mp -114.65 -37.65 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 t -56.95 -59.95 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -75.58 -26.46 57.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -67.26 -66.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.66 -29.45 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.309 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -53.12 -28.79 34.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.218 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 196' ' ' ALA . 47.5 t -95.86 -22.61 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.302 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.445 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -47.42 -38.61 13.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.485 ' CD1' HG12 ' A' ' 144' ' ' ILE . 61.5 m-85 -79.07 -26.99 43.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 193' ' ' CYS . . . -47.16 -43.87 21.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.127 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.05 -30.06 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.738 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.8 t -66.9 -58.87 4.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.779 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.438 ' CD1' ' CG2' ' B' ' 3' ' ' ILE . 2.1 pt? -117.54 51.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.547 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.423 ' CA ' ' O ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.721 0.296 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -163.34 -89.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.129 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' A' ' 199' ' ' LEU . 2.6 mm -109.17 -52.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.35 -74.97 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.473 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 CA--C 1.53 0.299 0 C-N-CA 123.159 2.573 . . . . 0.0 113.34 -179.042 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.711 0.291 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.92 -34.74 78.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.52 -51.42 8.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.991 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -58.71 -42.46 88.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.34 -36.91 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.691 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -86.11 -29.79 23.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.55 -57.59 10.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.793 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -49.4 -38.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -49.65 74.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.448 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.4 20.64 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.21 90.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t 179.5 44.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -112.62 162.27 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 32.4 t -172.64 154.0 2.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 82' ' ' SER . 91.2 m-85 -160.34 141.1 11.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.14 151.07 19.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.112 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 187' ' ' LEU . 0.8 OUTLIER -152.18 171.81 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 112.115 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -128.11 40.11 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.966 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 177' ' ' PHE . 6.0 t80 -44.57 123.91 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.608 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -68.55 -60.31 2.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . 159.31 -160.28 31.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.393 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.21 146.49 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.059 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' ' 109' ' ' LEU . 2.8 m -133.78 135.47 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.12 120.66 18.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 10.7 m -120.96 177.27 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.086 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.22 -22.92 18.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.194 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 19.5 mp0 -123.61 153.52 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.1 p -133.25 21.78 4.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.009 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.3 23.9 1.03 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.67 131.97 9.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.607 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -51.69 60.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.36 -26.75 8.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.49 -33.13 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.205 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -72.98 -41.39 64.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.68 -33.7 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.576 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.426 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 12.6 pt-20 -87.64 -40.34 14.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -57.39 -58.88 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -46.36 -40.56 12.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.899 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -64.55 -45.52 86.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 178.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.43 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.1 t -63.92 -30.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.883 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.435 ' CD2' HG23 ' A' ' 91' ' ' VAL . 3.5 mm? -59.04 -23.67 62.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.512 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -93.38 -36.23 12.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -72.97 -21.73 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.306 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.26 172.0 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -53.67 -22.73 9.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.435 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 7.4 mmp_? -46.05 92.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -94.96 150.42 37.74 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.23 166.26 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.767 2.311 . . . . 0.0 112.466 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 7.0 p -137.9 119.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.356 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -80.85 97.91 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.46 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.69 -169.08 18.96 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.775 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.87 124.43 51.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.388 . . . . 0.0 111.122 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 123' ' ' VAL . 6.9 tp -88.88 99.32 12.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.882 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.05 96.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.408 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.446 ' CG2' ' HG ' ' A' ' 121' ' ' LEU . 95.1 t -102.73 117.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.86 28.99 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.116 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 49.69 24.41 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -133.92 -44.3 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.27 116.69 0.71 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.435 HD11 ' CE2' ' A' ' 162' ' ' TYR . 8.5 mt -71.57 133.98 46.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -141.49 98.08 3.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.8 p -89.21 104.47 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 t -107.07 132.62 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.076 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 136' ' ' LYS . 41.3 t0 -70.17 133.28 46.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -79.08 -6.59 56.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -97.57 -24.49 15.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.9 p -123.61 -35.17 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.1 OUTLIER 75.54 25.25 1.24 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.54 123.83 8.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.262 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.5 tp -50.81 131.52 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.991 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.43 ' CD1' HG23 ' A' ' 117' ' ' VAL . 9.6 mt -105.11 -54.13 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.269 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 142' ' ' GLN . 59.7 t -111.11 65.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 35.7 p-10 -68.16 66.92 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 140' ' ' VAL . 19.2 mt-30 -138.34 134.59 34.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 0.2 OUTLIER -54.19 -176.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 18.1 tt -108.76 -15.83 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.767 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -99.6 -26.99 13.9 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -110.24 -171.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.289 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.39 14.78 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.475 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 73.66 149.56 0.1 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.874 0.369 . . . . 0.0 110.988 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 24.6 p -72.36 -178.56 2.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 171.75 80.83 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.79 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 160' ' ' PHE . 10.7 Cg_endo . . . . . 0 C--N 1.344 0.31 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.435 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.739 0.304 . . . . 0.0 111.181 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.63 141.18 12.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.899 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.527 ' CE1' ' CB ' ' A' ' 188' ' ' SER . 4.9 m-85 -118.34 -174.27 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.9 m -166.07 134.81 3.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.528 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.435 ' CE2' HD11 ' A' ' 128' ' ' LEU . 7.5 m-30 -102.34 175.28 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.286 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.421 ' O ' ' CG1' ' A' ' 147' ' ' VAL . 0.4 OUTLIER -159.21 150.96 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.964 0.411 . . . . 0.0 111.425 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.3 166.3 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.539 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.82 79.18 1.54 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.132 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 46.62 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.183 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.03 -34.17 6.0 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.107 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 94.7 m -150.75 -44.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -72.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.92 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -178.21 -79.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.629 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 173' ' ' MET . 1.6 ptp180 -131.81 -153.47 0.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.91 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.428 ' N ' ' HG3' ' A' ' 171' ' ' ARG . 11.5 m95 -62.83 80.09 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 171' ' ' ARG . 1.2 mmt -85.36 121.57 28.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.74 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.32 156.94 16.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.749 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.68 105.61 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.749 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.96 104.83 2.89 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.468 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.496 ' HB3' ' CD1' ' A' ' 87' ' ' TYR . 3.3 p90 -121.16 132.64 54.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.415 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.6 tp -102.26 147.24 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.688 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.22 140.09 56.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.175 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 35.8 t -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.753 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -36.24 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.9 66.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.435 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 2.6 p -148.98 16.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.733 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 43.33 34.71 2.43 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.861 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -144.82 50.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.0 mtt-85 -168.8 -42.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.74 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.455 ' CD1' ' CB ' ' A' ' 83' ' ' PHE . 9.8 mp -113.32 -42.44 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.527 ' CB ' ' CE1' ' A' ' 160' ' ' PHE . 23.2 p -53.36 -65.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -66.91 -25.44 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.44 -60.03 2.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 17.6 t -61.21 -40.5 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.881 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.73 -41.56 95.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.141 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.89 -34.0 64.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 110.332 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.439 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -56.41 -44.82 80.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -51.05 -26.29 6.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -48.13 -42.72 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.57 -32.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.621 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 46.6 t -49.85 -36.17 25.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.454 ' N ' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -118.91 -36.37 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 196' ' ' ALA . 6.9 tp10 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.451 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.803 0.335 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.46 -97.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.63 -29.85 2.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.74 -85.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.541 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.426 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 49.1 Cg_exo . . . . . 0 N--CA 1.464 -0.236 0 C-N-CA 122.467 2.112 . . . . 0.0 110.826 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.933 0.397 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -68.99 -33.4 73.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.632 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.02 -63.13 1.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.084 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.47 -47.53 57.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -29.77 11.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.4 -24.69 15.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.17 -64.82 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.039 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 81' ' ' CYS . 2.3 m -50.03 -32.68 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -59.66 -52.55 65.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.463 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 23.44 5.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.833 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 48.65 85.27 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -176.64 34.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.325 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.427 ' CB ' HG11 ' A' ' 76' ' ' VAL . 4.6 t -98.75 156.28 16.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.053 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.465 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 2.6 t -174.8 152.02 1.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.763 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.483 ' CG ' ' HB3' ' A' ' 186' ' ' ARG . 72.3 m-85 -162.18 147.68 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.6 t -55.31 151.88 9.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' A' ' 187' ' ' LEU . 1.6 t -152.68 168.35 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.107 0.48 . . . . 0.0 111.618 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -128.11 48.2 2.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.929 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 14.4 t80 -39.57 114.98 0.46 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.871 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 54.9 mt -66.89 -26.93 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.461 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 126.01 -152.91 18.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.222 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 2.8 m -126.95 150.45 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.014 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 109' ' ' LEU . 13.8 m -133.87 134.91 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' N ' ' HE3' ' A' ' 173' ' ' MET . 9.2 pt-20 -70.33 133.06 46.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.728 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 23.9 m -138.64 169.4 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 111.361 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.5 16.0 16.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -157.34 119.46 3.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 p -95.83 24.18 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -165.16 123.43 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.751 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 148.72 113.07 0.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -36.61 25.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.087 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.22 -41.28 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.35 -33.68 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.081 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -70.36 -39.04 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.05 -32.56 68.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.79 -36.51 12.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -50.11 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.895 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -50.09 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.686 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -44.06 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.01 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.68 -34.38 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.717 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.439 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 1.1 mm? -52.03 -28.49 17.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 0.0 110.196 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.0 -27.84 18.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.561 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.72 20.43 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.174 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.406 ' HB3' ' HG3' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -120.6 147.63 44.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.69 4.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.64 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.429 ' NE ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -45.28 171.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.366 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -138.62 151.74 69.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.037 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD3' ' NH1' ' A' ' 114' ' ' ARG . 89.1 Cg_endo -80.2 -179.9 5.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.636 2.224 . . . . 0.0 112.392 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -141.26 -173.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.616 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.6 96.24 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.614 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.7 -131.44 1.27 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.771 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.72 129.75 51.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.075 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 177' ' ' PHE . 10.5 tt -100.88 113.02 25.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.187 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -76.95 111.57 12.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.475 ' CG2' ' CD2' ' A' ' 121' ' ' LEU . 82.1 t -110.78 96.74 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.32 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -111.79 27.58 9.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.378 . . . . 0.0 111.292 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.431 ' HA3' ' CG2' ' A' ' 197' ' ' VAL . . . 47.62 26.37 3.83 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.274 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -140.15 -42.91 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.946 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -158.4 119.53 0.9 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.524 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.64 123.64 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.785 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -135.31 100.91 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.434 ' CG1' HG22 ' A' ' 140' ' ' VAL . 9.2 p -90.59 128.39 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.47 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.1 154.87 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.693 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 136' ' ' LYS . 54.5 t0 -102.79 135.72 43.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.5 -0.41 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.714 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -103.48 -31.16 10.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.867 0.365 . . . . 0.0 110.996 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 p -116.64 -29.09 6.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 66.93 29.62 8.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.54 -128.89 5.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.595 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 7.5 tp -156.97 134.63 10.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.773 0.32 . . . . 0.0 110.796 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 139' ' ' ILE . 4.3 mt -108.07 -54.85 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.434 HG22 ' CG1' ' A' ' 130' ' ' VAL . 7.6 t -109.09 71.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 111.24 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 14.9 p-10 -78.58 59.91 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.12 163.11 25.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.389 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.7 m -78.02 174.14 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.713 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.512 ' CG1' ' CE2' ' A' ' 195' ' ' PHE . 4.1 tt -97.64 -21.29 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -91.05 -39.52 12.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.835 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -72.66 -29.23 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 144' ' ' ILE . 8.3 p -74.82 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.804 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -72.55 -0.86 13.95 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.6 m-85 79.11 179.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.505 ' CB ' ' CD1' ' A' ' 162' ' ' TYR . 25.5 p -98.94 177.34 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' B' ' 5' ' ' PRO . . . -171.24 101.01 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.081 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.368 2.045 . . . . 0.0 111.977 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.845 0.355 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.18 106.31 1.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 188' ' ' SER . 0.1 OUTLIER -96.41 -177.22 3.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.439 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.83 122.72 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.948 0.404 . . . . 0.0 111.301 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.505 ' CD1' ' CB ' ' A' ' 150' ' ' CYS . 1.8 m-30 -95.73 -160.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -169.89 148.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -135.72 163.32 30.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -129.06 81.07 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 167' ' ' GLY . 2.0 p30 46.55 -161.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 166' ' ' ASP . . . 95.45 -57.08 1.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.137 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.39 19.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 170' ' ' ARG . 49.4 m -137.67 -86.03 0.29 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.673 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 169' ' ' THR . 4.9 mtt180 -164.08 -82.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.906 0.384 . . . . 0.0 111.008 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -138.12 -150.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.129 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.502 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 1.1 m95 -68.6 67.78 0.14 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.425 ' HE3' ' N ' ' A' ' 92' ' ' GLU . 20.4 mmm -89.73 119.97 30.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.39 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.407 ' C ' ' CD2' ' A' ' 175' ' ' HIS . 6.9 m -76.77 166.21 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.753 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.418 ' ND1' ' OH ' ' A' ' 87' ' ' TYR . 17.0 m-70 -138.43 93.09 2.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.401 ' HA3' ' HG ' ' A' ' 109' ' ' LEU . . . -75.89 118.74 5.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.602 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.485 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 4.2 m-85 -114.75 108.21 16.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.7 mt -88.88 98.52 11.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.46 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.413 ' HB3' ' CE2' ' A' ' 160' ' ' PHE . . . -47.18 135.98 9.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.443 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.0 t -54.15 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -55.81 -29.93 60.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.382 . . . . 0.0 110.589 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.93 67.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.116 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.77 21.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.349 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 188' ' ' SER . . . 40.96 34.42 0.8 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.337 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.3 -6.64 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.483 ' HB3' ' CG ' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -124.66 -10.82 7.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.441 ' CD2' ' CG1' ' A' ' 85' ' ' VAL . 7.9 mp -136.04 -46.54 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.482 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 14.9 t -61.11 -52.01 66.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.75 -30.19 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.75 -69.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.97 -48.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -61.1 -26.93 66.49 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.802 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -78.31 -33.0 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.46 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.464 ' CB ' ' CG1' ' A' ' 123' ' ' VAL . . . -51.46 -44.3 62.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CE2' ' CG1' ' A' ' 144' ' ' ILE . 93.8 m-85 -58.62 -22.44 56.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -47.48 -48.53 26.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.011 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.431 ' CG2' ' HA3' ' A' ' 125' ' ' GLY . 2.4 m -73.58 -35.79 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.146 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 35.4 t -44.07 -45.03 7.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.178 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.18 -29.8 10.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.471 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.506 179.149 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.421 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.71 80.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mm 70.43 -64.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.64 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.58 -79.07 0.07 OUTLIER Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.816 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.421 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 38.2 Cg_exo . . . . . 0 C--N 1.342 0.218 0 C-N-CA 122.771 2.314 . . . . 0.0 111.943 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 121.189 0.519 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 7.0 pt20 -48.06 -36.52 13.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.088 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -82.77 -58.5 2.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.434 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -46.88 -29.73 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.45 -40.77 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.29 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -93.98 -14.37 25.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 178.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.72 93.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 46.1 t -65.49 -49.55 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.514 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.417 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 19.9 mtm-85 -50.49 -53.47 29.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.733 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.28 -0.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.516 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 64.77 80.58 0.23 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.706 0.289 . . . . 0.0 111.07 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 t -179.32 44.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -106.9 163.51 12.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.739 0.304 . . . . 0.0 110.757 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.56 146.18 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -157.43 129.42 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.4 ' N ' HD22 ' A' ' 120' ' ' LEU . 1.4 t -52.38 159.1 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.524 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 86' ' ' LYS . 13.0 p -172.92 160.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 111.691 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' N ' HG23 ' A' ' 85' ' ' VAL . 7.3 mmtt -108.02 65.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.735 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.529 ' CE2' ' CG ' ' A' ' 177' ' ' PHE . 0.3 OUTLIER -60.36 126.05 26.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.414 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 88' ' ' LEU . 6.2 mp -77.92 -31.58 51.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.586 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.79 -164.13 15.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.254 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.426 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 20.2 m -105.19 147.59 27.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.992 0.425 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.429 ' O ' ' CE ' ' A' ' 173' ' ' MET . 0.4 OUTLIER -126.68 171.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.045 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 1.6 pt-20 -90.63 140.8 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 92' ' ' GLU . 34.3 m -158.41 179.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.839 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.07 18.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.46 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -152.72 112.99 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.414 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.442 ' CB ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -106.67 25.11 11.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.901 177.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.64 33.66 2.23 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.982 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.27 106.82 0.56 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -25.69 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 110.871 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -76.31 -26.26 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.859 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.6 t -67.44 -39.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.967 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.3 m -72.15 -48.09 46.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.345 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -52.95 -38.24 61.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.349 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.83 -42.13 14.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.768 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -49.78 -48.12 50.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 tt -50.87 -46.12 60.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -40.83 90.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.062 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' SER . 41.3 t -61.77 -31.19 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.058 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.441 ' CD1' ' HG3' ' A' ' 114' ' ' ARG . 3.2 mm? -67.54 -21.46 65.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -89.11 -50.38 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -24.08 64.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 96.2 p -79.17 170.82 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.27 -22.55 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.417 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -46.36 159.61 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.107 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -150.09 153.49 35.48 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.82 0.343 . . . . 0.0 111.418 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.53 163.2 15.85 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.801 2.334 . . . . 0.0 112.36 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.437 ' O ' ' CG1' ' A' ' 117' ' ' VAL . 7.4 p -133.82 110.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.85 74.31 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.439 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -134.48 -156.73 7.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 84' ' ' SER . 0.4 OUTLIER -123.92 125.54 44.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 111.43 -178.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.91 105.67 14.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.264 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -76.84 98.44 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.424 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.434 HG23 ' CG2' ' A' ' 191' ' ' VAL . 97.0 t -101.96 108.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 48.1 p -125.85 40.57 3.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.116 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.434 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 40.58 35.56 0.87 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.211 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.415 ' CA ' HG23 ' A' ' 144' ' ' ILE . 19.7 t0 -158.21 -40.5 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.551 0.215 . . . . 0.0 111.452 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -147.63 121.24 1.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.991 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.486 HD21 ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -83.56 91.37 7.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.817 0.341 . . . . 0.0 110.427 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.416 ' CA ' HD13 ' A' ' 138' ' ' LEU . 3.5 mtt85 -107.28 98.45 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 87' ' ' TYR . 4.4 p -90.11 106.26 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.32 163.84 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -109.96 136.8 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.43 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -79.18 3.06 18.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.97 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -116.03 -32.42 5.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.7 p -115.91 -23.05 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.359 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.14 18.37 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.129 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.67 125.42 8.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.062 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.416 HD13 ' CA ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -59.05 126.4 27.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.439 ' HB ' ' CG1' ' A' ' 130' ' ' VAL . 6.0 mt -89.73 -24.07 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.706 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.09 63.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.402 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 9.4 p-10 -73.32 61.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.554 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -131.89 159.84 37.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.418 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 91.5 m -75.88 143.17 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.712 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.415 HG23 ' CA ' ' A' ' 126' ' ' ASP . 7.9 tt -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -77.07 -30.19 55.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.707 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -76.44 -20.3 57.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 163' ' ' ILE . 0.6 OUTLIER -78.07 169.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.61 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -83.92 8.8 13.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.85 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.411 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.9 m-85 78.97 139.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.238 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.483 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 29.4 p -74.38 -174.42 2.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.767 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . -166.23 55.5 0.36 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.691 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 50.9 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 122.205 1.937 . . . . 0.0 111.374 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' A' ' 158' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.838 0.352 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.34 149.27 18.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.718 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -139.83 172.82 12.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 40.7 t -165.25 134.93 3.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.493 ' CE1' ' CZ ' ' A' ' 177' ' ' PHE . 2.7 m-30 -89.54 -165.28 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.502 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.422 ' O ' ' CG1' ' A' ' 147' ' ' VAL . 0.8 OUTLIER -164.77 158.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.392 . . . . 0.0 111.668 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 42.6 t -159.89 127.95 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HG3' ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.71 87.61 7.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.103 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 45.3 -158.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.03 -71.67 0.26 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.109 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.1 m -130.3 17.19 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 0.0 111.084 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.432 HG23 ' CG ' ' A' ' 173' ' ' MET . 18.6 m -131.07 23.83 4.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 169' ' ' THR . 11.5 mmm180 84.95 -71.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.456 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 -158.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.985 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.418 ' O ' ' N ' ' A' ' 93' ' ' VAL . 1.9 m-90 -65.77 94.67 0.22 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.432 ' CG ' HG23 ' A' ' 169' ' ' THR . 0.3 OUTLIER -110.61 158.37 18.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 111.702 -177.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.94 174.98 5.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.878 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -137.67 74.62 1.49 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.96 0.41 . . . . 0.0 110.774 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -76.55 129.22 9.76 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.92 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.529 ' CG ' ' CE2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -153.92 160.11 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.91 127.1 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.832 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -47.73 134.78 12.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.504 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -63.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -62.16 -29.27 70.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.556 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.45 80.16 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.178 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.65 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.462 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.25 29.96 0.25 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.201 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.02 56.55 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.401 ' O ' ' CB ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -169.17 -41.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.987 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.65 -45.56 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.688 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -49.37 67.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.807 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -82.75 -27.98 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.813 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -70.06 -57.6 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.883 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 123' ' ' VAL . 1.2 t -76.52 -26.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.69 -32.69 32.93 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.62 -20.76 22.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.648 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.447 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . . . -46.58 -37.99 8.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.142 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -77.09 -23.59 51.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.005 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -50.71 -35.34 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.825 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.93 -30.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.621 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 50.2 t -51.75 -39.84 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.308 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.06 -26.89 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.44 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -177.15 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mp -45.14 -27.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.85 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.56 -82.66 0.03 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.968 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 32.9 Cg_exo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 123.026 2.484 . . . . 0.0 112.085 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.0 m0 . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.862 0.363 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -47.69 -33.39 6.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.25 -61.01 1.87 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.304 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 34.1 m-20 -48.38 -32.14 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.186 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -28.93 69.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -99.45 -29.26 12.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.127 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 72' ' ' ASP . . . -48.26 -35.84 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.938 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -61.91 -34.27 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.004 0.43 . . . . 0.0 110.512 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -64.39 -56.49 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.23 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -10.49 56.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.342 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 73.18 76.47 0.14 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.733 0.302 . . . . 0.0 111.055 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t -177.58 47.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.7 173.14 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.699 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 12.5 m -171.45 150.77 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 82' ' ' SER . 85.8 m-85 -161.56 136.91 7.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.834 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.73 163.8 1.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 86' ' ' LYS . 7.4 p 178.88 155.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 111.512 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.427 ' N ' HG23 ' A' ' 85' ' ' VAL . 1.8 mtpp -109.93 62.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.332 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.429 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . 14.4 t80 -47.26 111.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.487 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.47 ' CD2' ' CB ' ' A' ' 109' ' ' LEU . 3.5 mp -55.22 -44.08 75.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.67 -157.96 22.82 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.461 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 25.9 p -116.68 156.08 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.5 m -152.28 135.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.022 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 139.36 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 11.0 m -142.02 169.49 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.68 -24.15 27.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -133.93 126.18 29.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.869 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.28 21.52 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.831 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.54 130.89 4.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.01 136.74 5.29 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.753 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 178.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 71.39 -61.63 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 110.355 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 105' ' ' ALA . 86.0 t -52.28 -44.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.292 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.9 p -63.26 -39.18 93.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.216 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -60.69 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.141 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 19.9 pt-20 -64.52 -38.54 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.052 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB2' ' CB ' ' A' ' 174' ' ' CYS . . . -53.39 -24.77 13.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.088 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -45.24 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.17 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 5.5 pttt -57.12 -34.15 68.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.453 ' N ' ' HG3' ' A' ' 107' ' ' LYS . 41.1 t -59.98 -37.64 73.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.03 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.47 ' CB ' ' CD2' ' A' ' 88' ' ' LEU . 4.6 mm? -54.91 -25.99 32.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.938 0.399 . . . . 0.0 110.001 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.88 -51.56 4.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -49.5 -26.36 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.518 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.41 -163.36 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.729 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.38 26.22 6.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.286 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.433 ' CB ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -78.18 81.46 4.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.735 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.415 ' HG3' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -73.48 130.13 84.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.247 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.415 ' HD2' ' HG3' ' A' ' 115' ' ' ARG . 77.4 Cg_exo -50.96 169.94 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.224 1.949 . . . . 0.0 111.937 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 117' ' ' VAL . 9.8 p -132.95 114.48 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.414 . . . . 0.0 111.612 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -74.59 78.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.996 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 131' ' ' VAL . . . -132.55 -158.52 8.93 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.332 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mt -116.91 131.98 56.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.362 . . . . 0.0 111.065 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.437 ' HG ' ' CG2' ' A' ' 123' ' ' VAL . 49.5 tp -91.42 102.54 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.446 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -74.53 83.59 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.597 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.437 ' CG2' ' HG ' ' A' ' 121' ' ' LEU . 84.1 t -89.25 115.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.47 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.9 33.38 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 45.52 45.13 11.91 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.563 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 144' ' ' ILE . 2.0 t0 -168.15 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -157.84 115.16 0.65 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.05 78.39 7.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.821 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -85.03 107.8 17.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.7 108.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 110.967 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.407 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 21.8 t -94.65 134.03 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.997 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -80.37 131.27 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.435 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 28.8 t0 -79.62 3.4 19.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.05 -24.74 14.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.75 0.309 . . . . 0.0 110.936 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 53.7 p -151.33 19.29 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.337 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 44.58 28.54 0.33 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.985 0.421 . . . . 0.0 111.307 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.55 138.21 16.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.314 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.447 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 5.0 tp -86.7 124.28 32.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 117' ' ' VAL . 8.6 mt -95.37 -54.74 6.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.562 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.61 83.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 111.461 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.447 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 7.2 t0 -93.85 73.86 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.192 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -141.89 137.07 31.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.279 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.44 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 23.9 m -60.52 135.28 57.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.443 ' CG1' ' CE1' ' A' ' 195' ' ' PHE . 19.3 tt -59.48 -34.19 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.696 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' CG ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -73.81 -22.75 59.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.249 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.09 26.55 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.193 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 143' ' ' THR . 0.2 OUTLIER -121.82 176.9 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.607 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 t -90.09 17.36 7.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.434 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 73.83 -167.45 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.988 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 25.0 p -123.51 176.3 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -171.42 103.6 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 C--N 1.345 0.385 0 C-N-CA 122.4 2.066 . . . . 0.0 112.466 -179.174 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -81.21 114.73 3.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.109 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 188' ' ' SER . 8.9 m-85 -120.42 166.44 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.87 112.77 0.48 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 111.35 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.494 ' CE2' ' CD2' ' A' ' 177' ' ' PHE . 2.5 m-30 -88.58 -178.68 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.572 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.43 ' O ' ' CG1' ' A' ' 147' ' ' VAL . 0.4 OUTLIER -158.39 145.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.785 0.326 . . . . 0.0 111.324 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 17.0 p -135.09 148.59 49.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.565 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -106.85 83.17 1.8 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.587 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 43.91 -173.61 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.518 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.94 -55.95 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.962 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.64 25.52 3.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.451 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -76.33 0.36 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.97 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.45 -78.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -133.68 -153.67 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.944 179.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.422 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 15.5 m95 -60.23 83.9 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.897 0.379 . . . . 0.0 109.992 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.6 OUTLIER -90.75 120.66 31.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.355 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 105' ' ' ALA . 1.3 m -92.39 159.25 15.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.932 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.426 ' ND1' ' OH ' ' A' ' 87' ' ' TYR . 19.5 m-70 -136.62 119.44 16.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.834 0.349 . . . . 0.0 111.309 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -92.8 110.89 3.99 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.951 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 162' ' ' TYR . 2.3 m-85 -108.42 119.51 39.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.116 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.7 108.28 16.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.99 141.01 18.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.314 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 31.5 t -63.37 -53.48 51.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.41 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.39 -22.12 63.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.748 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.65 71.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.974 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 p -166.53 27.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.792 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.72 26.67 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.925 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.68 54.33 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.462 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 3.1 tpt180 -175.72 -37.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' CD2' ' HB ' ' A' ' 85' ' ' VAL . 8.6 mp -120.52 -39.78 2.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.908 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 45.7 t -52.9 -55.72 21.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -31.64 58.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.771 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -66.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.8 t -56.0 -54.63 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.36 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.39 31.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.478 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 4.7 t -67.98 -27.48 66.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.488 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.49 -41.49 69.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.443 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 96.2 m-85 -63.37 -21.89 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.852 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -47.77 -28.3 2.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.27 -31.54 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.575 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -56.72 -41.36 77.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.137 178.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.1 -34.91 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 200' ' ' GLU . 30.1 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.779 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.43 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.796 0.331 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -176.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.361 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 mp -46.19 -26.1 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.073 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.04 -85.61 0.02 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.918 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.43 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 32.0 Cg_exo . . . . . 0 N--CA 1.462 -0.341 0 C-N-CA 122.544 2.163 . . . . 0.0 110.112 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 m0 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.938 0.399 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 6.9 pt20 -49.64 -35.42 21.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.979 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -76.7 -67.88 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.368 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -46.96 -45.36 20.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.307 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -49.45 -37.2 24.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.822 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -86.54 -35.4 19.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.757 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.54 -59.67 4.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -52.31 -36.82 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -48.07 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.422 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.06 17.65 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 54.72 92.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.662 0.268 . . . . 0.0 111.313 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t 174.43 46.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.29 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -121.01 152.27 38.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 1.8 m -157.7 144.48 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.922 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.532 ' CE1' ' CB ' ' A' ' 121' ' ' LEU . 3.5 p90 -146.83 172.14 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 111.247 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.405 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -84.08 154.49 23.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.438 ' CG2' ' CD2' ' A' ' 187' ' ' LEU . 11.4 p -174.2 160.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.738 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' N ' HG23 ' A' ' 85' ' ' VAL . 4.1 mmtt -117.24 75.65 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 177' ' ' PHE . 0.6 OUTLIER -56.69 115.56 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.402 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 177' ' ' PHE . 7.7 mp -64.91 -37.54 87.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.58 -129.07 3.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.532 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.7 p -171.02 124.12 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.61 129.68 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.365 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.429 ' N ' ' HE3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -57.47 155.55 9.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 19.5 m -150.6 177.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.195 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -94.68 -11.17 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.44 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.82 136.25 46.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.823 0.344 . . . . 0.0 110.921 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.3 p -101.32 23.02 11.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.767 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.54 -167.97 2.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.02 109.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -28.38 8.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.42 -45.5 94.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.7 t -51.41 -32.56 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -42.9 59.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.761 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -45.35 74.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.43 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -75.96 -38.07 57.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.83 -45.04 74.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.472 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp -56.8 -42.42 79.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.3 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -42.47 95.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.344 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.429 ' HA ' ' CG ' ' A' ' 111' ' ' GLN . 2.4 t -66.26 -40.55 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.011 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -52.08 -23.19 4.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.25 -50.23 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.536 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.429 ' CG ' ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.68 -22.48 66.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.553 -178.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.65 165.8 14.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.31 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -21.5 13.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -41.75 114.97 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.48 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 139.33 20.01 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 34.1 Cg_exo -58.39 154.04 43.78 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.627 2.218 . . . . 0.0 112.789 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 139' ' ' ILE . 3.4 p -110.97 170.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -137.82 88.29 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.538 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.71 -150.94 5.53 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.739 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 84' ' ' SER . 10.6 mt -123.04 151.22 42.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.487 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.532 ' CB ' ' CE1' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -99.04 106.88 19.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.478 ' CD2' HG22 ' A' ' 131' ' ' VAL . 41.7 m-70 -71.57 63.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.49 ' CG2' ' CE2' ' A' ' 83' ' ' PHE . 70.9 t -66.96 107.45 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.7 m -131.69 31.83 4.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 48.0 29.09 6.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.565 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -140.97 -43.25 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -159.39 122.18 1.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.977 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.466 HD22 ' CE2' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.04 82.98 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.76 0.314 . . . . 0.0 110.558 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.0 mtt85 -95.73 81.71 3.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.313 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.404 HG22 ' CD1' ' A' ' 87' ' ' TYR . 2.0 p -73.55 88.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.21 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.478 HG22 ' CD2' ' A' ' 122' ' ' HIS . 72.8 t -76.5 156.26 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.093 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -100.42 122.54 43.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.22 0.33 22.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.72 -32.21 8.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.5 p -119.82 -36.52 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.964 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.9 OUTLIER 67.02 44.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -109.83 16.65 30.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.095 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 137' ' ' GLY . 6.9 tp 46.23 107.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.361 0.601 . . . . 0.0 111.673 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.447 ' CD1' HG13 ' A' ' 117' ' ' VAL . 32.4 mt -72.94 -61.62 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.908 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.2 t -104.58 97.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -98.92 71.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.18 172.67 12.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.1 m -92.37 147.91 22.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.629 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.429 ' CD1' HD12 ' A' ' 128' ' ' LEU . 19.4 tt -81.12 -19.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.786 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -84.88 -36.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.212 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -43.17 14.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 144' ' ' ILE . 10.4 p -46.03 164.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.314 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -70.85 -2.54 15.3 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.0 m-85 84.22 166.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.887 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.494 ' CB ' ' CD1' ' A' ' 162' ' ' TYR . 29.0 p -87.43 -173.02 4.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.613 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 173.74 101.53 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.444 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 C--N 1.346 0.444 0 C-N-CA 122.594 2.196 . . . . 0.0 112.934 -178.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.41 ' CD ' ' OD2' ' A' ' 182' ' ' ASP . 7.2 ptt180 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.809 0.337 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 160' ' ' PHE . . . -104.69 127.55 9.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.644 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 6.1 m-85 -139.06 177.64 7.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 p -175.3 125.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.494 ' CD1' ' CB ' ' A' ' 150' ' ' CYS . 4.9 m-30 -98.1 -171.75 2.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -156.97 155.18 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 22.9 p -146.12 143.22 29.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.952 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 79.34 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.061 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 168' ' ' THR . 37.9 t0 59.36 -88.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.761 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.98 -83.11 0.01 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.431 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 166' ' ' ASP . 1.8 m -139.72 22.34 2.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 92.8 m -111.36 -82.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -158.03 -70.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.683 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -150.05 -155.51 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.977 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.524 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -65.46 76.23 0.06 Allowed 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.429 ' HE3' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -92.41 121.14 33.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.081 -177.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.16 142.54 28.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -114.49 118.7 34.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.998 0.428 . . . . 0.0 111.161 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -115.45 151.88 18.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.833 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 0.4 OUTLIER -178.62 176.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 111.956 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.28 139.82 35.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.153 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.434 ' HA ' ' CD2' ' A' ' 187' ' ' LEU . . . -64.25 138.71 58.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 0.0 111.615 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -76.81 -27.78 55.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.656 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.41 ' OD2' ' CD ' ' A' ' 158' ' ' ARG . 1.4 t70 60.31 36.92 20.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.464 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.4 p -151.56 19.09 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.674 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.88 26.53 1.19 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.263 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.76 24.14 13.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -179.34 37.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.086 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.497 ' HG ' ' CD1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -167.52 -52.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.469 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.9 t -73.75 -66.64 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -52.41 -36.81 55.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.478 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.424 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -63.49 -71.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.954 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.9 t -50.37 -48.86 25.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.994 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.03 -27.26 21.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.885 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 60.8 m -87.24 -28.32 22.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.94 0.4 . . . . 0.0 110.52 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.44 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -51.31 -51.31 55.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.461 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -55.06 -23.95 22.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.256 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 193' ' ' CYS . . . -46.53 -49.88 18.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.856 0.36 . . . . 0.0 111.202 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.75 -38.93 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 30.4 t -65.15 -30.78 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.201 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.32 57.4 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.296 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.402 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.432 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.35 -87.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.44 HD11 HG22 ' B' ' 3' ' ' ILE . 28.7 mm -116.01 -51.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.867 0.365 . . . . 0.0 111.094 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . 0.427 ' HA2' ' CB ' ' A' ' 149' ' ' PHE . . . -50.98 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.361 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.432 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 32.3 Cg_exo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.5 m0 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.838 0.351 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -49.59 -33.48 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.004 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.33 -70.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.67 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -47.39 -32.04 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.489 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -65.21 -25.66 67.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 110.959 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 13.4 mt-10 -102.28 -35.91 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.91 -55.44 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.7 m -55.14 -38.51 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -34.8 73.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -88.66 -12.13 43.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.198 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 75.28 73.16 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.841 0.353 . . . . 0.0 111.149 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -179.24 50.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.43 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 0.0 OUTLIER -112.84 -179.35 3.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB3' ' ND1' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -174.15 122.69 0.3 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.503 0.668 . . . . 0.0 111.096 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.5 ' CZ ' ' HA ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -127.77 130.15 48.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.511 -177.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -60.68 160.41 9.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 121' ' ' LEU . 7.5 p -177.77 159.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 111.923 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.424 ' N ' HG23 ' A' ' 85' ' ' VAL . 10.7 mttt -107.91 62.48 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.211 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.443 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . 31.6 t80 -55.6 119.86 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.472 -178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.83 -43.04 98.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.041 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 136.17 -159.02 24.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.975 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -115.51 145.8 42.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.023 0.44 . . . . 0.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.426 ' O ' ' CE ' ' A' ' 173' ' ' MET . 0.5 OUTLIER -137.27 174.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.401 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -101.16 146.7 27.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.305 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 4.5 m -144.55 163.85 13.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.027 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -84.79 -3.95 58.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.899 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -153.29 126.71 8.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.847 0.356 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 p -95.72 27.08 3.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.604 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -151.03 149.46 29.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.0 -147.06 18.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.96 -46.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -26.93 15.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.14 -36.73 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.782 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 53.7 m -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -39.23 87.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.53 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -82.4 -34.09 28.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.29 13.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.678 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -43.35 44.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.22 77.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.29 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.54 -43.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.917 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.418 ' CD1' ' HG3' ' A' ' 114' ' ' ARG . 3.1 mm? -53.14 -22.36 6.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -47.0 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.389 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -9.1 58.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.014 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.23 172.35 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.198 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.37 6.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.666 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.418 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 2.4 mmt180 -43.18 113.38 0.48 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.431 ' CG ' ' HD2' ' A' ' 116' ' ' PRO . 60.8 ttt180 -118.66 144.97 36.53 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.321 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 115' ' ' ARG . 75.3 Cg_exo -50.34 155.39 4.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.813 2.342 . . . . 0.0 112.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 10.7 p -126.39 109.55 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.252 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 133' ' ' ASP . 2.6 ttt180 -69.33 70.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.124 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.94 -165.26 11.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.232 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 122' ' ' HIS . 1.9 tm? -120.75 119.23 32.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 3.6 tp -77.38 83.7 3.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.075 0.464 . . . . 0.0 110.15 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.425 ' ND1' ' HB3' ' A' ' 82' ' ' SER . 0.3 OUTLIER -66.03 82.61 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.827 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 1.8 m -70.78 178.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 p -178.01 31.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.86 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 194' ' ' ALA . . . 40.93 32.55 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.722 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.442 ' CA ' HG23 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -172.12 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.553 0.216 . . . . 0.0 111.398 -178.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -153.75 117.12 0.78 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.879 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.13 130.02 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.748 0.309 . . . . 0.0 110.569 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.01 90.67 2.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.72 102.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.0 t -91.96 135.91 25.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -78.36 137.59 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 118' ' ' ARG . 11.3 t0 -87.83 16.12 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -117.43 -35.0 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 43.3 p -119.26 -15.88 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.649 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.92 36.07 7.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.91 -164.79 24.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.873 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -122.5 132.01 54.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.12 -23.52 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.77 60.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.195 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.417 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 20.3 p-10 -67.74 73.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.484 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -145.13 151.37 38.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 111.407 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.429 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 0.2 OUTLIER -60.62 179.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.746 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.442 HG23 ' CA ' ' A' ' 126' ' ' ASP . 16.4 tt -108.07 -23.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -86.89 -24.18 24.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.879 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -94.76 21.33 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 164' ' ' CYS . 0.0 OUTLIER -115.12 178.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.419 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -87.23 13.96 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 76.79 -177.61 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.771 0.319 . . . . 0.0 111.045 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 3.9 m -111.33 163.17 14.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 111.281 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -174.75 98.45 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.866 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.182 -179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.429 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.84 0.353 . . . . 0.0 110.961 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.05 110.71 2.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.593 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 5.9 m-85 -91.82 170.28 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -164.18 107.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 150' ' ' CYS . 4.0 m-30 -88.94 -179.5 5.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.325 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -159.32 148.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.44 ' CB ' HG11 ' A' ' 147' ' ' VAL . 19.6 p -139.21 157.84 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.752 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 87.32 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.885 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' THR . 3.1 p-10 47.62 26.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.169 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.72 80.04 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.417 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 166' ' ' ASP . 17.1 p 55.0 25.7 7.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.678 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -119.22 -78.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -158.79 -81.66 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 111.112 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -143.42 -148.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.891 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.493 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -66.76 74.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.426 ' CE ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.29 118.1 27.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.352 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.42 168.08 17.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.091 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.419 ' ND1' ' OH ' ' A' ' 87' ' ' TYR . 31.3 m-70 -140.58 90.54 2.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.783 0.325 . . . . 0.0 111.407 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -69.46 107.01 1.96 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -104.99 138.67 40.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.37 108.4 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.388 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -44.88 145.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.713 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.02 -59.7 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -68.31 -27.44 66.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.17 82.43 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.172 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.429 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 8.3 t -168.6 29.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.06 27.89 1.17 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.898 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.0 49.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.0 110.79 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 83' ' ' PHE . 25.3 mmt180 -149.84 -46.5 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.486 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.485 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . 2.6 mp -119.66 -36.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.122 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -58.42 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -18.46 47.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.543 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 193' ' ' CYS . . . -87.83 -74.25 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.272 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.413 HG11 ' N ' ' A' ' 192' ' ' GLY . 3.4 p -52.09 -29.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.117 0.484 . . . . 0.0 110.119 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.413 ' N ' HG11 ' A' ' 191' ' ' VAL . . . -74.13 -30.45 60.98 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -71.0 -32.04 68.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.139 0.495 . . . . 0.0 109.667 177.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.429 ' CB ' ' HA2' ' A' ' 125' ' ' GLY . . . -50.95 -33.6 25.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.564 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.418 ' O ' ' CD1' ' A' ' 199' ' ' LEU . 17.6 m-85 -61.45 -24.88 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.731 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.02 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.292 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.63 -34.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 31.9 t -52.16 -28.33 17.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.656 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' B' ' 3' ' ' ILE . 0.6 OUTLIER -121.43 -38.41 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.043 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.643 0.259 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 178.43 -92.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.069 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.422 ' CG2' HD22 ' A' ' 199' ' ' LEU . 5.1 mm -135.39 64.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.115 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.46 -78.63 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.457 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.531 2.154 . . . . 0.0 112.139 179.626 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.425 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 1.2 m0 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.011 0.434 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -24.13 65.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.965 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.66 -46.97 6.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.02 -46.04 65.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.08 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 69' ' ' TRP . 5.3 tt0 -50.57 -41.8 54.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.39 -23.23 35.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.57 -53.04 57.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.874 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' CG2' ' HB1' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -58.41 -43.64 87.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.266 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -53.42 -45.5 69.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.468 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 17.0 12.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.101 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 56.56 85.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.646 0.26 . . . . 0.0 111.303 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t 174.24 51.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.81 166.7 12.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.763 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 2.0 m -166.48 160.21 15.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.048 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.469 ' CG ' ' O ' ' A' ' 82' ' ' SER . 21.2 m-85 -167.99 141.35 3.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.428 ' N ' HD11 ' A' ' 120' ' ' LEU . 8.2 t -59.37 158.74 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 187' ' ' LEU . 14.9 p -175.47 160.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 111.952 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' N ' HG23 ' A' ' 85' ' ' VAL . 8.5 mttt -114.56 57.97 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.703 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 26.7 t80 -47.67 134.38 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 7.4 mp -79.21 -58.08 3.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.906 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.465 ' HA2' ' CE2' ' A' ' 87' ' ' TYR . . . 151.06 -155.34 26.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.543 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 20.0 p -121.26 144.03 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 m -134.78 142.59 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.1 124.63 24.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 15.4 m -127.25 176.92 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.985 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.22 2.9 53.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.886 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -153.85 164.97 37.49 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.974 0.416 . . . . 0.0 111.073 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 83.7 p -132.95 23.93 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.669 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.78 168.63 19.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.15 154.38 24.21 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -24.09 24.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.03 -42.5 97.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.044 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.73 -30.5 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -70.81 -58.08 3.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.037 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -48.27 -37.57 16.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 105' ' ' ALA . 12.3 pt-20 -83.86 -42.17 16.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.817 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.402 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -50.4 -48.76 55.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.82 -51.47 63.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -51.11 -42.45 60.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.468 178.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.424 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.2 t -66.27 -35.67 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.119 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.421 HD13 ' CA ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER -53.76 -39.57 65.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -52.6 8.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.04 -36.33 28.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.045 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.04 -167.0 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 31.15 3.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.471 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -90.56 79.41 6.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.631 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -58.35 128.35 82.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.16 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 33.4 Cg_exo -61.53 159.44 32.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.448 2.098 . . . . 0.0 112.435 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -104.88 -178.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -149.54 70.64 1.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.581 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -139.8 -130.09 2.66 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.721 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 84' ' ' SER . 1.4 tp -136.77 139.44 41.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.936 0.398 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.1 tp -92.93 124.66 37.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.392 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -85.24 103.35 14.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.431 ' CG1' ' HB1' ' A' ' 194' ' ' ALA . 96.1 t -109.48 105.97 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -128.73 39.76 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 39.35 48.36 2.87 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.216 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.433 ' N ' HG23 ' A' ' 144' ' ' ILE . 4.4 t70 -160.62 -41.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.79 117.8 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.546 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -65.6 133.78 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 0.0 110.97 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.5 mtm-85 -139.42 87.79 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.593 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 139' ' ' ILE . 7.4 p -77.62 140.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.581 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.2 t -135.26 152.7 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.478 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.5 t0 -95.82 149.49 21.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.781 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 5.8 t70 -91.77 19.96 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.351 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -127.27 -40.9 1.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 110.752 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 p -114.06 -19.59 11.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.125 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp 59.3 22.34 10.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 110.784 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.38 120.21 5.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.423 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.448 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 2.0 tp -55.75 133.52 50.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.68 0.276 . . . . 0.0 110.608 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' A' ' 130' ' ' VAL . 6.0 mt -108.12 -43.25 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.08 86.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.529 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.448 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 26.8 t0 -98.09 69.44 2.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.758 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -124.54 179.12 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.82 171.67 8.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.649 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.487 ' CG1' ' CE1' ' A' ' 195' ' ' PHE . 10.1 tt -107.64 -16.7 8.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.404 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.94 -38.32 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 111.022 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -81.15 -24.79 37.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 163' ' ' ILE . 11.6 p -70.64 164.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.651 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 3.1 m -72.91 -2.19 19.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.8 m-85 80.58 -167.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.1 p -129.8 -171.62 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.961 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.446 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . -164.07 58.31 0.66 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.425 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 50.1 Cg_exo . . . . . 0 C--N 1.344 0.291 0 C-N-CA 122.361 2.041 . . . . 0.0 111.807 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 120.909 0.385 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.83 147.6 17.19 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.541 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 152' ' ' PRO . 1.5 m-85 -131.06 151.07 51.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.04 125.91 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.881 0.372 . . . . 0.0 111.689 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 150' ' ' CYS . 4.4 m-30 -94.94 -172.48 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.198 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 1.0 OUTLIER -165.87 159.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.964 0.411 . . . . 0.0 111.379 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.0 p -157.56 157.66 34.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.494 ' HG3' ' CZ3' ' A' ' 172' ' ' TRP . 0.1 OUTLIER -116.03 85.09 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.3 p30 46.48 -163.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.76 -42.77 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.218 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.4 p -153.32 24.92 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.948 0.404 . . . . 0.0 110.734 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.68 -72.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.034 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.81 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.759 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' MET . 6.2 ptt180 -131.05 -152.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.149 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.494 ' CZ3' ' HG3' ' A' ' 165' ' ' ARG . 4.4 m95 -60.87 82.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -90.18 112.68 24.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.81 -177.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.29 171.41 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.974 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -146.3 118.83 8.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.92 0.391 . . . . 0.0 111.561 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 87' ' ' TYR . . . -92.32 124.19 7.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.74 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 4.7 m-85 -122.89 136.33 54.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.391 . . . . 0.0 111.327 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.79 108.59 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.438 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.469 ' HB1' ' CE2' ' A' ' 160' ' ' PHE . . . -50.1 134.38 22.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 111.177 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -60.38 3.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.79 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -57.6 -33.81 68.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.649 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.2 80.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.02 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.37 30.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.58 37.56 0.15 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 113.879 0.312 . . . . 0.0 113.879 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -147.58 49.4 1.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.019 0.438 . . . . 0.0 111.496 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.08 -42.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.0 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD2' ' HB ' ' A' ' 85' ' ' VAL . 5.7 mp -111.47 -44.47 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.4 p -53.9 -60.2 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -71.03 -28.1 64.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -71.94 -68.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.865 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 t -60.6 -41.37 87.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.28 -39.85 36.37 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.782 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.13 -27.76 57.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.061 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.431 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -60.58 -41.96 95.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.487 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 42.4 m-85 -59.99 -35.51 75.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -51.45 -27.06 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.6 t -71.77 -31.6 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 38.9 t -48.25 -52.74 19.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.442 ' N ' HD21 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.43 -33.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 196' ' ' ALA . 5.2 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.674 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.402 ' CB ' ' HD2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.736 0.303 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 179.77 74.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' B' ' 3' ' ' ILE . 4.8 mp 47.54 45.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . 0.43 ' CA ' ' C ' ' B' ' 5' ' ' PRO . . . 127.44 87.65 0.59 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.442 ' CD ' ' HA ' ' A' ' 151' ' ' ALA . 41.3 Cg_exo . . . . . 0 N--CA 1.482 0.801 0 CA-C-N 118.699 1.249 . . . . 0.0 114.922 6.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 . . . . . 0 CA--C 1.518 -0.255 0 CA-C-O 121.378 0.608 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -13.68 40.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.232 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.79 -27.32 6.26 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 4.7 p30 -90.34 -25.92 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.662 0.267 . . . . 0.0 111.504 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 49.4 mt-10 -61.31 -27.0 68.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.976 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.04 -24.64 13.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' THR . . . -46.29 -37.6 7.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 40.0 t -63.67 -50.47 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HA ' ' CG2' ' A' ' 197' ' ' VAL . 3.8 mtp180 -49.86 -48.63 51.12 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.107 0.479 . . . . 0.0 110.577 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.91 14.33 10.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.246 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 50.42 81.04 0.07 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.65 0.262 . . . . 0.0 111.116 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.8 t -171.96 29.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.586 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.435 ' CB ' HG21 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -97.59 157.87 15.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -171.43 144.81 2.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.467 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 54.1 m-85 -154.73 146.04 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.507 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.431 ' N ' HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -58.11 162.88 3.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.523 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.44 HG12 ' CD2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -159.63 172.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.208 0.528 . . . . 0.0 111.727 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -125.42 42.4 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.965 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.472 ' CD1' HG23 ' A' ' 130' ' ' VAL . 0.3 OUTLIER -38.98 122.33 1.18 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.388 -178.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 8.9 mp -67.59 -44.52 77.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.214 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.439 ' N ' HD13 ' A' ' 109' ' ' LEU . . . 145.37 -135.09 5.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.442 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 25.3 p -139.65 148.75 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.865 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.5 m -139.15 127.78 28.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.51 128.01 35.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.069 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 32.9 m -126.15 -174.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.687 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.93 24.93 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' CE3' ' A' ' 172' ' ' TRP . 28.5 mp0 -141.96 -81.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.172 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m 60.36 22.73 12.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.783 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 24.89 2.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -166.42 10.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.64 -39.35 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -59.54 -47.56 85.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.966 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.429 ' O ' ' CB ' ' A' ' 105' ' ' ALA . 62.0 t -49.65 -26.67 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.07 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.6 m -66.88 -44.23 81.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.84 -53.81 43.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 2.0 pt-20 -76.81 -36.93 56.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.776 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 101' ' ' VAL . . . -48.9 -25.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tt -81.8 -43.54 18.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.07 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 108' ' ' VAL . 6.8 pttt -60.76 -35.18 75.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.321 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.438 ' N ' ' HG3' ' A' ' 107' ' ' LYS . 21.2 t -68.16 -35.69 72.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.583 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.443 HD11 ' CB ' ' A' ' 114' ' ' ARG . 0.9 OUTLIER -54.37 -27.82 38.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -47.39 6.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.079 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -23.48 5.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.795 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.73 177.95 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -12.7 58.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.303 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.443 ' CB ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -43.23 108.91 0.12 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 0.0 111.537 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.2 ptt180 -98.92 144.76 28.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.8 160.37 12.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.461 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 132' ' ' ASP . 1.6 p -115.92 176.18 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.69 79.88 1.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.12 5.35 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.008 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 84' ' ' SER . 3.4 mt -121.1 131.19 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.475 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.432 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -88.04 104.89 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -72.09 69.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.261 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 194' ' ' ALA . 93.9 t -77.84 97.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.371 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 24.9 p -119.62 42.62 2.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.439 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 42.99 41.91 4.83 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.708 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.433 ' CA ' HG23 ' A' ' 144' ' ' ILE . 9.8 t0 -163.39 -43.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.613 0.244 . . . . 0.0 111.286 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -148.14 127.56 2.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.283 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -87.03 71.41 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.667 0.27 . . . . 0.0 110.886 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.48 89.84 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.8 0.334 . . . . 0.0 111.176 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 87' ' ' TYR . 5.8 p -85.93 90.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.952 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.2 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.93 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.436 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -99.62 147.68 25.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -100.66 14.41 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.676 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.89 -43.77 3.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 58.7 p -111.31 -19.96 12.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 38.45 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.049 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.41 139.99 15.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.103 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.434 HD22 ' CB ' ' A' ' 141' ' ' ASP . 2.6 tp -73.39 110.81 7.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.984 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.2 mt -68.38 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.31 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.28 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.075 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.434 ' CB ' HD22 ' A' ' 138' ' ' LEU . 26.6 t70 -93.89 73.25 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.497 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.2 170.37 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 126' ' ' ASP . 87.9 m -103.64 141.8 35.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.545 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 195' ' ' PHE . 13.0 tt -70.66 -27.09 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.014 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -30.92 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.772 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -91.42 -41.7 10.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.943 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.45 ' CG1' ' HA ' ' A' ' 144' ' ' ILE . 14.3 p -47.4 161.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.074 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.486 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 1.4 m -52.7 -50.95 62.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.518 ' CE1' ' CD1' ' A' ' 163' ' ' ILE . 3.0 p90 150.75 -176.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.673 0.789 . . . . 0.0 109.971 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.469 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 15.9 p -114.91 151.48 33.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.425 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -177.05 102.09 0.23 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.129 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 45.5 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.332 2.022 . . . . 0.0 111.963 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.409 ' CD ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.73 0.3 . . . . 0.0 111.232 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -110.81 154.14 16.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.594 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 188' ' ' SER . 0.3 OUTLIER -139.29 -175.46 4.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.75 0.309 . . . . 0.0 110.728 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.6 t -177.31 136.02 0.2 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.878 0.37 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.57 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 60.5 m-85 -105.06 -171.49 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.365 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.518 ' CD1' ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -165.31 142.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 111.474 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 20.0 p -132.98 142.58 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.466 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -108.51 83.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.429 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 170' ' ' ARG . 2.9 p30 45.45 -162.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.415 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.52 -64.06 4.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.664 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -44.35 5.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.353 . . . . 0.0 111.127 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 79.9 m -86.18 -88.29 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.91 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 166' ' ' ASP . 18.2 mmm180 -154.81 -81.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 110.372 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 172' ' ' TRP . 3.3 ptp180 -127.59 -152.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.492 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.452 ' CE3' ' O ' ' A' ' 95' ' ' GLU . 19.5 m95 -67.3 71.53 0.11 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -88.39 119.01 28.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 15.2 m -89.19 157.9 18.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.333 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -135.62 99.11 4.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.649 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -94.28 134.1 11.89 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.92 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.5 p90 -154.93 148.74 25.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 111.482 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.2 tp -118.52 132.7 56.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.396 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -49.29 140.43 9.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -61.35 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.685 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -68.21 -32.84 73.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.409 ' OD1' ' CD ' ' A' ' 158' ' ' ARG . 10.6 t70 67.24 73.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.062 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.4 23.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.624 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 41.15 30.87 0.47 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.42 ' O ' ' NE ' ' A' ' 186' ' ' ARG . 2.0 mt-10 -136.92 41.43 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.669 0.271 . . . . 0.0 111.191 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.467 ' HD3' ' CE1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -154.64 -45.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.911 0.386 . . . . 0.0 110.768 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.44 ' CD2' HG12 ' A' ' 85' ' ' VAL . 9.3 mp -113.54 -43.91 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.836 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.484 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 20.4 t -56.7 -61.16 2.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -67.3 -21.01 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.259 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.68 -60.92 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.176 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.74 -31.78 55.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.799 0.333 . . . . 0.0 110.553 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.21 -26.01 12.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.56 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 44.5 t -99.08 -23.02 15.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.439 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.453 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . . . -50.07 -28.33 6.97 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.499 ' CZ ' ' CG1' ' A' ' 144' ' ' ILE . 53.4 m-85 -84.87 -22.07 29.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -60.61 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.774 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.421 ' CG2' ' HA ' ' A' ' 77' ' ' ARG . 79.8 t -55.49 -39.09 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 34.9 t -57.61 -48.71 78.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.93 56.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.167 0.508 . . . . 0.0 110.754 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 29.3 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.709 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.819 0.342 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -134.48 -78.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 mm -134.91 -42.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.21 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.03 -77.78 0.11 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.643 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo . . . . . 0 C--N 1.345 0.352 0 C-N-CA 122.683 2.256 . . . . 0.0 112.213 179.909 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.967 0.413 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.14 -21.83 65.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.28 -62.84 1.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.408 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.9 p30 -53.14 -29.52 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.007 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.0 mm-40 -69.19 -36.0 76.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 0.0 110.522 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.8 -23.87 25.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.681 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.22 -57.37 13.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 1.2 t -50.59 -48.11 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.255 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -42.84 62.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.519 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.0 p -94.49 18.92 10.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.079 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.02 82.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -179.4 49.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.145 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.0 173.24 6.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.05 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 29.4 p 176.84 151.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CG ' ' O ' ' A' ' 82' ' ' SER . 53.3 m-85 -160.51 138.25 9.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.784 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.428 ' N ' HD22 ' A' ' 120' ' ' LEU . 20.8 t -49.23 167.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.692 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 187' ' ' LEU . 8.5 p -174.48 162.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 111.993 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 12.5 mtmm -111.96 56.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.617 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.522 ' CD1' ' CB ' ' A' ' 177' ' ' PHE . 0.4 OUTLIER -47.7 176.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.433 ' CD2' ' HG3' ' A' ' 116' ' ' PRO . 11.0 mt -137.48 -42.4 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.151 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.68 -144.67 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.485 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.5 m -136.58 155.93 49.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.61 128.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.873 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.67 124.28 20.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.852 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 28.7 m -126.59 164.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -93.56 17.78 11.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.193 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -159.0 114.38 2.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.05 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -93.62 21.35 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -151.84 130.9 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.63 130.34 3.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.457 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -32.81 74.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.751 0.31 . . . . 0.0 111.066 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -43.83 91.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.98 -28.48 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.4 m -69.08 -48.02 63.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.013 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -52.41 -59.01 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -62.56 -30.78 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.96 -57.42 10.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.02 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.52 -44.44 56.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.528 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.79 -39.75 71.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.399 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 15.0 t -64.24 -42.97 97.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.437 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.33 -22.42 4.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.228 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 -54.18 3.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.355 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -61.16 -30.98 70.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.486 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.32 172.39 11.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -22.36 11.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -45.26 102.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 141.36 24.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HG3' ' CD2' ' A' ' 88' ' ' LEU . 36.2 Cg_exo -59.82 152.25 65.11 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.481 2.12 . . . . 0.0 112.441 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.45 ' CG1' ' CB ' ' A' ' 87' ' ' TYR . 3.1 p -114.23 177.87 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.403 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.19 74.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.454 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -128.57 -144.87 5.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.282 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -122.2 130.5 53.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.678 0.275 . . . . 0.0 111.281 -178.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.439 ' HG ' ' CG2' ' A' ' 123' ' ' VAL . 41.8 tp -84.97 100.01 11.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -73.61 87.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.684 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.439 ' CG2' ' HG ' ' A' ' 121' ' ' LEU . 94.0 t -101.87 112.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.91 42.73 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 47.19 25.0 2.48 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.718 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.4 ' CA ' HG23 ' A' ' 144' ' ' ILE . 2.6 m-20 -174.38 27.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 156.43 121.92 0.72 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.14 -1.029 . . . . 0.0 113.468 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.485 HD12 ' CE1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -106.85 110.18 22.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 110.419 178.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -124.48 106.29 10.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 139' ' ' ILE . 10.2 p -86.98 112.45 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -116.31 120.24 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -54.58 146.65 15.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -94.14 20.67 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -126.06 -42.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.66 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 39.8 p -110.45 -24.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.906 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.43 25.27 6.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.38 123.41 6.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.364 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 tp -63.48 118.37 8.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 0.0 111.02 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 130' ' ' VAL . 3.7 mt -92.67 -50.63 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.09 123.08 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -116.94 65.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.169 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.27 165.55 11.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.683 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' A' ' 144' ' ' ILE . 1.9 t -111.28 2.75 17.87 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.484 HG12 ' CZ ' ' A' ' 195' ' ' PHE . 3.1 tt 72.63 -3.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.417 ' HB3' HG22 ' A' ' 143' ' ' THR . 25.9 tt0 -110.86 -37.53 5.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -30.69 27.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.574 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 163' ' ' ILE . 10.7 p -51.46 164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 149' ' ' PHE . 66.1 m -53.01 -53.91 43.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.323 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 148' ' ' SER . 0.1 OUTLIER 155.84 -15.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.862 0.726 . . . . 0.0 112.212 178.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 195' ' ' PHE . 0.5 OUTLIER 90.75 172.2 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.292 0.637 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 150' ' ' CYS . . . 166.55 107.0 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.474 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 46.0 Cg_endo . . . . . 0 C--N 1.345 0.348 0 C-N-CA 122.364 2.043 . . . . 0.0 112.089 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.773 0.321 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -129.54 146.31 17.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.567 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 177' ' ' PHE . 2.0 m-85 -111.63 -176.31 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.702 0.287 . . . . 0.0 110.718 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -168.41 106.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.893 0.378 . . . . 0.0 111.276 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.571 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 42.8 m-85 -85.12 -173.16 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.481 ' CD1' ' CB ' ' A' ' 148' ' ' SER . 0.0 OUTLIER -167.09 132.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 38.5 t -131.42 156.69 45.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.859 0.361 . . . . 0.0 111.033 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -113.99 80.53 1.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.001 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 t0 52.47 -161.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.21 -22.28 40.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.325 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.9 p -161.75 -42.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -75.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.05 -42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.1 ptp85 -166.67 -150.78 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.954 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.525 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 1.0 OUTLIER -66.27 74.42 0.09 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 71.0 mmm -89.19 117.9 28.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.651 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.68 165.05 23.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.713 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -131.89 120.87 23.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 111.29 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -116.3 113.68 2.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.432 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.571 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -143.65 162.2 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.53 131.15 31.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.983 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -47.85 138.94 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.375 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -56.41 11.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.885 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.21 -33.67 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 110.455 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.9 t70 66.17 69.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.28 25.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.901 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.18 37.81 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 113.985 0.354 . . . . 0.0 113.985 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -148.69 23.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.846 0.323 . . . . 0.0 111.585 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.74 21.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.394 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.449 HD21 ' N ' ' A' ' 188' ' ' SER . 0.6 OUTLIER 179.59 -38.92 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.449 ' N ' HD21 ' A' ' 187' ' ' LEU . 70.5 m -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.482 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -55.81 -28.13 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.093 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.0 -49.75 76.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.534 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.429 ' CG1' HD23 ' A' ' 128' ' ' LEU . 2.5 t -73.74 -38.82 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.531 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.09 -40.95 45.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.951 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -79.23 -29.53 42.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.288 178.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.441 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . . . -56.84 -43.02 80.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.519 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 150' ' ' CYS . 6.8 m-85 -58.09 -28.37 64.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.212 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -50.24 -51.14 47.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.013 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 64.7 t -50.78 -37.71 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.867 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.1 t -61.8 -35.97 79.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.449 ' CD2' HG12 ' B' ' 3' ' ' ILE . 1.2 pt? -140.13 64.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 196' ' ' ALA . 1.3 pt-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.469 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -161.34 -96.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 199' ' ' LEU . 4.8 mp -102.71 -47.67 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . 0.447 ' HA2' ' CD1' ' A' ' 149' ' ' PHE . . . -51.09 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 N--CA 1.463 -0.266 0 C-N-CA 122.692 2.262 . . . . 0.0 111.61 178.388 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.1 m0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.867 0.365 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -62.92 -34.8 78.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.633 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.27 -55.84 4.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.129 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -49.42 -49.17 46.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -49.69 -41.58 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -86.21 -23.38 26.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.764 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.439 ' CA ' HG21 ' A' ' 80' ' ' THR . . . -72.7 -66.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 110.709 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -48.27 -37.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.832 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -45.68 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.038 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -90.78 18.57 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.411 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 55.71 96.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.835 0.35 . . . . 0.0 111.103 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.439 HG21 ' CA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -178.8 -30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.92 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -41.12 158.21 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 111.278 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 175.49 145.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.103 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 82' ' ' SER . 89.6 m-85 -160.59 148.01 15.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.42 ' N ' HD11 ' A' ' 120' ' ' LEU . 32.3 t -47.32 166.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 8.8 p -173.9 159.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.979 0.418 . . . . 0.0 111.724 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -121.18 65.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.754 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' A' ' 89' ' ' GLY . 14.6 t80 -56.68 121.13 9.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.269 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.66 -41.21 94.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.474 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 141.9 -178.43 20.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.231 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.41 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 38.1 m -100.86 142.57 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.433 ' O ' ' CE ' ' A' ' 173' ' ' MET . 0.4 OUTLIER -136.51 172.42 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.893 -178.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.431 ' CG ' ' HD2' ' A' ' 171' ' ' ARG . 4.0 tt0 -109.83 148.43 31.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.165 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 12.9 m -148.73 173.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.426 ' O ' ' CD1' ' A' ' 172' ' ' TRP . 22.5 m-85 -87.94 -24.07 23.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 94' ' ' PHE . 4.5 mp0 -133.09 145.36 50.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 111.197 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 25.31 5.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.47 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -136.97 24.15 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.89 128.47 4.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -37.89 74.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -55.12 -34.4 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.86 -30.78 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.884 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 91.8 m -66.39 -43.68 85.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.21 -46.73 79.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.03 -32.14 59.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.984 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 109' ' ' LEU . . . -63.08 -59.79 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.31 -36.18 6.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -40.58 88.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.49 -32.42 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.434 ' CD1' ' HG3' ' A' ' 114' ' ' ARG . 4.0 mm? -60.36 -18.63 51.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.086 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -97.17 -45.31 6.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -64.35 -30.42 71.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.73 171.99 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -21.61 14.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.434 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 4.7 mmt180 -45.43 114.21 0.71 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.6 ptt-85 -124.51 148.15 57.74 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.292 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.1 156.64 2.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.785 2.324 . . . . 0.0 112.632 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 10.6 p -129.08 114.34 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.907 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.97 63.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.681 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -117.65 -139.29 6.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.478 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -144.27 137.79 27.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.985 0.421 . . . . 0.0 111.2 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.481 HD22 ' CE1' ' A' ' 177' ' ' PHE . 0.3 OUTLIER -88.8 104.0 16.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.486 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 129' ' ' ARG . 15.8 m-70 -72.01 117.16 13.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.489 ' CG1' ' CB ' ' A' ' 194' ' ' ALA . 65.8 t -131.65 88.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.428 ' HB3' ' N ' ' A' ' 80' ' ' THR . 5.5 m -119.26 46.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.89 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 35.23 61.37 0.66 Allowed Glycine 0 CA--C 1.521 0.456 0 O-C-N 123.415 0.447 . . . . 0.0 113.855 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.428 ' N ' HG23 ' A' ' 144' ' ' ILE . 6.2 t70 -178.94 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.65 122.35 0.95 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.56 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.78 146.44 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 122' ' ' HIS . 29.4 mtt180 -154.16 96.17 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.89 115.46 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.707 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.16 136.22 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 42.1 t0 -68.5 152.64 45.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 7.0 t0 -97.4 21.55 9.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.23 -46.12 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 110.654 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.3 p -102.17 -25.37 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 66.02 32.09 8.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.03 124.42 8.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.353 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 11.7 tp -55.89 118.17 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.6 mt -87.81 -50.51 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.262 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.69 79.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.147 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.3 p-10 -82.74 68.91 9.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -174.33 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -105.48 169.86 8.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.689 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.525 ' CG1' ' CE1' ' A' ' 195' ' ' PHE . 11.5 tt -99.62 -26.04 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.9 -42.32 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -45.65 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 163' ' ' ILE . 14.7 p -48.04 164.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -80.67 7.84 9.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.5 m-85 80.58 -161.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 110.933 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.3 p -143.75 163.46 33.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -154.91 110.3 2.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.707 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 25.5 Cg_endo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.268 1.979 . . . . 0.0 112.1 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.801 0.334 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.59 128.13 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.326 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -113.78 174.89 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.931 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 t -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.831 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.476 ' CD2' ' CE2' ' A' ' 177' ' ' PHE . 4.5 m-30 -93.82 -178.15 4.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.625 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 1.6 pt -163.93 136.97 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.13 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 3.0 m -131.22 160.15 35.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 23.5 mtm105 -119.28 85.1 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.075 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 46.58 -161.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.26 -82.24 1.06 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.304 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 24.13 11.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.332 . . . . 0.0 111.015 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.9 -82.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.248 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.5 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.431 ' HD2' ' CG ' ' A' ' 92' ' ' GLU . 4.6 ptp180 -133.27 -151.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.125 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.426 ' CD1' ' O ' ' A' ' 94' ' ' PHE . 12.2 m95 -63.15 82.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.433 ' CE ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -86.68 121.09 28.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.559 -178.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 155.09 17.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.067 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.418 ' ND1' ' OH ' ' A' ' 87' ' ' TYR . 15.9 m-70 -137.16 123.21 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.757 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -98.69 112.04 4.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.532 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.481 ' CE1' HD22 ' A' ' 121' ' ' LEU . 22.0 m-85 -109.0 158.7 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.751 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.84 99.29 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.299 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' A' ' 187' ' ' LEU . . . -42.32 141.23 0.99 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.415 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 34.7 t -63.94 -66.22 0.57 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.308 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -29.38 49.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.138 0.494 . . . . 0.0 109.907 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.76 75.19 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.223 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.06 30.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.428 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.438 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 39.1 30.25 0.12 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.421 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -133.71 49.63 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.476 ' HG2' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 169.71 -32.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.673 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -112.11 -30.33 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.905 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.438 ' CB ' ' HA2' ' A' ' 184' ' ' GLY . 11.1 t -87.65 -66.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.149 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -30.34 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.04 -68.87 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.996 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.7 t -52.87 -48.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.77 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.76 -35.18 23.27 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.716 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 14.5 t -86.46 -32.77 20.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.165 0.507 . . . . 0.0 109.884 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.489 ' CB ' ' CG1' ' A' ' 123' ' ' VAL . . . -52.38 -33.85 45.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.894 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.525 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 32.6 m-85 -71.9 -18.86 62.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.104 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -44.85 -59.32 2.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.576 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 198' ' ' CYS . 34.4 m -50.47 -47.0 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.179 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . 0.426 ' N ' HG22 ' A' ' 197' ' ' VAL . 41.0 t -54.41 -29.26 48.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 109.784 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.448 HD12 ' CG2' ' B' ' 3' ' ' ILE . 4.6 mp -123.28 43.29 2.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.521 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.169 179.761 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.666 0.27 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -176.1 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.986 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.448 ' CG2' HD12 ' A' ' 199' ' ' LEU . 4.2 mp -140.24 54.09 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.163 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.9 -67.1 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.418 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 123.139 2.56 . . . . 0.0 112.664 179.306 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.832 0.349 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -67.31 -40.27 85.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.27 65.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.81 -41.02 94.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -30.47 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.597 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -87.84 -25.61 23.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.662 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 81' ' ' CYS . . . -56.01 -50.21 71.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -61.12 -43.87 97.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.6 -179.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.8 83.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.448 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -95.05 19.85 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.046 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 124' ' ' SER . . . 49.22 84.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.238 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 t 178.56 47.51 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.645 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 123' ' ' VAL . 9.7 t -120.83 114.27 21.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.434 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.89 142.79 51.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.866 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' CD1' ' HD2' ' A' ' 186' ' ' ARG . 49.0 m-85 -152.02 142.84 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.435 ' CA ' HD22 ' A' ' 120' ' ' LEU . 5.0 m -54.98 164.32 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 86' ' ' LYS . 4.8 p 176.6 161.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 10.7 mtmm -113.11 79.33 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.488 ' CE2' ' HA2' ' A' ' 89' ' ' GLY . 12.6 t80 -65.39 99.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.432 ' CD2' ' HG3' ' A' ' 116' ' ' PRO . 49.9 mt -46.47 -49.57 18.11 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.488 ' HA2' ' CE2' ' A' ' 87' ' ' TYR . . . 147.01 -169.18 28.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.228 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 21.1 p -123.96 129.25 50.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 110.962 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.88 147.24 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.999 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.5 136.77 45.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 27.4 m -132.76 178.92 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -116.48 26.87 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -145.0 -82.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.315 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.0 m 63.42 28.25 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 21.45 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.9 168.01 30.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.565 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -32.01 22.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.0 110.894 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -63.51 -17.02 62.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.326 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.8 t -87.5 -21.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.602 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.5 p -69.56 -37.0 76.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.62 -59.58 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.478 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.431 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 11.4 pt-20 -64.35 -32.92 74.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HB2' ' CB ' ' A' ' 174' ' ' CYS . . . -67.63 -23.93 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.793 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.56 -24.14 18.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.874 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.412 ' C ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -81.61 -38.58 25.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 70.9 t -53.14 -55.41 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.262 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.43 ' CD1' ' O ' ' A' ' 89' ' ' GLY . 13.9 mt -56.45 -25.31 50.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -82.91 -27.57 30.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.459 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -10.39 45.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.259 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.0 p -106.36 -165.67 1.11 Allowed 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -83.65 -21.95 32.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.865 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -48.36 91.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -84.77 159.62 57.48 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.202 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HG3' ' CD2' ' A' ' 88' ' ' LEU . 4.4 Cg_exo -71.81 161.53 44.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.703 2.269 . . . . 0.0 111.962 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 9.6 p -117.64 118.19 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.44 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 64.93 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.349 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.34 -159.2 10.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.77 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.435 HD22 ' CA ' ' A' ' 84' ' ' SER . 5.3 mt -116.66 126.49 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.137 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.9 tp -86.82 100.36 12.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.436 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -76.45 103.61 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.538 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 81' ' ' CYS . 58.6 t -104.5 133.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.456 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -145.91 29.06 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.722 -178.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 48.08 23.62 2.83 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.596 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.426 ' CA ' HG23 ' A' ' 144' ' ' ILE . 41.5 t0 -165.03 22.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 143' ' ' THR . . . 152.36 112.07 0.5 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.88 101.41 13.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 110.523 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -104.49 89.88 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.69 112.96 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.67 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.413 HG21 ' N ' ' A' ' 132' ' ' ASP . 7.0 p -122.76 138.86 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.212 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 36.8 t0 -63.83 144.59 56.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 28.5 t70 -93.52 14.62 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.42 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -120.61 -39.28 2.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.778 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.7 p -104.85 -24.42 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.839 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.15 35.0 4.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.99 134.03 11.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.429 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 10.8 tp -67.02 120.95 14.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.398 . . . . 0.0 111.061 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.474 HG23 ' CE2' ' A' ' 87' ' ' TYR . 7.8 mt -90.55 -59.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.56 114.83 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.874 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.429 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 20.3 t0 -111.28 96.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.73 -163.93 1.49 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.682 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.443 HG22 ' CG ' ' A' ' 145' ' ' GLU . 5.1 t -135.93 8.91 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.48 HD13 ' CE1' ' A' ' 195' ' ' PHE . 4.7 tt 65.59 7.01 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.443 ' CG ' HG22 ' A' ' 143' ' ' THR . 0.7 OUTLIER -112.6 -36.23 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.132 0.491 . . . . 0.0 110.397 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -83.98 -19.85 33.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.37 177.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 163' ' ' ILE . 8.3 p -66.62 164.0 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.784 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -85.75 16.27 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' A' ' 148' ' ' SER . 15.4 m-85 82.58 -179.45 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.871 0.367 . . . . 0.0 110.957 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 26.6 p -114.53 -178.76 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.456 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 172.64 100.45 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.387 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.401 ' HD2' ' HD3' ' B' ' 5' ' ' PRO . 44.8 Cg_endo . . . . . 0 C--N 1.345 0.374 0 C-N-CA 122.507 2.138 . . . . 0.0 112.894 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -96.86 122.03 7.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.844 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.483 ' CE1' ' HB2' ' A' ' 188' ' ' SER . 5.6 m-85 -134.61 159.64 40.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.3 t -159.88 138.24 10.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.44 . . . . 0.0 111.636 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.527 ' CZ ' ' CZ ' ' A' ' 177' ' ' PHE . 6.0 m-85 -105.69 -173.23 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 1.1 pt -160.94 135.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.04 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 3.4 m -126.48 100.04 6.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.984 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 -65.04 80.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 168' ' ' THR . 34.4 t0 60.79 -87.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.747 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 49.06 -88.99 0.01 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.765 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 166' ' ' ASP . 2.6 m -116.54 -33.47 4.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.751 0.31 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.4 m -59.15 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.034 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -163.92 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -136.04 -154.72 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.762 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -64.27 78.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -99.71 120.96 40.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.153 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 105' ' ' ALA . 86.5 m -91.26 159.22 16.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -129.95 94.67 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.305 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.64 126.32 8.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.366 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.527 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -149.29 152.95 36.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.819 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.61 120.89 24.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -40.88 147.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.994 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -42.25 73.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.53 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -76.1 -34.68 59.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.498 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 67.07 64.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.332 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -162.22 24.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.584 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 42.33 27.81 0.5 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.257 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.4 43.4 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.889 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.478 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 16.5 mmt-85 -158.51 -44.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 83' ' ' PHE . 4.3 mp -115.2 -36.11 4.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.734 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 12.3 t -58.92 -65.87 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 186' ' ' ARG . 10.5 p80 -61.29 -35.68 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.89 -73.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.016 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.409 ' HA ' ' CB ' ' A' ' 194' ' ' ALA . 6.6 t -51.39 -43.57 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.631 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.65 -34.84 36.67 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.484 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 56.5 m -91.14 -27.39 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.073 177.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.438 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . . . -49.53 -45.47 47.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.99 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 144' ' ' ILE . 33.5 m-85 -57.2 -22.52 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.984 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -41.43 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.42 -34.38 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.819 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.97 -23.41 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.767 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 195' ' ' PHE . 5.3 mp -113.8 -45.73 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.824 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.407 -178.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 174.73 87.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.897 0.38 . . . . 0.0 111.366 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp 42.42 48.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.155 0.502 . . . . 0.0 111.753 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.17 86.27 1.7 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.853 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.401 ' HD3' ' HD2' ' A' ' 152' ' ' PRO . 32.5 Cg_exo . . . . . 0 N--CA 1.481 0.793 0 CA-C-N 118.137 0.969 . . . . 0.0 114.041 4.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.433 ' CZ2' ' CG ' ' A' ' 189' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.985 0.422 . . . . 0.0 110.478 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.79 -28.38 68.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . -85.24 -37.33 20.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.863 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.403 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 6.8 t0 -56.46 -49.65 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.66 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -58.15 4.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.354 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -29.15 53.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 81' ' ' CYS . . . -51.16 -68.49 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 194' ' ' ALA . 3.3 m -49.48 -27.43 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -52.14 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 m -95.37 15.94 18.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.152 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 61.97 84.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.036 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t 175.67 54.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.415 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.429 ' HB2' ' CB ' ' A' ' 75' ' ' ALA . 19.5 t -122.28 71.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.371 . . . . 0.0 110.65 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 122' ' ' HIS . 13.0 p -92.91 148.71 21.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.078 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CD2' ' O ' ' A' ' 186' ' ' ARG . 29.4 m-85 -151.52 139.63 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.54 139.47 31.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.731 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 121' ' ' LEU . 11.9 p -151.68 159.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.55 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -114.81 61.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.797 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.47 ' CZ ' ' O ' ' A' ' 89' ' ' GLY . 23.3 t80 -47.55 119.22 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 10.1 mp -56.49 -46.67 80.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 148.64 -176.38 27.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.99 130.43 51.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 111.372 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.424 ' O ' ' CE ' ' A' ' 173' ' ' MET . 7.0 m -121.72 174.35 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.09 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -105.7 154.41 20.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.087 0.47 . . . . 0.0 111.616 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 172' ' ' TRP . 16.0 m -157.65 -175.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.25 20.02 2.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.602 0.239 . . . . 0.0 111.39 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -115.76 -68.01 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.176 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.48 ' OG ' ' CD1' ' A' ' 172' ' ' TRP . 53.0 p 50.1 24.99 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.631 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -148.67 32.72 0.78 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.43 125.23 1.68 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.578 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -34.51 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -63.35 -25.97 68.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.695 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.67 -35.42 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -70.82 -34.88 72.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.48 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -64.18 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.14 -39.21 18.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.422 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.15 75.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.0 tp -51.6 -33.48 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -43.47 28.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.2 t -58.11 -33.31 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' CD1' ' HG3' ' A' ' 114' ' ' ARG . 0.7 OUTLIER -54.38 -31.07 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.215 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -50.43 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.539 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -54.09 -25.72 23.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.638 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.4 p -82.75 -177.85 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -3.73 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.407 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.438 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 11.9 mmp_? -48.54 177.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.774 0.321 . . . . 0.0 111.127 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.19 135.49 4.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.033 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 71.7 Cg_exo -48.56 152.04 4.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.314 2.009 . . . . 0.0 112.099 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 7.1 p -123.48 113.6 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.423 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 64.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.557 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -117.0 -150.17 9.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.91 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 83' ' ' PHE . 13.1 tp -137.42 128.21 27.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.773 0.321 . . . . 0.0 110.793 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.439 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -78.02 90.14 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -72.64 94.02 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.225 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 t -100.34 160.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.72 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.42 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -166.54 34.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 45.93 44.84 13.84 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.536 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.438 ' CA ' HG23 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -171.19 -43.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.679 0.276 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.53 114.4 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.286 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.486 HD11 ' CD2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -84.33 120.17 25.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 110.169 177.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -132.66 98.68 4.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.036 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 p -83.26 129.45 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.846 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.71 132.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.052 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -65.8 148.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.919 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -97.74 20.11 12.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -125.54 -42.15 1.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.3 p -104.27 -27.73 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.671 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tptm 49.35 49.9 18.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -113.69 14.03 22.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.076 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 tp 59.36 148.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 111.248 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.85 -51.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.786 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.16 136.78 49.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.038 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -143.06 58.96 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -113.07 162.06 16.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 63.4 m -97.67 122.73 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.603 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.529 ' CD1' ' CE1' ' A' ' 195' ' ' PHE . 7.3 tt -54.22 -31.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -72.97 -25.25 60.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.444 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.05 -39.55 9.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.499 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 143' ' ' THR . 17.8 t -49.76 144.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.272 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.476 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 9.1 m -50.51 -41.19 53.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.528 ' CE1' ' CD1' ' A' ' 163' ' ' ILE . 2.7 p90 155.77 -175.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.616 0.572 . . . . 0.0 110.074 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 19.5 p -121.23 140.13 52.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.738 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -167.94 133.06 1.54 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.803 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.423 ' CB ' ' O ' ' A' ' 159' ' ' GLY . 98.3 Cg_endo . . . . . 0 CA--C 1.535 0.534 0 C-N-CA 122.482 2.122 . . . . 0.0 112.298 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.445 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.704 0.288 . . . . 0.0 111.029 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 152' ' ' PRO . . . -122.05 141.3 14.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.569 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 188' ' ' SER . 0.1 OUTLIER -105.51 -163.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 0.0 110.83 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.8 t 172.5 129.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.736 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.486 ' CD2' HD11 ' A' ' 128' ' ' LEU . 3.9 m-30 -110.86 -179.56 3.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -163.83 143.24 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -169.1 133.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.579 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.484 ' HG3' ' CZ2' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -67.63 84.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.979 177.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.471 ' CB ' ' HB ' ' A' ' 169' ' ' THR . 97.8 m-20 -66.6 110.13 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.5 -20.72 59.64 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.467 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -48.56 3.33 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.471 ' HB ' ' CB ' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -50.2 -64.19 0.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.374 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 171' ' ' ARG . 53.7 mtp180 -164.54 -46.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.108 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.499 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 165.0 -145.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.484 ' CZ2' ' HG3' ' A' ' 165' ' ' ARG . 1.7 m-90 -64.17 81.7 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.81 134.9 39.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.333 0.587 . . . . 0.0 111.764 -176.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.402 ' SG ' ' CG1' ' A' ' 93' ' ' VAL . 1.2 m -101.89 169.03 9.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.978 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.434 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 39.8 m-70 -146.79 123.42 11.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 111.549 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -101.76 114.6 5.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.877 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.96 146.04 29.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.124 0.488 . . . . 0.0 111.623 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -145.76 110.46 5.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.26 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -42.39 143.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.858 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.8 t -71.91 -48.67 43.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.801 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -78.57 -25.13 45.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.99 77.84 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.445 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 39.9 t -169.9 28.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.503 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.05 34.99 0.62 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.144 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -136.21 47.54 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.446 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 1.6 mpt_? -153.47 -57.74 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.131 0.491 . . . . 0.0 110.158 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.49 -0.97 4.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.867 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.424 ' HA ' ' CE2' ' A' ' 160' ' ' PHE . 70.1 m -80.44 -44.08 19.87 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.076 0.465 . . . . 0.0 110.228 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CG ' ' CZ2' ' A' ' 69' ' ' TRP . 2.1 t-80 -94.84 -18.86 20.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.67 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.74 -63.07 1.5 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.4 t -48.41 -46.52 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.8 -24.22 57.2 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.792 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.1 m -85.84 -31.3 22.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.497 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 76' ' ' VAL . . . -52.68 -42.39 64.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.529 ' CE1' ' CD1' ' A' ' 144' ' ' ILE . 45.3 m-85 -65.44 -25.88 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.876 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -43.44 -42.05 4.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.908 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' PHE . 0.5 OUTLIER -43.03 -46.4 5.56 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.811 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.407 ' CD2' ' N ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -106.67 -27.28 10.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.096 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 196' ' ' ALA . 23.9 tt0 . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.139 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -157.41 68.44 0.53 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.209 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' B' ' 3' ' ' ILE . 2.0 mp 66.41 -65.19 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.353 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' B' ' 2' ' ' TYR . . . -40.49 -61.91 1.72 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.398 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.45 ' HG3' ' CB ' ' B' ' 1' ' ' ALA . 85.2 Cg_endo . . . . . 0 N--CA 1.464 -0.259 0 C-N-CA 122.908 2.405 . . . . 0.0 112.533 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.3 m0 . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.155 0.503 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -53.16 -24.42 10.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.332 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.57 23.1 13.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.994 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.45 -48.19 0.98 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.064 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.01 -37.97 22.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.899 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.08 -26.08 39.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.01 -65.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 m -51.45 -31.58 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -47.78 73.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.758 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -94.04 21.56 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.006 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 49.06 85.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.174 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -176.8 41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -109.2 161.84 14.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.899 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 78.7 p 178.66 155.16 0.42 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' SER . 49.5 m-85 -164.69 141.61 6.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.428 ' N ' HD22 ' A' ' 120' ' ' LEU . 6.6 t -51.84 149.92 4.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.352 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' CG1' HD13 ' A' ' 187' ' ' LEU . 1.7 t -146.66 167.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.231 0.539 . . . . 0.0 112.324 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -121.52 48.07 1.75 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.995 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 177' ' ' PHE . 0.6 OUTLIER -38.8 150.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.066 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 106' ' ' LEU . 75.1 mt -106.54 -38.82 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.643 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.43 169.52 12.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.192 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 9.2 p -101.58 144.3 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 110.914 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.407 ' HB ' HD12 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -127.32 176.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.873 -178.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -95.92 145.57 25.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 13.6 m -146.0 166.91 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.87 0.367 . . . . 0.0 111.274 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -93.61 20.65 7.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.307 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 94' ' ' PHE . 9.9 mt-10 -167.2 150.05 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.031 0.443 . . . . 0.0 110.906 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 96.3 p -125.32 20.61 8.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.16 74.19 1.02 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.785 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -164.56 117.6 0.76 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.444 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.42 ' CE ' ' O ' ' A' ' 152' ' ' PRO . 0.0 OUTLIER -56.9 -26.76 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -27.98 36.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.416 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 58.4 t -62.11 -48.3 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.779 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.1 m -60.57 -37.63 81.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.633 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.43 -42.31 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 11.0 pt-20 -79.45 -35.53 40.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.413 ' O ' ' CD2' ' A' ' 109' ' ' LEU . . . -55.44 -53.22 58.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -47.18 -46.2 23.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -42.68 86.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.66 -47.52 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.808 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.414 HD12 ' HG3' ' A' ' 114' ' ' ARG . 2.7 mm? -53.15 -23.31 7.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.92 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -59.99 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -53.15 -31.18 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.04 -171.96 3.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.955 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 25.44 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.414 ' HG3' HD12 ' A' ' 109' ' ' LEU . 8.5 mmt180 -65.04 76.53 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.41 135.07 5.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.508 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.424 ' CB ' ' O ' ' A' ' 87' ' ' TYR . 92.8 Cg_endo -82.4 164.93 16.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.574 2.183 . . . . 0.0 112.068 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.476 ' CG1' ' CB ' ' A' ' 87' ' ' TYR . 1.5 p -114.56 176.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.014 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -152.65 89.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.455 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.59 -137.73 2.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.846 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -122.75 121.72 36.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.646 0.26 . . . . 0.0 111.219 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.44 HD21 ' CB ' ' A' ' 187' ' ' LEU . 8.6 tp -87.61 104.21 16.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.437 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -74.22 110.75 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.434 ' CG2' HG21 ' A' ' 191' ' ' VAL . 68.3 t -114.04 105.75 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.2 p -118.17 16.13 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.09 11.49 32.39 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.964 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -149.33 16.13 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.698 0.249 . . . . 0.0 111.282 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 161.06 96.88 0.11 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.812 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 162' ' ' TYR . 1.6 mt -77.03 111.7 12.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.695 0.283 . . . . 0.0 110.501 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.35 86.76 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.312 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.2 p -77.93 100.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.602 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.2 t -99.72 154.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -91.85 139.49 30.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.82 14.33 8.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.524 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.4 OUTLIER -111.44 -30.62 7.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.05 0.452 . . . . 0.0 110.526 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 134' ' ' GLU . 67.0 p -139.12 8.64 2.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.512 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER 42.02 44.15 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.484 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.12 143.61 15.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.096 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.43 112.06 12.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.87 0.367 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.2 mt -81.18 -51.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.402 ' CG1' ' OE1' ' A' ' 142' ' ' GLN . 58.8 t -120.12 101.29 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -95.54 90.85 5.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.178 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.402 ' OE1' ' CG1' ' A' ' 140' ' ' VAL . 19.2 mt-30 -142.13 161.36 38.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.65 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.433 HG22 ' CG ' ' A' ' 145' ' ' GLU . 2.0 t -100.21 5.54 44.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 145' ' ' GLU . 2.1 tt 84.66 -39.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.122 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.455 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -86.45 -25.16 25.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.918 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -78.59 -18.43 54.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.257 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -79.08 -177.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -98.01 22.3 9.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.38 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.436 ' CB ' ' O ' ' A' ' 148' ' ' SER . 18.5 m-85 85.62 -171.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 20.4 p -134.4 168.05 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.733 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -175.49 110.44 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.488 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 25.8 Cg_endo . . . . . 0 C--N 1.347 0.471 0 C-N-CA 122.462 2.108 . . . . 0.0 112.919 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.702 0.287 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.06 129.5 5.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.799 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.488 ' CD1' ' HB3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER -104.77 -174.53 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 110.591 178.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER 179.68 126.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 111.426 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 177' ' ' PHE . 0.2 OUTLIER -97.77 -173.78 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.61 179.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -159.07 133.36 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 35.4 t -131.5 152.45 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.009 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.89 96.93 5.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.03 -166.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.719 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.76 -86.74 1.2 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.68 29.73 6.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.683 0.277 . . . . 0.0 110.883 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 -84.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.432 ' HG3' ' CG ' ' A' ' 173' ' ' MET . 9.3 ptm180 -179.21 -47.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -150.45 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.99 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.43 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 5.7 m95 -68.31 72.86 0.21 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.432 ' CG ' ' HG3' ' A' ' 170' ' ' ARG . 75.3 mmm -89.23 118.02 28.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.293 0.568 . . . . 0.0 111.772 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 161.64 26.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.135 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -133.64 109.52 9.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.42 125.8 7.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 1.7 p90 -144.5 144.6 31.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.412 ' CD1' ' OD1' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -110.34 140.51 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.841 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.51 140.47 58.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.39 -62.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -74.8 -26.7 59.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.412 ' OD1' ' CD1' ' A' ' 178' ' ' LEU . 0.3 OUTLIER 62.48 81.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.088 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.52 33.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.434 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 46.15 39.66 9.58 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.594 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.84 4.58 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.431 ' CB ' HD12 ' A' ' 187' ' ' LEU . 14.1 mmt180 -114.76 -64.51 1.3 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.81 0.338 . . . . 0.0 110.743 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.44 ' CB ' HD21 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -143.37 15.77 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.652 178.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.476 ' O ' ' CE1' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -96.38 -34.26 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 178.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.39 -21.42 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.52 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.18 -58.76 3.08 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.434 HG21 ' CG2' ' A' ' 123' ' ' VAL . 33.2 t -49.73 -49.75 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.106 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.38 -33.89 12.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.354 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 2.9 t -76.41 -28.56 56.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.544 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.434 ' CB ' ' CG1' ' A' ' 123' ' ' VAL . . . -57.92 -47.02 84.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.787 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -53.56 -26.63 22.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -50.37 -29.07 9.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 86.5 t -84.97 -31.32 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 11.5 t -53.94 -48.0 70.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.325 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -95.65 -24.5 16.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 121.287 0.565 . . . . 0.0 111.733 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.486 ' CD1' ' HB2' ' B' ' 1' ' ' ALA . 0.0 OUTLIER -130.65 -82.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.928 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mp -132.23 -58.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' B' ' 5' ' ' PRO . . . -45.59 -50.48 10.81 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.426 ' CG ' ' HB1' ' B' ' 1' ' ' ALA . 52.5 Cg_endo . . . . . 0 N--CA 1.459 -0.508 0 C-N-CA 123.332 2.688 . . . . 0.0 112.732 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.24 175.22 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -44.84 105.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.611 2.208 . . . . 0.0 112.748 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 171.2 -82.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.677 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -96.73 -34.93 11.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.385 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -31.9 71.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -66.47 -29.29 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.17 -56.65 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 1.5 p30 -58.5 -36.88 74.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.958 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 17.4 tt0 -60.19 -27.22 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.489 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 -30.5 14.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.863 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.21 -50.72 61.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 59.3 t -58.26 -38.75 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.422 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -39.9 70.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.561 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.78 1.41 55.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 65.92 78.51 0.27 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.829 0.347 . . . . 0.0 111.081 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 t 176.19 60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.2 -172.75 2.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.1 m 174.16 153.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.997 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 82' ' ' SER . 32.4 m-85 -162.1 139.78 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.422 ' N ' HD11 ' A' ' 120' ' ' LEU . 23.3 t -60.76 157.23 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.735 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 86' ' ' LYS . 7.1 p 178.67 160.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.987 0.422 . . . . 0.0 111.915 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.427 ' N ' HG23 ' A' ' 85' ' ' VAL . 1.7 mttp -111.31 71.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.636 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.479 ' CE1' ' HA2' ' A' ' 89' ' ' GLY . 41.4 t80 -55.02 107.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.996 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 6.9 mp -48.5 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.479 ' HA2' ' CE1' ' A' ' 87' ' ' TYR . . . 176.18 -133.32 2.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.419 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.95 151.14 38.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.954 0.407 . . . . 0.0 111.002 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.55 167.05 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.832 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.14 142.6 27.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 2.1 m -145.49 173.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.223 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -116.26 25.56 10.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.427 ' CB ' HG23 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -144.84 -74.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.253 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m 59.45 19.48 7.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.24 66.54 1.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.59 -161.03 27.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.344 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -36.26 3.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 111.06 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -61.58 -25.9 67.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.427 HG23 ' CB ' ' A' ' 95' ' ' GLU . 15.8 t -76.06 -30.44 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.31 -38.75 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.2 -37.72 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -88.31 -34.8 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.683 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.31 -51.31 65.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -45.52 62.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.595 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -39.12 73.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.399 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.66 -39.65 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.757 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.434 HD11 ' CB ' ' A' ' 114' ' ' ARG . 1.5 mm? -55.64 -26.26 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -86.21 -61.29 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.044 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -48.4 -33.44 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.034 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -165.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.41 42.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.434 ' CB ' HD11 ' A' ' 109' ' ' LEU . 1.7 mmp_? -93.1 70.39 4.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.825 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 133.84 19.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 71.7 Cg_endo -79.37 141.49 16.01 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.476 2.117 . . . . 0.0 112.63 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 87' ' ' TYR . 12.0 m -78.35 173.99 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.37 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -135.95 72.9 1.44 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.246 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -141.17 -130.4 2.58 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.852 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.441 ' CD2' ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -145.25 140.94 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.878 0.37 . . . . 0.0 111.433 -178.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 0.5 OUTLIER -85.68 116.22 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -81.05 84.25 6.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.968 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.445 ' CG1' ' HB3' ' A' ' 194' ' ' ALA . 38.0 t -94.89 125.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -142.82 44.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.499 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 41.35 51.91 4.42 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.949 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.428 ' CA ' HG23 ' A' ' 144' ' ' ILE . 20.9 t70 -164.94 -40.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.673 0.273 . . . . 0.0 111.072 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 144' ' ' ILE . . . -176.52 118.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.459 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -65.6 115.81 6.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.736 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -117.99 78.94 1.3 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 121' ' ' LEU . 5.8 p -68.14 132.79 32.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.081 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.31 139.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -75.95 163.05 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -103.17 15.68 28.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.327 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.03 -60.26 1.82 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.883 0.373 . . . . 0.0 110.579 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 42.9 p -82.01 -27.91 32.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.7 48.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -126.54 142.38 13.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.1 tp -69.45 132.63 46.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.745 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 87' ' ' TYR . 8.8 mt -100.63 -53.26 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.395 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.48 67.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.21 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.436 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.6 p-10 -72.97 67.59 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.51 152.57 48.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.5 m -78.71 145.06 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.69 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.485 HG12 ' CD1' ' A' ' 195' ' ' PHE . 7.0 tt -71.89 -30.71 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.897 0.38 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -75.5 -28.94 59.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.283 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -90.91 -39.23 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.368 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 144' ' ' ILE . 9.9 p -58.9 163.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.038 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 12.9 t -76.06 1.95 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.438 ' HA ' ' CE1' ' A' ' 195' ' ' PHE . 1.4 m-85 80.86 174.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.044 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.472 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 2.9 t -108.92 164.99 11.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -155.17 97.67 2.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.06 129.79 22.45 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.256 1.971 . . . . 0.0 111.789 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.49 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.416 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.67 23.26 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.231 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.6 t30 44.25 29.64 0.38 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.569 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -86.84 -17.57 33.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.523 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.33 25.33 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.139 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? 69.17 45.46 0.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.953 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 178' ' ' LEU . . . -109.87 144.97 16.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.39 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.488 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 3.5 m-85 -143.97 178.26 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.607 0.241 . . . . 0.0 110.852 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.8 m -172.26 134.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 111.554 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.577 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 98.2 m-85 -94.55 -174.31 3.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.486 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 0.9 OUTLIER -165.99 137.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.607 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.72 125.69 24.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.0 OUTLIER -76.89 87.48 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.046 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 168' ' ' THR . 23.1 t0 50.84 -90.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.234 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 165' ' ' ARG . . . 59.47 -82.35 0.01 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -140.96 25.15 2.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.481 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 170' ' ' ARG . 4.2 m -122.25 23.62 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.488 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 169' ' ' THR . 12.3 mtp180 86.74 -72.29 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.487 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -146.6 -164.33 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 0.0 111.02 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.417 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 2.0 m95 -56.01 90.17 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.429 ' HG3' ' CG2' ' A' ' 169' ' ' THR . 0.0 OUTLIER -98.07 110.74 23.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.828 -177.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -82.03 148.19 28.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.735 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 173' ' ' MET . 24.6 m-70 -128.66 158.58 38.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.857 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.63 138.53 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.845 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.577 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -153.98 115.06 4.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.178 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.432 ' CD2' ' HA2' ' A' ' 159' ' ' GLY . 0.1 OUTLIER -90.25 122.33 33.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.821 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' N ' HD11 ' A' ' 178' ' ' LEU . . . -46.1 135.44 7.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -67.08 0.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -33.3 65.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.343 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' CD1' ' A' ' 178' ' ' LEU . 1.4 m-20 63.27 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.268 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.22 28.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.863 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.43 29.22 0.22 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.23 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 186' ' ' ARG . 18.0 mt-10 -138.61 47.7 1.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.027 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.475 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -159.63 -42.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.427 ' CD2' ' HB ' ' A' ' 85' ' ' VAL . 5.9 mp -114.65 -37.65 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 t -56.95 -59.95 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -75.58 -26.46 57.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -67.26 -66.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.66 -29.45 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.309 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -53.12 -28.79 34.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.218 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 196' ' ' ALA . 47.5 t -95.86 -22.61 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.302 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.445 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -47.42 -38.61 13.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.485 ' CD1' HG12 ' A' ' 144' ' ' ILE . 61.5 m-85 -79.07 -26.99 43.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 193' ' ' CYS . . . -47.16 -43.87 21.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.127 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.05 -30.06 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.738 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.8 t -66.9 -58.87 4.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.779 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.438 ' CD1' ' CG2' ' B' ' 3' ' ' ILE . 2.1 pt? -117.54 51.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.547 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.423 ' CA ' ' O ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER -50.56 -33.08 20.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.44 22.07 5.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.695 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm 49.89 44.3 25.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.81 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -58.67 -18.36 30.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.434 ' NE ' HD12 ' A' ' 199' ' ' LEU . 0.6 OUTLIER -48.81 129.02 16.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.062 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.64 81.35 2.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.759 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.96 -39.82 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.142 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -99.52 -172.04 2.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.8 -50.97 45.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.01 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 69.06 103.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.034 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.891 -1.052 . . . . 0.0 111.104 179.869 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.721 0.296 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -163.34 -89.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.129 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' A' ' 199' ' ' LEU . 2.6 mm -109.17 -52.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.35 -74.97 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.473 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' B' ' 6' ' ' PTR . 17.5 Cg_exo -71.28 52.03 1.46 Allowed 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 123.159 2.573 . . . . 0.0 113.34 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.406 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 204' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.835 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.828 0.347 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.8 mttp 48.44 70.92 1.79 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.275 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.59 -77.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.589 2.193 . . . . 0.0 112.015 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.04 -69.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.54 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.46 -23.91 52.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -29.33 69.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.037 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.92 -34.74 78.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.52 -51.42 8.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.991 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -58.71 -42.46 88.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.34 -36.91 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.691 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -86.11 -29.79 23.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.55 -57.59 10.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.793 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -49.4 -38.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -49.65 74.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.448 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.4 20.64 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.21 90.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t 179.5 44.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -112.62 162.27 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 32.4 t -172.64 154.0 2.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 82' ' ' SER . 91.2 m-85 -160.34 141.1 11.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.14 151.07 19.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.112 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 187' ' ' LEU . 0.8 OUTLIER -152.18 171.81 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 112.115 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -128.11 40.11 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.966 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 177' ' ' PHE . 6.0 t80 -44.57 123.91 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.608 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -68.55 -60.31 2.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . 159.31 -160.28 31.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.393 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.21 146.49 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.059 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' ' 109' ' ' LEU . 2.8 m -133.78 135.47 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.12 120.66 18.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 10.7 m -120.96 177.27 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.086 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.22 -22.92 18.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.194 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 19.5 mp0 -123.61 153.52 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.1 p -133.25 21.78 4.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.009 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.3 23.9 1.03 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.67 131.97 9.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.607 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -51.69 60.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.36 -26.75 8.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.49 -33.13 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.205 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -72.98 -41.39 64.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.68 -33.7 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.576 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.426 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 12.6 pt-20 -87.64 -40.34 14.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -57.39 -58.88 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -46.36 -40.56 12.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.899 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -64.55 -45.52 86.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 178.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.43 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.1 t -63.92 -30.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.883 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.435 ' CD2' HG23 ' A' ' 91' ' ' VAL . 3.5 mm? -59.04 -23.67 62.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.512 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -93.38 -36.23 12.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -72.97 -21.73 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.306 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.26 172.0 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -53.67 -22.73 9.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.435 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 7.4 mmp_? -46.05 92.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -94.96 150.42 37.74 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.23 166.26 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.767 2.311 . . . . 0.0 112.466 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 7.0 p -137.9 119.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.356 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -80.85 97.91 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.46 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.69 -169.08 18.96 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.775 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.87 124.43 51.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.388 . . . . 0.0 111.122 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 123' ' ' VAL . 6.9 tp -88.88 99.32 12.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.882 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.05 96.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.408 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.446 ' CG2' ' HG ' ' A' ' 121' ' ' LEU . 95.1 t -102.73 117.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.86 28.99 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.116 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 49.69 24.41 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -133.92 -44.3 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.27 116.69 0.71 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.435 HD11 ' CE2' ' A' ' 162' ' ' TYR . 8.5 mt -71.57 133.98 46.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -141.49 98.08 3.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.8 p -89.21 104.47 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 t -107.07 132.62 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.076 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 136' ' ' LYS . 41.3 t0 -70.17 133.28 46.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -79.08 -6.59 56.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -97.57 -24.49 15.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.9 p -123.61 -35.17 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.1 OUTLIER 75.54 25.25 1.24 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.54 123.83 8.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.262 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.5 tp -50.81 131.52 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.991 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.43 ' CD1' HG23 ' A' ' 117' ' ' VAL . 9.6 mt -105.11 -54.13 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.269 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 142' ' ' GLN . 59.7 t -111.11 65.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 35.7 p-10 -68.16 66.92 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 140' ' ' VAL . 19.2 mt-30 -138.34 134.59 34.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 0.2 OUTLIER -54.19 -176.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 18.1 tt -108.76 -15.83 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.767 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -99.6 -26.99 13.9 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -110.24 -171.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.289 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.39 14.78 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.475 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 73.66 149.56 0.1 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.874 0.369 . . . . 0.0 110.988 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 24.6 p -72.36 -178.56 2.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 171.75 80.83 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.79 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 160' ' ' PHE . 10.7 Cg_endo -53.84 146.61 45.18 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.12 -59.66 2.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.416 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.34 31.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.3 m120 42.36 32.23 0.32 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.598 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -108.01 7.35 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.975 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -152.24 19.18 0.66 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.832 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.435 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER 58.84 33.82 23.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.739 0.304 . . . . 0.0 111.181 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.63 141.18 12.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.899 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.527 ' CE1' ' CB ' ' A' ' 188' ' ' SER . 4.9 m-85 -118.34 -174.27 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.9 m -166.07 134.81 3.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.528 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.435 ' CE2' HD11 ' A' ' 128' ' ' LEU . 7.5 m-30 -102.34 175.28 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.286 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.421 ' O ' ' CG1' ' A' ' 147' ' ' VAL . 0.4 OUTLIER -159.21 150.96 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.964 0.411 . . . . 0.0 111.425 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.3 166.3 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.539 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.82 79.18 1.54 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.132 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 46.62 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.183 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.03 -34.17 6.0 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.107 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 94.7 m -150.75 -44.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -72.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.92 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -178.21 -79.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.629 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 173' ' ' MET . 1.6 ptp180 -131.81 -153.47 0.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.91 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.428 ' N ' ' HG3' ' A' ' 171' ' ' ARG . 11.5 m95 -62.83 80.09 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 171' ' ' ARG . 1.2 mmt -85.36 121.57 28.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.74 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.32 156.94 16.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.749 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.68 105.61 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.749 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.96 104.83 2.89 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.468 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.496 ' HB3' ' CD1' ' A' ' 87' ' ' TYR . 3.3 p90 -121.16 132.64 54.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.415 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.6 tp -102.26 147.24 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.688 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.22 140.09 56.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.175 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 35.8 t -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.753 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -36.24 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.9 66.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.435 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 2.6 p -148.98 16.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.733 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 43.33 34.71 2.43 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.861 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -144.82 50.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.0 mtt-85 -168.8 -42.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.74 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.455 ' CD1' ' CB ' ' A' ' 83' ' ' PHE . 9.8 mp -113.32 -42.44 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.527 ' CB ' ' CE1' ' A' ' 160' ' ' PHE . 23.2 p -53.36 -65.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -66.91 -25.44 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.44 -60.03 2.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 17.6 t -61.21 -40.5 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.881 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.73 -41.56 95.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.141 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.89 -34.0 64.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 110.332 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.439 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -56.41 -44.82 80.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -51.05 -26.29 6.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -48.13 -42.72 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.57 -32.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.621 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 46.6 t -49.85 -36.17 25.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.454 ' N ' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -118.91 -36.37 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 196' ' ' ALA . 6.9 tp10 66.88 126.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.451 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 63.22 21.71 12.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.216 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.45 ' HA ' ' CD1' ' A' ' 199' ' ' LEU . 11.0 mptt 44.8 38.76 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.83 0.348 . . . . 0.0 111.318 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -67.46 -32.49 73.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.989 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 38.09 -159.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.611 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mmt-85 -145.26 25.21 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.818 0.342 . . . . 0.0 111.112 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -24.44 11.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.797 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -48.93 -40.17 29.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.107 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -118.21 85.04 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.151 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.24 -172.72 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.03 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.999 -1.001 . . . . 0.0 111.012 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.803 0.335 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.46 -97.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.411 ' CG2' ' OXT' ' B' ' 7' ' ' LEU . 2.7 mp -112.63 -29.85 2.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.74 -85.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.541 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.426 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 49.1 Cg_exo -57.41 89.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.467 2.112 . . . . 0.0 110.826 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.4 ' HB2' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.411 ' OXT' ' CG2' ' B' ' 3' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.91 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.798 0.332 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt 45.28 55.96 14.73 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.237 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -47.64 -59.0 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.849 2.366 . . . . 0.0 112.22 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -170.84 -61.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -80.83 -26.67 36.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.682 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -54.64 -30.18 54.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -68.99 -33.4 73.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.632 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.02 -63.13 1.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.084 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.47 -47.53 57.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -29.77 11.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.4 -24.69 15.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.17 -64.82 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.039 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 81' ' ' CYS . 2.3 m -50.03 -32.68 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -59.66 -52.55 65.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.463 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 23.44 5.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.833 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 48.65 85.27 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -176.64 34.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.325 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.427 ' CB ' HG11 ' A' ' 76' ' ' VAL . 4.6 t -98.75 156.28 16.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.053 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.465 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 2.6 t -174.8 152.02 1.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.763 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.483 ' CG ' ' HB3' ' A' ' 186' ' ' ARG . 72.3 m-85 -162.18 147.68 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.6 t -55.31 151.88 9.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' A' ' 187' ' ' LEU . 1.6 t -152.68 168.35 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.107 0.48 . . . . 0.0 111.618 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -128.11 48.2 2.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.929 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 14.4 t80 -39.57 114.98 0.46 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.871 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 54.9 mt -66.89 -26.93 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.461 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 126.01 -152.91 18.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.222 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 2.8 m -126.95 150.45 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.014 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 109' ' ' LEU . 13.8 m -133.87 134.91 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' N ' ' HE3' ' A' ' 173' ' ' MET . 9.2 pt-20 -70.33 133.06 46.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.728 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 23.9 m -138.64 169.4 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 111.361 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.5 16.0 16.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -157.34 119.46 3.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 p -95.83 24.18 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -165.16 123.43 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.751 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 148.72 113.07 0.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -36.61 25.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.087 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.22 -41.28 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.35 -33.68 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.081 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -70.36 -39.04 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.05 -32.56 68.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.79 -36.51 12.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -50.11 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.895 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -50.09 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.686 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -44.06 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.01 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.68 -34.38 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.717 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.439 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 1.1 mm? -52.03 -28.49 17.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 0.0 110.196 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.0 -27.84 18.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.561 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.72 20.43 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.174 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.406 ' HB3' ' HG3' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -120.6 147.63 44.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.69 4.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.64 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.429 ' NE ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -45.28 171.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.366 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -138.62 151.74 69.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.037 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD3' ' NH1' ' A' ' 114' ' ' ARG . 89.1 Cg_endo -80.2 -179.9 5.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.636 2.224 . . . . 0.0 112.392 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -141.26 -173.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.616 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.6 96.24 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.614 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.7 -131.44 1.27 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.771 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.72 129.75 51.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.075 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 177' ' ' PHE . 10.5 tt -100.88 113.02 25.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.187 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -76.95 111.57 12.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.475 ' CG2' ' CD2' ' A' ' 121' ' ' LEU . 82.1 t -110.78 96.74 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.32 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -111.79 27.58 9.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.378 . . . . 0.0 111.292 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.431 ' HA3' ' CG2' ' A' ' 197' ' ' VAL . . . 47.62 26.37 3.83 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.274 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -140.15 -42.91 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.946 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -158.4 119.53 0.9 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.524 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.64 123.64 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.785 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -135.31 100.91 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.434 ' CG1' HG22 ' A' ' 140' ' ' VAL . 9.2 p -90.59 128.39 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.47 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.1 154.87 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.693 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 136' ' ' LYS . 54.5 t0 -102.79 135.72 43.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.5 -0.41 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.714 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -103.48 -31.16 10.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.867 0.365 . . . . 0.0 110.996 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 p -116.64 -29.09 6.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 66.93 29.62 8.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.54 -128.89 5.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.595 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 7.5 tp -156.97 134.63 10.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.773 0.32 . . . . 0.0 110.796 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 139' ' ' ILE . 4.3 mt -108.07 -54.85 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.434 HG22 ' CG1' ' A' ' 130' ' ' VAL . 7.6 t -109.09 71.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 111.24 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 14.9 p-10 -78.58 59.91 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.12 163.11 25.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.389 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.7 m -78.02 174.14 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.713 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.512 ' CG1' ' CE2' ' A' ' 195' ' ' PHE . 4.1 tt -97.64 -21.29 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -91.05 -39.52 12.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.835 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -72.66 -29.23 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 144' ' ' ILE . 8.3 p -74.82 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.804 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -72.55 -0.86 13.95 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.6 m-85 79.11 179.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.505 ' CB ' ' CD1' ' A' ' 162' ' ' TYR . 25.5 p -98.94 177.34 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' B' ' 5' ' ' PRO . . . -171.24 101.01 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.081 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.75 120.84 8.08 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.368 2.045 . . . . 0.0 111.977 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -39.03 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.959 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -143.42 21.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.306 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 48.24 26.88 1.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.815 0.34 . . . . 0.0 111.111 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 156' ' ' HIS . 11.8 t-160 -130.94 63.92 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 158' ' ' ARG . 0.5 OUTLIER 166.04 -25.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.515 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER 82.63 26.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.677 -179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.18 106.31 1.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 188' ' ' SER . 0.1 OUTLIER -96.41 -177.22 3.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.439 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.83 122.72 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.948 0.404 . . . . 0.0 111.301 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.505 ' CD1' ' CB ' ' A' ' 150' ' ' CYS . 1.8 m-30 -95.73 -160.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -169.89 148.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -135.72 163.32 30.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -129.06 81.07 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 167' ' ' GLY . 2.0 p30 46.55 -161.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 166' ' ' ASP . . . 95.45 -57.08 1.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.137 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.39 19.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 170' ' ' ARG . 49.4 m -137.67 -86.03 0.29 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.673 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 169' ' ' THR . 4.9 mtt180 -164.08 -82.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.906 0.384 . . . . 0.0 111.008 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -138.12 -150.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.129 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.502 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 1.1 m95 -68.6 67.78 0.14 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.425 ' HE3' ' N ' ' A' ' 92' ' ' GLU . 20.4 mmm -89.73 119.97 30.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.39 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.407 ' C ' ' CD2' ' A' ' 175' ' ' HIS . 6.9 m -76.77 166.21 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.753 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.418 ' ND1' ' OH ' ' A' ' 87' ' ' TYR . 17.0 m-70 -138.43 93.09 2.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.401 ' HA3' ' HG ' ' A' ' 109' ' ' LEU . . . -75.89 118.74 5.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.602 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.485 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 4.2 m-85 -114.75 108.21 16.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.7 mt -88.88 98.52 11.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.46 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.413 ' HB3' ' CE2' ' A' ' 160' ' ' PHE . . . -47.18 135.98 9.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.443 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.0 t -54.15 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -55.81 -29.93 60.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.382 . . . . 0.0 110.589 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.93 67.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.116 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.77 21.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.349 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 188' ' ' SER . . . 40.96 34.42 0.8 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.337 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.3 -6.64 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.483 ' HB3' ' CG ' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -124.66 -10.82 7.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.441 ' CD2' ' CG1' ' A' ' 85' ' ' VAL . 7.9 mp -136.04 -46.54 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.482 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 14.9 t -61.11 -52.01 66.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.75 -30.19 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.75 -69.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.97 -48.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -61.1 -26.93 66.49 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.802 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -78.31 -33.0 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.46 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.464 ' CB ' ' CG1' ' A' ' 123' ' ' VAL . . . -51.46 -44.3 62.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CE2' ' CG1' ' A' ' 144' ' ' ILE . 93.8 m-85 -58.62 -22.44 56.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -47.48 -48.53 26.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.011 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.431 ' CG2' ' HA3' ' A' ' 125' ' ' GLY . 2.4 m -73.58 -35.79 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.146 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 35.4 t -44.07 -45.03 7.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.178 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.18 -29.8 10.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.471 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 58.91 120.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.506 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 68.41 39.41 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.316 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm 48.54 29.0 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.01 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -80.99 67.03 6.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.118 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -27.77 38.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 62.82 44.34 6.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.9 p -55.82 -44.72 78.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.013 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.26 -54.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.973 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 59.07 105.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.006 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.77 -71.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.012 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.421 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.71 80.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mm 70.43 -64.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.64 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.58 -79.07 0.07 OUTLIER Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.816 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.421 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 38.2 Cg_exo -57.45 -33.33 96.16 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.771 2.314 . . . . 0.0 111.943 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.436 ' C ' ' CD2' ' B' ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.841 179.774 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.4 95.43 12.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.33 -7.12 19.19 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.632 2.221 . . . . 0.0 112.84 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -110.26 140.66 44.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.715 0.293 . . . . 0.0 110.76 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.62 -64.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.338 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -52.86 -46.65 67.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.522 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 7.0 pt20 -48.06 -36.52 13.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.088 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -82.77 -58.5 2.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.434 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -46.88 -29.73 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.45 -40.77 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.29 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -93.98 -14.37 25.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 178.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.72 93.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 46.1 t -65.49 -49.55 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.514 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.417 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 19.9 mtm-85 -50.49 -53.47 29.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.733 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.28 -0.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.516 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 64.77 80.58 0.23 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.706 0.289 . . . . 0.0 111.07 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 t -179.32 44.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -106.9 163.51 12.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.739 0.304 . . . . 0.0 110.757 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.56 146.18 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -157.43 129.42 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.4 ' N ' HD22 ' A' ' 120' ' ' LEU . 1.4 t -52.38 159.1 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.524 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 86' ' ' LYS . 13.0 p -172.92 160.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 111.691 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' N ' HG23 ' A' ' 85' ' ' VAL . 7.3 mmtt -108.02 65.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.735 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.529 ' CE2' ' CG ' ' A' ' 177' ' ' PHE . 0.3 OUTLIER -60.36 126.05 26.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.414 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 88' ' ' LEU . 6.2 mp -77.92 -31.58 51.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.586 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.79 -164.13 15.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.254 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.426 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 20.2 m -105.19 147.59 27.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.992 0.425 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.429 ' O ' ' CE ' ' A' ' 173' ' ' MET . 0.4 OUTLIER -126.68 171.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.045 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 1.6 pt-20 -90.63 140.8 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 92' ' ' GLU . 34.3 m -158.41 179.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.839 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.07 18.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.46 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -152.72 112.99 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.414 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.442 ' CB ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -106.67 25.11 11.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.901 177.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.64 33.66 2.23 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.982 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.27 106.82 0.56 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.433 ' CE ' ' HB3' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -49.82 -25.69 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 110.871 179.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -76.31 -26.26 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.859 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.6 t -67.44 -39.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.967 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.3 m -72.15 -48.09 46.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.345 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -52.95 -38.24 61.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.349 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.83 -42.13 14.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.768 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -49.78 -48.12 50.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 tt -50.87 -46.12 60.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -40.83 90.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.062 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' SER . 41.3 t -61.77 -31.19 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.058 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.441 ' CD1' ' HG3' ' A' ' 114' ' ' ARG . 3.2 mm? -67.54 -21.46 65.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -89.11 -50.38 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -24.08 64.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 96.2 p -79.17 170.82 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.27 -22.55 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.417 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -46.36 159.61 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.107 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -150.09 153.49 35.48 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.82 0.343 . . . . 0.0 111.418 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.53 163.2 15.85 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.801 2.334 . . . . 0.0 112.36 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.437 ' O ' ' CG1' ' A' ' 117' ' ' VAL . 7.4 p -133.82 110.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.85 74.31 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.439 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -134.48 -156.73 7.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 84' ' ' SER . 0.4 OUTLIER -123.92 125.54 44.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 111.43 -178.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.91 105.67 14.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.264 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -76.84 98.44 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.424 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.434 HG23 ' CG2' ' A' ' 191' ' ' VAL . 97.0 t -101.96 108.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 48.1 p -125.85 40.57 3.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.116 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.434 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 40.58 35.56 0.87 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.211 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.415 ' CA ' HG23 ' A' ' 144' ' ' ILE . 19.7 t0 -158.21 -40.5 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.551 0.215 . . . . 0.0 111.452 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -147.63 121.24 1.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.991 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.486 HD21 ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -83.56 91.37 7.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.817 0.341 . . . . 0.0 110.427 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.416 ' CA ' HD13 ' A' ' 138' ' ' LEU . 3.5 mtt85 -107.28 98.45 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 87' ' ' TYR . 4.4 p -90.11 106.26 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.32 163.84 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -109.96 136.8 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.43 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -79.18 3.06 18.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.97 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -116.03 -32.42 5.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.7 p -115.91 -23.05 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.359 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.14 18.37 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.129 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.67 125.42 8.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.062 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.416 HD13 ' CA ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -59.05 126.4 27.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.439 ' HB ' ' CG1' ' A' ' 130' ' ' VAL . 6.0 mt -89.73 -24.07 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.706 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.09 63.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.402 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 9.4 p-10 -73.32 61.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.554 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -131.89 159.84 37.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.418 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 91.5 m -75.88 143.17 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.712 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.415 HG23 ' CA ' ' A' ' 126' ' ' ASP . 7.9 tt -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -77.07 -30.19 55.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.707 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -76.44 -20.3 57.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 163' ' ' ILE . 0.6 OUTLIER -78.07 169.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.61 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -83.92 8.8 13.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.85 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.411 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.9 m-85 78.97 139.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.238 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.483 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 29.4 p -74.38 -174.42 2.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.767 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . -166.23 55.5 0.36 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.691 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 50.9 Cg_exo -52.2 110.86 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.205 1.937 . . . . 0.0 111.374 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.433 ' HB3' ' CE ' ' A' ' 99' ' ' MET . 29.9 t0 -171.46 79.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.246 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.401 ' NH1' ' O ' ' A' ' 151' ' ' ALA . 6.6 mpt_? -130.62 -43.64 1.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.52 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 46.41 27.76 0.64 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -122.68 -33.98 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.402 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -149.87 18.22 0.89 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.007 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' A' ' 158' ' ' ARG . 0.1 OUTLIER 58.97 57.5 3.54 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.533 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.34 149.27 18.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.718 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -139.83 172.82 12.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 40.7 t -165.25 134.93 3.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.493 ' CE1' ' CZ ' ' A' ' 177' ' ' PHE . 2.7 m-30 -89.54 -165.28 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.502 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.422 ' O ' ' CG1' ' A' ' 147' ' ' VAL . 0.8 OUTLIER -164.77 158.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.392 . . . . 0.0 111.668 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 42.6 t -159.89 127.95 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HG3' ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.71 87.61 7.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.103 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 45.3 -158.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.03 -71.67 0.26 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.109 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.1 m -130.3 17.19 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 0.0 111.084 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.432 HG23 ' CG ' ' A' ' 173' ' ' MET . 18.6 m -131.07 23.83 4.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 169' ' ' THR . 11.5 mmm180 84.95 -71.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.456 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 -158.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.985 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.418 ' O ' ' N ' ' A' ' 93' ' ' VAL . 1.9 m-90 -65.77 94.67 0.22 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.432 ' CG ' HG23 ' A' ' 169' ' ' THR . 0.3 OUTLIER -110.61 158.37 18.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 111.702 -177.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.94 174.98 5.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.878 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -137.67 74.62 1.49 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.96 0.41 . . . . 0.0 110.774 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -76.55 129.22 9.76 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.92 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.529 ' CG ' ' CE2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -153.92 160.11 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.91 127.1 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.832 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -47.73 134.78 12.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.504 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -63.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -62.16 -29.27 70.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.556 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.45 80.16 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.178 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.65 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.462 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.25 29.96 0.25 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.201 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.02 56.55 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.401 ' O ' ' CB ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -169.17 -41.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.987 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.65 -45.56 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.688 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -49.37 67.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.807 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -82.75 -27.98 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.813 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -70.06 -57.6 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.883 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 123' ' ' VAL . 1.2 t -76.52 -26.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.69 -32.69 32.93 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.62 -20.76 22.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.648 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.447 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . . . -46.58 -37.99 8.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.142 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -77.09 -23.59 51.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.005 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -50.71 -35.34 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.825 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.93 -30.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.621 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 50.2 t -51.75 -39.84 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.308 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 203' ' ' GLN . 0.1 OUTLIER -107.06 -26.89 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.25 123.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.28 19.25 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.124 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt 46.74 48.76 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.487 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . 0.405 ' N ' HD11 ' A' ' 199' ' ' LEU . 40.2 tp60 -51.96 -47.34 64.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.87 0.366 . . . . 0.0 110.521 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 42.82 97.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.778 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -69.87 72.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.831 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.4 p -113.01 38.97 2.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.034 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -136.57 -60.7 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.031 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -98.95 73.11 1.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.21 -170.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.154 -0.926 . . . . 0.0 111.01 179.936 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.44 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -177.15 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mp -45.14 -27.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.85 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' B' ' 6' ' ' PTR . . . -48.56 -82.66 0.03 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.968 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 32.9 Cg_exo -66.09 60.34 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.026 2.484 . . . . 0.0 112.085 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.407 ' N ' ' O ' ' B' ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.427 HD11 ' N ' ' B' ' 7' ' ' LEU . 4.7 mp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.922 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.906 0.384 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -71.3 142.62 87.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.966 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.56 -178.3 3.63 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.66 2.24 . . . . 0.0 112.295 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.4 -162.93 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -43.22 -36.09 1.64 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.09 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -54.03 -43.93 70.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.925 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -47.69 -33.39 6.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.25 -61.01 1.87 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.304 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 34.1 m-20 -48.38 -32.14 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.186 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -28.93 69.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -99.45 -29.26 12.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.127 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 72' ' ' ASP . . . -48.26 -35.84 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.938 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -61.91 -34.27 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.004 0.43 . . . . 0.0 110.512 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -64.39 -56.49 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.23 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -10.49 56.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.342 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 73.18 76.47 0.14 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.733 0.302 . . . . 0.0 111.055 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t -177.58 47.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.7 173.14 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.699 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 12.5 m -171.45 150.77 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 82' ' ' SER . 85.8 m-85 -161.56 136.91 7.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.834 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.73 163.8 1.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 86' ' ' LYS . 7.4 p 178.88 155.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 111.512 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.427 ' N ' HG23 ' A' ' 85' ' ' VAL . 1.8 mtpp -109.93 62.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.332 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.429 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . 14.4 t80 -47.26 111.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.487 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.47 ' CD2' ' CB ' ' A' ' 109' ' ' LEU . 3.5 mp -55.22 -44.08 75.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.67 -157.96 22.82 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.461 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 25.9 p -116.68 156.08 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.5 m -152.28 135.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.022 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 139.36 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 11.0 m -142.02 169.49 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.68 -24.15 27.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -133.93 126.18 29.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.869 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.28 21.52 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.831 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.54 130.89 4.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.01 136.74 5.29 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.753 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 178.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 71.39 -61.63 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 110.355 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 105' ' ' ALA . 86.0 t -52.28 -44.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.292 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.9 p -63.26 -39.18 93.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.216 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -60.69 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.141 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 19.9 pt-20 -64.52 -38.54 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.052 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB2' ' CB ' ' A' ' 174' ' ' CYS . . . -53.39 -24.77 13.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.088 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -45.24 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.17 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 5.5 pttt -57.12 -34.15 68.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.453 ' N ' ' HG3' ' A' ' 107' ' ' LYS . 41.1 t -59.98 -37.64 73.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.03 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.47 ' CB ' ' CD2' ' A' ' 88' ' ' LEU . 4.6 mm? -54.91 -25.99 32.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.938 0.399 . . . . 0.0 110.001 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.88 -51.56 4.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -49.5 -26.36 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.518 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.41 -163.36 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.729 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.38 26.22 6.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.286 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.433 ' CB ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -78.18 81.46 4.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.735 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.415 ' HG3' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -73.48 130.13 84.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.247 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.415 ' HD2' ' HG3' ' A' ' 115' ' ' ARG . 77.4 Cg_exo -50.96 169.94 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.224 1.949 . . . . 0.0 111.937 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 117' ' ' VAL . 9.8 p -132.95 114.48 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.414 . . . . 0.0 111.612 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -74.59 78.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.996 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 131' ' ' VAL . . . -132.55 -158.52 8.93 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.332 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mt -116.91 131.98 56.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.362 . . . . 0.0 111.065 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.437 ' HG ' ' CG2' ' A' ' 123' ' ' VAL . 49.5 tp -91.42 102.54 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.446 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -74.53 83.59 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.597 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.437 ' CG2' ' HG ' ' A' ' 121' ' ' LEU . 84.1 t -89.25 115.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.47 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.9 33.38 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 45.52 45.13 11.91 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.563 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 144' ' ' ILE . 2.0 t0 -168.15 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -157.84 115.16 0.65 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.05 78.39 7.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.821 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -85.03 107.8 17.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.7 108.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 110.967 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.407 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 21.8 t -94.65 134.03 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.997 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -80.37 131.27 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.435 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 28.8 t0 -79.62 3.4 19.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.05 -24.74 14.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.75 0.309 . . . . 0.0 110.936 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 53.7 p -151.33 19.29 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.337 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 44.58 28.54 0.33 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.985 0.421 . . . . 0.0 111.307 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.55 138.21 16.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.314 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.447 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 5.0 tp -86.7 124.28 32.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 117' ' ' VAL . 8.6 mt -95.37 -54.74 6.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.562 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.61 83.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 111.461 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.447 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 7.2 t0 -93.85 73.86 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.192 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -141.89 137.07 31.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.279 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.44 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 23.9 m -60.52 135.28 57.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.443 ' CG1' ' CE1' ' A' ' 195' ' ' PHE . 19.3 tt -59.48 -34.19 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.696 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' CG ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -73.81 -22.75 59.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.249 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.09 26.55 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.193 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 143' ' ' THR . 0.2 OUTLIER -121.82 176.9 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.607 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 t -90.09 17.36 7.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.434 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 73.83 -167.45 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.988 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 25.0 p -123.51 176.3 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -171.42 103.6 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.7 123.67 12.75 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.4 2.066 . . . . 0.0 112.466 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.66 -156.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.526 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -98.8 22.4 10.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 110.854 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 156' ' ' HIS . 1.9 m120 -57.11 -20.21 24.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.29 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 155' ' ' ASN . 6.9 t-160 91.56 -34.24 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.479 0.712 . . . . 0.0 111.866 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 158' ' ' ARG . 0.0 OUTLIER 176.6 70.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 111.845 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 5.8 ptp180 165.23 -33.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.114 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -81.21 114.73 3.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.109 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 188' ' ' SER . 8.9 m-85 -120.42 166.44 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.87 112.77 0.48 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 111.35 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.494 ' CE2' ' CD2' ' A' ' 177' ' ' PHE . 2.5 m-30 -88.58 -178.68 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.572 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.43 ' O ' ' CG1' ' A' ' 147' ' ' VAL . 0.4 OUTLIER -158.39 145.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.785 0.326 . . . . 0.0 111.324 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 17.0 p -135.09 148.59 49.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.565 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -106.85 83.17 1.8 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.587 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 43.91 -173.61 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.518 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.94 -55.95 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.962 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.64 25.52 3.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.451 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -76.33 0.36 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.97 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.45 -78.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -133.68 -153.67 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.944 179.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.422 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 15.5 m95 -60.23 83.9 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.897 0.379 . . . . 0.0 109.992 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.6 OUTLIER -90.75 120.66 31.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.355 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 105' ' ' ALA . 1.3 m -92.39 159.25 15.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.932 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.426 ' ND1' ' OH ' ' A' ' 87' ' ' TYR . 19.5 m-70 -136.62 119.44 16.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.834 0.349 . . . . 0.0 111.309 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -92.8 110.89 3.99 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.951 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 162' ' ' TYR . 2.3 m-85 -108.42 119.51 39.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.116 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.7 108.28 16.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.99 141.01 18.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.314 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 31.5 t -63.37 -53.48 51.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.41 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.39 -22.12 63.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.748 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.65 71.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.974 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 p -166.53 27.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.792 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.72 26.67 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.925 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.68 54.33 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.462 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 3.1 tpt180 -175.72 -37.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' CD2' ' HB ' ' A' ' 85' ' ' VAL . 8.6 mp -120.52 -39.78 2.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.908 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 45.7 t -52.9 -55.72 21.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -31.64 58.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.771 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -66.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.8 t -56.0 -54.63 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.36 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.39 31.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.478 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 4.7 t -67.98 -27.48 66.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.488 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.49 -41.49 69.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.443 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 96.2 m-85 -63.37 -21.89 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.852 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -47.77 -28.3 2.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.27 -31.54 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.575 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -56.72 -41.36 77.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.137 178.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.1 -34.91 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 200' ' ' GLU . 30.1 tt0 58.81 20.03 7.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.779 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 176.54 35.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.304 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm 41.55 37.65 0.74 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.854 0.359 . . . . 0.0 111.365 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.09 -32.77 7.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.2 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.427 ' HG2' ' CD2' ' B' ' 7' ' ' LEU . 0.0 OUTLIER 42.48 62.67 1.63 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.546 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -51.1 115.09 1.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.978 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.5 p -146.78 25.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.09 -58.32 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -149.99 -76.34 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.024 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 60.88 154.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.058 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.065 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.43 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.796 0.331 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -176.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.361 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.402 ' HA ' ' HB3' ' B' ' 7' ' ' LEU . 3.8 mp -46.19 -26.1 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.073 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.04 -85.61 0.02 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.918 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.446 ' O ' ' CG ' ' B' ' 6' ' ' PTR . 32.0 Cg_exo -61.22 109.91 0.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.544 2.163 . . . . 0.0 110.112 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.446 ' CG ' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.436 ' N ' ' HD2' ' B' ' 6' ' ' PTR . 3.0 mt . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.864 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.83 0.347 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -114.71 69.89 2.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.005 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.62 56.65 4.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.561 2.174 . . . . 0.0 112.548 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -141.81 -58.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.711 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -105.1 -40.74 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.516 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -61.85 -45.0 95.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.692 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 6.9 pt20 -49.64 -35.42 21.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.979 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -76.7 -67.88 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.368 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -46.96 -45.36 20.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.307 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -49.45 -37.2 24.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.822 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -86.54 -35.4 19.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.757 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.54 -59.67 4.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -52.31 -36.82 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -48.07 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.422 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.06 17.65 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 54.72 92.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.662 0.268 . . . . 0.0 111.313 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t 174.43 46.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.29 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -121.01 152.27 38.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 1.8 m -157.7 144.48 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.922 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.532 ' CE1' ' CB ' ' A' ' 121' ' ' LEU . 3.5 p90 -146.83 172.14 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 111.247 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.405 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -84.08 154.49 23.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 ' CG2' ' CD2' ' A' ' 187' ' ' LEU . 11.4 p -174.2 160.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.738 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' N ' HG23 ' A' ' 85' ' ' VAL . 4.1 mmtt -117.24 75.65 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 177' ' ' PHE . 0.6 OUTLIER -56.69 115.56 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.402 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 177' ' ' PHE . 7.7 mp -64.91 -37.54 87.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.58 -129.07 3.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.532 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.7 p -171.02 124.12 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.61 129.68 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.365 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.429 ' N ' ' HE3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -57.47 155.55 9.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 19.5 m -150.6 177.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.195 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -94.68 -11.17 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.44 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.82 136.25 46.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.823 0.344 . . . . 0.0 110.921 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.3 p -101.32 23.02 11.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.767 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.54 -167.97 2.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.02 109.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -28.38 8.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.42 -45.5 94.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.7 t -51.41 -32.56 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -42.9 59.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.761 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -45.35 74.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.43 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -75.96 -38.07 57.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.83 -45.04 74.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.472 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp -56.8 -42.42 79.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.3 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -42.47 95.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.344 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.429 ' HA ' ' CG ' ' A' ' 111' ' ' GLN . 2.4 t -66.26 -40.55 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.011 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -52.08 -23.19 4.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.25 -50.23 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.536 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.429 ' CG ' ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.68 -22.48 66.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.553 -178.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.65 165.8 14.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.31 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -21.5 13.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -41.75 114.97 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.48 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 139.33 20.01 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 34.1 Cg_exo -58.39 154.04 43.78 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.627 2.218 . . . . 0.0 112.789 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 139' ' ' ILE . 3.4 p -110.97 170.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -137.82 88.29 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.538 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.71 -150.94 5.53 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.739 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 84' ' ' SER . 10.6 mt -123.04 151.22 42.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.487 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.532 ' CB ' ' CE1' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -99.04 106.88 19.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.478 ' CD2' HG22 ' A' ' 131' ' ' VAL . 41.7 m-70 -71.57 63.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.49 ' CG2' ' CE2' ' A' ' 83' ' ' PHE . 70.9 t -66.96 107.45 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.7 m -131.69 31.83 4.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 48.0 29.09 6.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.565 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -140.97 -43.25 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -159.39 122.18 1.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.977 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.466 HD22 ' CE2' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.04 82.98 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.76 0.314 . . . . 0.0 110.558 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.0 mtt85 -95.73 81.71 3.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.313 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.404 HG22 ' CD1' ' A' ' 87' ' ' TYR . 2.0 p -73.55 88.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.21 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.478 HG22 ' CD2' ' A' ' 122' ' ' HIS . 72.8 t -76.5 156.26 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.093 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -100.42 122.54 43.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.22 0.33 22.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.72 -32.21 8.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.5 p -119.82 -36.52 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.964 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.9 OUTLIER 67.02 44.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -109.83 16.65 30.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.095 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 137' ' ' GLY . 6.9 tp 46.23 107.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.361 0.601 . . . . 0.0 111.673 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.447 ' CD1' HG13 ' A' ' 117' ' ' VAL . 32.4 mt -72.94 -61.62 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.908 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.2 t -104.58 97.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -98.92 71.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.18 172.67 12.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.1 m -92.37 147.91 22.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.629 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.429 ' CD1' HD12 ' A' ' 128' ' ' LEU . 19.4 tt -81.12 -19.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.786 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -84.88 -36.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.212 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -43.17 14.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 144' ' ' ILE . 10.4 p -46.03 164.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.314 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -70.85 -2.54 15.3 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.0 m-85 84.22 166.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.887 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.494 ' CB ' ' CD1' ' A' ' 162' ' ' TYR . 29.0 p -87.43 -173.02 4.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.613 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 173.74 101.53 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.444 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.65 129.79 18.33 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.594 2.196 . . . . 0.0 112.934 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -60.65 -150.34 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.209 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -107.97 19.66 19.73 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.625 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 156' ' ' HIS . 0.7 OUTLIER -55.77 -21.97 21.81 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.234 177.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' CB ' ' O ' ' A' ' 155' ' ' ASN . 4.0 t-80 90.49 -30.84 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.32 0.648 . . . . 0.0 111.47 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.06 71.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.706 0.288 . . . . 0.0 111.505 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.41 ' CD ' ' OD2' ' A' ' 182' ' ' ASP . 7.2 ptt180 167.82 -29.69 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.809 0.337 . . . . 0.0 111.225 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 160' ' ' PHE . . . -104.69 127.55 9.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.644 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 6.1 m-85 -139.06 177.64 7.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 p -175.3 125.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.494 ' CD1' ' CB ' ' A' ' 150' ' ' CYS . 4.9 m-30 -98.1 -171.75 2.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -156.97 155.18 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 22.9 p -146.12 143.22 29.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.952 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 79.34 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.061 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 168' ' ' THR . 37.9 t0 59.36 -88.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.761 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.98 -83.11 0.01 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.431 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 166' ' ' ASP . 1.8 m -139.72 22.34 2.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 92.8 m -111.36 -82.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -158.03 -70.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.683 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -150.05 -155.51 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.977 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.524 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -65.46 76.23 0.06 Allowed 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.429 ' HE3' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -92.41 121.14 33.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.081 -177.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.16 142.54 28.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -114.49 118.7 34.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.998 0.428 . . . . 0.0 111.161 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -115.45 151.88 18.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.833 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 0.4 OUTLIER -178.62 176.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 111.956 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.28 139.82 35.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.153 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.434 ' HA ' ' CD2' ' A' ' 187' ' ' LEU . . . -64.25 138.71 58.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 0.0 111.615 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -76.81 -27.78 55.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.656 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.41 ' OD2' ' CD ' ' A' ' 158' ' ' ARG . 1.4 t70 60.31 36.92 20.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.464 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.4 p -151.56 19.09 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.674 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.88 26.53 1.19 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.263 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.76 24.14 13.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -179.34 37.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.086 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.497 ' HG ' ' CD1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -167.52 -52.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.469 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.9 t -73.75 -66.64 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -52.41 -36.81 55.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.478 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.424 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -63.49 -71.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.954 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.9 t -50.37 -48.86 25.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.994 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.03 -27.26 21.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.885 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 60.8 m -87.24 -28.32 22.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.94 0.4 . . . . 0.0 110.52 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.44 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -51.31 -51.31 55.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.461 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -55.06 -23.95 22.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.256 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 193' ' ' CYS . . . -46.53 -49.88 18.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.856 0.36 . . . . 0.0 111.202 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.75 -38.93 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 30.4 t -65.15 -30.78 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.201 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.32 57.4 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.296 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -48.22 -26.82 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -121.31 25.18 9.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.524 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp 48.07 45.36 19.43 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.081 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -71.56 66.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.848 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.412 ' CG ' ' O ' ' A' ' 204' ' ' ARG . 0.3 OUTLIER -76.71 76.93 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.986 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -82.83 65.29 7.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.421 HG23 ' CB ' ' B' ' 7' ' ' LEU . 7.1 p -92.09 170.35 9.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -57.53 138.97 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 55.9 92.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -74.3 152.49 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.136 179.78 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.432 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.35 -87.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.44 HD11 HG22 ' B' ' 3' ' ' ILE . 28.7 mm -116.01 -51.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.867 0.365 . . . . 0.0 111.094 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.427 ' HA2' ' CB ' ' A' ' 149' ' ' PHE . . . -50.98 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.361 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.432 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 32.3 Cg_exo -57.78 -34.41 98.19 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.423 HD23 ' CG2' ' B' ' 3' ' ' ILE . 6.2 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.855 0.36 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.483 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 1.7 ptpt -137.69 47.32 1.63 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.357 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 65' ' ' LYS . 10.0 Cg_endo -51.18 -70.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.654 2.236 . . . . 0.0 112.189 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -136.74 -83.03 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.775 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.62 -28.78 65.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.759 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.432 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m0 -55.86 -46.41 78.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.07 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 65' ' ' LYS . 2.0 pp0? -49.59 -33.48 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.004 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.33 -70.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.67 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -47.39 -32.04 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.489 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -65.21 -25.66 67.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 110.959 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 13.4 mt-10 -102.28 -35.91 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.91 -55.44 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.7 m -55.14 -38.51 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -34.8 73.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -88.66 -12.13 43.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.198 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 75.28 73.16 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.841 0.353 . . . . 0.0 111.149 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -179.24 50.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.43 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 0.0 OUTLIER -112.84 -179.35 3.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB3' ' ND1' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -174.15 122.69 0.3 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.503 0.668 . . . . 0.0 111.096 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.5 ' CZ ' ' HA ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -127.77 130.15 48.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.511 -177.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -60.68 160.41 9.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 121' ' ' LEU . 7.5 p -177.77 159.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 111.923 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.424 ' N ' HG23 ' A' ' 85' ' ' VAL . 10.7 mttt -107.91 62.48 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.211 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.443 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . 31.6 t80 -55.6 119.86 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.472 -178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.83 -43.04 98.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.041 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 136.17 -159.02 24.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.975 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -115.51 145.8 42.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.023 0.44 . . . . 0.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.426 ' O ' ' CE ' ' A' ' 173' ' ' MET . 0.5 OUTLIER -137.27 174.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.401 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -101.16 146.7 27.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.305 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 4.5 m -144.55 163.85 13.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.027 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -84.79 -3.95 58.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.899 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -153.29 126.71 8.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.847 0.356 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 p -95.72 27.08 3.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.604 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -151.03 149.46 29.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.0 -147.06 18.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.96 -46.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -26.93 15.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.14 -36.73 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.782 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 53.7 m -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -39.23 87.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.53 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -82.4 -34.09 28.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.29 13.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.678 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -43.35 44.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.22 77.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.29 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.54 -43.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.917 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.418 ' CD1' ' HG3' ' A' ' 114' ' ' ARG . 3.1 mm? -53.14 -22.36 6.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -47.0 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.389 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -9.1 58.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.014 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.23 172.35 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.198 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.37 6.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.666 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.418 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 2.4 mmt180 -43.18 113.38 0.48 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.431 ' CG ' ' HD2' ' A' ' 116' ' ' PRO . 60.8 ttt180 -118.66 144.97 36.53 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.321 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 115' ' ' ARG . 75.3 Cg_exo -50.34 155.39 4.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.813 2.342 . . . . 0.0 112.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 10.7 p -126.39 109.55 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.252 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 133' ' ' ASP . 2.6 ttt180 -69.33 70.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.124 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.94 -165.26 11.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.232 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 122' ' ' HIS . 1.9 tm? -120.75 119.23 32.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 3.6 tp -77.38 83.7 3.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.075 0.464 . . . . 0.0 110.15 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.425 ' ND1' ' HB3' ' A' ' 82' ' ' SER . 0.3 OUTLIER -66.03 82.61 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.827 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 1.8 m -70.78 178.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 p -178.01 31.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.86 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 194' ' ' ALA . . . 40.93 32.55 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.722 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.442 ' CA ' HG23 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -172.12 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.553 0.216 . . . . 0.0 111.398 -178.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -153.75 117.12 0.78 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.879 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.13 130.02 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.748 0.309 . . . . 0.0 110.569 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.01 90.67 2.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.72 102.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.0 t -91.96 135.91 25.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -78.36 137.59 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 118' ' ' ARG . 11.3 t0 -87.83 16.12 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -117.43 -35.0 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 43.3 p -119.26 -15.88 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.649 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.92 36.07 7.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.91 -164.79 24.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.873 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -122.5 132.01 54.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.12 -23.52 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.77 60.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.195 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.417 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 20.3 p-10 -67.74 73.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.484 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -145.13 151.37 38.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 111.407 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.429 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 0.2 OUTLIER -60.62 179.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.746 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.442 HG23 ' CA ' ' A' ' 126' ' ' ASP . 16.4 tt -108.07 -23.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -86.89 -24.18 24.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.879 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -94.76 21.33 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 164' ' ' CYS . 0.0 OUTLIER -115.12 178.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.419 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -87.23 13.96 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 76.79 -177.61 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.771 0.319 . . . . 0.0 111.045 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 3.9 m -111.33 163.17 14.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 111.281 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -174.75 98.45 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.866 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.34 159.44 43.8 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.182 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 22.4 m-20 -78.33 57.3 1.88 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.43 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 153' ' ' ASP . 1.3 ttt180 82.02 6.43 1.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.023 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 40.39 30.68 0.08 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.78 0.324 . . . . 0.0 111.716 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.99 -15.17 52.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.796 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.68 29.23 2.14 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.473 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.429 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.0 OUTLIER 60.48 40.58 16.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.961 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.05 110.71 2.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.593 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 5.9 m-85 -91.82 170.28 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -164.18 107.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 150' ' ' CYS . 4.0 m-30 -88.94 -179.5 5.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.325 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -159.32 148.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.44 ' CB ' HG11 ' A' ' 147' ' ' VAL . 19.6 p -139.21 157.84 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.752 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 87.32 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.885 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' THR . 3.1 p-10 47.62 26.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.169 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.72 80.04 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.417 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 166' ' ' ASP . 17.1 p 55.0 25.7 7.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.678 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -119.22 -78.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -158.79 -81.66 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 111.112 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -143.42 -148.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.891 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.493 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -66.76 74.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.426 ' CE ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.29 118.1 27.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.352 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.42 168.08 17.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.091 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.419 ' ND1' ' OH ' ' A' ' 87' ' ' TYR . 31.3 m-70 -140.58 90.54 2.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.783 0.325 . . . . 0.0 111.407 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -69.46 107.01 1.96 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -104.99 138.67 40.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.37 108.4 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.388 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -44.88 145.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.713 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.02 -59.7 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -68.31 -27.44 66.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.17 82.43 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.172 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.429 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 8.3 t -168.6 29.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.06 27.89 1.17 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.898 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.0 49.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.0 110.79 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 83' ' ' PHE . 25.3 mmt180 -149.84 -46.5 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.486 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.485 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . 2.6 mp -119.66 -36.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.122 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -58.42 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -18.46 47.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.543 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 193' ' ' CYS . . . -87.83 -74.25 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.272 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.413 HG11 ' N ' ' A' ' 192' ' ' GLY . 3.4 p -52.09 -29.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.117 0.484 . . . . 0.0 110.119 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' N ' HG11 ' A' ' 191' ' ' VAL . . . -74.13 -30.45 60.98 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -71.0 -32.04 68.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.139 0.495 . . . . 0.0 109.667 177.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.429 ' CB ' ' HA2' ' A' ' 125' ' ' GLY . . . -50.95 -33.6 25.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.564 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.418 ' O ' ' CD1' ' A' ' 199' ' ' LEU . 17.6 m-85 -61.45 -24.88 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.731 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.02 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.292 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.63 -34.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 31.9 t -52.16 -28.33 17.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.656 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' B' ' 3' ' ' ILE . 0.6 OUTLIER -121.43 -38.41 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 201' ' ' ARG . 0.8 OUTLIER 63.2 105.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.043 -178.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.414 ' CB ' ' O ' ' A' ' 200' ' ' GLU . 1.1 ttt85 79.4 20.0 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.711 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm 47.45 47.89 16.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.322 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -58.56 -30.6 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.57 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.28 145.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.107 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -93.41 21.66 5.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.189 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.7 p -85.52 -165.33 1.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.31 74.23 1.85 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.817 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -48.96 -45.06 41.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.217 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 48.9 39.67 14.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.169 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.037 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.643 0.259 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 178.43 -92.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.069 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.422 ' CG2' HD22 ' A' ' 199' ' ' LEU . 5.1 mm -135.39 64.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.115 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.46 -78.63 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.457 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -47.16 -42.22 26.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.531 2.154 . . . . 0.0 112.139 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.417 ' CD1' ' N ' ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' B' ' 6' ' ' PTR . 4.0 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.691 0.282 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 8.0 mtmt 51.8 51.07 9.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 110.765 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' LYS . 10.6 Cg_endo -53.37 -82.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.75 2.3 . . . . 0.0 112.241 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -141.62 -69.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 110.183 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.95 -28.91 40.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.081 0.467 . . . . 0.0 109.778 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.425 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 1.2 m0 -81.77 -33.9 30.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.168 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -24.13 65.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.965 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.66 -46.97 6.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.02 -46.04 65.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.08 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 69' ' ' TRP . 5.3 tt0 -50.57 -41.8 54.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.39 -23.23 35.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.57 -53.04 57.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.874 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' CG2' ' HB1' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -58.41 -43.64 87.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.266 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -53.42 -45.5 69.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.468 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 17.0 12.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.101 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 56.56 85.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.646 0.26 . . . . 0.0 111.303 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t 174.24 51.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.81 166.7 12.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.763 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 2.0 m -166.48 160.21 15.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.048 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.469 ' CG ' ' O ' ' A' ' 82' ' ' SER . 21.2 m-85 -167.99 141.35 3.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.428 ' N ' HD11 ' A' ' 120' ' ' LEU . 8.2 t -59.37 158.74 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 187' ' ' LEU . 14.9 p -175.47 160.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 111.952 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' N ' HG23 ' A' ' 85' ' ' VAL . 8.5 mttt -114.56 57.97 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.703 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 26.7 t80 -47.67 134.38 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 7.4 mp -79.21 -58.08 3.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.906 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.465 ' HA2' ' CE2' ' A' ' 87' ' ' TYR . . . 151.06 -155.34 26.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.543 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 20.0 p -121.26 144.03 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 m -134.78 142.59 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.1 124.63 24.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 15.4 m -127.25 176.92 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.985 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.22 2.9 53.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.886 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -153.85 164.97 37.49 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.974 0.416 . . . . 0.0 111.073 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 83.7 p -132.95 23.93 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.669 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.78 168.63 19.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.15 154.38 24.21 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -24.09 24.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.03 -42.5 97.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.044 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.73 -30.5 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -70.81 -58.08 3.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.037 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -48.27 -37.57 16.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 105' ' ' ALA . 12.3 pt-20 -83.86 -42.17 16.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.817 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -50.4 -48.76 55.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.431 HD23 ' NH2' ' A' ' 154' ' ' ARG . 0.3 OUTLIER -53.82 -51.47 63.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -51.11 -42.45 60.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.468 178.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.424 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 2.2 t -66.27 -35.67 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.119 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.421 HD13 ' CA ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER -53.76 -39.57 65.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -52.6 8.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.04 -36.33 28.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.045 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.04 -167.0 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 31.15 3.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.471 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -90.56 79.41 6.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.631 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -58.35 128.35 82.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.16 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 33.4 Cg_exo -61.53 159.44 32.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.448 2.098 . . . . 0.0 112.435 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -104.88 -178.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -149.54 70.64 1.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.581 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -139.8 -130.09 2.66 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.721 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 84' ' ' SER . 1.4 tp -136.77 139.44 41.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.936 0.398 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.1 tp -92.93 124.66 37.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.392 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -85.24 103.35 14.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.431 ' CG1' ' HB1' ' A' ' 194' ' ' ALA . 96.1 t -109.48 105.97 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -128.73 39.76 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 39.35 48.36 2.87 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.216 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' N ' HG23 ' A' ' 144' ' ' ILE . 4.4 t70 -160.62 -41.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.79 117.8 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.546 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -65.6 133.78 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 0.0 110.97 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.5 mtm-85 -139.42 87.79 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.593 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 139' ' ' ILE . 7.4 p -77.62 140.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.581 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.2 t -135.26 152.7 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.478 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.5 t0 -95.82 149.49 21.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.781 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 5.8 t70 -91.77 19.96 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.351 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -127.27 -40.9 1.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 110.752 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 p -114.06 -19.59 11.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.125 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp 59.3 22.34 10.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 110.784 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.38 120.21 5.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.423 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.448 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 2.0 tp -55.75 133.52 50.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.68 0.276 . . . . 0.0 110.608 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' A' ' 130' ' ' VAL . 6.0 mt -108.12 -43.25 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.08 86.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.529 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.448 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 26.8 t0 -98.09 69.44 2.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.758 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -124.54 179.12 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.82 171.67 8.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.649 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.487 ' CG1' ' CE1' ' A' ' 195' ' ' PHE . 10.1 tt -107.64 -16.7 8.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.404 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.94 -38.32 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 111.022 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -81.15 -24.79 37.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 163' ' ' ILE . 11.6 p -70.64 164.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.651 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 3.1 m -72.91 -2.19 19.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.8 m-85 80.58 -167.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.1 p -129.8 -171.62 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.961 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.446 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . -164.07 58.31 0.66 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.425 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 50.1 Cg_exo -52.87 113.41 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.361 2.041 . . . . 0.0 111.807 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -172.57 95.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 0.0 111.817 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.431 ' NH2' HD23 ' A' ' 106' ' ' LEU . 8.4 ptt180 -179.37 111.38 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.587 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -72.33 -3.82 26.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.462 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -43.57 -65.56 0.48 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -157.15 40.76 0.32 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.828 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 60.55 62.7 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.732 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.83 147.6 17.19 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.541 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 152' ' ' PRO . 1.5 m-85 -131.06 151.07 51.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.04 125.91 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.881 0.372 . . . . 0.0 111.689 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 150' ' ' CYS . 4.4 m-30 -94.94 -172.48 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.198 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 1.0 OUTLIER -165.87 159.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.964 0.411 . . . . 0.0 111.379 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.0 p -157.56 157.66 34.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.494 ' HG3' ' CZ3' ' A' ' 172' ' ' TRP . 0.1 OUTLIER -116.03 85.09 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.3 p30 46.48 -163.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.76 -42.77 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.218 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.4 p -153.32 24.92 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.948 0.404 . . . . 0.0 110.734 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.68 -72.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.034 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.81 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.759 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' MET . 6.2 ptt180 -131.05 -152.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.149 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.494 ' CZ3' ' HG3' ' A' ' 165' ' ' ARG . 4.4 m95 -60.87 82.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -90.18 112.68 24.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.81 -177.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.29 171.41 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.974 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -146.3 118.83 8.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.92 0.391 . . . . 0.0 111.561 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 87' ' ' TYR . . . -92.32 124.19 7.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.74 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 4.7 m-85 -122.89 136.33 54.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.391 . . . . 0.0 111.327 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.79 108.59 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.438 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.469 ' HB1' ' CE2' ' A' ' 160' ' ' PHE . . . -50.1 134.38 22.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 111.177 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -60.38 3.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.79 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -57.6 -33.81 68.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.649 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.2 80.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.02 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.37 30.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.58 37.56 0.15 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 113.879 0.312 . . . . 0.0 113.879 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -147.58 49.4 1.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.019 0.438 . . . . 0.0 111.496 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.08 -42.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.0 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD2' ' HB ' ' A' ' 85' ' ' VAL . 5.7 mp -111.47 -44.47 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.4 p -53.9 -60.2 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -71.03 -28.1 64.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -71.94 -68.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.865 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 t -60.6 -41.37 87.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.28 -39.85 36.37 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.782 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.13 -27.76 57.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.061 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.431 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -60.58 -41.96 95.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.487 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 42.4 m-85 -59.99 -35.51 75.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -51.45 -27.06 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.6 t -71.77 -31.6 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 38.9 t -48.25 -52.74 19.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.442 ' N ' HD21 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.43 -33.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 196' ' ' ALA . 5.2 tt0 45.62 35.3 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.674 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 178.69 34.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.25 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? 44.05 31.38 0.52 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.875 0.369 . . . . 0.0 111.267 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -59.56 -15.77 20.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.034 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.443 ' HD3' ' CG2' ' B' ' 3' ' ' ILE . 0.0 OUTLIER -38.71 151.33 0.03 OUTLIER 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.589 0.356 . . . . 0.0 111.821 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 64.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.485 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.484 ' CG2' ' CD2' ' B' ' 7' ' ' LEU . 3.4 p -96.91 -48.91 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.241 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -148.22 118.87 7.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 55.51 167.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -145.71 99.26 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.043 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 117.938 -1.029 . . . . 0.0 111.149 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.402 ' CB ' ' HD2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.736 0.303 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 179.77 74.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.443 ' CG2' ' HD3' ' A' ' 204' ' ' ARG . 4.8 mp 47.54 45.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.43 ' CA ' ' C ' ' B' ' 5' ' ' PRO . . . 127.44 87.65 0.59 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' B' ' 6' ' ' PTR . 41.3 Cg_exo -49.69 140.8 5.57 Favored 'Cis proline' 0 N--CA 1.482 0.801 0 CA-C-N 118.699 1.249 . . . . 0.0 114.922 6.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.458 ' C ' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.484 ' CD2' ' CG2' ' A' ' 206' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.843 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.84 0.352 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.446 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER 59.67 170.15 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 179.344 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 65' ' ' LYS . 37.5 Cg_endo -66.1 61.63 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.551 2.167 . . . . 0.0 112.393 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -148.5 -57.33 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.198 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.73 -46.83 9.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.009 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -58.97 -36.59 75.11 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.378 0.608 . . . . 0.0 110.05 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -13.68 40.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.232 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.79 -27.32 6.26 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 4.7 p30 -90.34 -25.92 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.662 0.267 . . . . 0.0 111.504 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 49.4 mt-10 -61.31 -27.0 68.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.976 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.04 -24.64 13.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' THR . . . -46.29 -37.6 7.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 40.0 t -63.67 -50.47 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HA ' ' CG2' ' A' ' 197' ' ' VAL . 3.8 mtp180 -49.86 -48.63 51.12 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.107 0.479 . . . . 0.0 110.577 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.91 14.33 10.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.246 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 50.42 81.04 0.07 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.65 0.262 . . . . 0.0 111.116 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.8 t -171.96 29.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.586 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.435 ' CB ' HG21 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -97.59 157.87 15.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -171.43 144.81 2.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.467 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 54.1 m-85 -154.73 146.04 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.507 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.431 ' N ' HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -58.11 162.88 3.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.523 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG12 ' CD2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -159.63 172.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.208 0.528 . . . . 0.0 111.727 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -125.42 42.4 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.965 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.472 ' CD1' HG23 ' A' ' 130' ' ' VAL . 0.3 OUTLIER -38.98 122.33 1.18 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.388 -178.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 8.9 mp -67.59 -44.52 77.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.214 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.439 ' N ' HD13 ' A' ' 109' ' ' LEU . . . 145.37 -135.09 5.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.442 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 25.3 p -139.65 148.75 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.865 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.5 m -139.15 127.78 28.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.51 128.01 35.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.069 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 32.9 m -126.15 -174.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.687 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.93 24.93 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' CE3' ' A' ' 172' ' ' TRP . 28.5 mp0 -141.96 -81.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.172 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m 60.36 22.73 12.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.783 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 24.89 2.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -166.42 10.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.64 -39.35 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -59.54 -47.56 85.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.966 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.429 ' O ' ' CB ' ' A' ' 105' ' ' ALA . 62.0 t -49.65 -26.67 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.07 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.6 m -66.88 -44.23 81.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.84 -53.81 43.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 2.0 pt-20 -76.81 -36.93 56.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.776 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 101' ' ' VAL . . . -48.9 -25.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tt -81.8 -43.54 18.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.07 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 108' ' ' VAL . 6.8 pttt -60.76 -35.18 75.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.321 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.438 ' N ' ' HG3' ' A' ' 107' ' ' LYS . 21.2 t -68.16 -35.69 72.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.583 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.443 HD11 ' CB ' ' A' ' 114' ' ' ARG . 0.9 OUTLIER -54.37 -27.82 38.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -47.39 6.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.079 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -23.48 5.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.795 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.73 177.95 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -12.7 58.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.303 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.443 ' CB ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -43.23 108.91 0.12 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 0.0 111.537 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.2 ptt180 -98.92 144.76 28.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.8 160.37 12.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.461 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 132' ' ' ASP . 1.6 p -115.92 176.18 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.69 79.88 1.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.12 5.35 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.008 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 84' ' ' SER . 3.4 mt -121.1 131.19 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.475 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.432 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -88.04 104.89 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -72.09 69.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.261 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 194' ' ' ALA . 93.9 t -77.84 97.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.371 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 24.9 p -119.62 42.62 2.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.439 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 42.99 41.91 4.83 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.708 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' CA ' HG23 ' A' ' 144' ' ' ILE . 9.8 t0 -163.39 -43.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.613 0.244 . . . . 0.0 111.286 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -148.14 127.56 2.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.283 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -87.03 71.41 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.667 0.27 . . . . 0.0 110.886 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.48 89.84 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.8 0.334 . . . . 0.0 111.176 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 87' ' ' TYR . 5.8 p -85.93 90.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.952 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.2 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.93 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.436 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -99.62 147.68 25.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -100.66 14.41 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.676 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.89 -43.77 3.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 58.7 p -111.31 -19.96 12.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 38.45 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.049 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.41 139.99 15.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.103 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.434 HD22 ' CB ' ' A' ' 141' ' ' ASP . 2.6 tp -73.39 110.81 7.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.984 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.2 mt -68.38 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.31 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.28 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.075 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.434 ' CB ' HD22 ' A' ' 138' ' ' LEU . 26.6 t70 -93.89 73.25 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.497 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.2 170.37 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 126' ' ' ASP . 87.9 m -103.64 141.8 35.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.545 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 195' ' ' PHE . 13.0 tt -70.66 -27.09 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.014 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -30.92 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.772 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -91.42 -41.7 10.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.943 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.45 ' CG1' ' HA ' ' A' ' 144' ' ' ILE . 14.3 p -47.4 161.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.074 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.486 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 1.4 m -52.7 -50.95 62.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.518 ' CE1' ' CD1' ' A' ' 163' ' ' ILE . 3.0 p90 150.75 -176.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.673 0.789 . . . . 0.0 109.971 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.469 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 15.9 p -114.91 151.48 33.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.425 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -177.05 102.09 0.23 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.129 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 45.5 Cg_endo -67.31 159.11 53.82 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.332 2.022 . . . . 0.0 111.963 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.63 -59.82 2.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.28 33.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.197 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 41.56 30.97 0.16 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.662 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.415 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 15.1 t60 -104.88 16.58 25.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.588 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -169.8 29.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.671 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.409 ' CD ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER 53.2 26.12 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.73 0.3 . . . . 0.0 111.232 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -110.81 154.14 16.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.594 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 188' ' ' SER . 0.3 OUTLIER -139.29 -175.46 4.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.75 0.309 . . . . 0.0 110.728 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.6 t -177.31 136.02 0.2 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.878 0.37 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.57 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 60.5 m-85 -105.06 -171.49 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.365 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.518 ' CD1' ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -165.31 142.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 111.474 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 20.0 p -132.98 142.58 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.466 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -108.51 83.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.429 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 170' ' ' ARG . 2.9 p30 45.45 -162.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.415 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.52 -64.06 4.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.664 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -44.35 5.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.353 . . . . 0.0 111.127 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 79.9 m -86.18 -88.29 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.91 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 166' ' ' ASP . 18.2 mmm180 -154.81 -81.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 110.372 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 172' ' ' TRP . 3.3 ptp180 -127.59 -152.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.492 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.452 ' CE3' ' O ' ' A' ' 95' ' ' GLU . 19.5 m95 -67.3 71.53 0.11 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -88.39 119.01 28.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 15.2 m -89.19 157.9 18.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.333 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -135.62 99.11 4.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.649 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -94.28 134.1 11.89 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.92 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.5 p90 -154.93 148.74 25.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 111.482 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.2 tp -118.52 132.7 56.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.396 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -49.29 140.43 9.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -61.35 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.685 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -68.21 -32.84 73.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.409 ' OD1' ' CD ' ' A' ' 158' ' ' ARG . 10.6 t70 67.24 73.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.062 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.4 23.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.624 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 41.15 30.87 0.47 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.42 ' O ' ' NE ' ' A' ' 186' ' ' ARG . 2.0 mt-10 -136.92 41.43 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.669 0.271 . . . . 0.0 111.191 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.467 ' HD3' ' CE1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -154.64 -45.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.911 0.386 . . . . 0.0 110.768 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.44 ' CD2' HG12 ' A' ' 85' ' ' VAL . 9.3 mp -113.54 -43.91 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.836 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.484 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 20.4 t -56.7 -61.16 2.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -67.3 -21.01 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.259 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.68 -60.92 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.176 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.74 -31.78 55.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.799 0.333 . . . . 0.0 110.553 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.21 -26.01 12.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.56 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 44.5 t -99.08 -23.02 15.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.439 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.453 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . . . -50.07 -28.33 6.97 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.499 ' CZ ' ' CG1' ' A' ' 144' ' ' ILE . 53.4 m-85 -84.87 -22.07 29.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -60.61 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.774 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.421 ' CG2' ' HA ' ' A' ' 77' ' ' ARG . 79.8 t -55.49 -39.09 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 34.9 t -57.61 -48.71 78.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.439 ' CD1' ' HD2' ' A' ' 204' ' ' ARG . 1.2 pt? -129.93 56.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.167 0.508 . . . . 0.0 110.754 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 29.3 tt0 -45.1 -28.01 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.709 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -96.47 31.35 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 199' ' ' LEU . 6.0 mptt 47.84 35.08 4.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.005 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -69.65 65.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.439 ' HD2' ' CD1' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -127.16 45.42 2.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.19 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 51.83 25.56 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.82 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.4 t -116.9 103.62 10.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 65.79 133.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 61.58 49.33 5.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.237 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -168.49 35.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.247 -179.646 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.819 0.342 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -134.48 -78.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 mm -134.91 -42.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.21 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.03 -77.78 0.11 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.643 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' B' ' 7' ' ' LEU . 83.5 Cg_exo -47.34 140.86 14.73 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.683 2.256 . . . . 0.0 112.213 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.419 ' CD1' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' B' ' 5' ' ' PRO . 5.2 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.326 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.85 0.357 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 19.5 pttt -148.74 165.2 18.51 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.786 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 83.2 Cg_exo -45.59 161.93 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.458 2.105 . . . . 0.0 112.456 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.478 ' CD2' ' HB2' ' A' ' 66' ' ' PRO . 24.0 m-70 71.85 -68.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -69.1 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.739 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -32.6 67.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.699 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.14 -21.83 65.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.28 -62.84 1.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.408 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.9 p30 -53.14 -29.52 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.007 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.0 mm-40 -69.19 -36.0 76.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 0.0 110.522 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.8 -23.87 25.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.681 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.22 -57.37 13.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 1.2 t -50.59 -48.11 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.255 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -42.84 62.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.519 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.0 p -94.49 18.92 10.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.079 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.02 82.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -179.4 49.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.145 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.0 173.24 6.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.05 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 29.4 p 176.84 151.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CG ' ' O ' ' A' ' 82' ' ' SER . 53.3 m-85 -160.51 138.25 9.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.784 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.428 ' N ' HD22 ' A' ' 120' ' ' LEU . 20.8 t -49.23 167.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.692 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 187' ' ' LEU . 8.5 p -174.48 162.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 111.993 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 12.5 mtmm -111.96 56.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.617 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.522 ' CD1' ' CB ' ' A' ' 177' ' ' PHE . 0.4 OUTLIER -47.7 176.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.433 ' CD2' ' HG3' ' A' ' 116' ' ' PRO . 11.0 mt -137.48 -42.4 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.151 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.68 -144.67 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.485 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.5 m -136.58 155.93 49.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.61 128.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.873 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.67 124.28 20.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.852 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 28.7 m -126.59 164.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -93.56 17.78 11.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.193 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -159.0 114.38 2.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.05 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -93.62 21.35 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -151.84 130.9 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.63 130.34 3.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.457 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -32.81 74.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.751 0.31 . . . . 0.0 111.066 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -43.83 91.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.98 -28.48 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.4 m -69.08 -48.02 63.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.013 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -52.41 -59.01 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -62.56 -30.78 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.96 -57.42 10.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.02 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.52 -44.44 56.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.528 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.79 -39.75 71.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.399 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 15.0 t -64.24 -42.97 97.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.437 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.33 -22.42 4.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.228 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 -54.18 3.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.355 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -61.16 -30.98 70.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.486 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.32 172.39 11.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -22.36 11.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -45.26 102.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 141.36 24.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HG3' ' CD2' ' A' ' 88' ' ' LEU . 36.2 Cg_exo -59.82 152.25 65.11 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.481 2.12 . . . . 0.0 112.441 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.45 ' CG1' ' CB ' ' A' ' 87' ' ' TYR . 3.1 p -114.23 177.87 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.403 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.19 74.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.454 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -128.57 -144.87 5.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.282 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -122.2 130.5 53.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.678 0.275 . . . . 0.0 111.281 -178.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.439 ' HG ' ' CG2' ' A' ' 123' ' ' VAL . 41.8 tp -84.97 100.01 11.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -73.61 87.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.684 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.439 ' CG2' ' HG ' ' A' ' 121' ' ' LEU . 94.0 t -101.87 112.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.91 42.73 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 47.19 25.0 2.48 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.718 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.4 ' CA ' HG23 ' A' ' 144' ' ' ILE . 2.6 m-20 -174.38 27.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 156.43 121.92 0.72 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.14 -1.029 . . . . 0.0 113.468 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.485 HD12 ' CE1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -106.85 110.18 22.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 110.419 178.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -124.48 106.29 10.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 139' ' ' ILE . 10.2 p -86.98 112.45 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -116.31 120.24 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -54.58 146.65 15.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -94.14 20.67 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -126.06 -42.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.66 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 39.8 p -110.45 -24.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.906 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.43 25.27 6.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.38 123.41 6.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.364 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 tp -63.48 118.37 8.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 0.0 111.02 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 130' ' ' VAL . 3.7 mt -92.67 -50.63 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.09 123.08 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -116.94 65.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.169 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.27 165.55 11.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.683 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' A' ' 144' ' ' ILE . 1.9 t -111.28 2.75 17.87 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.484 HG12 ' CZ ' ' A' ' 195' ' ' PHE . 3.1 tt 72.63 -3.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.417 ' HB3' HG22 ' A' ' 143' ' ' THR . 25.9 tt0 -110.86 -37.53 5.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -30.69 27.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.574 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 163' ' ' ILE . 10.7 p -51.46 164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 149' ' ' PHE . 66.1 m -53.01 -53.91 43.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.323 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 148' ' ' SER . 0.1 OUTLIER 155.84 -15.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.862 0.726 . . . . 0.0 112.212 178.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 195' ' ' PHE . 0.5 OUTLIER 90.75 172.2 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.292 0.637 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 150' ' ' CYS . . . 166.55 107.0 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.474 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 46.0 Cg_endo -68.49 140.33 47.51 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.364 2.043 . . . . 0.0 112.089 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.95 -85.29 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.361 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -149.76 22.43 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.3 m120 45.82 34.48 1.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.295 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -91.28 -18.41 24.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.409 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -142.47 15.8 2.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.703 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.26 51.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.321 . . . . 0.0 110.891 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -129.54 146.31 17.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.567 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 177' ' ' PHE . 2.0 m-85 -111.63 -176.31 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.702 0.287 . . . . 0.0 110.718 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -168.41 106.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.893 0.378 . . . . 0.0 111.276 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.571 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 42.8 m-85 -85.12 -173.16 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.481 ' CD1' ' CB ' ' A' ' 148' ' ' SER . 0.0 OUTLIER -167.09 132.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 38.5 t -131.42 156.69 45.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.859 0.361 . . . . 0.0 111.033 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -113.99 80.53 1.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.001 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 t0 52.47 -161.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.21 -22.28 40.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.325 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.9 p -161.75 -42.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -75.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.05 -42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.1 ptp85 -166.67 -150.78 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.954 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.525 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 1.0 OUTLIER -66.27 74.42 0.09 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 71.0 mmm -89.19 117.9 28.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.651 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.68 165.05 23.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.713 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -131.89 120.87 23.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 111.29 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -116.3 113.68 2.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.432 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.571 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -143.65 162.2 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.53 131.15 31.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.983 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -47.85 138.94 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.375 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -56.41 11.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.885 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.21 -33.67 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 110.455 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.9 t70 66.17 69.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.28 25.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.901 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.18 37.81 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 113.985 0.354 . . . . 0.0 113.985 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -148.69 23.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.846 0.323 . . . . 0.0 111.585 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.74 21.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.394 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.449 HD21 ' N ' ' A' ' 188' ' ' SER . 0.6 OUTLIER 179.59 -38.92 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.449 ' N ' HD21 ' A' ' 187' ' ' LEU . 70.5 m -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.482 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -55.81 -28.13 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.093 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.0 -49.75 76.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.534 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.429 ' CG1' HD23 ' A' ' 128' ' ' LEU . 2.5 t -73.74 -38.82 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.531 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.09 -40.95 45.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.951 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -79.23 -29.53 42.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.288 178.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.441 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . . . -56.84 -43.02 80.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.519 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 150' ' ' CYS . 6.8 m-85 -58.09 -28.37 64.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.212 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -50.24 -51.14 47.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.013 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 64.7 t -50.78 -37.71 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.867 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.1 t -61.8 -35.97 79.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.449 ' CD2' HG12 ' B' ' 3' ' ' ILE . 1.2 pt? -140.13 64.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 196' ' ' ALA . 1.3 pt-20 -50.29 -30.09 11.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.469 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.73 24.94 3.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.039 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.53 33.97 11.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.44 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -67.74 82.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.268 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -106.02 17.44 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.117 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -23.53 14.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.744 0.307 . . . . 0.0 111.069 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.1 t -48.03 167.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.232 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.23 -75.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.298 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.37 169.87 10.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.349 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 64.12 168.87 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.174 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.971 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -161.34 -96.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 199' ' ' LEU . 4.8 mp -102.71 -47.67 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.447 ' HA2' ' CD1' ' A' ' 149' ' ' PHE . . . -51.09 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.59 161.2 46.17 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.692 2.262 . . . . 0.0 111.61 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.407 ' CD1' ' N ' ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -129.12 150.62 75.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.54 159.8 28.69 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.632 2.221 . . . . 0.0 112.626 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' TRP . 12.6 m80 63.1 112.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.149 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.66 -73.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.201 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.417 ' N ' ' O ' ' A' ' 67' ' ' HIS . 3.1 m0 -46.3 -34.45 4.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.201 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -62.92 -34.8 78.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.633 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.27 -55.84 4.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.129 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -49.42 -49.17 46.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -49.69 -41.58 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -86.21 -23.38 26.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.764 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.439 ' CA ' HG21 ' A' ' 80' ' ' THR . . . -72.7 -66.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 110.709 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -48.27 -37.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.832 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -45.68 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.038 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -90.78 18.57 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.411 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 55.71 96.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.835 0.35 . . . . 0.0 111.103 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.439 HG21 ' CA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -178.8 -30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.92 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -41.12 158.21 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 111.278 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 175.49 145.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.103 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 82' ' ' SER . 89.6 m-85 -160.59 148.01 15.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.42 ' N ' HD11 ' A' ' 120' ' ' LEU . 32.3 t -47.32 166.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 8.8 p -173.9 159.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.979 0.418 . . . . 0.0 111.724 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -121.18 65.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.754 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' A' ' 89' ' ' GLY . 14.6 t80 -56.68 121.13 9.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.269 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.66 -41.21 94.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.474 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 141.9 -178.43 20.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.231 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.41 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 38.1 m -100.86 142.57 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.433 ' O ' ' CE ' ' A' ' 173' ' ' MET . 0.4 OUTLIER -136.51 172.42 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.893 -178.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.431 ' CG ' ' HD2' ' A' ' 171' ' ' ARG . 4.0 tt0 -109.83 148.43 31.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.165 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 12.9 m -148.73 173.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.426 ' O ' ' CD1' ' A' ' 172' ' ' TRP . 22.5 m-85 -87.94 -24.07 23.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 94' ' ' PHE . 4.5 mp0 -133.09 145.36 50.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 111.197 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 25.31 5.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.47 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -136.97 24.15 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.89 128.47 4.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -37.89 74.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -55.12 -34.4 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.86 -30.78 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.884 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 91.8 m -66.39 -43.68 85.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.21 -46.73 79.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.03 -32.14 59.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.984 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 109' ' ' LEU . . . -63.08 -59.79 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.31 -36.18 6.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -40.58 88.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.49 -32.42 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.434 ' CD1' ' HG3' ' A' ' 114' ' ' ARG . 4.0 mm? -60.36 -18.63 51.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.086 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -97.17 -45.31 6.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -64.35 -30.42 71.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.73 171.99 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -21.61 14.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.434 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 4.7 mmt180 -45.43 114.21 0.71 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.6 ptt-85 -124.51 148.15 57.74 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.292 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.1 156.64 2.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.785 2.324 . . . . 0.0 112.632 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 10.6 p -129.08 114.34 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.907 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.97 63.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.681 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -117.65 -139.29 6.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.478 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -144.27 137.79 27.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.985 0.421 . . . . 0.0 111.2 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.481 HD22 ' CE1' ' A' ' 177' ' ' PHE . 0.3 OUTLIER -88.8 104.0 16.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.486 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 129' ' ' ARG . 15.8 m-70 -72.01 117.16 13.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.489 ' CG1' ' CB ' ' A' ' 194' ' ' ALA . 65.8 t -131.65 88.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.428 ' HB3' ' N ' ' A' ' 80' ' ' THR . 5.5 m -119.26 46.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.89 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 35.23 61.37 0.66 Allowed Glycine 0 CA--C 1.521 0.456 0 O-C-N 123.415 0.447 . . . . 0.0 113.855 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.428 ' N ' HG23 ' A' ' 144' ' ' ILE . 6.2 t70 -178.94 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.65 122.35 0.95 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.56 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.78 146.44 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 122' ' ' HIS . 29.4 mtt180 -154.16 96.17 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.89 115.46 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.707 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.16 136.22 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 42.1 t0 -68.5 152.64 45.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 7.0 t0 -97.4 21.55 9.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.23 -46.12 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 110.654 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.3 p -102.17 -25.37 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 66.02 32.09 8.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.03 124.42 8.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.353 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 11.7 tp -55.89 118.17 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.6 mt -87.81 -50.51 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.262 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.69 79.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.147 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.3 p-10 -82.74 68.91 9.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -174.33 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -105.48 169.86 8.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.689 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.525 ' CG1' ' CE1' ' A' ' 195' ' ' PHE . 11.5 tt -99.62 -26.04 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.9 -42.32 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -45.65 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 163' ' ' ILE . 14.7 p -48.04 164.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -80.67 7.84 9.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.5 m-85 80.58 -161.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 110.933 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.3 p -143.75 163.46 33.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -154.91 110.3 2.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.707 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 25.5 Cg_endo -61.68 132.32 39.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.268 1.979 . . . . 0.0 112.1 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -43.31 -54.56 4.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 177.99 35.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.261 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 42.15 35.26 0.56 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.455 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -78.35 -13.82 59.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.884 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.04 24.48 0.13 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.894 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 64.0 48.07 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 111.045 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.59 128.13 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.326 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -113.78 174.89 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.931 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 t -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.831 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.476 ' CD2' ' CE2' ' A' ' 177' ' ' PHE . 4.5 m-30 -93.82 -178.15 4.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.625 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 1.6 pt -163.93 136.97 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.13 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 3.0 m -131.22 160.15 35.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 23.5 mtm105 -119.28 85.1 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.075 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 46.58 -161.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.26 -82.24 1.06 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.304 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 24.13 11.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.332 . . . . 0.0 111.015 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.9 -82.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.248 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.5 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.431 ' HD2' ' CG ' ' A' ' 92' ' ' GLU . 4.6 ptp180 -133.27 -151.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.125 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.426 ' CD1' ' O ' ' A' ' 94' ' ' PHE . 12.2 m95 -63.15 82.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.433 ' CE ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -86.68 121.09 28.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.559 -178.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 155.09 17.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.067 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.418 ' ND1' ' OH ' ' A' ' 87' ' ' TYR . 15.9 m-70 -137.16 123.21 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.757 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -98.69 112.04 4.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.532 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.481 ' CE1' HD22 ' A' ' 121' ' ' LEU . 22.0 m-85 -109.0 158.7 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.751 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.84 99.29 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.299 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' A' ' 187' ' ' LEU . . . -42.32 141.23 0.99 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.415 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 34.7 t -63.94 -66.22 0.57 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.308 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -29.38 49.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.138 0.494 . . . . 0.0 109.907 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.76 75.19 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.223 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.06 30.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.428 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.438 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 39.1 30.25 0.12 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.421 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -133.71 49.63 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.476 ' HG2' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 169.71 -32.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.673 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -112.11 -30.33 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.905 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.438 ' CB ' ' HA2' ' A' ' 184' ' ' GLY . 11.1 t -87.65 -66.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.149 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -30.34 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.04 -68.87 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.996 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.7 t -52.87 -48.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.77 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.76 -35.18 23.27 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.716 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 14.5 t -86.46 -32.77 20.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.165 0.507 . . . . 0.0 109.884 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.489 ' CB ' ' CG1' ' A' ' 123' ' ' VAL . . . -52.38 -33.85 45.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.894 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.525 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 32.6 m-85 -71.9 -18.86 62.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.104 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -44.85 -59.32 2.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.576 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 198' ' ' CYS . 34.4 m -50.47 -47.0 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.179 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.426 ' N ' HG22 ' A' ' 197' ' ' VAL . 41.0 t -54.41 -29.26 48.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 109.784 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.448 HD12 ' CG2' ' B' ' 3' ' ' ILE . 4.6 mp -123.28 43.29 2.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.521 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -44.93 -28.17 0.63 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.169 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 26.23 9.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm 49.76 47.6 22.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -87.72 50.84 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.29 119.4 12.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.811 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -94.18 78.91 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.999 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.2 t -120.49 104.78 10.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.985 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 71.15 -63.96 0.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.071 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -152.59 -84.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 177.01 46.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.104 179.899 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.666 0.27 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -176.1 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.986 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.448 ' CG2' HD12 ' A' ' 199' ' ' LEU . 4.2 mp -140.24 54.09 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.163 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.486 ' N ' ' CD1' ' B' ' 7' ' ' LEU . . . -165.9 -67.1 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.418 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.24 1.88 8.55 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.139 2.56 . . . . 0.0 112.664 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.484 ' CD1' ' C ' ' B' ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' B' ' 4' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.04 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.7 mttt 50.43 58.16 17.27 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.712 0.291 . . . . 0.0 111.067 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -44.38 -61.92 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.555 2.17 . . . . 0.0 112.474 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.89 -68.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.762 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -70.98 -23.59 62.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.598 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -33.26 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.006 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -67.31 -40.27 85.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.27 65.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.81 -41.02 94.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -30.47 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.597 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -87.84 -25.61 23.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.662 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 81' ' ' CYS . . . -56.01 -50.21 71.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -61.12 -43.87 97.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.6 -179.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.8 83.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.448 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -95.05 19.85 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.046 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 124' ' ' SER . . . 49.22 84.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.238 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 t 178.56 47.51 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.645 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 123' ' ' VAL . 9.7 t -120.83 114.27 21.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.434 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.89 142.79 51.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.866 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' CD1' ' HD2' ' A' ' 186' ' ' ARG . 49.0 m-85 -152.02 142.84 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.435 ' CA ' HD22 ' A' ' 120' ' ' LEU . 5.0 m -54.98 164.32 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 86' ' ' LYS . 4.8 p 176.6 161.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 10.7 mtmm -113.11 79.33 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.488 ' CE2' ' HA2' ' A' ' 89' ' ' GLY . 12.6 t80 -65.39 99.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.432 ' CD2' ' HG3' ' A' ' 116' ' ' PRO . 49.9 mt -46.47 -49.57 18.11 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.488 ' HA2' ' CE2' ' A' ' 87' ' ' TYR . . . 147.01 -169.18 28.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.228 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 21.1 p -123.96 129.25 50.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 110.962 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.88 147.24 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.999 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.5 136.77 45.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 27.4 m -132.76 178.92 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -116.48 26.87 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -145.0 -82.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.315 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.0 m 63.42 28.25 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 21.45 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.9 168.01 30.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.565 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -32.01 22.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.0 110.894 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -63.51 -17.02 62.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.326 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.8 t -87.5 -21.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.602 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.5 p -69.56 -37.0 76.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.62 -59.58 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.478 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.431 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 11.4 pt-20 -64.35 -32.92 74.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HB2' ' CB ' ' A' ' 174' ' ' CYS . . . -67.63 -23.93 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.793 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.56 -24.14 18.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.874 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.412 ' C ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -81.61 -38.58 25.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 70.9 t -53.14 -55.41 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.262 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.43 ' CD1' ' O ' ' A' ' 89' ' ' GLY . 13.9 mt -56.45 -25.31 50.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -82.91 -27.57 30.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.459 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -10.39 45.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.259 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.0 p -106.36 -165.67 1.11 Allowed 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -83.65 -21.95 32.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.865 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -48.36 91.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -84.77 159.62 57.48 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.202 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HG3' ' CD2' ' A' ' 88' ' ' LEU . 4.4 Cg_exo -71.81 161.53 44.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.703 2.269 . . . . 0.0 111.962 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 9.6 p -117.64 118.19 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.44 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 64.93 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.349 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.34 -159.2 10.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.77 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.435 HD22 ' CA ' ' A' ' 84' ' ' SER . 5.3 mt -116.66 126.49 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.137 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.9 tp -86.82 100.36 12.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.436 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -76.45 103.61 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.538 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 81' ' ' CYS . 58.6 t -104.5 133.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.456 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -145.91 29.06 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.722 -178.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 48.08 23.62 2.83 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.596 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.426 ' CA ' HG23 ' A' ' 144' ' ' ILE . 41.5 t0 -165.03 22.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 143' ' ' THR . . . 152.36 112.07 0.5 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.88 101.41 13.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 110.523 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -104.49 89.88 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.69 112.96 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.67 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.413 HG21 ' N ' ' A' ' 132' ' ' ASP . 7.0 p -122.76 138.86 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.212 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 36.8 t0 -63.83 144.59 56.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 28.5 t70 -93.52 14.62 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.42 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -120.61 -39.28 2.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.778 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.7 p -104.85 -24.42 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.839 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.15 35.0 4.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.99 134.03 11.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.429 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 10.8 tp -67.02 120.95 14.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.398 . . . . 0.0 111.061 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.474 HG23 ' CE2' ' A' ' 87' ' ' TYR . 7.8 mt -90.55 -59.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.56 114.83 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.874 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.429 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 20.3 t0 -111.28 96.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.73 -163.93 1.49 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.682 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.443 HG22 ' CG ' ' A' ' 145' ' ' GLU . 5.1 t -135.93 8.91 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.48 HD13 ' CE1' ' A' ' 195' ' ' PHE . 4.7 tt 65.59 7.01 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.443 ' CG ' HG22 ' A' ' 143' ' ' THR . 0.7 OUTLIER -112.6 -36.23 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.132 0.491 . . . . 0.0 110.397 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -83.98 -19.85 33.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.37 177.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 163' ' ' ILE . 8.3 p -66.62 164.0 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.784 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -85.75 16.27 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' A' ' 148' ' ' SER . 15.4 m-85 82.58 -179.45 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.871 0.367 . . . . 0.0 110.957 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 26.6 p -114.53 -178.76 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.456 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 172.64 100.45 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.387 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.401 ' HD2' ' HD3' ' B' ' 5' ' ' PRO . 44.8 Cg_endo -68.9 143.83 56.52 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.507 2.138 . . . . 0.0 112.894 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -66.43 -153.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.14 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -98.78 24.04 8.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.813 0.339 . . . . 0.0 110.683 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 156' ' ' HIS . 2.4 m120 -58.05 -18.83 27.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.574 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 155' ' ' ASN . 3.0 t60 86.19 -51.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.571 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -168.64 75.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 111.427 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER 165.72 -28.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 179.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -96.86 122.03 7.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.844 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.483 ' CE1' ' HB2' ' A' ' 188' ' ' SER . 5.6 m-85 -134.61 159.64 40.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.3 t -159.88 138.24 10.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.44 . . . . 0.0 111.636 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.527 ' CZ ' ' CZ ' ' A' ' 177' ' ' PHE . 6.0 m-85 -105.69 -173.23 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 1.1 pt -160.94 135.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.04 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 3.4 m -126.48 100.04 6.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.984 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 -65.04 80.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 168' ' ' THR . 34.4 t0 60.79 -87.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.747 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 49.06 -88.99 0.01 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.765 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 166' ' ' ASP . 2.6 m -116.54 -33.47 4.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.751 0.31 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.4 m -59.15 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.034 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -163.92 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -136.04 -154.72 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.762 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -64.27 78.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -99.71 120.96 40.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.153 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 105' ' ' ALA . 86.5 m -91.26 159.22 16.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -129.95 94.67 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.305 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.64 126.32 8.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.366 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.527 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -149.29 152.95 36.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.819 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.61 120.89 24.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -40.88 147.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.994 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -42.25 73.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.53 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -76.1 -34.68 59.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.498 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 67.07 64.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.332 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -162.22 24.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.584 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 42.33 27.81 0.5 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.257 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.4 43.4 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.889 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.478 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 16.5 mmt-85 -158.51 -44.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 83' ' ' PHE . 4.3 mp -115.2 -36.11 4.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.734 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 12.3 t -58.92 -65.87 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 186' ' ' ARG . 10.5 p80 -61.29 -35.68 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.89 -73.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.016 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.409 ' HA ' ' CB ' ' A' ' 194' ' ' ALA . 6.6 t -51.39 -43.57 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.631 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.65 -34.84 36.67 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.484 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 56.5 m -91.14 -27.39 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.073 177.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.438 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . . . -49.53 -45.47 47.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.99 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 144' ' ' ILE . 33.5 m-85 -57.2 -22.52 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.984 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -41.43 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.42 -34.38 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.819 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.97 -23.41 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.767 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 195' ' ' PHE . 5.3 mp -113.8 -45.73 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.824 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 201' ' ' ARG . 60.7 tt0 60.95 115.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.407 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.406 ' CB ' ' O ' ' A' ' 200' ' ' GLU . 3.8 ttm180 78.74 0.95 2.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.391 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.12 52.19 2.58 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.065 0.459 . . . . 0.0 110.961 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -76.97 59.92 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.817 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.73 104.56 2.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -73.86 61.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.0 t -154.78 38.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -145.16 -52.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -99.3 88.5 3.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.034 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -108.9 165.06 11.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.087 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.171 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 174.73 87.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.897 0.38 . . . . 0.0 111.366 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp 42.42 48.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.155 0.502 . . . . 0.0 111.753 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.17 86.27 1.7 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.853 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' B' ' 6' ' ' PTR . 32.5 Cg_exo -71.47 114.09 2.3 Favored 'Cis proline' 0 N--CA 1.481 0.793 0 CA-C-N 118.137 0.969 . . . . 0.0 114.041 4.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.413 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.403 ' OXT' ' C ' ' B' ' 6' ' ' PTR . 12.0 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.945 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.781 0.324 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HA ' ' CB ' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -104.84 83.74 0.86 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.327 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 68' ' ' GLN . 58.6 Cg_endo -71.95 74.28 2.38 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.586 2.191 . . . . 0.0 112.521 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 64.34 -72.83 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.201 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -46.06 -39.24 8.96 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -81.94 -31.32 31.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.478 179.128 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.79 -28.38 68.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . -85.24 -37.33 20.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.863 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.403 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 6.8 t0 -56.46 -49.65 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.66 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -58.15 4.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.354 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -29.15 53.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 81' ' ' CYS . . . -51.16 -68.49 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 194' ' ' ALA . 3.3 m -49.48 -27.43 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -52.14 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 m -95.37 15.94 18.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.152 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 61.97 84.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.036 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t 175.67 54.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.415 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.429 ' HB2' ' CB ' ' A' ' 75' ' ' ALA . 19.5 t -122.28 71.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.371 . . . . 0.0 110.65 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 122' ' ' HIS . 13.0 p -92.91 148.71 21.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.078 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CD2' ' O ' ' A' ' 186' ' ' ARG . 29.4 m-85 -151.52 139.63 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.54 139.47 31.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.731 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 121' ' ' LEU . 11.9 p -151.68 159.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.55 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -114.81 61.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.797 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.47 ' CZ ' ' O ' ' A' ' 89' ' ' GLY . 23.3 t80 -47.55 119.22 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 10.1 mp -56.49 -46.67 80.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 148.64 -176.38 27.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.99 130.43 51.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 111.372 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.424 ' O ' ' CE ' ' A' ' 173' ' ' MET . 7.0 m -121.72 174.35 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.09 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -105.7 154.41 20.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.087 0.47 . . . . 0.0 111.616 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 172' ' ' TRP . 16.0 m -157.65 -175.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.25 20.02 2.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.602 0.239 . . . . 0.0 111.39 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -115.76 -68.01 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.176 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.48 ' OG ' ' CD1' ' A' ' 172' ' ' TRP . 53.0 p 50.1 24.99 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.631 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -148.67 32.72 0.78 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.43 125.23 1.68 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.578 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -34.51 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -63.35 -25.97 68.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.695 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.67 -35.42 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -70.82 -34.88 72.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.48 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -64.18 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.14 -39.21 18.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.422 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.15 75.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.0 tp -51.6 -33.48 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -43.47 28.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.2 t -58.11 -33.31 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' CD1' ' HG3' ' A' ' 114' ' ' ARG . 0.7 OUTLIER -54.38 -31.07 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.215 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -50.43 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.539 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -54.09 -25.72 23.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.638 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.4 p -82.75 -177.85 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -3.73 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.407 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.438 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 11.9 mmp_? -48.54 177.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.774 0.321 . . . . 0.0 111.127 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.19 135.49 4.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.033 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 71.7 Cg_exo -48.56 152.04 4.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.314 2.009 . . . . 0.0 112.099 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 87' ' ' TYR . 7.1 p -123.48 113.6 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.423 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 64.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.557 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -117.0 -150.17 9.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.91 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 83' ' ' PHE . 13.1 tp -137.42 128.21 27.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.773 0.321 . . . . 0.0 110.793 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.439 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -78.02 90.14 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -72.64 94.02 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.225 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 t -100.34 160.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.72 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.42 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -166.54 34.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 45.93 44.84 13.84 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.536 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.438 ' CA ' HG23 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -171.19 -43.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.679 0.276 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.53 114.4 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.286 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.486 HD11 ' CD2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -84.33 120.17 25.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 110.169 177.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -132.66 98.68 4.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.036 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 p -83.26 129.45 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.846 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.71 132.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.052 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -65.8 148.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.919 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -97.74 20.11 12.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -125.54 -42.15 1.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.3 p -104.27 -27.73 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.671 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tptm 49.35 49.9 18.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -113.69 14.03 22.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.076 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 tp 59.36 148.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 111.248 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.85 -51.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.786 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.16 136.78 49.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.038 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -143.06 58.96 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -113.07 162.06 16.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 63.4 m -97.67 122.73 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.603 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.529 ' CD1' ' CE1' ' A' ' 195' ' ' PHE . 7.3 tt -54.22 -31.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -72.97 -25.25 60.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.444 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.05 -39.55 9.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.499 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 143' ' ' THR . 17.8 t -49.76 144.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.272 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.476 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 9.1 m -50.51 -41.19 53.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.528 ' CE1' ' CD1' ' A' ' 163' ' ' ILE . 2.7 p90 155.77 -175.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.616 0.572 . . . . 0.0 110.074 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 19.5 p -121.23 140.13 52.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.738 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -167.94 133.06 1.54 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.803 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.423 ' CB ' ' O ' ' A' ' 159' ' ' GLY . 98.3 Cg_endo -82.0 -96.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.482 2.122 . . . . 0.0 112.298 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -159.06 -62.83 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.874 0.369 . . . . 0.0 110.393 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -162.76 26.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.994 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 56.6 t30 45.18 48.69 9.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.284 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.98 -1.33 7.81 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.73 11.13 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.371 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.445 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER 58.84 37.17 24.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.029 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 152' ' ' PRO . . . -122.05 141.3 14.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.569 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 188' ' ' SER . 0.1 OUTLIER -105.51 -163.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 0.0 110.83 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.8 t 172.5 129.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.736 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.486 ' CD2' HD11 ' A' ' 128' ' ' LEU . 3.9 m-30 -110.86 -179.56 3.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -163.83 143.24 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -169.1 133.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.579 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.484 ' HG3' ' CZ2' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -67.63 84.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.979 177.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.471 ' CB ' ' HB ' ' A' ' 169' ' ' THR . 97.8 m-20 -66.6 110.13 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.5 -20.72 59.64 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.467 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -48.56 3.33 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.471 ' HB ' ' CB ' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -50.2 -64.19 0.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.374 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 171' ' ' ARG . 53.7 mtp180 -164.54 -46.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.108 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.499 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 165.0 -145.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.484 ' CZ2' ' HG3' ' A' ' 165' ' ' ARG . 1.7 m-90 -64.17 81.7 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.81 134.9 39.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.333 0.587 . . . . 0.0 111.764 -176.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.402 ' SG ' ' CG1' ' A' ' 93' ' ' VAL . 1.2 m -101.89 169.03 9.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.978 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.434 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 39.8 m-70 -146.79 123.42 11.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 111.549 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -101.76 114.6 5.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.877 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.96 146.04 29.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.124 0.488 . . . . 0.0 111.623 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -145.76 110.46 5.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.26 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -42.39 143.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.858 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.8 t -71.91 -48.67 43.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.801 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -78.57 -25.13 45.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.99 77.84 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.445 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 39.9 t -169.9 28.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.503 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.05 34.99 0.62 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.144 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -136.21 47.54 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.446 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 1.6 mpt_? -153.47 -57.74 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.131 0.491 . . . . 0.0 110.158 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.49 -0.97 4.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.867 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.424 ' HA ' ' CE2' ' A' ' 160' ' ' PHE . 70.1 m -80.44 -44.08 19.87 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.076 0.465 . . . . 0.0 110.228 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CG ' ' CZ2' ' A' ' 69' ' ' TRP . 2.1 t-80 -94.84 -18.86 20.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.67 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.74 -63.07 1.5 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.4 t -48.41 -46.52 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.8 -24.22 57.2 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.792 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.1 m -85.84 -31.3 22.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.497 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 76' ' ' VAL . . . -52.68 -42.39 64.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.529 ' CE1' ' CD1' ' A' ' 144' ' ' ILE . 45.3 m-85 -65.44 -25.88 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.876 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -43.44 -42.05 4.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.908 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' PHE . 0.5 OUTLIER -43.03 -46.4 5.56 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.811 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.439 ' CD1' ' HA ' ' A' ' 202' ' ' LYS . 0.2 OUTLIER -106.67 -27.28 10.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.096 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 196' ' ' ALA . 23.9 tt0 72.84 -63.54 0.43 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.139 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -90.55 29.95 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.757 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.439 ' HA ' ' CD1' ' A' ' 199' ' ' LEU . 3.7 mmmt 45.95 36.42 2.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.147 0.498 . . . . 0.0 110.388 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . 0.424 ' N ' HD11 ' A' ' 199' ' ' LEU . 1.2 mt-30 -102.59 73.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.473 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.45 ' HD3' ' CG2' ' B' ' 3' ' ' ILE . 0.1 OUTLIER -86.4 -73.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.321 178.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.64 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.922 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.24 108.62 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.971 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -74.82 160.59 30.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.09 98.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.06 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -175.3 -75.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.05 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.074 -179.948 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -157.41 68.44 0.53 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.209 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' B' ' 3' ' ' ILE . 2.0 mp 66.41 -65.19 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.353 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' B' ' 2' ' ' TYR . . . -40.49 -61.91 1.72 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.398 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.45 ' HG3' ' CB ' ' B' ' 1' ' ' ALA . 85.2 Cg_endo -76.43 -23.46 11.5 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.908 2.405 . . . . 0.0 112.533 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . 0.462 ' CD2' ' N ' ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' B' ' 6' ' ' PTR . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.711 0.291 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -153.79 146.54 17.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.046 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.07 41.2 0.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.866 2.377 . . . . 0.0 112.8 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -138.95 -63.53 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.49 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -79.26 -56.4 4.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.057 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -58.94 -38.6 79.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.155 0.503 . . . . 0.0 109.89 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -53.16 -24.42 10.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.332 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.57 23.1 13.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.994 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.45 -48.19 0.98 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.064 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.01 -37.97 22.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.899 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.08 -26.08 39.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.01 -65.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 m -51.45 -31.58 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -47.78 73.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.758 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -94.04 21.56 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.006 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 49.06 85.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.174 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -176.8 41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -109.2 161.84 14.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.899 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 78.7 p 178.66 155.16 0.42 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' SER . 49.5 m-85 -164.69 141.61 6.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.428 ' N ' HD22 ' A' ' 120' ' ' LEU . 6.6 t -51.84 149.92 4.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.352 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' CG1' HD13 ' A' ' 187' ' ' LEU . 1.7 t -146.66 167.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.231 0.539 . . . . 0.0 112.324 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -121.52 48.07 1.75 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.995 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 177' ' ' PHE . 0.6 OUTLIER -38.8 150.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.066 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 106' ' ' LEU . 75.1 mt -106.54 -38.82 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.643 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.43 169.52 12.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.192 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 9.2 p -101.58 144.3 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 110.914 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.407 ' HB ' HD12 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -127.32 176.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.873 -178.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -95.92 145.57 25.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 172' ' ' TRP . 13.6 m -146.0 166.91 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.87 0.367 . . . . 0.0 111.274 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -93.61 20.65 7.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.307 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 94' ' ' PHE . 9.9 mt-10 -167.2 150.05 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.031 0.443 . . . . 0.0 110.906 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 96.3 p -125.32 20.61 8.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.16 74.19 1.02 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.785 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -164.56 117.6 0.76 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.444 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.42 ' CE ' ' O ' ' A' ' 152' ' ' PRO . 0.0 OUTLIER -56.9 -26.76 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -27.98 36.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.416 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 58.4 t -62.11 -48.3 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.779 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.1 m -60.57 -37.63 81.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.633 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.43 -42.31 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 11.0 pt-20 -79.45 -35.53 40.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.413 ' O ' ' CD2' ' A' ' 109' ' ' LEU . . . -55.44 -53.22 58.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -47.18 -46.2 23.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -42.68 86.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.66 -47.52 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.808 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.414 HD12 ' HG3' ' A' ' 114' ' ' ARG . 2.7 mm? -53.15 -23.31 7.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.92 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -59.99 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -53.15 -31.18 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.04 -171.96 3.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.955 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 25.44 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.414 ' HG3' HD12 ' A' ' 109' ' ' LEU . 8.5 mmt180 -65.04 76.53 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.41 135.07 5.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.508 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' CB ' ' O ' ' A' ' 87' ' ' TYR . 92.8 Cg_endo -82.4 164.93 16.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.574 2.183 . . . . 0.0 112.068 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.476 ' CG1' ' CB ' ' A' ' 87' ' ' TYR . 1.5 p -114.56 176.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.014 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -152.65 89.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.455 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.59 -137.73 2.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.846 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -122.75 121.72 36.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.646 0.26 . . . . 0.0 111.219 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.44 HD21 ' CB ' ' A' ' 187' ' ' LEU . 8.6 tp -87.61 104.21 16.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.437 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -74.22 110.75 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.434 ' CG2' HG21 ' A' ' 191' ' ' VAL . 68.3 t -114.04 105.75 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.2 p -118.17 16.13 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.09 11.49 32.39 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.964 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -149.33 16.13 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.698 0.249 . . . . 0.0 111.282 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 161.06 96.88 0.11 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.812 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 162' ' ' TYR . 1.6 mt -77.03 111.7 12.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.695 0.283 . . . . 0.0 110.501 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.35 86.76 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.312 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.2 p -77.93 100.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.602 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.2 t -99.72 154.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -91.85 139.49 30.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.82 14.33 8.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.524 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.4 OUTLIER -111.44 -30.62 7.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.05 0.452 . . . . 0.0 110.526 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 134' ' ' GLU . 67.0 p -139.12 8.64 2.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.512 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER 42.02 44.15 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.484 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.12 143.61 15.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.096 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.43 112.06 12.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.87 0.367 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.2 mt -81.18 -51.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.402 ' CG1' ' OE1' ' A' ' 142' ' ' GLN . 58.8 t -120.12 101.29 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -95.54 90.85 5.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.178 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.402 ' OE1' ' CG1' ' A' ' 140' ' ' VAL . 19.2 mt-30 -142.13 161.36 38.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.65 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.433 HG22 ' CG ' ' A' ' 145' ' ' GLU . 2.0 t -100.21 5.54 44.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 145' ' ' GLU . 2.1 tt 84.66 -39.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.122 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.455 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -86.45 -25.16 25.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.918 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -78.59 -18.43 54.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.257 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -79.08 -177.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -98.01 22.3 9.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.38 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.436 ' CB ' ' O ' ' A' ' 148' ' ' SER . 18.5 m-85 85.62 -171.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 20.4 p -134.4 168.05 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.733 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -175.49 110.44 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.488 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 25.8 Cg_endo -62.14 158.95 36.81 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.462 2.108 . . . . 0.0 112.919 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 26.6 t0 -95.9 53.56 1.41 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.036 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER 88.65 93.66 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.985 -178.238 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -52.66 -20.85 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.368 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 -23.49 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.685 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -109.92 1.14 18.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.466 -0.493 . . . . 0.0 112.214 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 70.33 50.96 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.702 0.287 . . . . 0.0 111.073 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.06 129.5 5.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.799 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.488 ' CD1' ' HB3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER -104.77 -174.53 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 110.591 178.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER 179.68 126.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 111.426 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 177' ' ' PHE . 0.2 OUTLIER -97.77 -173.78 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.61 179.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -159.07 133.36 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 35.4 t -131.5 152.45 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.009 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.89 96.93 5.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.03 -166.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.719 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.76 -86.74 1.2 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.68 29.73 6.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.683 0.277 . . . . 0.0 110.883 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 -84.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.432 ' HG3' ' CG ' ' A' ' 173' ' ' MET . 9.3 ptm180 -179.21 -47.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -150.45 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.99 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.43 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 5.7 m95 -68.31 72.86 0.21 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.432 ' CG ' ' HG3' ' A' ' 170' ' ' ARG . 75.3 mmm -89.23 118.02 28.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.293 0.568 . . . . 0.0 111.772 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 161.64 26.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.135 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -133.64 109.52 9.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.42 125.8 7.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 1.7 p90 -144.5 144.6 31.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.412 ' CD1' ' OD1' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -110.34 140.51 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.841 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.51 140.47 58.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.39 -62.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -74.8 -26.7 59.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.412 ' OD1' ' CD1' ' A' ' 178' ' ' LEU . 0.3 OUTLIER 62.48 81.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.088 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.52 33.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.434 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 46.15 39.66 9.58 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.594 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.84 4.58 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.431 ' CB ' HD12 ' A' ' 187' ' ' LEU . 14.1 mmt180 -114.76 -64.51 1.3 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.81 0.338 . . . . 0.0 110.743 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.44 ' CB ' HD21 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -143.37 15.77 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.652 178.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.476 ' O ' ' CE1' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -96.38 -34.26 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 178.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.39 -21.42 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.52 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.18 -58.76 3.08 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.434 HG21 ' CG2' ' A' ' 123' ' ' VAL . 33.2 t -49.73 -49.75 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.106 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.38 -33.89 12.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.354 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 2.9 t -76.41 -28.56 56.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.544 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.434 ' CB ' ' CG1' ' A' ' 123' ' ' VAL . . . -57.92 -47.02 84.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.787 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -53.56 -26.63 22.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -50.37 -29.07 9.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 86.5 t -84.97 -31.32 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 11.5 t -53.94 -48.0 70.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.325 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -95.65 -24.5 16.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER 53.57 120.76 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.287 0.565 . . . . 0.0 111.733 179.077 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER 78.07 25.39 0.63 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.905 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt 49.85 44.31 25.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.231 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -66.49 70.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.78 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.469 ' CG ' ' CD2' ' B' ' 7' ' ' LEU . 0.2 OUTLIER -66.3 112.47 4.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.191 -179.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.11 106.01 8.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.977 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 33.7 p -154.4 64.82 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -57.23 10.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.057 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 60.77 82.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.039 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.27 79.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.002 -0.999 . . . . 0.0 111.082 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.486 ' CD1' ' HB2' ' B' ' 1' ' ' ALA . 0.0 OUTLIER -130.65 -82.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.928 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' B' ' 7' ' ' LEU . 3.7 mp -132.23 -58.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' B' ' 5' ' ' PRO . . . -45.59 -50.48 10.81 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.426 ' CG ' ' HB1' ' B' ' 1' ' ' ALA . 52.5 Cg_endo -88.02 -28.83 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.332 2.688 . . . . 0.0 112.732 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.469 ' CD2' ' CG ' ' A' ' 204' ' ' ARG . 11.8 mt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.357 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.403 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.92 0.39 . . . . 0.0 110.5 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -66.47 -29.29 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.17 -56.65 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 1.5 p30 -58.5 -36.88 74.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.958 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 17.4 tt0 -60.19 -27.22 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.489 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 -30.5 14.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.863 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.757 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -52.21 -50.72 61.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' O ' HG21 ' A' ' 197' ' ' VAL . 59.3 t -58.26 -38.75 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.422 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -39.9 70.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.561 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.78 1.41 55.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 124' ' ' SER . . . 65.92 78.51 0.27 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.829 0.347 . . . . 0.0 111.081 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 79' ' ' ALA . 2.9 t 176.19 60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -118.2 -172.75 2.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.912 ' HB3' HD21 ' A' ' 120' ' ' LEU . 2.1 m 174.16 153.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.997 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.489 ' C ' HD12 ' A' ' 120' ' ' LEU . 32.4 m-85 -162.1 139.78 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.686 ' N ' HD12 ' A' ' 120' ' ' LEU . 23.3 t -60.76 157.23 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.735 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.887 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.1 p 178.67 160.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.987 0.422 . . . . 0.0 111.915 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.551 ' N ' HG22 ' A' ' 85' ' ' VAL . 1.7 mttp -111.31 71.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.636 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.607 ' CB ' HG21 ' A' ' 130' ' ' VAL . 41.4 t80 -55.02 107.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.996 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.923 HD23 ' HB3' ' A' ' 109' ' ' LEU . 6.9 mp -48.5 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA2' ' CE1' ' A' ' 87' ' ' TYR . . . 176.18 -133.32 2.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.419 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.95 151.14 38.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.954 0.407 . . . . 0.0 111.002 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 109' ' ' LEU . 6.7 m -139.55 167.05 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.832 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.14 142.6 27.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 172' ' ' TRP . 2.1 m -145.49 173.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.223 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -116.26 25.56 10.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' HG21 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -144.84 -74.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.253 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m 59.45 19.48 7.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.24 66.54 1.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.59 -161.03 27.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.344 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.496 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -119.57 -36.26 3.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 111.06 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -61.58 -25.9 67.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.405 HG21 ' CB ' ' A' ' 95' ' ' GLU . 15.8 t -76.06 -30.44 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.31 -38.75 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.2 -37.72 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.5 pt-20 -88.31 -34.8 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -54.31 -51.31 65.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -45.52 62.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.595 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -39.12 73.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.399 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 104' ' ' GLU . 6.3 t -65.66 -39.65 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.757 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.923 ' HB3' HD23 ' A' ' 88' ' ' LEU . 1.5 mm? -55.64 -26.26 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -86.21 -61.29 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.044 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -48.4 -33.44 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.034 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -165.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.41 42.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.44 ' HG3' HD13 ' A' ' 109' ' ' LEU . 1.7 mmp_? -93.1 70.39 4.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.825 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 133.84 19.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HB3' HD12 ' A' ' 88' ' ' LEU . 71.7 Cg_endo -79.37 141.49 16.01 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.476 2.117 . . . . 0.0 112.63 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.683 HG11 HD11 ' A' ' 139' ' ' ILE . 12.0 m -78.35 173.99 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.37 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -135.95 72.9 1.44 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.246 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -141.17 -130.4 2.58 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.852 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.912 HD21 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -145.25 140.94 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.878 0.37 . . . . 0.0 111.433 -178.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -85.68 116.22 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -81.05 84.25 6.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.968 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 191' ' ' VAL . 38.0 t -94.89 125.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.506 ' O ' ' HB1' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -142.82 44.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.499 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 41.35 51.91 4.42 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.949 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.786 ' O ' HG22 ' A' ' 144' ' ' ILE . 20.9 t70 -164.94 -40.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.673 0.273 . . . . 0.0 111.072 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.433 ' HA2' ' N ' ' A' ' 144' ' ' ILE . . . -176.52 118.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.459 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.802 HD11 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.6 115.81 6.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.736 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -117.99 78.94 1.3 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.607 HG21 ' CB ' ' A' ' 87' ' ' TYR . 5.8 p -68.14 132.79 32.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.081 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.31 139.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -75.95 163.05 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.415 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 48.6 t0 -103.17 15.68 28.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.327 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.03 -60.26 1.82 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.883 0.373 . . . . 0.0 110.579 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 42.9 p -82.01 -27.91 32.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.7 48.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -126.54 142.38 13.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.1 tp -69.45 132.63 46.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.745 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.683 HD11 HG11 ' A' ' 117' ' ' VAL . 8.8 mt -100.63 -53.26 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.395 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 130' ' ' VAL . 13.9 t -111.48 67.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.21 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.459 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.6 p-10 -72.97 67.59 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.51 152.57 48.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 145' ' ' GLU . 64.5 m -78.71 145.06 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.69 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.802 HD12 HD11 ' A' ' 128' ' ' LEU . 7.0 tt -71.89 -30.71 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.897 0.38 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.631 ' H ' HG22 ' A' ' 143' ' ' THR . 8.6 tt0 -75.5 -28.94 59.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.283 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.1 mttm -90.91 -39.23 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.368 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 148' ' ' SER . 9.9 p -58.9 163.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.038 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.516 ' N ' HG22 ' A' ' 147' ' ' VAL . 12.9 t -76.06 1.95 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' HA ' ' CE1' ' A' ' 195' ' ' PHE . 1.4 m-85 80.86 174.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.044 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.459 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 2.9 t -108.92 164.99 11.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -155.17 97.67 2.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.404 ' HG2' ' OH ' ' B' ' 2' ' ' TYR . 53.2 Cg_exo . . . . . 0 C--N 1.345 0.352 0 C-N-CA 122.256 1.971 . . . . 0.0 111.789 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 178' ' ' LEU . 2.6 mmp_? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.704 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -109.87 144.97 16.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.39 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 3.5 m-85 -143.97 178.26 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.607 0.241 . . . . 0.0 110.852 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.409 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 1.8 m -172.26 134.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 111.554 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.577 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 98.2 m-85 -94.55 -174.31 3.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.486 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -165.99 137.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.607 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.72 125.69 24.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.0 OUTLIER -76.89 87.48 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.046 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 168' ' ' THR . 23.1 t0 50.84 -90.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.234 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 165' ' ' ARG . . . 59.47 -82.35 0.01 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -140.96 25.15 2.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.481 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.681 HG22 ' SD ' ' A' ' 173' ' ' MET . 4.2 m -122.25 23.62 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.488 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 169' ' ' THR . 12.3 mtp180 86.74 -72.29 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.487 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -146.6 -164.33 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 0.0 111.02 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.423 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 m95 -56.01 90.17 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.681 ' SD ' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -98.07 110.74 23.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.828 -177.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.495 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 0.6 OUTLIER -82.03 148.19 28.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.735 177.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 173' ' ' MET . 24.6 m-70 -128.66 158.58 38.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.857 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.409 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -144.63 138.53 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.845 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.577 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -153.98 115.06 4.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.178 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.704 HD22 ' HA2' ' A' ' 159' ' ' GLY . 0.1 OUTLIER -90.25 122.33 33.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.821 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -46.1 135.44 7.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -67.08 0.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -33.3 65.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.343 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' CD1' ' A' ' 178' ' ' LEU . 1.4 m-20 63.27 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.268 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.22 28.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.863 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.43 29.22 0.22 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.23 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 186' ' ' ARG . 18.0 mt-10 -138.61 47.7 1.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.027 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.5 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -159.63 -42.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.887 HD21 ' HB ' ' A' ' 85' ' ' VAL . 5.9 mp -114.65 -37.65 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 t -56.95 -59.95 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -75.58 -26.46 57.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -67.26 -66.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 187' ' ' LEU . 1.5 t -70.66 -29.45 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -53.12 -28.79 34.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.218 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 47.5 t -95.86 -22.61 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.302 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.501 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -47.42 -38.61 13.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 199' ' ' LEU . 61.5 m-85 -79.07 -26.99 43.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -47.16 -43.87 21.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.127 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 76' ' ' VAL . 54.2 t -67.05 -30.06 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.738 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.8 t -66.9 -58.87 4.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.779 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.943 HD21 HG21 ' B' ' 3' ' ' ILE . 2.1 pt? -117.54 51.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.547 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.423 ' CA ' ' O ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.721 0.296 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -163.34 -89.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.129 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.943 HG21 HD21 ' A' ' 199' ' ' LEU . 2.6 mm -109.17 -52.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.35 -74.97 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.473 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 CA--C 1.53 0.299 0 C-N-CA 123.159 2.573 . . . . 0.0 113.34 -179.042 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.711 0.291 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.92 -34.74 78.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.52 -51.42 8.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.991 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -58.71 -42.46 88.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.34 -36.91 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.691 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -86.11 -29.79 23.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.708 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -53.55 -57.59 10.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.793 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.741 HG21 ' SG ' ' A' ' 193' ' ' CYS . 0.3 OUTLIER -49.4 -38.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -49.65 74.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.448 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.4 20.64 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 49.21 90.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t 179.5 44.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -112.62 162.27 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.769 ' OG ' HD22 ' A' ' 120' ' ' LEU . 32.4 t -172.64 154.0 2.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.526 ' CB ' HD11 ' A' ' 187' ' ' LEU . 91.2 m-85 -160.34 141.1 11.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -58.14 151.07 19.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.112 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.986 HG22 HD21 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -152.18 171.81 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 112.115 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.578 ' H ' HG12 ' A' ' 85' ' ' VAL . 1.3 mttm -128.11 40.11 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.966 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.523 ' CD1' ' HB3' ' A' ' 177' ' ' PHE . 6.0 t80 -44.57 123.91 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.608 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.63 HD23 ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.55 -60.31 2.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . 159.31 -160.28 31.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.393 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.21 146.49 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.059 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.622 HG22 HD21 ' A' ' 109' ' ' LEU . 2.8 m -133.78 135.47 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.12 120.66 18.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 172' ' ' TRP . 10.7 m -120.96 177.27 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.086 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.22 -22.92 18.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.194 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HB2' HG21 ' A' ' 101' ' ' VAL . 19.5 mp0 -123.61 153.52 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.1 p -133.25 21.78 4.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.009 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.3 23.9 1.03 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.67 131.97 9.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.607 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -51.69 60.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.36 -26.75 8.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 95' ' ' GLU . 47.1 t -65.49 -33.13 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -72.98 -41.39 64.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.68 -33.7 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.576 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.6 pt-20 -87.64 -40.34 14.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -57.39 -58.88 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.61 HD13 ' C ' ' A' ' 106' ' ' LEU . 2.4 tm? -46.36 -40.56 12.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.899 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -64.55 -45.52 86.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 178.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.1 t -63.92 -30.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.883 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.63 ' HB3' HD23 ' A' ' 88' ' ' LEU . 3.5 mm? -59.04 -23.67 62.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.512 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -93.38 -36.23 12.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -72.97 -21.73 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.306 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.26 172.0 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -53.67 -22.73 9.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HG3' HD13 ' A' ' 109' ' ' LEU . 7.4 mmp_? -46.05 92.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -94.96 150.42 37.74 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.416 ' HB3' ' HB3' ' A' ' 86' ' ' LYS . 52.7 Cg_exo -53.23 166.26 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.767 2.311 . . . . 0.0 112.466 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 139' ' ' ILE . 7.0 p -137.9 119.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.356 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -80.85 97.91 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.46 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.69 -169.08 18.96 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.769 HD22 ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -109.87 124.43 51.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.388 . . . . 0.0 111.122 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.731 ' HG ' HG23 ' A' ' 123' ' ' VAL . 6.9 tp -88.88 99.32 12.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.882 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.05 96.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.408 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.731 HG23 ' HG ' ' A' ' 121' ' ' LEU . 95.1 t -102.73 117.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.512 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -136.86 28.99 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.116 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 49.69 24.41 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.759 ' O ' HG22 ' A' ' 144' ' ' ILE . 12.3 t70 -133.92 -44.3 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.27 116.69 0.71 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.71 HD13 ' CE2' ' A' ' 162' ' ' TYR . 8.5 mt -71.57 133.98 46.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -141.49 98.08 3.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 139' ' ' ILE . 4.8 p -89.21 104.47 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 136' ' ' LYS . 14.3 t -107.07 132.62 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.076 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 136' ' ' LYS . 41.3 t0 -70.17 133.28 46.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -79.08 -6.59 56.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -97.57 -24.49 15.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.9 p -123.61 -35.17 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.539 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.1 OUTLIER 75.54 25.25 1.24 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.54 123.83 8.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.262 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.5 tp -50.81 131.52 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.991 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.696 ' HB ' HG13 ' A' ' 130' ' ' VAL . 9.6 mt -105.11 -54.13 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.269 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 140' ' ' VAL . 59.7 t -111.11 65.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.464 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 35.7 p-10 -68.16 66.92 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 140' ' ' VAL . 19.2 mt-30 -138.34 134.59 34.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -54.19 -176.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 126' ' ' ASP . 18.1 tt -108.76 -15.83 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.767 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -99.6 -26.99 13.9 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.0 OUTLIER -110.24 -171.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.289 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.39 14.78 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.475 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HB3' ' HA2' ' B' ' 4' ' ' GLY . 2.5 m-85 73.66 149.56 0.1 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.874 0.369 . . . . 0.0 110.988 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 24.6 p -72.36 -178.56 2.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 171.75 80.83 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.79 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 10.7 Cg_endo . . . . . 0 C--N 1.344 0.31 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.453 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.739 0.304 . . . . 0.0 111.181 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 178' ' ' LEU . . . -126.63 141.18 12.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.899 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.527 ' CE1' ' CB ' ' A' ' 188' ' ' SER . 4.9 m-85 -118.34 -174.27 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.9 m -166.07 134.81 3.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.528 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.71 ' CE2' HD13 ' A' ' 128' ' ' LEU . 7.5 m-30 -102.34 175.28 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.286 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.891 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -159.21 150.96 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.964 0.411 . . . . 0.0 111.425 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.3 166.3 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.539 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.82 79.18 1.54 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.132 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 46.62 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.183 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.03 -34.17 6.0 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.107 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 94.7 m -150.75 -44.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -72.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.92 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -178.21 -79.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.629 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 173' ' ' MET . 1.6 ptp180 -131.81 -153.47 0.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.91 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.607 ' O ' HG22 ' A' ' 93' ' ' VAL . 11.5 m95 -62.83 80.09 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 171' ' ' ARG . 1.2 mmt -85.36 121.57 28.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.74 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.32 156.94 16.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.749 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.68 105.61 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.749 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.96 104.83 2.89 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.468 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.601 ' HD2' HG11 ' A' ' 85' ' ' VAL . 3.3 p90 -121.16 132.64 54.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.415 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.669 ' O ' HG12 ' A' ' 85' ' ' VAL . 10.6 tp -102.26 147.24 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.688 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -68.22 140.09 56.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.175 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.424 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 35.8 t -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.753 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -36.24 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.9 66.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.453 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 2.6 p -148.98 16.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.733 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 43.33 34.71 2.43 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.861 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -144.82 50.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.475 ' C ' HD12 ' A' ' 187' ' ' LEU . 33.0 mtt-85 -168.8 -42.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.74 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.986 HD21 HG22 ' A' ' 85' ' ' VAL . 9.8 mp -113.32 -42.44 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.527 ' CB ' ' CE1' ' A' ' 160' ' ' PHE . 23.2 p -53.36 -65.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -66.91 -25.44 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -69.44 -60.03 2.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 187' ' ' LEU . 17.6 t -61.21 -40.5 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.881 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.73 -41.56 95.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.141 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.741 ' SG ' HG21 ' A' ' 76' ' ' VAL . 14.0 p -73.89 -34.0 64.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 110.332 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.437 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -56.41 -44.82 80.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -51.05 -26.29 6.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.72 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.57 -32.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.621 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.474 ' HB3' HD23 ' A' ' 199' ' ' LEU . 46.6 t -49.85 -36.17 25.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.548 HD11 HG12 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -118.91 -36.37 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.451 178.222 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.415 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.803 0.335 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.46 -97.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.548 HG12 HD11 ' A' ' 199' ' ' LEU . 2.7 mp -112.63 -29.85 2.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 149' ' ' PHE . . . -55.74 -85.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.541 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 49.1 Cg_exo . . . . . 0 N--CA 1.464 -0.236 0 C-N-CA 122.467 2.112 . . . . 0.0 110.826 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.933 0.397 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -68.99 -33.4 73.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.632 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.02 -63.13 1.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.084 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.47 -47.53 57.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -29.77 11.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.4 -24.69 15.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 81' ' ' CYS . . . -59.17 -64.82 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.76 HG21 ' HB3' ' A' ' 193' ' ' CYS . 2.3 m -50.03 -32.68 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -59.66 -52.55 65.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.463 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 23.44 5.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.833 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 48.65 85.27 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -176.64 34.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.325 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.505 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 4.6 t -98.75 156.28 16.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.053 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' HD22 ' A' ' 120' ' ' LEU . 2.6 t -174.8 152.02 1.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.763 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.486 ' CG ' ' HB3' ' A' ' 186' ' ' ARG . 72.3 m-85 -162.18 147.68 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 44.6 t -55.31 151.88 9.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.905 HG22 HD21 ' A' ' 187' ' ' LEU . 1.6 t -152.68 168.35 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.107 0.48 . . . . 0.0 111.618 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.521 ' H ' HG12 ' A' ' 85' ' ' VAL . 2.5 mttt -128.11 48.2 2.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.929 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.641 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.4 t80 -39.57 114.98 0.46 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.871 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 116' ' ' PRO . 54.9 mt -66.89 -26.93 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.651 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 126.01 -152.91 18.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.222 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 2.8 m -126.95 150.45 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.014 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.576 HG13 HD13 ' A' ' 109' ' ' LEU . 13.8 m -133.87 134.91 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.33 133.06 46.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.728 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.727 HG22 ' O ' ' A' ' 172' ' ' TRP . 23.9 m -138.64 169.4 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 111.361 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.5 16.0 16.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -157.34 119.46 3.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 1.7 p -95.83 24.18 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -165.16 123.43 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.751 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 148.72 113.07 0.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -49.71 -36.61 25.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.087 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.22 -41.28 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.35 -33.68 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.081 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -70.36 -39.04 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.05 -32.56 68.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.8 pt-20 -93.79 -36.51 12.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -50.11 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.895 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -50.09 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.686 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -44.06 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.01 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.5 t -65.68 -34.38 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.717 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.651 HD11 ' C ' ' A' ' 89' ' ' GLY . 1.1 mm? -52.03 -28.49 17.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 0.0 110.196 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.0 -27.84 18.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.561 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.72 20.43 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.174 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -120.6 147.63 44.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.69 4.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.64 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HG3' ' HB3' ' A' ' 112' ' ' SER . 0.0 OUTLIER -45.28 171.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.366 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -138.62 151.74 69.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.037 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.732 ' HB3' HD23 ' A' ' 88' ' ' LEU . 89.1 Cg_endo -80.2 -179.9 5.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.636 2.224 . . . . 0.0 112.392 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -141.26 -173.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.616 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.617 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -166.6 96.24 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -158.7 -131.44 1.27 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.771 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.533 HD22 ' OG ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -124.72 129.75 51.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.075 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.622 HD12 ' CE1' ' A' ' 177' ' ' PHE . 10.5 tt -100.88 113.02 25.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.187 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -76.95 111.57 12.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.911 ' CG1' ' HB2' ' A' ' 194' ' ' ALA . 82.1 t -110.78 96.74 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.32 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.443 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -111.79 27.58 9.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.378 . . . . 0.0 111.292 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.77 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 47.62 26.37 3.83 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.274 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.813 ' O ' HG22 ' A' ' 144' ' ' ILE . 24.5 t0 -140.15 -42.91 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.946 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -158.4 119.53 0.9 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.524 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -73.64 123.64 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.42 ' HD2' HD21 ' A' ' 138' ' ' LEU . 5.4 mmm-85 -135.31 100.91 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 139' ' ' ILE . 9.2 p -90.59 128.39 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.47 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 132' ' ' ASP . 54.6 t -116.1 154.87 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.693 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 131' ' ' VAL . 54.5 t0 -102.79 135.72 43.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.5 -0.41 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.714 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -103.48 -31.16 10.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.867 0.365 . . . . 0.0 110.996 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 p -116.64 -29.09 6.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 66.93 29.62 8.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 131' ' ' VAL . . . -95.54 -128.89 5.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.595 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 7.5 tp -156.97 134.63 10.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.773 0.32 . . . . 0.0 110.796 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 117' ' ' VAL . 4.3 mt -108.07 -54.85 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 130' ' ' VAL . 7.6 t -109.09 71.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 111.24 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.455 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 14.9 p-10 -78.58 59.91 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.12 163.11 25.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.389 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.7 m -78.02 174.14 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.713 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 126' ' ' ASP . 4.1 tt -97.64 -21.29 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -91.05 -39.52 12.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.835 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -72.66 -29.23 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 148' ' ' SER . 8.3 p -74.82 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.804 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.541 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -72.55 -0.86 13.95 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.6 m-85 79.11 179.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 25.5 p -98.94 177.34 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HA ' ' HG3' ' B' ' 5' ' ' PRO . . . -171.24 101.01 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.081 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.368 2.045 . . . . 0.0 111.977 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.845 0.355 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.18 106.31 1.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 0.1 OUTLIER -96.41 -177.22 3.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.439 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.83 122.72 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.948 0.404 . . . . 0.0 111.301 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.572 ' OH ' HG11 ' A' ' 191' ' ' VAL . 1.8 m-30 -95.73 -160.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.495 ' O ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -169.89 148.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -135.72 163.32 30.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -129.06 81.07 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 167' ' ' GLY . 2.0 p30 46.55 -161.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 166' ' ' ASP . . . 95.45 -57.08 1.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.137 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.39 19.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 170' ' ' ARG . 49.4 m -137.67 -86.03 0.29 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.673 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 169' ' ' THR . 4.9 mtt180 -164.08 -82.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.906 0.384 . . . . 0.0 111.008 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.6 ptp180 -138.12 -150.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.129 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.727 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.1 m95 -68.6 67.78 0.14 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.416 ' HE3' ' C ' ' A' ' 91' ' ' VAL . 20.4 mmm -89.73 119.97 30.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.39 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HB2' HG23 ' A' ' 91' ' ' VAL . 6.9 m -76.77 166.21 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.753 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 174' ' ' CYS . 17.0 m-70 -138.43 93.09 2.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.407 ' HA3' ' HG ' ' A' ' 109' ' ' LEU . . . -75.89 118.74 5.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.602 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.622 ' CE1' HD12 ' A' ' 121' ' ' LEU . 4.2 m-85 -114.75 108.21 16.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 178' ' ' LEU . 10.7 mt -88.88 98.52 11.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.46 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.859 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -47.18 135.98 9.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.443 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.0 t -54.15 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -55.81 -29.93 60.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.382 . . . . 0.0 110.589 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.93 67.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.116 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.77 21.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.349 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 188' ' ' SER . . . 40.96 34.42 0.8 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.337 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.3 -6.64 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.777 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -124.66 -10.82 7.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.905 HD21 HG22 ' A' ' 85' ' ' VAL . 7.9 mp -136.04 -46.54 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.499 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 14.9 t -61.11 -52.01 66.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -80.75 -30.19 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.748 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -76.75 -69.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 187' ' ' LEU . 21.4 t -48.97 -48.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -61.1 -26.93 66.49 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.802 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.76 ' HB3' HG21 ' A' ' 76' ' ' VAL . 1.2 m -78.31 -33.0 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.46 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.911 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -51.46 -44.3 62.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CE2' ' CG1' ' A' ' 144' ' ' ILE . 93.8 m-85 -58.62 -22.44 56.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -47.48 -48.53 26.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.011 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 194' ' ' ALA . 2.4 m -73.58 -35.79 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.146 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 35.4 t -44.07 -45.03 7.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.178 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.431 HD22 HG21 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -105.18 -29.8 10.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.471 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.506 179.149 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.696 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.71 80.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.568 ' N ' HD13 ' B' ' 3' ' ' ILE . 1.6 mm 70.43 -64.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.64 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.58 -79.07 0.07 OUTLIER Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.816 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.696 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 38.2 Cg_exo . . . . . 0 C--N 1.342 0.218 0 C-N-CA 122.771 2.314 . . . . 0.0 111.943 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 121.189 0.519 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 7.0 pt20 -48.06 -36.52 13.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.088 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -82.77 -58.5 2.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.434 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -46.88 -29.73 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.45 -40.77 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.29 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -93.98 -14.37 25.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 178.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -60.21 -41.72 93.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 194' ' ' ALA . 46.1 t -65.49 -49.55 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.514 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 19.9 mtm-85 -50.49 -53.47 29.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.733 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.28 -0.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.516 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 64.77 80.58 0.23 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.706 0.289 . . . . 0.0 111.07 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 t -179.32 44.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -106.9 163.51 12.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.739 0.304 . . . . 0.0 110.757 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.56 146.18 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.512 ' C ' HD23 ' A' ' 120' ' ' LEU . 81.2 m-85 -157.43 129.42 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -52.38 159.1 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.524 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.846 ' HB ' HD21 ' A' ' 187' ' ' LEU . 13.0 p -172.92 160.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 111.691 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.522 ' N ' HG22 ' A' ' 85' ' ' VAL . 7.3 mmtt -108.02 65.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.735 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.557 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -60.36 126.05 26.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.414 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 88' ' ' LEU . 6.2 mp -77.92 -31.58 51.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.586 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.79 -164.13 15.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.254 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.426 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 20.2 m -105.19 147.59 27.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.992 0.425 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 174' ' ' CYS . 0.4 OUTLIER -126.68 171.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.045 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 1.6 pt-20 -90.63 140.8 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 92' ' ' GLU . 34.3 m -158.41 179.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.839 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.07 18.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.46 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HB2' HG21 ' A' ' 101' ' ' VAL . 58.0 mp0 -152.72 112.99 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.414 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.469 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -106.67 25.11 11.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.901 177.093 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.64 33.66 2.23 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.982 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.27 106.82 0.56 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -25.69 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 110.871 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -76.31 -26.26 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.859 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 95' ' ' GLU . 23.6 t -67.44 -39.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.967 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.3 m -72.15 -48.09 46.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.345 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -52.95 -38.24 61.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.349 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.5 pt-20 -85.83 -42.13 14.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.768 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 101' ' ' VAL . . . -49.78 -48.12 50.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 160' ' ' PHE . 6.5 tt -50.87 -46.12 60.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -40.83 90.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.062 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' SER . 41.3 t -61.77 -31.19 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.058 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.606 HD13 ' HG3' ' A' ' 114' ' ' ARG . 3.2 mm? -67.54 -21.46 65.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -89.11 -50.38 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -24.08 64.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 96.2 p -79.17 170.82 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.27 -22.55 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.417 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.606 ' HG3' HD13 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -46.36 159.61 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.107 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -150.09 153.49 35.48 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.82 0.343 . . . . 0.0 111.418 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.5 Cg_exo -60.53 163.2 15.85 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.801 2.334 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 117' ' ' VAL . 7.4 p -133.82 110.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -74.85 74.31 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.439 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 131' ' ' VAL . . . -134.48 -156.73 7.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -123.92 125.54 44.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 111.43 -178.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.473 ' HG ' HG23 ' A' ' 123' ' ' VAL . 42.8 tp -83.91 105.67 14.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.264 177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -76.84 98.44 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.424 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.934 HG21 HG22 ' A' ' 191' ' ' VAL . 97.0 t -101.96 108.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 48.1 p -125.85 40.57 3.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.116 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.451 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 40.58 35.56 0.87 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.211 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 144' ' ' ILE . 19.7 t0 -158.21 -40.5 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.551 0.215 . . . . 0.0 111.452 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -147.63 121.24 1.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.991 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.772 HD11 ' CG1' ' A' ' 191' ' ' VAL . 0.0 OUTLIER -83.56 91.37 7.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.817 0.341 . . . . 0.0 110.427 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.832 ' HB3' HD11 ' A' ' 138' ' ' LEU . 3.5 mtt85 -107.28 98.45 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 139' ' ' ILE . 4.4 p -90.11 106.26 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 132' ' ' ASP . 4.1 t -93.32 163.84 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 131' ' ' VAL . 46.1 t0 -109.96 136.8 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.43 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 118' ' ' ARG . 49.4 t0 -79.18 3.06 18.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.97 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -116.03 -32.42 5.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.7 p -115.91 -23.05 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.359 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.5 OUTLIER 62.14 18.37 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.129 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.67 125.42 8.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.062 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -59.05 126.4 27.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.664 ' HB ' HG13 ' A' ' 130' ' ' VAL . 6.0 mt -89.73 -24.07 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.706 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.409 HG23 ' CG1' ' A' ' 130' ' ' VAL . 3.5 t -144.09 63.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.444 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 9.4 p-10 -73.32 61.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.554 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -131.89 159.84 37.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 145' ' ' GLU . 91.5 m -75.88 143.17 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.712 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 126' ' ' ASP . 7.9 tt -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.72 ' H ' HG22 ' A' ' 143' ' ' THR . 4.3 tt0 -77.07 -30.19 55.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.707 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -76.44 -20.3 57.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.908 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.6 OUTLIER -78.07 169.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.61 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.438 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -83.92 8.8 13.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.85 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.411 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.9 m-85 78.97 139.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.238 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.511 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 29.4 p -74.38 -174.42 2.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.767 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.483 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . -166.23 55.5 0.36 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.691 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 151' ' ' ALA . 50.9 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 122.205 1.937 . . . . 0.0 111.374 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 183' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.838 0.352 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.34 149.27 18.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.718 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.492 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 0.1 OUTLIER -139.83 172.82 12.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 40.7 t -165.25 134.93 3.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.592 ' CE2' HD23 ' A' ' 128' ' ' LEU . 2.7 m-30 -89.54 -165.28 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.502 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.908 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -164.77 158.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.392 . . . . 0.0 111.668 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 42.6 t -159.89 127.95 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.465 ' HG3' ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.71 87.61 7.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.103 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 45.3 -158.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.03 -71.67 0.26 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.109 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 168' ' ' THR . 26.1 m -130.3 17.19 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 0.0 111.084 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.603 HG22 ' SD ' ' A' ' 173' ' ' MET . 18.6 m -131.07 23.83 4.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 169' ' ' THR . 11.5 mmm180 84.95 -71.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.456 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 -158.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.985 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -65.77 94.67 0.22 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.603 ' SD ' HG22 ' A' ' 169' ' ' THR . 0.3 OUTLIER -110.61 158.37 18.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 111.702 -177.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.562 ' HB2' HG12 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -111.94 174.98 5.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.878 178.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -137.67 74.62 1.49 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.96 0.41 . . . . 0.0 110.774 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -76.55 129.22 9.76 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.92 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.529 ' CG ' ' CE2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -153.92 160.11 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.529 HD21 ' OD2' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -132.91 127.1 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.832 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.498 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -47.73 134.78 12.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.504 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -63.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -62.16 -29.27 70.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.556 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.529 ' OD2' HD21 ' A' ' 178' ' ' LEU . 0.3 OUTLIER 60.45 80.16 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.178 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.419 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -170.65 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.462 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.25 29.96 0.25 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.201 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.02 56.55 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -169.17 -41.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.987 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.846 HD21 ' HB ' ' A' ' 85' ' ' VAL . 6.5 mp -115.65 -45.56 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.688 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -49.37 67.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.807 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -82.75 -27.98 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.813 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -70.06 -57.6 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.883 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 123' ' ' VAL . 1.2 t -76.52 -26.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.69 -32.69 32.93 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.555 ' HB3' HG11 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -90.62 -20.76 22.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.648 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.661 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -46.58 -37.99 8.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.142 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -77.09 -23.59 51.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.005 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.71 -35.34 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.825 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.93 -30.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.621 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 50.2 t -51.75 -39.84 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.308 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.406 HD11 HD11 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -107.06 -26.89 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.474 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -177.15 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.494 ' H ' HD12 ' B' ' 3' ' ' ILE . 3.7 mp -45.14 -27.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.85 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.56 -82.66 0.03 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.968 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 32.9 Cg_exo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 123.026 2.484 . . . . 0.0 112.085 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 3.0 m0 . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.862 0.363 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -47.69 -33.39 6.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.25 -61.01 1.87 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.304 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -48.38 -32.14 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.186 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -61.99 -28.93 69.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -99.45 -29.26 12.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.859 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -48.26 -35.84 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.938 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -61.91 -34.27 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.004 0.43 . . . . 0.0 110.512 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.8 mtm180 -64.39 -56.49 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.23 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -68.6 -10.49 56.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.342 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 78' ' ' SER . . . 73.18 76.47 0.14 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.733 0.302 . . . . 0.0 111.055 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t -177.58 47.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.859 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -108.7 173.14 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.699 178.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 12.5 m -171.45 150.77 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 82' ' ' SER . 85.8 m-85 -161.56 136.91 7.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.834 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.73 163.8 1.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.947 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.4 p 178.88 155.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 111.512 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 85' ' ' VAL . 1.8 mtpp -109.93 62.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.332 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.639 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.4 t80 -47.26 111.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.487 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.937 HD23 ' CB ' ' A' ' 109' ' ' LEU . 3.5 mp -55.22 -44.08 75.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.567 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 132.67 -157.96 22.82 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.461 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 25.9 p -116.68 156.08 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.496 HG11 HD22 ' A' ' 109' ' ' LEU . 27.5 m -152.28 135.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.022 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 139.36 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.581 HG21 ' SG ' ' A' ' 174' ' ' CYS . 11.0 m -142.02 169.49 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.68 -24.15 27.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.617 ' O ' HG11 ' A' ' 101' ' ' VAL . 23.6 mm-40 -133.93 126.18 29.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.869 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.527 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -97.28 21.52 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.831 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.54 130.89 4.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.01 136.74 5.29 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.753 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 178.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 71.39 -61.63 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 110.355 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 95' ' ' GLU . 86.0 t -52.28 -44.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.292 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.9 p -63.26 -39.18 93.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.216 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -60.69 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.141 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.624 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.9 pt-20 -64.52 -38.54 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.052 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 174' ' ' CYS . . . -53.39 -24.77 13.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.088 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -45.24 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.17 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 5.5 pttt -57.12 -34.15 68.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 104' ' ' GLU . 41.1 t -59.98 -37.64 73.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.03 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.937 ' CB ' HD23 ' A' ' 88' ' ' LEU . 4.6 mm? -54.91 -25.99 32.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.938 0.399 . . . . 0.0 110.001 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.88 -51.56 4.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 6.0 mm-40 -49.5 -26.36 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.518 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 114' ' ' ARG . 0.3 OUTLIER -99.41 -163.36 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.729 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.38 26.22 6.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.286 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -78.18 81.46 4.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.735 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.433 ' HG3' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -73.48 130.13 84.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.247 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HD2' ' HG3' ' A' ' 115' ' ' ARG . 77.4 Cg_exo -50.96 169.94 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.224 1.949 . . . . 0.0 111.937 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 87' ' ' TYR . 9.8 p -132.95 114.48 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.414 . . . . 0.0 111.612 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -74.59 78.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.996 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -132.55 -158.52 8.93 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.332 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 120' ' ' LEU . 1.4 mt -116.91 131.98 56.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.362 . . . . 0.0 111.065 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.734 ' HG ' HG23 ' A' ' 123' ' ' VAL . 49.5 tp -91.42 102.54 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.446 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 1.1 t-80 -74.53 83.59 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.597 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.734 HG23 ' HG ' ' A' ' 121' ' ' LEU . 84.1 t -89.25 115.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.47 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.9 33.38 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 45.52 45.13 11.91 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.563 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.583 ' C ' HG22 ' A' ' 144' ' ' ILE . 2.0 t0 -168.15 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -157.84 115.16 0.65 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 162' ' ' TYR . 4.5 mt -81.05 78.39 7.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 122' ' ' HIS . 71.6 mtm-85 -85.03 107.8 17.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 139' ' ' ILE . 2.7 p -92.7 108.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 110.967 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.422 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 21.8 t -94.65 134.03 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.997 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.434 ' OD1' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -80.37 131.27 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.435 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 28.8 t0 -79.62 3.4 19.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.05 -24.74 14.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.75 0.309 . . . . 0.0 110.936 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 53.7 p -151.33 19.29 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.337 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.415 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER 44.58 28.54 0.33 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.985 0.421 . . . . 0.0 111.307 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.55 138.21 16.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.314 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.446 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 5.0 tp -86.7 124.28 32.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 117' ' ' VAL . 8.6 mt -95.37 -54.74 6.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.562 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.61 83.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 111.461 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.446 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 7.2 t0 -93.85 73.86 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.192 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -141.89 137.07 31.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.279 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.44 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 23.9 m -60.52 135.28 57.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.583 HG22 ' C ' ' A' ' 126' ' ' ASP . 19.3 tt -59.48 -34.19 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.696 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -73.81 -22.75 59.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.249 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -97.09 26.55 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.193 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.935 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -121.82 176.9 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.607 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 147' ' ' VAL . 2.5 t -90.09 17.36 7.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 73.83 -167.45 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.988 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 25.0 p -123.51 176.3 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -171.42 103.6 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 C--N 1.345 0.385 0 C-N-CA 122.4 2.066 . . . . 0.0 112.466 -179.174 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -81.21 114.73 3.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.109 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.795 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 8.9 m-85 -120.42 166.44 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.87 112.77 0.48 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 111.35 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.68 ' OH ' HG21 ' A' ' 191' ' ' VAL . 2.5 m-30 -88.58 -178.68 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.572 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.935 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -158.39 145.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.785 0.326 . . . . 0.0 111.324 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.449 ' HB3' HG13 ' A' ' 147' ' ' VAL . 17.0 p -135.09 148.59 49.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.565 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -106.85 83.17 1.8 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.587 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 43.91 -173.61 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.518 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.94 -55.95 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.962 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.64 25.52 3.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.451 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -76.33 0.36 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.97 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.45 -78.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -133.68 -153.67 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.944 179.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.572 ' O ' HG22 ' A' ' 93' ' ' VAL . 15.5 m95 -60.23 83.9 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.897 0.379 . . . . 0.0 109.992 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.6 OUTLIER -90.75 120.66 31.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.355 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.581 ' SG ' HG21 ' A' ' 93' ' ' VAL . 1.3 m -92.39 159.25 15.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.932 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -136.62 119.44 16.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.834 0.349 . . . . 0.0 111.309 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -92.8 110.89 3.99 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.951 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 162' ' ' TYR . 2.3 m-85 -108.42 119.51 39.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.116 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.7 108.28 16.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.795 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -51.99 141.01 18.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.314 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 31.5 t -63.37 -53.48 51.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.41 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.39 -22.12 63.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.748 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.65 71.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.974 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 p -166.53 27.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.792 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.72 26.67 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.925 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.68 54.33 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.656 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.1 tpt180 -175.72 -37.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.947 HD21 ' HB ' ' A' ' 85' ' ' VAL . 8.6 mp -120.52 -39.78 2.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.908 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 45.7 t -52.9 -55.72 21.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 193' ' ' CYS . 0.0 OUTLIER -76.03 -31.64 58.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.771 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -66.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.68 HG21 ' OH ' ' A' ' 162' ' ' TYR . 39.8 t -56.0 -54.63 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.36 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.39 31.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.478 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 4.7 t -67.98 -27.48 66.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.488 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -54.49 -41.49 69.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.622 ' O ' HD12 ' A' ' 199' ' ' LEU . 96.2 m-85 -63.37 -21.89 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.852 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -47.77 -28.3 2.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.27 -31.54 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.575 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -56.72 -41.36 77.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.137 178.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -99.1 -34.91 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 200' ' ' GLU . 30.1 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.779 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.594 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.796 0.331 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -176.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.361 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.487 ' H ' HD12 ' B' ' 3' ' ' ILE . 3.8 mp -46.19 -26.1 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.073 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.04 -85.61 0.02 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.918 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.594 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 32.0 Cg_exo . . . . . 0 N--CA 1.462 -0.341 0 C-N-CA 122.544 2.163 . . . . 0.0 110.112 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 m0 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.938 0.399 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 6.9 pt20 -49.64 -35.42 21.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.979 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -76.7 -67.88 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.368 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -46.96 -45.36 20.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.307 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -49.45 -37.2 24.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.822 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -86.54 -35.4 19.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.757 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.492 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -52.54 -59.67 4.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 193' ' ' CYS . 27.5 m -52.31 -36.82 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -48.07 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.422 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.06 17.65 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . 54.72 92.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.662 0.268 . . . . 0.0 111.313 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 t 174.43 46.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.29 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -121.01 152.27 38.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 1.8 m -157.7 144.48 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.922 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.729 ' CE2' HG21 ' A' ' 123' ' ' VAL . 3.5 p90 -146.83 172.14 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 111.247 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.08 154.49 23.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.828 ' HB ' HD21 ' A' ' 187' ' ' LEU . 11.4 p -174.2 160.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.738 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.545 ' N ' HG22 ' A' ' 85' ' ' VAL . 4.1 mmtt -117.24 75.65 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.655 ' CD1' HG21 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -56.69 115.56 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.402 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.829 HD13 ' HA ' ' A' ' 177' ' ' PHE . 7.7 mp -64.91 -37.54 87.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.58 -129.07 3.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.532 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.551 ' N ' HD11 ' A' ' 109' ' ' LEU . 3.7 p -171.02 124.12 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.506 HG13 HD13 ' A' ' 109' ' ' LEU . 26.8 m -116.61 129.68 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.365 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -57.47 155.55 9.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 172' ' ' TRP . 19.5 m -150.6 177.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.195 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -94.68 -11.17 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.44 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.82 136.25 46.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.823 0.344 . . . . 0.0 110.921 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.3 p -101.32 23.02 11.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.767 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.54 -167.97 2.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.02 109.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -28.38 8.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.42 -45.5 94.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.637 HG12 ' SG ' ' A' ' 174' ' ' CYS . 38.7 t -51.41 -32.56 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -42.9 59.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.761 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -45.35 74.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.43 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.3 pt-20 -75.96 -38.07 57.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -54.83 -45.04 74.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.472 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp -56.8 -42.42 79.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.3 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -42.47 95.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.344 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.4 t -66.26 -40.55 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.011 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.551 HD11 ' N ' ' A' ' 90' ' ' CYS . 1.5 mm? -52.08 -23.19 4.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.25 -50.23 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.536 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.434 ' CG ' ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.68 -22.48 66.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.553 -178.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -88.65 165.8 14.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.31 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -21.5 13.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -41.75 114.97 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.48 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 139.33 20.01 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.39 154.04 43.78 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.627 2.218 . . . . 0.0 112.789 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.945 HG21 HD11 ' A' ' 139' ' ' ILE . 3.4 p -110.97 170.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.55 ' H ' HG22 ' A' ' 117' ' ' VAL . 5.9 ttt85 -137.82 88.29 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.538 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.71 -150.94 5.53 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.739 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.648 HD23 ' C ' ' A' ' 83' ' ' PHE . 10.6 mt -123.04 151.22 42.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.487 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.532 ' CB ' ' CE1' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -99.04 106.88 19.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 129' ' ' ARG . 41.7 m-70 -71.57 63.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 194' ' ' ALA . 70.9 t -66.96 107.45 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.7 m -131.69 31.83 4.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.448 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 48.0 29.09 6.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.565 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.562 ' C ' HG22 ' A' ' 144' ' ' ILE . 24.0 t0 -140.97 -43.25 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -159.39 122.18 1.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.977 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.742 ' CD1' HD12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -73.04 82.98 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.76 0.314 . . . . 0.0 110.558 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 48.0 mtt85 -95.73 81.71 3.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.313 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 87' ' ' TYR . 2.0 p -73.55 88.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.21 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 132' ' ' ASP . 72.8 t -76.5 156.26 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.093 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -100.42 122.54 43.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.22 0.33 22.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.72 -32.21 8.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.5 p -119.82 -36.52 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.964 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.9 OUTLIER 67.02 44.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -109.83 16.65 30.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.095 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 137' ' ' GLY . 6.9 tp 46.23 107.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.361 0.601 . . . . 0.0 111.673 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.945 HD11 HG21 ' A' ' 117' ' ' VAL . 32.4 mt -72.94 -61.62 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.908 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.2 t -104.58 97.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -98.92 71.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.18 172.67 12.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 145' ' ' GLU . 12.1 m -92.37 147.91 22.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.629 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.742 HD12 ' CD1' ' A' ' 128' ' ' LEU . 19.4 tt -81.12 -19.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.786 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.602 ' H ' HG22 ' A' ' 143' ' ' THR . 1.5 mt-10 -84.88 -36.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.212 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -43.17 14.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 148' ' ' SER . 10.4 p -46.03 164.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.314 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -70.85 -2.54 15.3 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.0 m-85 84.22 166.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.887 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 29.0 p -87.43 -173.02 4.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.613 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 173.74 101.53 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.444 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 52.0 Cg_endo . . . . . 0 C--N 1.346 0.444 0 C-N-CA 122.594 2.196 . . . . 0.0 112.934 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.41 ' CD ' ' OD2' ' A' ' 182' ' ' ASP . 7.2 ptt180 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.809 0.337 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 160' ' ' PHE . . . -104.69 127.55 9.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.644 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 6.1 m-85 -139.06 177.64 7.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 p -175.3 125.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.756 ' OH ' HG21 ' A' ' 191' ' ' VAL . 4.9 m-30 -98.1 -171.75 2.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -156.97 155.18 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 22.9 p -146.12 143.22 29.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.952 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 79.34 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.061 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 168' ' ' THR . 37.9 t0 59.36 -88.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.761 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.98 -83.11 0.01 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.431 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 166' ' ' ASP . 1.8 m -139.72 22.34 2.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 92.8 m -111.36 -82.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -158.03 -70.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.683 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -150.05 -155.51 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.977 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.622 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -65.46 76.23 0.06 Allowed 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.01 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -92.41 121.14 33.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.081 -177.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.637 ' SG ' HG12 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.16 142.54 28.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -114.49 118.7 34.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.998 0.428 . . . . 0.0 111.161 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' LEU . . . -115.45 151.88 18.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.833 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.829 ' HA ' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -178.62 176.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 111.956 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.28 139.82 35.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.153 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 187' ' ' LEU . . . -64.25 138.71 58.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 0.0 111.615 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 186' ' ' ARG . 21.9 mmtt -76.81 -27.78 55.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.656 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.41 ' OD2' ' CD ' ' A' ' 158' ' ' ARG . 1.4 t70 60.31 36.92 20.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.464 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.4 p -151.56 19.09 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.674 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.88 26.53 1.19 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.263 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.76 24.14 13.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.552 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -179.34 37.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.086 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 1.002 HD13 ' HB1' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -167.52 -52.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.469 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 2.9 t -73.75 -66.64 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -52.41 -36.81 55.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.478 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.954 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.756 HG21 ' OH ' ' A' ' 162' ' ' TYR . 38.9 t -50.37 -48.86 25.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.994 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.03 -27.26 21.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.885 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.671 ' HB3' HG21 ' A' ' 76' ' ' VAL . 60.8 m -87.24 -28.32 22.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.94 0.4 . . . . 0.0 110.52 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.816 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -51.31 -51.31 55.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.461 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.712 ' O ' HD12 ' A' ' 199' ' ' LEU . 86.5 m-85 -55.06 -23.95 22.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.256 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -46.53 -49.88 18.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.856 0.36 . . . . 0.0 111.202 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 76' ' ' VAL . 86.2 t -58.75 -38.93 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 30.4 t -65.15 -30.78 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.201 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 195' ' ' PHE . 1.2 mp -130.32 57.4 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.296 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.402 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.35 -87.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 199' ' ' LEU . 28.7 mm -116.01 -51.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.867 0.365 . . . . 0.0 111.094 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 149' ' ' PHE . . . -50.98 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.361 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 32.3 Cg_exo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.5 m0 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.838 0.351 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 2.0 pp0? -49.59 -33.48 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.004 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.33 -70.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.67 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 76' ' ' VAL . 11.5 m-20 -47.39 -32.04 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.489 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -65.21 -25.66 67.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 110.959 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 13.4 mt-10 -102.28 -35.91 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -53.91 -55.44 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 193' ' ' CYS . 28.7 m -55.14 -38.51 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -34.8 73.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 23.2 t -88.66 -12.13 43.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.198 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 78' ' ' SER . . . 75.28 73.16 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.841 0.353 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -179.24 50.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -112.84 -179.35 3.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB2' HD11 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -174.15 122.69 0.3 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.503 0.668 . . . . 0.0 111.096 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -127.77 130.15 48.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.511 -177.165 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -60.68 160.41 9.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.935 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.5 p -177.77 159.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 111.923 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.518 ' N ' HG22 ' A' ' 85' ' ' VAL . 10.7 mttt -107.91 62.48 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.211 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.748 ' O ' HG12 ' A' ' 117' ' ' VAL . 31.6 t80 -55.6 119.86 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.472 -178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 109' ' ' LEU . 9.0 mp -60.83 -43.04 98.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.041 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 136.17 -159.02 24.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.975 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -115.51 145.8 42.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.023 0.44 . . . . 0.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -137.27 174.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.401 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.475 ' N ' HG13 ' A' ' 91' ' ' VAL . 2.8 pm0 -101.16 146.7 27.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.305 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 172' ' ' TRP . 4.5 m -144.55 163.85 13.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.027 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -84.79 -3.95 58.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.899 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG11 ' A' ' 101' ' ' VAL . 22.7 mm-40 -153.29 126.71 8.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.847 0.356 . . . . 0.0 110.912 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 3.0 p -95.72 27.08 3.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.604 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -151.03 149.46 29.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.0 -147.06 18.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.96 -46.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -26.93 15.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 95' ' ' GLU . 48.5 t -68.14 -36.73 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.782 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 53.7 m -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -39.23 87.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.53 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.0 pt-20 -82.4 -34.09 28.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.29 13.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.678 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -49.4 -43.35 44.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.22 77.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.29 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.7 t -67.54 -43.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.917 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' A' ' 88' ' ' LEU . 3.1 mm? -53.14 -22.36 6.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -47.0 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.389 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -9.1 58.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.014 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.23 172.35 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.198 -179.437 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.37 6.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.666 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.648 ' HG3' HD13 ' A' ' 109' ' ' LEU . 2.4 mmt180 -43.18 113.38 0.48 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.441 ' CG ' ' HD2' ' A' ' 116' ' ' PRO . 60.8 ttt180 -118.66 144.97 36.53 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.321 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 115' ' ' ARG . 75.3 Cg_exo -50.34 155.39 4.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.813 2.342 . . . . 0.0 112.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 139' ' ' ILE . 10.7 p -126.39 109.55 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.252 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 133' ' ' ASP . 2.6 ttt180 -69.33 70.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.124 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.94 -165.26 11.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.232 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.625 HD13 ' C ' ' A' ' 120' ' ' LEU . 1.9 tm? -120.75 119.23 32.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.6 tp -77.38 83.7 3.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.075 0.464 . . . . 0.0 110.15 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.499 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -66.03 82.61 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.827 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 81' ' ' CYS . 1.8 m -70.78 178.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 p -178.01 31.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.86 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.636 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 40.93 32.55 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.722 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -172.12 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.553 0.216 . . . . 0.0 111.398 -178.721 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -153.75 117.12 0.78 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.879 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.527 HD21 HD12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -90.13 130.02 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.748 0.309 . . . . 0.0 110.569 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.55 ' HB3' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -135.01 90.67 2.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.901 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 130' ' ' VAL . 3.9 p -72.72 102.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.0 t -91.96 135.91 25.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.36 137.59 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 118' ' ' ARG . 11.3 t0 -87.83 16.12 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -117.43 -35.0 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 43.3 p -119.26 -15.88 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.649 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.92 36.07 7.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.91 -164.79 24.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.873 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -122.5 132.01 54.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.846 HD11 HG21 ' A' ' 117' ' ' VAL . 4.3 mt -100.12 -23.52 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 140' ' ' VAL . 22.0 t -143.77 60.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.195 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.457 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 20.3 p-10 -67.74 73.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.484 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -145.13 151.37 38.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 111.407 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -60.62 179.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.746 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 126' ' ' ASP . 16.4 tt -108.07 -23.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -86.89 -24.18 24.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.879 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -94.76 21.33 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.0 OUTLIER -115.12 178.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.419 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.488 ' OG ' HD12 ' A' ' 163' ' ' ILE . 23.1 t -87.23 13.96 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 76.79 -177.61 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.771 0.319 . . . . 0.0 111.045 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 3.9 m -111.33 163.17 14.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 111.281 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -174.75 98.45 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.866 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 34.1 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.182 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.84 0.353 . . . . 0.0 110.961 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.05 110.71 2.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.593 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.683 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 5.9 m-85 -91.82 170.28 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -164.18 107.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.786 ' OH ' HG11 ' A' ' 191' ' ' VAL . 4.0 m-30 -88.94 -179.5 5.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.325 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -159.32 148.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.404 ' HB3' ' CG1' ' A' ' 147' ' ' VAL . 19.6 p -139.21 157.84 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.752 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 87.32 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.885 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' THR . 3.1 p-10 47.62 26.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.169 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.72 80.04 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.417 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 166' ' ' ASP . 17.1 p 55.0 25.7 7.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.678 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -119.22 -78.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -158.79 -81.66 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 111.112 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -143.42 -148.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.891 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.638 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -66.76 74.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.171 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.452 ' HE3' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.29 118.1 27.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.352 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.42 168.08 17.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.091 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -140.58 90.54 2.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.783 0.325 . . . . 0.0 111.407 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -69.46 107.01 1.96 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -104.99 138.67 40.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 179' ' ' ALA . 2.8 tm? -135.37 108.4 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.388 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.683 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -44.88 145.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.713 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.02 -59.7 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -68.31 -27.44 66.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD1' HD21 ' A' ' 178' ' ' LEU . 0.5 OUTLIER 59.17 82.43 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.172 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.438 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 8.3 t -168.6 29.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.06 27.89 1.17 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.898 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.0 49.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.0 110.79 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.55 ' C ' HD12 ' A' ' 187' ' ' LEU . 25.3 mmt180 -149.84 -46.5 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.486 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.935 HD21 ' HB ' ' A' ' 85' ' ' VAL . 2.6 mp -119.66 -36.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.122 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -58.42 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -18.46 47.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.543 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 193' ' ' CYS . . . -87.83 -74.25 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.272 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 187' ' ' LEU . 3.4 p -52.09 -29.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.117 0.484 . . . . 0.0 110.119 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.13 -30.45 60.98 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.832 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -71.0 -32.04 68.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.139 0.495 . . . . 0.0 109.667 177.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.636 ' HB1' ' HA2' ' A' ' 125' ' ' GLY . . . -50.95 -33.6 25.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.564 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.785 ' O ' HD12 ' A' ' 199' ' ' LEU . 17.6 m-85 -61.45 -24.88 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.731 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.02 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.292 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.63 -34.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 31.9 t -52.16 -28.33 17.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.656 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -121.43 -38.41 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.043 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.428 ' C ' ' CG ' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.643 0.259 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.789 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER 178.43 -92.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.069 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.789 HD13 ' O ' ' B' ' 2' ' ' TYR . 5.1 mm -135.39 64.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.115 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.46 -78.63 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.457 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.4 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 75.9 Cg_exo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.531 2.154 . . . . 0.0 112.139 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.425 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 1.2 m0 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.011 0.434 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -24.13 65.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.965 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.66 -46.97 6.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.02 -46.04 65.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.08 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 69' ' ' TRP . 5.3 tt0 -50.57 -41.8 54.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.39 -23.23 35.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -63.57 -53.04 57.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.874 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -58.41 -43.64 87.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.266 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -53.42 -45.5 69.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.468 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 17.0 12.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.101 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . 56.56 85.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.646 0.26 . . . . 0.0 111.303 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.639 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.6 t 174.24 51.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -119.81 166.7 12.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.763 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.914 ' HB3' HD21 ' A' ' 120' ' ' LEU . 2.0 m -166.48 160.21 15.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.048 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.469 ' CG ' ' O ' ' A' ' 82' ' ' SER . 21.2 m-85 -167.99 141.35 3.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 120' ' ' LEU . 8.2 t -59.37 158.74 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.893 ' HB ' HD21 ' A' ' 187' ' ' LEU . 14.9 p -175.47 160.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 111.952 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 85' ' ' VAL . 8.5 mttt -114.56 57.97 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.703 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.765 ' O ' HG22 ' A' ' 117' ' ' VAL . 26.7 t80 -47.67 134.38 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 109' ' ' LEU . 7.4 mp -79.21 -58.08 3.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.906 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.576 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 151.06 -155.34 26.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.543 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 20.0 p -121.26 144.03 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 109' ' ' LEU . 7.5 m -134.78 142.59 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.1 124.63 24.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 172' ' ' TRP . 15.4 m -127.25 176.92 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.985 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.22 2.9 53.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.886 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.5 mm-40 -153.85 164.97 37.49 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.974 0.416 . . . . 0.0 111.073 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.503 ' HG ' ' HE3' ' A' ' 172' ' ' TRP . 83.7 p -132.95 23.93 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.669 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.78 168.63 19.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.15 154.38 24.21 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -24.09 24.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.03 -42.5 97.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.044 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 45.5 t -64.73 -30.5 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -70.81 -58.08 3.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.037 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -48.27 -37.57 16.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.7 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.3 pt-20 -83.86 -42.17 16.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.817 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 101' ' ' VAL . . . -50.4 -48.76 55.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HG ' ' HA2' ' A' ' 176' ' ' GLY . 0.3 OUTLIER -53.82 -51.47 63.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -51.11 -42.45 60.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.468 178.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -66.27 -35.67 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.119 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.627 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -53.76 -39.57 65.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -52.6 8.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.04 -36.33 28.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.045 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.04 -167.0 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 31.15 3.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.471 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -90.56 79.41 6.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.631 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -58.35 128.35 82.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.16 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.53 159.44 32.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.448 2.098 . . . . 0.0 112.435 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.933 HG11 HD11 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -104.88 -178.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.404 ' HG3' ' HE3' ' A' ' 86' ' ' LYS . 12.1 ttt180 -149.54 70.64 1.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.581 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.8 -130.09 2.66 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.721 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' A' ' 82' ' ' SER . 1.4 tp -136.77 139.44 41.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.936 0.398 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 85' ' ' VAL . 20.1 tp -92.93 124.66 37.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.392 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 129' ' ' ARG . 12.1 m170 -85.24 103.35 14.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.014 HG21 HG22 ' A' ' 191' ' ' VAL . 96.1 t -109.48 105.97 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -128.73 39.76 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.454 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 39.35 48.36 2.87 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.216 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.642 ' O ' HG22 ' A' ' 144' ' ' ILE . 4.4 t70 -160.62 -41.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.79 117.8 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.546 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.723 HD11 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.6 133.78 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 0.0 110.97 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 14.5 mtm-85 -139.42 87.79 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.593 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.504 HG13 ' HB ' ' A' ' 139' ' ' ILE . 7.4 p -77.62 140.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.581 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 136' ' ' LYS . 5.2 t -135.26 152.7 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.478 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.5 t0 -95.82 149.49 21.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.781 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.422 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t70 -91.77 19.96 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.351 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -127.27 -40.9 1.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 110.752 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 p -114.06 -19.59 11.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.125 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HA ' HG12 ' A' ' 131' ' ' VAL . 5.4 mmtp 59.3 22.34 10.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 110.784 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.38 120.21 5.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.423 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.456 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 2.0 tp -55.75 133.52 50.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.68 0.276 . . . . 0.0 110.608 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.933 HD11 HG11 ' A' ' 117' ' ' VAL . 6.0 mt -108.12 -43.25 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.08 86.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.529 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.456 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 26.8 t0 -98.09 69.44 2.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.758 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -124.54 179.12 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -91.82 171.67 8.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.649 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.723 HD12 HD11 ' A' ' 128' ' ' LEU . 10.1 tt -107.64 -16.7 8.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.404 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.94 -38.32 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 111.022 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -81.15 -24.79 37.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 163' ' ' ILE . 11.6 p -70.64 164.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.651 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.1 m -72.91 -2.19 19.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.8 m-85 80.58 -167.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.1 p -129.8 -171.62 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.961 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB1' ' HG3' ' B' ' 5' ' ' PRO . . . -164.07 58.31 0.66 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.425 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 50.1 Cg_exo . . . . . 0 C--N 1.344 0.291 0 C-N-CA 122.361 2.041 . . . . 0.0 111.807 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 120.909 0.385 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.83 147.6 17.19 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.541 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 1.5 m-85 -131.06 151.07 51.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.04 125.91 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.881 0.372 . . . . 0.0 111.689 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.669 ' O ' HG23 ' A' ' 163' ' ' ILE . 4.4 m-30 -94.94 -172.48 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.198 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -165.87 159.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.964 0.411 . . . . 0.0 111.379 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.47 ' HB3' HG23 ' A' ' 147' ' ' VAL . 24.0 p -157.56 157.66 34.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.514 ' HG3' ' CZ3' ' A' ' 172' ' ' TRP . 0.1 OUTLIER -116.03 85.09 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.3 p30 46.48 -163.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.76 -42.77 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.218 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.4 p -153.32 24.92 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.948 0.404 . . . . 0.0 110.734 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.68 -72.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.034 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.418 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER 179.81 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.759 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' MET . 6.2 ptt180 -131.05 -152.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.149 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 4.4 m95 -60.87 82.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -90.18 112.68 24.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.81 -177.151 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' A' ' 93' ' ' VAL . 1.2 m -82.29 171.41 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.974 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -146.3 118.83 8.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.92 0.391 . . . . 0.0 111.561 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 87' ' ' TYR . . . -92.32 124.19 7.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.74 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 4.7 m-85 -122.89 136.33 54.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.391 . . . . 0.0 111.327 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.79 108.59 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.438 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.597 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -50.1 134.38 22.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 111.177 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -60.38 3.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.79 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -57.6 -33.81 68.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.649 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.2 80.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.02 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.37 30.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.58 37.56 0.15 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 113.879 0.312 . . . . 0.0 113.879 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -147.58 49.4 1.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.019 0.438 . . . . 0.0 111.496 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.08 -42.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.0 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.893 HD21 ' HB ' ' A' ' 85' ' ' VAL . 5.7 mp -111.47 -44.47 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.4 p -53.9 -60.2 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -71.03 -28.1 64.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -71.94 -68.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.865 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 1.014 HG22 HG21 ' A' ' 123' ' ' VAL . 2.7 t -60.6 -41.37 87.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.28 -39.85 36.37 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.782 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 1.7 m -76.13 -27.76 57.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.061 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.619 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -60.58 -41.96 95.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.542 ' CD2' HD11 ' A' ' 144' ' ' ILE . 42.4 m-85 -59.99 -35.51 75.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -51.45 -27.06 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.6 t -71.77 -31.6 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.45 ' HB3' HD23 ' A' ' 199' ' ' LEU . 38.9 t -48.25 -52.74 19.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.731 HD21 HG21 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -100.43 -33.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 5.2 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.674 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.736 0.303 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 179.77 74.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.731 HG21 HD21 ' A' ' 199' ' ' LEU . 4.8 mp 47.54 45.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.43 ' CA ' ' C ' ' B' ' 5' ' ' PRO . . . 127.44 87.65 0.59 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.514 ' HG3' ' HB1' ' A' ' 151' ' ' ALA . 41.3 Cg_exo . . . . . 0 N--CA 1.482 0.801 0 CA-C-N 118.699 1.249 . . . . 0.0 114.922 6.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 . . . . . 0 CA--C 1.518 -0.255 0 CA-C-O 121.378 0.608 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -13.68 40.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.232 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.79 -27.32 6.26 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 4.7 p30 -90.34 -25.92 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.662 0.267 . . . . 0.0 111.504 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 49.4 mt-10 -61.31 -27.0 68.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.976 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -102.04 -24.64 13.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' THR . . . -46.29 -37.6 7.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 194' ' ' ALA . 40.0 t -63.67 -50.47 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HA ' ' CG2' ' A' ' 197' ' ' VAL . 3.8 mtp180 -49.86 -48.63 51.12 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.107 0.479 . . . . 0.0 110.577 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.91 14.33 10.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.246 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 50.42 81.04 0.07 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.65 0.262 . . . . 0.0 111.116 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.8 t -171.96 29.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.586 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.57 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -97.59 157.87 15.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -171.43 144.81 2.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 54.1 m-85 -154.73 146.04 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.507 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -58.11 162.88 3.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.523 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.632 HG13 ' CD2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -159.63 172.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.208 0.528 . . . . 0.0 111.727 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.432 ' H ' HG12 ' A' ' 85' ' ' VAL . 4.4 mttt -125.42 42.4 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.965 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.496 ' N ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -38.98 122.33 1.18 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.388 -178.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.723 HD23 ' HB3' ' A' ' 109' ' ' LEU . 8.9 mp -67.59 -44.52 77.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.214 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.515 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 145.37 -135.09 5.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.442 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.404 ' N ' HD11 ' A' ' 109' ' ' LEU . 25.3 p -139.65 148.75 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.865 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 174' ' ' CYS . 12.5 m -139.15 127.78 28.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.51 128.01 35.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.069 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 172' ' ' TRP . 32.9 m -126.15 -174.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.687 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.93 24.93 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.618 ' HB2' HG21 ' A' ' 101' ' ' VAL . 28.5 mp0 -141.96 -81.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.172 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m 60.36 22.73 12.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.783 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 24.89 2.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -166.42 10.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.64 -39.35 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -59.54 -47.56 85.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.966 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' A' ' 95' ' ' GLU . 62.0 t -49.65 -26.67 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.07 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.6 m -66.88 -44.23 81.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.84 -53.81 43.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 pt-20 -76.81 -36.93 56.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.776 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.597 ' O ' HD23 ' A' ' 109' ' ' LEU . . . -48.9 -25.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tt -81.8 -43.54 18.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.07 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 6.8 pttt -60.76 -35.18 75.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.321 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -68.16 -35.69 72.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.583 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.723 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -54.37 -27.82 38.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -47.39 6.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.079 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -23.48 5.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.795 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.73 177.95 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -12.7 58.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.303 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.702 ' HG2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -43.23 108.91 0.12 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 0.0 111.537 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.2 ptt180 -98.92 144.76 28.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.8 160.37 12.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.461 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.984 HG21 HD11 ' A' ' 139' ' ' ILE . 1.6 p -115.92 176.18 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.599 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -147.69 79.88 1.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.12 5.35 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.008 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 120' ' ' LEU . 3.4 mt -121.1 131.19 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.475 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -88.04 104.89 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -72.09 69.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.261 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.849 HG21 HG22 ' A' ' 191' ' ' VAL . 93.9 t -77.84 97.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.371 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 24.9 p -119.62 42.62 2.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.459 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 42.99 41.91 4.83 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.708 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.764 ' O ' HG22 ' A' ' 144' ' ' ILE . 9.8 t0 -163.39 -43.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.613 0.244 . . . . 0.0 111.286 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -148.14 127.56 2.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.283 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 191' ' ' VAL . 0.2 OUTLIER -87.03 71.41 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.667 0.27 . . . . 0.0 110.886 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.48 89.84 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.8 0.334 . . . . 0.0 111.176 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.864 HG13 ' HB ' ' A' ' 139' ' ' ILE . 5.8 p -85.93 90.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.952 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 132' ' ' ASP . 7.2 p -86.2 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -99.62 147.68 25.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -100.66 14.41 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.676 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.89 -43.77 3.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 58.7 p -111.31 -19.96 12.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 38.45 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.049 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.41 139.99 15.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.103 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 139' ' ' ILE . 2.6 tp -73.39 110.81 7.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.984 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 117' ' ' VAL . 38.2 mt -68.38 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.31 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 138' ' ' LEU . 66.2 t -110.28 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.075 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.442 ' HA ' HD21 ' A' ' 138' ' ' LEU . 26.6 t70 -93.89 73.25 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.497 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.2 170.37 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 145' ' ' GLU . 87.9 m -103.64 141.8 35.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.545 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.889 HD11 ' CE1' ' A' ' 195' ' ' PHE . 13.0 tt -70.66 -27.09 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.014 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.68 ' H ' HG22 ' A' ' 143' ' ' THR . 0.4 OUTLIER -81.79 -30.92 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.772 178.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -91.42 -41.7 10.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.943 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 163' ' ' ILE . 14.3 p -47.4 161.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.074 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.536 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.4 m -52.7 -50.95 62.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 1.061 ' CE1' HD11 ' A' ' 163' ' ' ILE . 3.0 p90 150.75 -176.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.673 0.789 . . . . 0.0 109.971 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 15.9 p -114.91 151.48 33.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.425 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -177.05 102.09 0.23 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.129 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 45.5 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.332 2.022 . . . . 0.0 111.963 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.409 ' CD ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.73 0.3 . . . . 0.0 111.232 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -110.81 154.14 16.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.594 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 0.3 OUTLIER -139.29 -175.46 4.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.75 0.309 . . . . 0.0 110.728 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.6 t -177.31 136.02 0.2 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.878 0.37 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.645 ' OH ' HG11 ' A' ' 191' ' ' VAL . 60.5 m-85 -105.06 -171.49 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.365 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.061 HD11 ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -165.31 142.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 111.474 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 20.0 p -132.98 142.58 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.466 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 172' ' ' TRP . 4.5 ptt180 -108.51 83.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.429 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 170' ' ' ARG . 2.9 p30 45.45 -162.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.415 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.52 -64.06 4.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.664 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -44.35 5.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.353 . . . . 0.0 111.127 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 79.9 m -86.18 -88.29 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.91 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 166' ' ' ASP . 18.2 mmm180 -154.81 -81.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 110.372 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 3.3 ptp180 -127.59 -152.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.492 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.804 ' O ' HG22 ' A' ' 93' ' ' VAL . 19.5 m95 -67.3 71.53 0.11 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -88.39 119.01 28.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.596 ' SG ' HG11 ' A' ' 93' ' ' VAL . 15.2 m -89.19 157.9 18.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.333 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -135.62 99.11 4.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.649 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -94.28 134.1 11.89 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.92 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.5 p90 -154.93 148.74 25.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 111.482 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.537 HD11 ' OD2' ' A' ' 182' ' ' ASP . 8.2 tp -118.52 132.7 56.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.396 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -49.29 140.43 9.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -61.35 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.685 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -68.21 -32.84 73.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.537 ' OD2' HD11 ' A' ' 178' ' ' LEU . 10.6 t70 67.24 73.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.062 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.4 23.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.624 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 41.15 30.87 0.47 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.42 ' O ' ' NE ' ' A' ' 186' ' ' ARG . 2.0 mt-10 -136.92 41.43 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.669 0.271 . . . . 0.0 111.191 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.487 ' HD3' ' CE1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -154.64 -45.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.911 0.386 . . . . 0.0 110.768 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 191' ' ' VAL . 9.3 mp -113.54 -43.91 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.836 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 20.4 t -56.7 -61.16 2.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -67.3 -21.01 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.259 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.57 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -83.68 -60.92 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.176 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.849 HG22 HG21 ' A' ' 123' ' ' VAL . 2.2 t -66.74 -31.78 55.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.799 0.333 . . . . 0.0 110.553 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.21 -26.01 12.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.56 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 44.5 t -99.08 -23.02 15.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.439 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.619 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -50.07 -28.33 6.97 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.889 ' CE1' HD11 ' A' ' 144' ' ' ILE . 53.4 m-85 -84.87 -22.07 29.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -60.61 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.774 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 77' ' ' ARG . 79.8 t -55.49 -39.09 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 34.9 t -57.61 -48.71 78.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.058 HD21 HG21 ' B' ' 3' ' ' ILE . 1.2 pt? -129.93 56.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.167 0.508 . . . . 0.0 110.754 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 29.3 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.709 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.819 0.342 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.628 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -134.48 -78.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 1.058 HG21 HD21 ' A' ' 199' ' ' LEU . 8.1 mm -134.91 -42.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.21 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.03 -77.78 0.11 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.643 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo . . . . . 0 C--N 1.345 0.352 0 C-N-CA 122.683 2.256 . . . . 0.0 112.213 179.909 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.967 0.413 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.14 -21.83 65.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.28 -62.84 1.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.408 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.9 p30 -53.14 -29.52 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.007 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.0 mm-40 -69.19 -36.0 76.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 0.0 110.522 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.8 -23.87 25.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.681 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.759 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -59.22 -57.37 13.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.677 HG13 ' HA ' ' A' ' 194' ' ' ALA . 1.2 t -50.59 -48.11 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.255 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -42.84 62.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.519 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.0 p -94.49 18.92 10.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.079 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.02 82.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -179.4 49.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.145 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -116.0 173.24 6.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.05 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 29.4 p 176.84 151.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.512 ' C ' HD23 ' A' ' 120' ' ' LEU . 53.3 m-85 -160.51 138.25 9.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.784 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.8 t -49.23 167.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.692 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 86' ' ' LYS . 8.5 p -174.48 162.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 111.993 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.526 ' N ' HG22 ' A' ' 85' ' ' VAL . 12.5 mtmm -111.96 56.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.617 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.616 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -47.7 176.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 116' ' ' PRO . 11.0 mt -137.48 -42.4 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.151 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.68 -144.67 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.485 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.5 m -136.58 155.93 49.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.586 HG13 HD13 ' A' ' 109' ' ' LEU . 2.8 m -134.61 128.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.873 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.67 124.28 20.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.852 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 172' ' ' TRP . 28.7 m -126.59 164.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -93.56 17.78 11.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.193 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HB2' HG21 ' A' ' 101' ' ' VAL . 38.3 mt-10 -159.0 114.38 2.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.05 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -93.62 21.35 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -151.84 130.9 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.63 130.34 3.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.457 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -32.81 74.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.751 0.31 . . . . 0.0 111.066 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -43.83 91.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 95' ' ' GLU . 59.6 t -61.98 -28.48 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.049 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.4 m -69.08 -48.02 63.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.013 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -52.41 -59.01 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.912 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -62.56 -30.78 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -62.96 -57.42 10.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.02 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -50.52 -44.44 56.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.528 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.79 -39.75 71.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.399 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 104' ' ' GLU . 15.0 t -64.24 -42.97 97.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.437 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.586 HD13 HG13 ' A' ' 91' ' ' VAL . 2.6 mm? -52.33 -22.42 4.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.228 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 -54.18 3.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.355 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 1.5 pp0? -61.16 -30.98 70.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.486 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -84.32 172.39 11.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -22.36 11.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HG3' HD13 ' A' ' 109' ' ' LEU . 1.1 mmt180 -45.26 102.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 141.36 24.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.714 ' HA ' HD23 ' A' ' 88' ' ' LEU . 36.2 Cg_exo -59.82 152.25 65.11 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.481 2.12 . . . . 0.0 112.441 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 118' ' ' ARG . 3.1 p -114.23 177.87 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.403 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.622 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -146.19 74.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.454 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -128.57 -144.87 5.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.282 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -122.2 130.5 53.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.678 0.275 . . . . 0.0 111.281 -178.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.727 ' HG ' HG23 ' A' ' 123' ' ' VAL . 41.8 tp -84.97 100.01 11.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -73.61 87.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.684 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.954 HG21 HG22 ' A' ' 191' ' ' VAL . 94.0 t -101.87 112.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.91 42.73 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.576 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 47.19 25.0 2.48 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.718 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -174.38 27.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 156.43 121.92 0.72 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.14 -1.029 . . . . 0.0 113.468 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.922 HD13 ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -106.85 110.18 22.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 110.419 178.632 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -124.48 106.29 10.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 87' ' ' TYR . 10.2 p -86.98 112.45 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 136' ' ' LYS . 77.3 t -116.31 120.24 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -54.58 146.65 15.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -94.14 20.67 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -126.06 -42.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.66 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 39.8 p -110.45 -24.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.906 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.461 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER 68.43 25.27 6.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.38 123.41 6.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.364 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 141' ' ' ASP . 14.6 tp -63.48 118.37 8.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 0.0 111.02 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' A' ' 130' ' ' VAL . 3.7 mt -92.67 -50.63 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.41 HG21 ' OH ' ' A' ' 87' ' ' TYR . 11.7 t -120.09 123.08 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.529 ' HB3' HD21 ' A' ' 138' ' ' LEU . 2.2 p-10 -116.94 65.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.169 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.27 165.55 11.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.683 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.81 ' O ' HG22 ' A' ' 144' ' ' ILE . 1.9 t -111.28 2.75 17.87 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.857 HD12 HD21 ' A' ' 128' ' ' LEU . 3.1 tt 72.63 -3.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.403 ' HB3' HG23 ' A' ' 143' ' ' THR . 25.9 tt0 -110.86 -37.53 5.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -30.69 27.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.574 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 148' ' ' SER . 10.7 p -51.46 164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.915 ' CB ' HD12 ' A' ' 163' ' ' ILE . 66.1 m -53.01 -53.91 43.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.323 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 163' ' ' ILE . 0.1 OUTLIER 155.84 -15.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.862 0.726 . . . . 0.0 112.212 178.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 0.5 OUTLIER 90.75 172.2 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.292 0.637 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 166.55 107.0 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 46.0 Cg_endo . . . . . 0 C--N 1.345 0.348 0 C-N-CA 122.364 2.043 . . . . 0.0 112.089 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.773 0.321 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -129.54 146.31 17.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.567 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 177' ' ' PHE . 2.0 m-85 -111.63 -176.31 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.702 0.287 . . . . 0.0 110.718 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.429 ' OG ' HD12 ' A' ' 106' ' ' LEU . 1.7 m -168.41 106.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.893 0.378 . . . . 0.0 111.276 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.922 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 42.8 m-85 -85.12 -173.16 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.915 HD12 ' CB ' ' A' ' 148' ' ' SER . 0.0 OUTLIER -167.09 132.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 38.5 t -131.42 156.69 45.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.859 0.361 . . . . 0.0 111.033 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -113.99 80.53 1.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.001 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 t0 52.47 -161.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 168' ' ' THR . . . 100.21 -22.28 40.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.325 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 167' ' ' GLY . 18.9 p -161.75 -42.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -75.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.05 -42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.1 ptp85 -166.67 -150.78 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.954 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.739 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.27 74.42 0.09 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 71.0 mmm -89.19 117.9 28.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.651 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.54 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 0.8 OUTLIER -79.68 165.05 23.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.713 177.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -131.89 120.87 23.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 111.29 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.411 ' HA2' ' HG ' ' A' ' 106' ' ' LEU . . . -116.3 113.68 2.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.432 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.571 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -143.65 162.2 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -137.53 131.15 31.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.983 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 187' ' ' LEU . . . -47.85 138.94 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.375 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -56.41 11.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.885 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.21 -33.67 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 110.455 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.9 t70 66.17 69.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.28 25.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.901 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.18 37.81 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 113.985 0.354 . . . . 0.0 113.985 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -148.69 23.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.846 0.323 . . . . 0.0 111.585 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.74 21.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.394 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.912 ' O ' HG23 ' A' ' 191' ' ' VAL . 0.6 OUTLIER 179.59 -38.92 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.539 ' N ' HD23 ' A' ' 187' ' ' LEU . 70.5 m -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.482 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -55.81 -28.13 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.093 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 76' ' ' VAL . . . -59.0 -49.75 76.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.534 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.954 HG22 HG21 ' A' ' 123' ' ' VAL . 2.5 t -73.74 -38.82 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.531 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.09 -40.95 45.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.951 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -79.23 -29.53 42.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.288 178.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.677 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -56.84 -43.02 80.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.519 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 144' ' ' ILE . 6.8 m-85 -58.09 -28.37 64.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.212 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -51.14 47.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.013 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 64.7 t -50.78 -37.71 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.867 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.1 t -61.8 -35.97 79.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.576 HD11 HD11 ' B' ' 3' ' ' ILE . 1.2 pt? -140.13 64.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 196' ' ' ALA . 1.3 pt-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.469 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.699 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -161.34 -96.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' B' ' 2' ' ' TYR . 4.8 mp -102.71 -47.67 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.456 ' HA2' ' CD1' ' A' ' 149' ' ' PHE . . . -51.09 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' B' ' 1' ' ' ALA . 16.2 Cg_exo . . . . . 0 N--CA 1.463 -0.266 0 C-N-CA 122.692 2.262 . . . . 0.0 111.61 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.1 m0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.867 0.365 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -62.92 -34.8 78.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.633 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.27 -55.84 4.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.129 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 15.9 t70 -49.42 -49.17 46.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -49.69 -41.58 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -86.21 -23.38 26.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.764 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB1' HG23 ' A' ' 80' ' ' THR . . . -72.7 -66.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 110.709 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.653 ' CG2' ' HB2' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -48.27 -37.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.832 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -45.68 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.038 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -90.78 18.57 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.411 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 55.71 96.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.835 0.35 . . . . 0.0 111.103 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.574 HG23 ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -178.8 -30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.92 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.571 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 0.7 OUTLIER -41.12 158.21 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 111.278 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 175.49 145.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.103 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.502 ' CD1' ' HG2' ' A' ' 186' ' ' ARG . 89.6 m-85 -160.59 148.01 15.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 120' ' ' LEU . 32.3 t -47.32 166.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.615 ' HB ' HD11 ' A' ' 187' ' ' LEU . 8.8 p -173.9 159.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.979 0.418 . . . . 0.0 111.724 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.441 ' N ' HG22 ' A' ' 85' ' ' VAL . 32.0 mttm -121.18 65.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.754 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.489 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.6 t80 -56.68 121.13 9.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.269 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.66 -41.21 94.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.474 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 141.9 -178.43 20.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.231 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.41 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 38.1 m -100.86 142.57 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.453 ' O ' ' HE1' ' A' ' 173' ' ' MET . 0.4 OUTLIER -136.51 172.42 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.893 -178.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' CG ' ' HD2' ' A' ' 171' ' ' ARG . 4.0 tt0 -109.83 148.43 31.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.165 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 172' ' ' TRP . 12.9 m -148.73 173.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.426 ' O ' ' CD1' ' A' ' 172' ' ' TRP . 22.5 m-85 -87.94 -24.07 23.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.658 ' HB2' HG21 ' A' ' 101' ' ' VAL . 4.5 mp0 -133.09 145.36 50.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 111.197 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 25.31 5.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.47 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.406 ' HG2' ' HD3' ' A' ' 165' ' ' ARG . 28.3 mtm180 -136.97 24.15 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.89 128.47 4.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.478 ' HG3' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -57.92 -37.89 74.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -55.12 -34.4 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 95' ' ' GLU . 82.2 t -64.86 -30.78 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.884 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 91.8 m -66.39 -43.68 85.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.21 -46.73 79.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.8 pt-20 -76.03 -32.14 59.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.984 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' O ' HD23 ' A' ' 109' ' ' LEU . . . -63.08 -59.79 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.31 -36.18 6.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -40.58 88.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.4 t -67.49 -32.42 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.615 HD13 ' HG3' ' A' ' 114' ' ' ARG . 4.0 mm? -60.36 -18.63 51.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.086 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -97.17 -45.31 6.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -64.35 -30.42 71.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.73 171.99 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -21.61 14.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD13 ' A' ' 109' ' ' LEU . 4.7 mmt180 -45.43 114.21 0.71 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.6 ptt-85 -124.51 148.15 57.74 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.292 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.1 156.64 2.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.785 2.324 . . . . 0.0 112.632 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 117' ' ' VAL . 10.6 p -129.08 114.34 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.907 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.97 63.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.681 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -117.65 -139.29 6.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.478 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.646 HD23 ' ND1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -144.27 137.79 27.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.985 0.421 . . . . 0.0 111.2 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.623 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -88.8 104.0 16.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.486 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.646 ' ND1' HD23 ' A' ' 120' ' ' LEU . 21.2 m80 -72.01 117.16 13.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.785 HG21 HG22 ' A' ' 191' ' ' VAL . 65.8 t -131.65 88.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.416 ' HB3' ' N ' ' A' ' 80' ' ' THR . 5.5 m -119.26 46.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.89 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 197' ' ' VAL . . . 35.23 61.37 0.66 Allowed Glycine 0 CA--C 1.521 0.456 0 O-C-N 123.415 0.447 . . . . 0.0 113.855 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.708 ' C ' HG22 ' A' ' 144' ' ' ILE . 6.2 t70 -178.94 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.65 122.35 0.95 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.56 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 162' ' ' TYR . 12.8 mt -78.78 146.44 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -154.16 96.17 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.737 HG13 ' HB ' ' A' ' 139' ' ' ILE . 3.5 p -86.89 115.46 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.707 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.16 136.22 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 42.1 t0 -68.5 152.64 45.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 7.0 t0 -97.4 21.55 9.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.23 -46.12 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 110.654 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.3 p -102.17 -25.37 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 66.02 32.09 8.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.03 124.42 8.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.353 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 11.7 tp -55.89 118.17 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.737 ' HB ' HG13 ' A' ' 130' ' ' VAL . 8.6 mt -87.81 -50.51 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.262 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.496 HG23 ' CG1' ' A' ' 130' ' ' VAL . 57.3 t -112.69 79.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.147 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.452 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.3 p-10 -82.74 68.91 9.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -174.33 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.5 m -105.48 169.86 8.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.708 HG22 ' C ' ' A' ' 126' ' ' ASP . 11.5 tt -99.62 -26.04 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.9 -42.32 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -45.65 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 163' ' ' ILE . 14.7 p -48.04 164.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -80.67 7.84 9.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.449 ' H ' HG13 ' A' ' 147' ' ' VAL . 1.5 m-85 80.58 -161.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 110.933 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.48 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.3 p -143.75 163.46 33.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 99' ' ' MET . . . -154.91 110.3 2.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.707 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 25.5 Cg_endo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.268 1.979 . . . . 0.0 112.1 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.801 0.334 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.59 128.13 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.326 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -113.78 174.89 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.931 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 t -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.831 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.623 ' OH ' HD11 ' A' ' 121' ' ' LEU . 4.5 m-30 -93.82 -178.15 4.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.625 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.6 pt -163.93 136.97 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.13 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.513 ' SG ' HG23 ' A' ' 147' ' ' VAL . 3.0 m -131.22 160.15 35.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.411 ' HB2' ' NH1' ' A' ' 165' ' ' ARG . 23.5 mtm105 -119.28 85.1 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.075 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 46.58 -161.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.26 -82.24 1.06 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.304 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 24.13 11.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.332 . . . . 0.0 111.015 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.9 -82.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.248 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.5 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.428 ' HD2' ' CG ' ' A' ' 92' ' ' GLU . 4.6 ptp180 -133.27 -151.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.125 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.51 ' O ' HG22 ' A' ' 93' ' ' VAL . 12.2 m95 -63.15 82.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.453 ' HE1' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -86.68 121.09 28.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.559 -178.109 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 155.09 17.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.067 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -137.16 123.21 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.757 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -98.69 112.04 4.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.532 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.476 ' CE2' ' CD2' ' A' ' 162' ' ' TYR . 22.0 m-85 -109.0 158.7 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.751 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 178' ' ' LEU . 0.4 OUTLIER -149.84 99.29 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.299 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 85' ' ' VAL . . . -42.32 141.23 0.99 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.436 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 34.7 t -63.94 -66.22 0.57 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.308 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -29.38 49.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.138 0.494 . . . . 0.0 109.907 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.76 75.19 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.223 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.06 30.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.428 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.454 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 39.1 30.25 0.12 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.421 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -133.71 49.63 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.502 ' HG2' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 169.71 -32.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.673 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.615 HD11 ' HB ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER -112.11 -30.33 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.905 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.454 ' CB ' ' HA2' ' A' ' 184' ' ' GLY . 11.1 t -87.65 -66.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.149 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -30.34 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.571 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -68.04 -68.87 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.996 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.785 HG22 HG21 ' A' ' 123' ' ' VAL . 29.7 t -52.87 -48.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.77 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.76 -35.18 23.27 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.716 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.413 ' HB3' HG11 ' A' ' 76' ' ' VAL . 14.5 t -86.46 -32.77 20.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.165 0.507 . . . . 0.0 109.884 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.653 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . . . -52.38 -33.85 45.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.894 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.525 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 32.6 m-85 -71.9 -18.86 62.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.104 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -44.85 -59.32 2.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.576 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 198' ' ' CYS . 34.4 m -50.47 -47.0 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.179 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.571 ' N ' HG23 ' A' ' 197' ' ' VAL . 41.0 t -54.41 -29.26 48.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 109.784 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.769 HD13 HG12 ' B' ' 3' ' ' ILE . 4.6 mp -123.28 43.29 2.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.521 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.169 179.761 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.443 ' HB1' ' CE1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.666 0.27 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.735 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -176.1 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.986 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.769 HG12 HD13 ' A' ' 199' ' ' LEU . 4.2 mp -140.24 54.09 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.163 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.9 -67.1 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.418 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 123.139 2.56 . . . . 0.0 112.664 179.306 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.832 0.349 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -67.31 -40.27 85.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.27 65.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.81 -41.02 94.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -30.47 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.597 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -87.84 -25.61 23.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.662 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -56.01 -50.21 71.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -61.12 -43.87 97.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.6 -179.374 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.8 83.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.448 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -95.05 19.85 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.046 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB1' ' CB ' ' A' ' 124' ' ' SER . . . 49.22 84.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.238 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 3.4 t 178.56 47.51 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.645 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 123' ' ' VAL . 9.7 t -120.83 114.27 21.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.434 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.89 142.79 51.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.866 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.489 ' HB2' HD11 ' A' ' 187' ' ' LEU . 49.0 m-85 -152.02 142.84 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.678 ' HA ' HD23 ' A' ' 120' ' ' LEU . 5.0 m -54.98 164.32 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 121' ' ' LEU . 4.8 p 176.6 161.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 85' ' ' VAL . 10.7 mtmm -113.11 79.33 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 139' ' ' ILE . 12.6 t80 -65.39 99.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.82 HD23 ' HG3' ' A' ' 116' ' ' PRO . 49.9 mt -46.47 -49.57 18.11 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA2' ' CE2' ' A' ' 87' ' ' TYR . . . 147.01 -169.18 28.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.228 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 21.1 p -123.96 129.25 50.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 110.962 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -117.88 147.24 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.999 -178.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.5 136.77 45.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 172' ' ' TRP . 27.4 m -132.76 178.92 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -116.48 26.87 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.674 ' CB ' HG21 ' A' ' 101' ' ' VAL . 3.9 mt-10 -145.0 -82.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.315 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.0 m 63.42 28.25 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 21.45 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.9 168.01 30.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.565 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -32.01 22.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.0 110.894 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -63.51 -17.02 62.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.326 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.674 HG21 ' CB ' ' A' ' 95' ' ' GLU . 25.8 t -87.5 -21.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.602 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.5 p -69.56 -37.0 76.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.62 -59.58 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.478 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.916 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.4 pt-20 -64.35 -32.92 74.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.611 ' HB1' ' CB ' ' A' ' 174' ' ' CYS . . . -67.63 -23.93 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.793 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.56 -24.14 18.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.874 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.412 ' C ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -81.61 -38.58 25.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.221 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.916 HG23 ' O ' ' A' ' 104' ' ' GLU . 70.9 t -53.14 -55.41 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.262 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.681 ' CD2' HG13 ' A' ' 91' ' ' VAL . 13.9 mt -56.45 -25.31 50.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -82.91 -27.57 30.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.459 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -89.87 -10.39 45.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.259 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.0 p -106.36 -165.67 1.11 Allowed 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -83.65 -21.95 32.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.865 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -48.36 91.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -84.77 159.62 57.48 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.202 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.82 ' HG3' HD23 ' A' ' 88' ' ' LEU . 4.4 Cg_exo -71.81 161.53 44.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.703 2.269 . . . . 0.0 111.962 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.736 HG12 ' HB3' ' A' ' 87' ' ' TYR . 9.6 p -117.64 118.19 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.44 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 64.93 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.349 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -122.34 -159.2 10.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.77 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' ' 84' ' ' SER . 5.3 mt -116.66 126.49 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.137 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.64 ' HB2' HG11 ' A' ' 85' ' ' VAL . 5.9 tp -86.82 100.36 12.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.436 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -76.45 103.61 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.538 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.59 HG21 HG22 ' A' ' 191' ' ' VAL . 58.6 t -104.5 133.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.456 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.461 ' CB ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -145.91 29.06 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.722 -178.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 48.08 23.62 2.83 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.596 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HA ' HG22 ' A' ' 144' ' ' ILE . 41.5 t0 -165.03 22.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 143' ' ' THR . . . 152.36 112.07 0.5 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' A' ' 162' ' ' TYR . 1.4 mt -91.88 101.41 13.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 110.523 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -104.49 89.88 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.689 HG13 ' HB ' ' A' ' 139' ' ' ILE . 7.6 p -83.69 112.96 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.67 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 137' ' ' GLY . 7.0 p -122.76 138.86 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.212 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 36.8 t0 -63.83 144.59 56.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 28.5 t70 -93.52 14.62 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.42 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -120.61 -39.28 2.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.778 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.7 p -104.85 -24.42 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.839 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.15 35.0 4.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -103.99 134.03 11.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.612 HD21 ' CG ' ' A' ' 141' ' ' ASP . 10.8 tp -67.02 120.95 14.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.398 . . . . 0.0 111.061 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.746 HG21 ' CE2' ' A' ' 87' ' ' TYR . 7.8 mt -90.55 -59.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.56 114.83 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.874 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.612 ' CG ' HD21 ' A' ' 138' ' ' LEU . 20.3 t0 -111.28 96.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.73 -163.93 1.49 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.682 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.816 ' O ' HG22 ' A' ' 144' ' ' ILE . 5.1 t -135.93 8.91 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 143' ' ' THR . 4.7 tt 65.59 7.01 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 143' ' ' THR . 0.7 OUTLIER -112.6 -36.23 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.132 0.491 . . . . 0.0 110.397 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -83.98 -19.85 33.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.37 177.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 148' ' ' SER . 8.3 p -66.62 164.0 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.784 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.53 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -85.75 16.27 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' A' ' 148' ' ' SER . 15.4 m-85 82.58 -179.45 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.871 0.367 . . . . 0.0 110.957 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 26.6 p -114.53 -178.76 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.456 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 172.64 100.45 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.387 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' B' ' 5' ' ' PRO . 44.8 Cg_endo . . . . . 0 C--N 1.345 0.374 0 C-N-CA 122.507 2.138 . . . . 0.0 112.894 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -96.86 122.03 7.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.844 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.499 ' HB3' ' CE1' ' A' ' 177' ' ' PHE . 5.6 m-85 -134.61 159.64 40.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.3 t -159.88 138.24 10.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.44 . . . . 0.0 111.636 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.84 ' CE2' HD13 ' A' ' 128' ' ' LEU . 6.0 m-85 -105.69 -173.23 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.1 pt -160.94 135.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.04 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 3.4 m -126.48 100.04 6.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.984 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 -65.04 80.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 168' ' ' THR . 34.4 t0 60.79 -87.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.747 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 49.06 -88.99 0.01 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.765 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 166' ' ' ASP . 2.6 m -116.54 -33.47 4.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.751 0.31 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 81.4 m -59.15 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.034 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 169' ' ' THR . 58.5 mtp180 -163.92 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -136.04 -154.72 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.762 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.75 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -64.27 78.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -99.71 120.96 40.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.153 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.611 ' CB ' ' HB1' ' A' ' 105' ' ' ALA . 86.5 m -91.26 159.22 16.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -129.95 94.67 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.305 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.64 126.32 8.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.366 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.527 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -149.29 152.95 36.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.819 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.464 HD21 ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -130.61 120.89 24.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -40.88 147.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.994 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -42.25 73.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.53 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -76.1 -34.68 59.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.498 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' HD21 ' A' ' 178' ' ' LEU . 3.9 m-20 67.07 64.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.332 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -162.22 24.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.584 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 42.33 27.81 0.5 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.257 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 1.9 mt-10 -125.4 43.4 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.889 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.584 ' C ' HD12 ' A' ' 187' ' ' LEU . 16.5 mmt-85 -158.51 -44.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 191' ' ' VAL . 4.3 mp -115.2 -36.11 4.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.734 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 12.3 t -58.92 -65.87 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 186' ' ' ARG . 10.5 p80 -61.29 -35.68 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.89 -73.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.016 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 187' ' ' LEU . 6.6 t -51.39 -43.57 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.631 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.65 -34.84 36.67 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.484 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 56.5 m -91.14 -27.39 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.073 177.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.618 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -49.53 -45.47 47.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.99 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.603 ' O ' HD12 ' A' ' 199' ' ' LEU . 33.5 m-85 -57.2 -22.52 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.984 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -41.43 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.42 -34.38 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.819 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.97 -23.41 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.767 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 195' ' ' PHE . 5.3 mp -113.8 -45.73 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.824 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.407 -178.959 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 174.73 87.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.897 0.38 . . . . 0.0 111.366 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.582 HG22 ' O ' ' B' ' 3' ' ' ILE . 4.1 mp 42.42 48.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.155 0.502 . . . . 0.0 111.753 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.17 86.27 1.7 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.853 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' B' ' 1' ' ' ALA . 32.5 Cg_exo . . . . . 0 N--CA 1.481 0.793 0 CA-C-N 118.137 0.969 . . . . 0.0 114.041 4.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.433 ' CZ2' ' CG ' ' A' ' 189' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.985 0.422 . . . . 0.0 110.478 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.79 -28.38 68.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -85.24 -37.33 20.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.863 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.561 ' O ' HG22 ' A' ' 76' ' ' VAL . 6.8 t0 -56.46 -49.65 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.66 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -58.15 4.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.354 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -29.15 53.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -51.16 -68.49 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.877 HG21 ' HB3' ' A' ' 193' ' ' CYS . 3.3 m -49.48 -27.43 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -52.14 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 m -95.37 15.94 18.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.152 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 61.97 84.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.036 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.592 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.7 t 175.67 54.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.415 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.712 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 19.5 t -122.28 71.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.371 . . . . 0.0 110.65 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 122' ' ' HIS . 13.0 p -92.91 148.71 21.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.078 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.662 ' C ' HD12 ' A' ' 120' ' ' LEU . 29.4 m-85 -151.52 139.63 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -53.54 139.47 31.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 86' ' ' LYS . 11.9 p -151.68 159.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.55 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.527 ' N ' HG22 ' A' ' 85' ' ' VAL . 23.9 mtpp -114.81 61.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.797 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.543 ' HB3' HG12 ' A' ' 117' ' ' VAL . 23.3 t80 -47.55 119.22 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 109' ' ' LEU . 10.1 mp -56.49 -46.67 80.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.69 ' O ' HD11 ' A' ' 109' ' ' LEU . . . 148.64 -176.38 27.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.99 130.43 51.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 111.372 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG13 HD13 ' A' ' 109' ' ' LEU . 7.0 m -121.72 174.35 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.09 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 93' ' ' VAL . 2.9 pt-20 -105.7 154.41 20.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.087 0.47 . . . . 0.0 111.616 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.736 HG11 ' SG ' ' A' ' 174' ' ' CYS . 16.0 m -157.65 -175.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.25 20.02 2.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.602 0.239 . . . . 0.0 111.39 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HB2' HG21 ' A' ' 101' ' ' VAL . 1.2 mm-40 -115.76 -68.01 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.176 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 53.0 p 50.1 24.99 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.631 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -148.67 32.72 0.78 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.43 125.23 1.68 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.578 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -34.51 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -63.35 -25.97 68.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.695 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.659 HG21 ' HB2' ' A' ' 95' ' ' GLU . 43.3 t -62.67 -35.42 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -70.82 -34.88 72.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.48 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -64.18 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.2 pt-20 -85.14 -39.21 18.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.422 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.15 75.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 160' ' ' PHE . 33.0 tp -51.6 -33.48 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -43.47 28.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 104' ' ' GLU . 13.2 t -58.11 -33.31 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.69 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.7 OUTLIER -54.38 -31.07 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.215 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -50.43 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.539 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -54.09 -25.72 23.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.638 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.4 p -82.75 -177.85 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -3.73 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.407 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.433 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 11.9 mmp_? -48.54 177.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.774 0.321 . . . . 0.0 111.127 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.19 135.49 4.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.033 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 152.04 4.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.314 2.009 . . . . 0.0 112.099 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 139' ' ' ILE . 7.1 p -123.48 113.6 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.423 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 64.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.557 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -117.0 -150.17 9.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.91 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 83' ' ' PHE . 13.1 tp -137.42 128.21 27.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.773 0.321 . . . . 0.0 110.793 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -78.02 90.14 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -72.64 94.02 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.225 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.822 HG13 HD23 ' A' ' 128' ' ' LEU . 4.2 t -100.34 160.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.72 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -166.54 34.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.501 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 45.93 44.84 13.84 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.536 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -171.19 -43.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.679 0.276 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.53 114.4 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.286 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.918 HD13 ' CE2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -84.33 120.17 25.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 110.169 177.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -132.66 98.68 4.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.036 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 139' ' ' ILE . 5.7 p -83.26 129.45 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.846 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.499 HG23 ' H ' ' A' ' 138' ' ' LEU . 6.1 p -133.71 132.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.052 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.423 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 40.3 t0 -65.8 148.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.919 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -97.74 20.11 12.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -125.54 -42.15 1.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.3 p -104.27 -27.73 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.671 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tptm 49.35 49.9 18.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -113.69 14.03 22.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.076 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.736 HD12 ' H ' ' A' ' 139' ' ' ILE . 8.7 tp 59.36 148.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 111.248 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.996 HD11 HG21 ' A' ' 117' ' ' VAL . 3.3 mt -127.85 -51.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.493 ' O ' HD11 ' A' ' 138' ' ' LEU . 21.9 t -114.16 136.78 49.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.038 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -143.06 58.96 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -113.07 162.06 16.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.958 ' O ' HG23 ' A' ' 147' ' ' VAL . 63.4 m -97.67 122.73 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.603 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.94 HD11 ' CD1' ' A' ' 195' ' ' PHE . 7.3 tt -54.22 -31.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 143' ' ' THR . 24.3 tt0 -72.97 -25.25 60.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.444 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.2 OUTLIER -96.05 -39.55 9.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.499 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 143' ' ' THR . 17.8 t -49.76 144.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.272 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.476 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 9.1 m -50.51 -41.19 53.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.976 ' CE1' HD11 ' A' ' 163' ' ' ILE . 2.7 p90 155.77 -175.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.616 0.572 . . . . 0.0 110.074 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 19.5 p -121.23 140.13 52.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.738 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -167.94 133.06 1.54 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.803 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.423 ' CB ' ' O ' ' A' ' 159' ' ' GLY . 98.3 Cg_endo . . . . . 0 CA--C 1.535 0.534 0 C-N-CA 122.482 2.122 . . . . 0.0 112.298 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.704 0.288 . . . . 0.0 111.029 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 152' ' ' PRO . . . -122.05 141.3 14.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.569 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.473 ' O ' HD13 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -105.51 -163.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 0.0 110.83 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.8 t 172.5 129.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.736 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.918 ' CE2' HD13 ' A' ' 128' ' ' LEU . 3.9 m-30 -110.86 -179.56 3.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.976 HD11 ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -163.83 143.24 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.446 ' HB3' HG13 ' A' ' 147' ' ' VAL . 1.8 p -169.1 133.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.579 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.502 ' HG3' ' CZ2' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -67.63 84.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.979 177.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 169' ' ' THR . 97.8 m-20 -66.6 110.13 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.5 -20.72 59.64 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.467 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -48.56 3.33 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.473 ' CB ' ' HB3' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -50.2 -64.19 0.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.374 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 171' ' ' ARG . 53.7 mtp180 -164.54 -46.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.108 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 165.0 -145.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.502 ' CZ2' ' HG3' ' A' ' 165' ' ' ARG . 1.7 m-90 -64.17 81.7 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.489 ' HE2' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.81 134.9 39.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.333 0.587 . . . . 0.0 111.764 -176.028 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.736 ' SG ' HG11 ' A' ' 93' ' ' VAL . 1.2 m -101.89 169.03 9.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.978 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 39.8 m-70 -146.79 123.42 11.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 111.549 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -101.76 114.6 5.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.877 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.424 ' HD1' HG21 ' A' ' 85' ' ' VAL . 6.8 m-85 -104.96 146.04 29.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.124 0.488 . . . . 0.0 111.623 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.706 HD13 ' O ' ' A' ' 179' ' ' ALA . 3.1 tm? -145.76 110.46 5.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.706 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -42.39 143.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.858 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.8 t -71.91 -48.67 43.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.801 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -78.57 -25.13 45.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.99 77.84 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.462 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 39.9 t -169.9 28.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.503 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.05 34.99 0.62 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.144 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -136.21 47.54 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.546 ' CB ' HD13 ' A' ' 187' ' ' LEU . 1.6 mpt_? -153.47 -57.74 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.131 0.491 . . . . 0.0 110.158 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.49 -0.97 4.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.867 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.428 ' HA ' ' CE2' ' A' ' 160' ' ' PHE . 70.1 m -80.44 -44.08 19.87 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.076 0.465 . . . . 0.0 110.228 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CG ' ' CZ2' ' A' ' 69' ' ' TRP . 1.3 t60 -94.84 -18.86 20.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.67 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.712 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -78.74 -63.07 1.5 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.539 HG21 ' OH ' ' A' ' 162' ' ' TYR . 54.4 t -48.41 -46.52 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.8 -24.22 57.2 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.792 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.877 ' HB3' HG21 ' A' ' 76' ' ' VAL . 56.1 m -85.84 -31.3 22.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.497 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.547 ' HB2' HG11 ' A' ' 123' ' ' VAL . . . -52.68 -42.39 64.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.94 ' CD1' HD11 ' A' ' 144' ' ' ILE . 45.3 m-85 -65.44 -25.88 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.876 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -43.44 -42.05 4.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.908 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.607 ' HB3' HD23 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -43.03 -46.4 5.56 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.811 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.64 ' N ' HD23 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -106.67 -27.28 10.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.096 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.139 177.213 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.95 ' HB3' ' HG3' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -157.41 68.44 0.53 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.209 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.678 HD12 ' N ' ' B' ' 3' ' ' ILE . 2.0 mp 66.41 -65.19 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.353 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 149' ' ' PHE . . . -40.49 -61.91 1.72 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.398 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.95 ' HG3' ' HB3' ' B' ' 1' ' ' ALA . 85.2 Cg_endo . . . . . 0 N--CA 1.464 -0.259 0 C-N-CA 122.908 2.405 . . . . 0.0 112.533 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.3 m0 . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.155 0.503 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -53.16 -24.42 10.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.332 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.57 23.1 13.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.994 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -131.45 -48.19 0.98 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.064 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.01 -37.97 22.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.899 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.08 -26.08 39.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -52.01 -65.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 197' ' ' VAL . 2.7 m -51.45 -31.58 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -47.78 73.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.758 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -94.04 21.56 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.006 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 49.06 85.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.174 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -176.8 41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -109.2 161.84 14.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.899 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 78.7 p 178.66 155.16 0.42 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' SER . 49.5 m-85 -164.69 141.61 6.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 t -51.84 149.92 4.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.352 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 187' ' ' LEU . 1.7 t -146.66 167.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.231 0.539 . . . . 0.0 112.324 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.531 ' H ' HG12 ' A' ' 85' ' ' VAL . 17.7 mmtt -121.52 48.07 1.75 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.995 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.936 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -38.8 150.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.066 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 116' ' ' PRO . 75.1 mt -106.54 -38.82 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.643 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.43 169.52 12.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.192 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 9.2 p -101.58 144.3 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 110.914 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -127.32 176.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.873 -178.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.5 ' N ' HG13 ' A' ' 91' ' ' VAL . 2.5 pt-20 -95.92 145.57 25.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.909 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 172' ' ' TRP . 13.6 m -146.0 166.91 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.87 0.367 . . . . 0.0 111.274 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -93.61 20.65 7.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.307 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 94' ' ' PHE . 9.9 mt-10 -167.2 150.05 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.031 0.443 . . . . 0.0 110.906 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 96.3 p -125.32 20.61 8.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.16 74.19 1.02 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.785 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -164.56 117.6 0.76 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.444 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.642 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -56.9 -26.76 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -27.98 36.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.416 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 58.4 t -62.11 -48.3 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.779 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.1 m -60.57 -37.63 81.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.633 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.43 -42.31 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.0 pt-20 -79.45 -35.53 40.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.503 ' O ' HD22 ' A' ' 109' ' ' LEU . . . -55.44 -53.22 58.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.453 ' CD1' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -47.18 -46.2 23.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -42.68 86.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 104' ' ' GLU . 25.2 t -57.66 -47.52 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.808 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.572 HD13 ' HG3' ' A' ' 114' ' ' ARG . 2.7 mm? -53.15 -23.31 7.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.92 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -59.99 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.408 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 1.3 pp0? -53.15 -31.18 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -85.04 -171.96 3.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.955 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 25.44 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.572 ' HG3' HD13 ' A' ' 109' ' ' LEU . 8.5 mmt180 -65.04 76.53 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.41 135.07 5.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.508 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.708 ' HB3' HD23 ' A' ' 88' ' ' LEU . 92.8 Cg_endo -82.4 164.93 16.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.574 2.183 . . . . 0.0 112.068 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.936 HG12 ' CB ' ' A' ' 87' ' ' TYR . 1.5 p -114.56 176.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.014 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.58 ' H ' HG22 ' A' ' 117' ' ' VAL . 3.0 ttt180 -152.65 89.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.455 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -149.59 -137.73 2.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.846 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -122.75 121.72 36.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.646 0.26 . . . . 0.0 111.219 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.636 ' HB2' HG21 ' A' ' 85' ' ' VAL . 8.6 tp -87.61 104.21 16.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.437 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -74.22 110.75 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.717 ' CG1' ' HB2' ' A' ' 194' ' ' ALA . 68.3 t -114.04 105.75 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.2 p -118.17 16.13 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.739 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 62.09 11.49 32.39 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.964 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -149.33 16.13 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.698 0.249 . . . . 0.0 111.282 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 161.06 96.88 0.11 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.812 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.867 HD13 ' CE2' ' A' ' 162' ' ' TYR . 1.6 mt -77.03 111.7 12.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.695 0.283 . . . . 0.0 110.501 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.35 86.76 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.312 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 139' ' ' ILE . 6.2 p -77.93 100.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.602 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 132' ' ' ASP . 65.2 t -99.72 154.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.562 ' OD2' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -91.85 139.49 30.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.425 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 38.7 t70 -87.82 14.33 8.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.524 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.4 OUTLIER -111.44 -30.62 7.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.05 0.452 . . . . 0.0 110.526 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.435 ' N ' ' HG3' ' A' ' 134' ' ' GLU . 67.0 p -139.12 8.64 2.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.512 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER 42.02 44.15 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.484 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.12 143.61 15.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.096 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.43 112.06 12.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.87 0.367 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.799 HD11 HG21 ' A' ' 117' ' ' VAL . 10.2 mt -81.18 -51.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.438 ' HB ' HG12 ' A' ' 130' ' ' VAL . 58.8 t -120.12 101.29 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -95.54 90.85 5.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.178 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 147' ' ' VAL . 19.2 mt-30 -142.13 161.36 38.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.65 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.702 ' O ' HG22 ' A' ' 144' ' ' ILE . 2.0 t -100.21 5.54 44.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 143' ' ' THR . 2.1 tt 84.66 -39.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.122 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -86.45 -25.16 25.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.918 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -78.59 -18.43 54.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.257 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.957 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -79.08 -177.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.607 ' HB3' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -98.01 22.3 9.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.38 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.436 ' CB ' ' O ' ' A' ' 148' ' ' SER . 18.5 m-85 85.62 -171.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 20.4 p -134.4 168.05 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.733 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.642 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -175.49 110.44 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 25.8 Cg_endo . . . . . 0 C--N 1.347 0.471 0 C-N-CA 122.462 2.108 . . . . 0.0 112.919 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.702 0.287 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.06 129.5 5.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.799 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 177' ' ' PHE . 0.5 OUTLIER -104.77 -174.53 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 110.591 178.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER 179.68 126.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 111.426 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.867 ' CE2' HD13 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -97.77 -173.78 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.61 179.099 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.957 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -159.07 133.36 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.622 ' HB2' HG13 ' A' ' 147' ' ' VAL . 35.4 t -131.5 152.45 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.009 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.89 96.93 5.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.03 -166.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.719 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.76 -86.74 1.2 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.68 29.73 6.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.683 0.277 . . . . 0.0 110.883 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 -84.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 173' ' ' MET . 9.3 ptm180 -179.21 -47.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -150.45 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.99 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.623 ' O ' HG22 ' A' ' 93' ' ' VAL . 5.7 m95 -68.31 72.86 0.21 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.468 ' HE3' ' O ' ' A' ' 91' ' ' VAL . 75.3 mmm -89.23 118.02 28.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.293 0.568 . . . . 0.0 111.772 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 161.64 26.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.135 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -133.64 109.52 9.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.42 125.8 7.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 1.7 p90 -144.5 144.6 31.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.642 HD12 ' OD2' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -110.34 140.51 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.841 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 182' ' ' ASP . . . -62.51 140.47 58.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.149 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.39 -62.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -74.8 -26.7 59.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.642 ' OD2' HD12 ' A' ' 178' ' ' LEU . 0.3 OUTLIER 62.48 81.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.088 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.52 33.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.447 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 46.15 39.66 9.58 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.594 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.84 4.58 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.574 ' CB ' HD13 ' A' ' 187' ' ' LEU . 14.1 mmt180 -114.76 -64.51 1.3 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.81 0.338 . . . . 0.0 110.743 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.844 HD12 HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -143.37 15.77 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.652 178.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.476 ' O ' ' CE1' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -96.38 -34.26 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 178.282 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.39 -21.42 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.52 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.18 -58.76 3.08 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 123' ' ' VAL . 33.2 t -49.73 -49.75 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.106 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.38 -33.89 12.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.354 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 2.9 t -76.41 -28.56 56.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.544 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.739 ' HB1' ' HA2' ' A' ' 125' ' ' GLY . . . -57.92 -47.02 84.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.787 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -53.56 -26.63 22.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.37 -29.07 9.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 76' ' ' VAL . 86.5 t -84.97 -31.32 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.505 ' HB3' HD23 ' A' ' 199' ' ' LEU . 11.5 t -53.94 -48.0 70.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.325 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 198' ' ' CYS . 0.1 OUTLIER -95.65 -24.5 16.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 121.287 0.565 . . . . 0.0 111.733 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.742 ' HB3' ' CG ' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.47 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -130.65 -82.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.928 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' B' ' 2' ' ' TYR . 3.7 mp -132.23 -58.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' B' ' 5' ' ' PRO . . . -45.59 -50.48 10.81 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.742 ' CG ' ' HB3' ' B' ' 1' ' ' ALA . 52.5 Cg_endo . . . . . 0 N--CA 1.459 -0.508 0 C-N-CA 123.332 2.688 . . . . 0.0 112.732 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.24 175.22 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -44.84 105.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.611 2.208 . . . . 0.0 112.748 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 171.2 -82.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.677 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -96.73 -34.93 11.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.385 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.403 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -61.0 -31.9 71.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -66.47 -29.29 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.17 -56.65 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 1.5 p30 -58.5 -36.88 74.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.958 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 17.4 tt0 -60.19 -27.22 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.489 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 -30.5 14.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.863 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.757 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -52.21 -50.72 61.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' O ' HG21 ' A' ' 197' ' ' VAL . 59.3 t -58.26 -38.75 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.422 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -39.9 70.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.561 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.78 1.41 55.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 124' ' ' SER . . . 65.92 78.51 0.27 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.829 0.347 . . . . 0.0 111.081 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 79' ' ' ALA . 2.9 t 176.19 60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -118.2 -172.75 2.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.912 ' HB3' HD21 ' A' ' 120' ' ' LEU . 2.1 m 174.16 153.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.997 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.489 ' C ' HD12 ' A' ' 120' ' ' LEU . 32.4 m-85 -162.1 139.78 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.686 ' N ' HD12 ' A' ' 120' ' ' LEU . 23.3 t -60.76 157.23 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.735 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.887 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.1 p 178.67 160.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.987 0.422 . . . . 0.0 111.915 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.551 ' N ' HG22 ' A' ' 85' ' ' VAL . 1.7 mttp -111.31 71.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.636 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.607 ' CB ' HG21 ' A' ' 130' ' ' VAL . 41.4 t80 -55.02 107.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.996 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.923 HD23 ' HB3' ' A' ' 109' ' ' LEU . 6.9 mp -48.5 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA2' ' CE1' ' A' ' 87' ' ' TYR . . . 176.18 -133.32 2.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.419 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.95 151.14 38.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.954 0.407 . . . . 0.0 111.002 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 109' ' ' LEU . 6.7 m -139.55 167.05 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.832 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.14 142.6 27.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 172' ' ' TRP . 2.1 m -145.49 173.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.223 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -116.26 25.56 10.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' HG21 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -144.84 -74.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.253 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m 59.45 19.48 7.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.24 66.54 1.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.59 -161.03 27.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.344 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.496 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -119.57 -36.26 3.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 111.06 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -61.58 -25.9 67.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.405 HG21 ' CB ' ' A' ' 95' ' ' GLU . 15.8 t -76.06 -30.44 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.31 -38.75 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.2 -37.72 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.5 pt-20 -88.31 -34.8 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -54.31 -51.31 65.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -45.52 62.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.595 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -39.12 73.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.399 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 104' ' ' GLU . 6.3 t -65.66 -39.65 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.757 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.923 ' HB3' HD23 ' A' ' 88' ' ' LEU . 1.5 mm? -55.64 -26.26 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -86.21 -61.29 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.044 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -48.4 -33.44 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.034 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -165.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.41 42.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.44 ' HG3' HD13 ' A' ' 109' ' ' LEU . 1.7 mmp_? -93.1 70.39 4.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.825 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 133.84 19.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HB3' HD12 ' A' ' 88' ' ' LEU . 71.7 Cg_endo -79.37 141.49 16.01 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.476 2.117 . . . . 0.0 112.63 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.683 HG11 HD11 ' A' ' 139' ' ' ILE . 12.0 m -78.35 173.99 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.37 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -135.95 72.9 1.44 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.246 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -141.17 -130.4 2.58 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.852 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.912 HD21 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -145.25 140.94 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.878 0.37 . . . . 0.0 111.433 -178.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -85.68 116.22 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -81.05 84.25 6.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.968 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 191' ' ' VAL . 38.0 t -94.89 125.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.506 ' O ' ' HB1' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -142.82 44.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.499 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 41.35 51.91 4.42 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.949 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.786 ' O ' HG22 ' A' ' 144' ' ' ILE . 20.9 t70 -164.94 -40.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.673 0.273 . . . . 0.0 111.072 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.433 ' HA2' ' N ' ' A' ' 144' ' ' ILE . . . -176.52 118.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.459 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.802 HD11 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.6 115.81 6.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.736 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -117.99 78.94 1.3 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.607 HG21 ' CB ' ' A' ' 87' ' ' TYR . 5.8 p -68.14 132.79 32.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.081 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.31 139.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -75.95 163.05 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.415 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 48.6 t0 -103.17 15.68 28.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.327 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.03 -60.26 1.82 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.883 0.373 . . . . 0.0 110.579 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 42.9 p -82.01 -27.91 32.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.7 48.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -126.54 142.38 13.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.1 tp -69.45 132.63 46.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.745 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.683 HD11 HG11 ' A' ' 117' ' ' VAL . 8.8 mt -100.63 -53.26 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.395 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 130' ' ' VAL . 13.9 t -111.48 67.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.21 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.459 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.6 p-10 -72.97 67.59 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.51 152.57 48.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 145' ' ' GLU . 64.5 m -78.71 145.06 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.69 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.802 HD12 HD11 ' A' ' 128' ' ' LEU . 7.0 tt -71.89 -30.71 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.897 0.38 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.631 ' H ' HG22 ' A' ' 143' ' ' THR . 8.6 tt0 -75.5 -28.94 59.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.283 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.1 mttm -90.91 -39.23 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.368 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 148' ' ' SER . 9.9 p -58.9 163.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.038 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.516 ' N ' HG22 ' A' ' 147' ' ' VAL . 12.9 t -76.06 1.95 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' HA ' ' CE1' ' A' ' 195' ' ' PHE . 1.4 m-85 80.86 174.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.044 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.459 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 2.9 t -108.92 164.99 11.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -155.17 97.67 2.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.404 ' HG2' ' OH ' ' B' ' 2' ' ' TYR . 53.2 Cg_exo -49.06 129.79 22.45 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.256 1.971 . . . . 0.0 111.789 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.49 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.416 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -156.67 23.26 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.231 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.6 t30 44.25 29.64 0.38 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.569 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.408 ' HB2' ' HG3' ' A' ' 154' ' ' ARG . 1.1 t-80 -86.84 -17.57 33.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.523 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.33 25.33 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.139 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 178' ' ' LEU . 2.6 mmp_? 69.17 45.46 0.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.953 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.704 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -109.87 144.97 16.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.39 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 3.5 m-85 -143.97 178.26 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.607 0.241 . . . . 0.0 110.852 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.409 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 1.8 m -172.26 134.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 111.554 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.577 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 98.2 m-85 -94.55 -174.31 3.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.486 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -165.99 137.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.607 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.72 125.69 24.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.0 OUTLIER -76.89 87.48 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.046 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 168' ' ' THR . 23.1 t0 50.84 -90.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.234 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 165' ' ' ARG . . . 59.47 -82.35 0.01 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -140.96 25.15 2.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.481 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.681 HG22 ' SD ' ' A' ' 173' ' ' MET . 4.2 m -122.25 23.62 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.488 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 169' ' ' THR . 12.3 mtp180 86.74 -72.29 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.487 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -146.6 -164.33 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 0.0 111.02 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.423 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 m95 -56.01 90.17 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.681 ' SD ' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -98.07 110.74 23.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.828 -177.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.495 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 0.6 OUTLIER -82.03 148.19 28.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.735 177.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 173' ' ' MET . 24.6 m-70 -128.66 158.58 38.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.857 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.409 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -144.63 138.53 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.845 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.577 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -153.98 115.06 4.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.178 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.704 HD22 ' HA2' ' A' ' 159' ' ' GLY . 0.1 OUTLIER -90.25 122.33 33.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.821 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -46.1 135.44 7.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -67.08 0.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -33.3 65.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.343 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' CD1' ' A' ' 178' ' ' LEU . 1.4 m-20 63.27 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.268 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.22 28.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.863 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.43 29.22 0.22 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.23 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 186' ' ' ARG . 18.0 mt-10 -138.61 47.7 1.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.027 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.5 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -159.63 -42.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.887 HD21 ' HB ' ' A' ' 85' ' ' VAL . 5.9 mp -114.65 -37.65 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 t -56.95 -59.95 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -75.58 -26.46 57.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -67.26 -66.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 187' ' ' LEU . 1.5 t -70.66 -29.45 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -53.12 -28.79 34.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.218 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 47.5 t -95.86 -22.61 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.302 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.501 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -47.42 -38.61 13.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 199' ' ' LEU . 61.5 m-85 -79.07 -26.99 43.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -47.16 -43.87 21.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.127 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 76' ' ' VAL . 54.2 t -67.05 -30.06 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.738 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.8 t -66.9 -58.87 4.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.779 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.943 HD21 HG21 ' B' ' 3' ' ' ILE . 2.1 pt? -117.54 51.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.547 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.423 ' CA ' ' O ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER -50.56 -33.08 20.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.44 22.07 5.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.695 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm 49.89 44.3 25.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.81 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -58.67 -18.36 30.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.915 ' CD ' HD13 ' A' ' 199' ' ' LEU . 0.6 OUTLIER -48.81 129.02 16.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.062 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.64 81.35 2.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.759 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.476 HG21 ' HA ' ' B' ' 7' ' ' LEU . 0.5 OUTLIER -115.96 -39.82 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.142 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -99.52 -172.04 2.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 209' ' ' ALA . . . -68.8 -50.97 45.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.01 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 208' ' ' ALA . . . 69.06 103.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.034 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 209' ' ' ALA . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.891 -1.052 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.721 0.296 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -163.34 -89.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.129 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.943 HG21 HD21 ' A' ' 199' ' ' LEU . 2.6 mm -109.17 -52.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.35 -74.97 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.473 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' B' ' 6' ' ' PTR . 17.5 Cg_exo -71.28 52.03 1.46 Allowed 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 123.159 2.573 . . . . 0.0 113.34 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.424 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 206' ' ' THR . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.835 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.828 0.347 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.8 mttp 48.44 70.92 1.79 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.275 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.59 -77.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.589 2.193 . . . . 0.0 112.015 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.04 -69.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.54 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.46 -23.91 52.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -29.33 69.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.037 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.92 -34.74 78.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.52 -51.42 8.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.991 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -58.71 -42.46 88.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.34 -36.91 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.691 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -86.11 -29.79 23.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.708 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -53.55 -57.59 10.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.793 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.741 HG21 ' SG ' ' A' ' 193' ' ' CYS . 0.3 OUTLIER -49.4 -38.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -49.65 74.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.448 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.4 20.64 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 49.21 90.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t 179.5 44.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -112.62 162.27 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.769 ' OG ' HD22 ' A' ' 120' ' ' LEU . 32.4 t -172.64 154.0 2.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.526 ' CB ' HD11 ' A' ' 187' ' ' LEU . 91.2 m-85 -160.34 141.1 11.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -58.14 151.07 19.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.112 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.986 HG22 HD21 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -152.18 171.81 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 112.115 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.578 ' H ' HG12 ' A' ' 85' ' ' VAL . 1.3 mttm -128.11 40.11 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.966 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.523 ' CD1' ' HB3' ' A' ' 177' ' ' PHE . 6.0 t80 -44.57 123.91 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.608 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.63 HD23 ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.55 -60.31 2.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . 159.31 -160.28 31.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.393 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.21 146.49 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.059 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.622 HG22 HD21 ' A' ' 109' ' ' LEU . 2.8 m -133.78 135.47 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.12 120.66 18.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 172' ' ' TRP . 10.7 m -120.96 177.27 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.086 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.22 -22.92 18.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.194 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HB2' HG21 ' A' ' 101' ' ' VAL . 19.5 mp0 -123.61 153.52 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.1 p -133.25 21.78 4.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.009 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.3 23.9 1.03 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.67 131.97 9.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.607 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -51.69 60.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.36 -26.75 8.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 95' ' ' GLU . 47.1 t -65.49 -33.13 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -72.98 -41.39 64.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 4.1 mt-10 -58.68 -33.7 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.576 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.6 pt-20 -87.64 -40.34 14.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -57.39 -58.88 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.61 HD13 ' C ' ' A' ' 106' ' ' LEU . 2.4 tm? -46.36 -40.56 12.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.899 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -64.55 -45.52 86.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 178.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.1 t -63.92 -30.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.883 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.63 ' HB3' HD23 ' A' ' 88' ' ' LEU . 3.5 mm? -59.04 -23.67 62.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.512 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -93.38 -36.23 12.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -72.97 -21.73 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.306 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.26 172.0 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -53.67 -22.73 9.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HG3' HD13 ' A' ' 109' ' ' LEU . 7.4 mmp_? -46.05 92.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -94.96 150.42 37.74 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.416 ' HB3' ' HB3' ' A' ' 86' ' ' LYS . 52.7 Cg_exo -53.23 166.26 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.767 2.311 . . . . 0.0 112.466 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 139' ' ' ILE . 7.0 p -137.9 119.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.356 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -80.85 97.91 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.46 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.69 -169.08 18.96 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.769 HD22 ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -109.87 124.43 51.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.388 . . . . 0.0 111.122 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.731 ' HG ' HG23 ' A' ' 123' ' ' VAL . 6.9 tp -88.88 99.32 12.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.882 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.05 96.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.408 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.731 HG23 ' HG ' ' A' ' 121' ' ' LEU . 95.1 t -102.73 117.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.512 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -136.86 28.99 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.116 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 49.69 24.41 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.759 ' O ' HG22 ' A' ' 144' ' ' ILE . 12.3 t70 -133.92 -44.3 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.27 116.69 0.71 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.71 HD13 ' CE2' ' A' ' 162' ' ' TYR . 8.5 mt -71.57 133.98 46.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -141.49 98.08 3.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 139' ' ' ILE . 4.8 p -89.21 104.47 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 136' ' ' LYS . 14.3 t -107.07 132.62 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.076 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 136' ' ' LYS . 41.3 t0 -70.17 133.28 46.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -79.08 -6.59 56.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -97.57 -24.49 15.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.9 p -123.61 -35.17 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.539 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.1 OUTLIER 75.54 25.25 1.24 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.54 123.83 8.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.262 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.5 tp -50.81 131.52 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.991 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.696 ' HB ' HG13 ' A' ' 130' ' ' VAL . 9.6 mt -105.11 -54.13 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.269 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 140' ' ' VAL . 59.7 t -111.11 65.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.464 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 35.7 p-10 -68.16 66.92 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 140' ' ' VAL . 19.2 mt-30 -138.34 134.59 34.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -54.19 -176.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 126' ' ' ASP . 18.1 tt -108.76 -15.83 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.767 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -99.6 -26.99 13.9 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.0 OUTLIER -110.24 -171.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.289 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.39 14.78 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.475 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HB3' ' HA2' ' B' ' 4' ' ' GLY . 2.5 m-85 73.66 149.56 0.1 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.874 0.369 . . . . 0.0 110.988 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 24.6 p -72.36 -178.56 2.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 171.75 80.83 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.79 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 10.7 Cg_endo -53.84 146.61 45.18 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -44.12 -59.66 2.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.416 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.34 31.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.3 m120 42.36 32.23 0.32 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.598 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -108.01 7.35 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.975 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -152.24 19.18 0.66 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.832 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.453 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER 58.84 33.82 23.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.739 0.304 . . . . 0.0 111.181 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 178' ' ' LEU . . . -126.63 141.18 12.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.899 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.527 ' CE1' ' CB ' ' A' ' 188' ' ' SER . 4.9 m-85 -118.34 -174.27 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.9 m -166.07 134.81 3.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.528 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.71 ' CE2' HD13 ' A' ' 128' ' ' LEU . 7.5 m-30 -102.34 175.28 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.286 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.891 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -159.21 150.96 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.964 0.411 . . . . 0.0 111.425 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.3 166.3 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.539 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.82 79.18 1.54 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.132 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 46.62 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.183 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.03 -34.17 6.0 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.107 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 94.7 m -150.75 -44.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -72.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.92 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -178.21 -79.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.629 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 173' ' ' MET . 1.6 ptp180 -131.81 -153.47 0.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.91 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.607 ' O ' HG22 ' A' ' 93' ' ' VAL . 11.5 m95 -62.83 80.09 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 171' ' ' ARG . 1.2 mmt -85.36 121.57 28.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.74 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.32 156.94 16.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.749 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.68 105.61 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.749 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.96 104.83 2.89 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.468 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.601 ' HD2' HG11 ' A' ' 85' ' ' VAL . 3.3 p90 -121.16 132.64 54.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.415 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.669 ' O ' HG12 ' A' ' 85' ' ' VAL . 10.6 tp -102.26 147.24 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.688 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -68.22 140.09 56.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.175 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.424 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 35.8 t -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.753 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -36.24 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.9 66.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.453 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 2.6 p -148.98 16.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.733 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 43.33 34.71 2.43 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.861 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -144.82 50.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.475 ' C ' HD12 ' A' ' 187' ' ' LEU . 33.0 mtt-85 -168.8 -42.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.74 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.986 HD21 HG22 ' A' ' 85' ' ' VAL . 9.8 mp -113.32 -42.44 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.527 ' CB ' ' CE1' ' A' ' 160' ' ' PHE . 23.2 p -53.36 -65.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -66.91 -25.44 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -69.44 -60.03 2.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 187' ' ' LEU . 17.6 t -61.21 -40.5 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.881 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.73 -41.56 95.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.141 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.741 ' SG ' HG21 ' A' ' 76' ' ' VAL . 14.0 p -73.89 -34.0 64.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 110.332 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.437 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -56.41 -44.82 80.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -51.05 -26.29 6.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.72 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.57 -32.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.621 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.474 ' HB3' HD23 ' A' ' 199' ' ' LEU . 46.6 t -49.85 -36.17 25.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 202' ' ' LYS . 0.2 OUTLIER -118.91 -36.37 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 66.88 126.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.451 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 63.22 21.71 12.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.216 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.811 ' HA ' HD12 ' A' ' 199' ' ' LEU . 11.0 mptt 44.8 38.76 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.83 0.348 . . . . 0.0 111.318 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -67.46 -32.49 73.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.989 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.616 ' HD2' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER 38.09 -159.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.611 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mmt-85 -145.26 25.21 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.818 0.342 . . . . 0.0 111.112 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.536 HG21 HD12 ' B' ' 7' ' ' LEU . 0.1 OUTLIER -108.0 -24.44 11.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.797 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -48.93 -40.17 29.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.107 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -118.21 85.04 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.151 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 210' ' ' ALA . . . -77.24 -172.72 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.03 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 209' ' ' ALA . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.999 -1.001 . . . . 0.0 111.012 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.415 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.803 0.335 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.46 -97.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.832 HG23 ' OXT' ' B' ' 7' ' ' LEU . 2.7 mp -112.63 -29.85 2.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 149' ' ' PHE . . . -55.74 -85.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.541 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 49.1 Cg_exo -57.41 89.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.467 2.112 . . . . 0.0 110.826 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.407 ' HB2' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.832 ' OXT' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.91 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.798 0.332 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt 45.28 55.96 14.73 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.237 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -47.64 -59.0 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.849 2.366 . . . . 0.0 112.22 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -170.84 -61.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -80.83 -26.67 36.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.682 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -54.64 -30.18 54.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -68.99 -33.4 73.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.632 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.02 -63.13 1.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.084 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.47 -47.53 57.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -29.77 11.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.4 -24.69 15.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 81' ' ' CYS . . . -59.17 -64.82 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.76 HG21 ' HB3' ' A' ' 193' ' ' CYS . 2.3 m -50.03 -32.68 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -59.66 -52.55 65.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.463 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 23.44 5.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.833 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 48.65 85.27 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -176.64 34.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.325 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.505 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 4.6 t -98.75 156.28 16.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.053 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' HD22 ' A' ' 120' ' ' LEU . 2.6 t -174.8 152.02 1.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.763 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.486 ' CG ' ' HB3' ' A' ' 186' ' ' ARG . 72.3 m-85 -162.18 147.68 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 44.6 t -55.31 151.88 9.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.905 HG22 HD21 ' A' ' 187' ' ' LEU . 1.6 t -152.68 168.35 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.107 0.48 . . . . 0.0 111.618 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.521 ' H ' HG12 ' A' ' 85' ' ' VAL . 2.5 mttt -128.11 48.2 2.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.929 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.641 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.4 t80 -39.57 114.98 0.46 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.871 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 116' ' ' PRO . 54.9 mt -66.89 -26.93 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.651 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 126.01 -152.91 18.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.222 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 2.8 m -126.95 150.45 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.014 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.576 HG13 HD13 ' A' ' 109' ' ' LEU . 13.8 m -133.87 134.91 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.33 133.06 46.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.728 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.727 HG22 ' O ' ' A' ' 172' ' ' TRP . 23.9 m -138.64 169.4 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 111.361 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.5 16.0 16.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -157.34 119.46 3.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 1.7 p -95.83 24.18 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -165.16 123.43 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.751 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 148.72 113.07 0.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -49.71 -36.61 25.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.087 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.22 -41.28 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.35 -33.68 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.081 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -70.36 -39.04 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.05 -32.56 68.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.8 pt-20 -93.79 -36.51 12.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -50.11 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.895 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -50.09 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.686 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -44.06 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.01 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.5 t -65.68 -34.38 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.717 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.651 HD11 ' C ' ' A' ' 89' ' ' GLY . 1.1 mm? -52.03 -28.49 17.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 0.0 110.196 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.0 -27.84 18.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.561 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.72 20.43 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.174 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -120.6 147.63 44.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.69 4.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.64 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HG3' ' HB3' ' A' ' 112' ' ' SER . 0.0 OUTLIER -45.28 171.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.366 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -138.62 151.74 69.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.037 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.732 ' HB3' HD23 ' A' ' 88' ' ' LEU . 89.1 Cg_endo -80.2 -179.9 5.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.636 2.224 . . . . 0.0 112.392 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -141.26 -173.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.616 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.617 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -166.6 96.24 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -158.7 -131.44 1.27 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.771 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.533 HD22 ' OG ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -124.72 129.75 51.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.075 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.622 HD12 ' CE1' ' A' ' 177' ' ' PHE . 10.5 tt -100.88 113.02 25.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.187 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -76.95 111.57 12.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.911 ' CG1' ' HB2' ' A' ' 194' ' ' ALA . 82.1 t -110.78 96.74 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.32 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.443 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -111.79 27.58 9.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.378 . . . . 0.0 111.292 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.77 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 47.62 26.37 3.83 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.274 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.813 ' O ' HG22 ' A' ' 144' ' ' ILE . 24.5 t0 -140.15 -42.91 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.946 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -158.4 119.53 0.9 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.524 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -73.64 123.64 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.42 ' HD2' HD21 ' A' ' 138' ' ' LEU . 5.4 mmm-85 -135.31 100.91 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 139' ' ' ILE . 9.2 p -90.59 128.39 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.47 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 132' ' ' ASP . 54.6 t -116.1 154.87 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.693 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 131' ' ' VAL . 54.5 t0 -102.79 135.72 43.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.5 -0.41 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.714 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -103.48 -31.16 10.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.867 0.365 . . . . 0.0 110.996 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 p -116.64 -29.09 6.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 66.93 29.62 8.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 131' ' ' VAL . . . -95.54 -128.89 5.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.595 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 7.5 tp -156.97 134.63 10.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.773 0.32 . . . . 0.0 110.796 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 117' ' ' VAL . 4.3 mt -108.07 -54.85 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 130' ' ' VAL . 7.6 t -109.09 71.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 111.24 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.455 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 14.9 p-10 -78.58 59.91 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.12 163.11 25.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.389 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.7 m -78.02 174.14 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.713 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 126' ' ' ASP . 4.1 tt -97.64 -21.29 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -91.05 -39.52 12.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.835 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -72.66 -29.23 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 148' ' ' SER . 8.3 p -74.82 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.804 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.541 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -72.55 -0.86 13.95 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.6 m-85 79.11 179.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 25.5 p -98.94 177.34 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HA ' ' HG3' ' B' ' 5' ' ' PRO . . . -171.24 101.01 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.081 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.75 120.84 8.08 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.368 2.045 . . . . 0.0 111.977 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -39.03 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.959 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -143.42 21.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.306 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 48.24 26.88 1.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.815 0.34 . . . . 0.0 111.111 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 156' ' ' HIS . 11.8 t-160 -130.94 63.92 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 158' ' ' ARG . 0.5 OUTLIER 166.04 -25.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.515 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER 82.63 26.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.677 -179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.18 106.31 1.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 0.1 OUTLIER -96.41 -177.22 3.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.439 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.83 122.72 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.948 0.404 . . . . 0.0 111.301 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.572 ' OH ' HG11 ' A' ' 191' ' ' VAL . 1.8 m-30 -95.73 -160.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.495 ' O ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -169.89 148.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -135.72 163.32 30.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -129.06 81.07 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 167' ' ' GLY . 2.0 p30 46.55 -161.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 166' ' ' ASP . . . 95.45 -57.08 1.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.137 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.39 19.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 170' ' ' ARG . 49.4 m -137.67 -86.03 0.29 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.673 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 169' ' ' THR . 4.9 mtt180 -164.08 -82.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.906 0.384 . . . . 0.0 111.008 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.6 ptp180 -138.12 -150.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.129 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.727 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.1 m95 -68.6 67.78 0.14 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.416 ' HE3' ' C ' ' A' ' 91' ' ' VAL . 20.4 mmm -89.73 119.97 30.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.39 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HB2' HG23 ' A' ' 91' ' ' VAL . 6.9 m -76.77 166.21 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.753 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 174' ' ' CYS . 17.0 m-70 -138.43 93.09 2.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.407 ' HA3' ' HG ' ' A' ' 109' ' ' LEU . . . -75.89 118.74 5.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.602 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.622 ' CE1' HD12 ' A' ' 121' ' ' LEU . 4.2 m-85 -114.75 108.21 16.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 178' ' ' LEU . 10.7 mt -88.88 98.52 11.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.46 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.859 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -47.18 135.98 9.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.443 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.0 t -54.15 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -55.81 -29.93 60.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.382 . . . . 0.0 110.589 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.93 67.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.116 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.77 21.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.349 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 188' ' ' SER . . . 40.96 34.42 0.8 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.337 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.3 -6.64 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.777 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -124.66 -10.82 7.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.905 HD21 HG22 ' A' ' 85' ' ' VAL . 7.9 mp -136.04 -46.54 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.499 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 14.9 t -61.11 -52.01 66.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -80.75 -30.19 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.748 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -76.75 -69.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 187' ' ' LEU . 21.4 t -48.97 -48.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -61.1 -26.93 66.49 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.802 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.76 ' HB3' HG21 ' A' ' 76' ' ' VAL . 1.2 m -78.31 -33.0 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.46 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.911 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -51.46 -44.3 62.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CE2' ' CG1' ' A' ' 144' ' ' ILE . 93.8 m-85 -58.62 -22.44 56.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -47.48 -48.53 26.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.011 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 194' ' ' ALA . 2.4 m -73.58 -35.79 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.146 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 35.4 t -44.07 -45.03 7.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.178 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.431 HD22 HG21 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -105.18 -29.8 10.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.471 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 58.91 120.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.506 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 68.41 39.41 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.316 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm 48.54 29.0 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.01 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -80.99 67.03 6.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.118 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.643 ' CG ' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -54.36 -27.77 38.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 62.82 44.34 6.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.461 HG22 HD23 ' B' ' 7' ' ' LEU . 59.9 p -55.82 -44.72 78.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.013 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.26 -54.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.973 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 59.07 105.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.006 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.77 -71.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.012 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.696 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.71 80.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.643 HD12 ' CG ' ' A' ' 204' ' ' ARG . 1.6 mm 70.43 -64.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.64 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.58 -79.07 0.07 OUTLIER Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.816 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.696 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 38.2 Cg_exo -57.45 -33.33 96.16 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.771 2.314 . . . . 0.0 111.943 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.469 ' HD2' ' C ' ' B' ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.461 HD23 HG22 ' A' ' 206' ' ' THR . 1.4 mp . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.841 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 69' ' ' TRP . 0.7 OUTLIER -136.4 95.43 12.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.33 -7.12 19.19 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.632 2.221 . . . . 0.0 112.84 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -110.26 140.66 44.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.715 0.293 . . . . 0.0 110.76 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.62 -64.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.338 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 1.4 m0 -52.86 -46.65 67.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.522 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 7.0 pt20 -48.06 -36.52 13.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.088 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -82.77 -58.5 2.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.434 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -46.88 -29.73 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.45 -40.77 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.29 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -93.98 -14.37 25.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 178.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -60.21 -41.72 93.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 194' ' ' ALA . 46.1 t -65.49 -49.55 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.514 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 19.9 mtm-85 -50.49 -53.47 29.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.733 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.28 -0.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.516 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 64.77 80.58 0.23 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.706 0.289 . . . . 0.0 111.07 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 t -179.32 44.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -106.9 163.51 12.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.739 0.304 . . . . 0.0 110.757 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.56 146.18 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' C ' HD23 ' A' ' 120' ' ' LEU . 81.2 m-85 -157.43 129.42 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -52.38 159.1 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.524 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.846 ' HB ' HD21 ' A' ' 187' ' ' LEU . 13.0 p -172.92 160.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 111.691 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.522 ' N ' HG22 ' A' ' 85' ' ' VAL . 7.3 mmtt -108.02 65.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.735 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.557 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -60.36 126.05 26.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.414 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 88' ' ' LEU . 6.2 mp -77.92 -31.58 51.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.586 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.79 -164.13 15.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.254 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.426 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 20.2 m -105.19 147.59 27.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.992 0.425 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 174' ' ' CYS . 0.4 OUTLIER -126.68 171.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.045 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 1.6 pt-20 -90.63 140.8 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 92' ' ' GLU . 34.3 m -158.41 179.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.839 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.07 18.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.46 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HB2' HG21 ' A' ' 101' ' ' VAL . 58.0 mp0 -152.72 112.99 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.414 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.469 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -106.67 25.11 11.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.901 177.093 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.64 33.66 2.23 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.982 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.27 106.82 0.56 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.444 ' CE ' ' HB3' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -49.82 -25.69 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 110.871 179.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -76.31 -26.26 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.859 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 95' ' ' GLU . 23.6 t -67.44 -39.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.967 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.3 m -72.15 -48.09 46.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.345 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -52.95 -38.24 61.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.349 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.5 pt-20 -85.83 -42.13 14.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.768 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 101' ' ' VAL . . . -49.78 -48.12 50.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 160' ' ' PHE . 6.5 tt -50.87 -46.12 60.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -40.83 90.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.062 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' SER . 41.3 t -61.77 -31.19 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.058 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.606 HD13 ' HG3' ' A' ' 114' ' ' ARG . 3.2 mm? -67.54 -21.46 65.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -89.11 -50.38 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -24.08 64.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 96.2 p -79.17 170.82 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.27 -22.55 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.417 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.606 ' HG3' HD13 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -46.36 159.61 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.107 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -150.09 153.49 35.48 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.82 0.343 . . . . 0.0 111.418 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.5 Cg_exo -60.53 163.2 15.85 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.801 2.334 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 117' ' ' VAL . 7.4 p -133.82 110.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -74.85 74.31 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.439 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 131' ' ' VAL . . . -134.48 -156.73 7.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -123.92 125.54 44.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 111.43 -178.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.473 ' HG ' HG23 ' A' ' 123' ' ' VAL . 42.8 tp -83.91 105.67 14.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.264 177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -76.84 98.44 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.424 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.934 HG21 HG22 ' A' ' 191' ' ' VAL . 97.0 t -101.96 108.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 48.1 p -125.85 40.57 3.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.116 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.451 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 40.58 35.56 0.87 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.211 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 144' ' ' ILE . 19.7 t0 -158.21 -40.5 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.551 0.215 . . . . 0.0 111.452 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -147.63 121.24 1.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.991 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.772 HD11 ' CG1' ' A' ' 191' ' ' VAL . 0.0 OUTLIER -83.56 91.37 7.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.817 0.341 . . . . 0.0 110.427 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.832 ' HB3' HD11 ' A' ' 138' ' ' LEU . 3.5 mtt85 -107.28 98.45 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 139' ' ' ILE . 4.4 p -90.11 106.26 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 132' ' ' ASP . 4.1 t -93.32 163.84 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 131' ' ' VAL . 46.1 t0 -109.96 136.8 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.43 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 118' ' ' ARG . 49.4 t0 -79.18 3.06 18.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.97 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -116.03 -32.42 5.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.7 p -115.91 -23.05 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.359 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.5 OUTLIER 62.14 18.37 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.129 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.67 125.42 8.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.062 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -59.05 126.4 27.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.664 ' HB ' HG13 ' A' ' 130' ' ' VAL . 6.0 mt -89.73 -24.07 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.706 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.409 HG23 ' CG1' ' A' ' 130' ' ' VAL . 3.5 t -144.09 63.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.444 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 9.4 p-10 -73.32 61.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.554 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -131.89 159.84 37.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 145' ' ' GLU . 91.5 m -75.88 143.17 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.712 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 126' ' ' ASP . 7.9 tt -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.72 ' H ' HG22 ' A' ' 143' ' ' THR . 4.3 tt0 -77.07 -30.19 55.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.707 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -76.44 -20.3 57.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.908 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.6 OUTLIER -78.07 169.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.61 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.438 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -83.92 8.8 13.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.85 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.411 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.9 m-85 78.97 139.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.238 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.511 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 29.4 p -74.38 -174.42 2.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.767 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.483 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . -166.23 55.5 0.36 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.691 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 151' ' ' ALA . 50.9 Cg_exo -52.2 110.86 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.205 1.937 . . . . 0.0 111.374 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.444 ' HB3' ' CE ' ' A' ' 99' ' ' MET . 29.9 t0 -171.46 79.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.246 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.401 ' NH1' ' O ' ' A' ' 151' ' ' ALA . 6.6 mpt_? -130.62 -43.64 1.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.52 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 46.41 27.76 0.64 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -122.68 -33.98 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.402 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -149.87 18.22 0.89 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.007 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 183' ' ' SER . 0.1 OUTLIER 58.97 57.5 3.54 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.533 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.34 149.27 18.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.718 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.492 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 0.1 OUTLIER -139.83 172.82 12.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 40.7 t -165.25 134.93 3.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.592 ' CE2' HD23 ' A' ' 128' ' ' LEU . 2.7 m-30 -89.54 -165.28 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.502 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.908 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -164.77 158.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.392 . . . . 0.0 111.668 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 42.6 t -159.89 127.95 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.465 ' HG3' ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.71 87.61 7.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.103 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 45.3 -158.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.03 -71.67 0.26 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.109 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 168' ' ' THR . 26.1 m -130.3 17.19 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 0.0 111.084 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.603 HG22 ' SD ' ' A' ' 173' ' ' MET . 18.6 m -131.07 23.83 4.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 169' ' ' THR . 11.5 mmm180 84.95 -71.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.456 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 -158.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.985 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -65.77 94.67 0.22 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.603 ' SD ' HG22 ' A' ' 169' ' ' THR . 0.3 OUTLIER -110.61 158.37 18.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 111.702 -177.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.562 ' HB2' HG12 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -111.94 174.98 5.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.878 178.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -137.67 74.62 1.49 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.96 0.41 . . . . 0.0 110.774 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -76.55 129.22 9.76 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.92 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.529 ' CG ' ' CE2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -153.92 160.11 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.529 HD21 ' OD2' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -132.91 127.1 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.832 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.498 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -47.73 134.78 12.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.504 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -63.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -62.16 -29.27 70.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.556 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.529 ' OD2' HD21 ' A' ' 178' ' ' LEU . 0.3 OUTLIER 60.45 80.16 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.178 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.419 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -170.65 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.462 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.25 29.96 0.25 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.201 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.02 56.55 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -169.17 -41.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.987 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.846 HD21 ' HB ' ' A' ' 85' ' ' VAL . 6.5 mp -115.65 -45.56 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.688 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -49.37 67.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.807 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -82.75 -27.98 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.813 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -70.06 -57.6 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.883 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 123' ' ' VAL . 1.2 t -76.52 -26.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.69 -32.69 32.93 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.555 ' HB3' HG11 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -90.62 -20.76 22.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.648 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.661 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -46.58 -37.99 8.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.142 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -77.09 -23.59 51.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.005 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.71 -35.34 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.825 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.93 -30.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.621 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 50.2 t -51.75 -39.84 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.308 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -107.06 -26.89 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.25 123.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.28 19.25 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.124 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.567 ' HA ' HD12 ' A' ' 199' ' ' LEU . 2.0 mmmt 46.74 48.76 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.487 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -51.96 -47.34 64.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.87 0.366 . . . . 0.0 110.521 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 42.82 97.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.778 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -69.87 72.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.831 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.808 ' CG2' HD23 ' B' ' 7' ' ' LEU . 40.4 p -113.01 38.97 2.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.034 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -136.57 -60.7 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.031 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -98.95 73.11 1.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.21 -170.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.154 -0.926 . . . . 0.0 111.01 179.936 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.474 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -177.15 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.543 ' HA ' HD12 ' B' ' 7' ' ' LEU . 3.7 mp -45.14 -27.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.85 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 6' ' ' PTR . . . -48.56 -82.66 0.03 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.968 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 32.9 Cg_exo -66.09 60.34 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.026 2.484 . . . . 0.0 112.085 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.437 ' N ' ' O ' ' B' ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.808 HD23 ' CG2' ' A' ' 206' ' ' THR . 4.7 mp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.922 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.906 0.384 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -71.3 142.62 87.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.966 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.56 -178.3 3.63 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.66 2.24 . . . . 0.0 112.295 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.4 -162.93 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -43.22 -36.09 1.64 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.09 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 3.0 m0 -54.03 -43.93 70.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.925 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -47.69 -33.39 6.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.25 -61.01 1.87 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.304 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -48.38 -32.14 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.186 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -61.99 -28.93 69.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -99.45 -29.26 12.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.859 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -48.26 -35.84 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.938 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -61.91 -34.27 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.004 0.43 . . . . 0.0 110.512 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.8 mtm180 -64.39 -56.49 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.23 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -68.6 -10.49 56.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.342 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 78' ' ' SER . . . 73.18 76.47 0.14 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.733 0.302 . . . . 0.0 111.055 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t -177.58 47.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.859 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -108.7 173.14 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.699 178.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 12.5 m -171.45 150.77 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 82' ' ' SER . 85.8 m-85 -161.56 136.91 7.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.834 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.73 163.8 1.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.947 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.4 p 178.88 155.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 111.512 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 85' ' ' VAL . 1.8 mtpp -109.93 62.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.332 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.639 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.4 t80 -47.26 111.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.487 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.937 HD23 ' CB ' ' A' ' 109' ' ' LEU . 3.5 mp -55.22 -44.08 75.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.567 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 132.67 -157.96 22.82 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.461 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 25.9 p -116.68 156.08 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.496 HG11 HD22 ' A' ' 109' ' ' LEU . 27.5 m -152.28 135.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.022 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 139.36 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.581 HG21 ' SG ' ' A' ' 174' ' ' CYS . 11.0 m -142.02 169.49 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.68 -24.15 27.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.617 ' O ' HG11 ' A' ' 101' ' ' VAL . 23.6 mm-40 -133.93 126.18 29.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.869 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.527 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -97.28 21.52 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.831 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.54 130.89 4.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.01 136.74 5.29 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.753 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 178.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 71.39 -61.63 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 110.355 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 95' ' ' GLU . 86.0 t -52.28 -44.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.292 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.9 p -63.26 -39.18 93.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.216 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -60.69 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.141 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.624 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.9 pt-20 -64.52 -38.54 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.052 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 174' ' ' CYS . . . -53.39 -24.77 13.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.088 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.614 HD13 ' OD2' ' A' ' 153' ' ' ASP . 0.6 OUTLIER -82.15 -45.24 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.17 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 5.5 pttt -57.12 -34.15 68.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 104' ' ' GLU . 41.1 t -59.98 -37.64 73.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.03 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.937 ' CB ' HD23 ' A' ' 88' ' ' LEU . 4.6 mm? -54.91 -25.99 32.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.938 0.399 . . . . 0.0 110.001 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.88 -51.56 4.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 6.0 mm-40 -49.5 -26.36 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.518 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 114' ' ' ARG . 0.3 OUTLIER -99.41 -163.36 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.729 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.38 26.22 6.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.286 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -78.18 81.46 4.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.735 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.433 ' HG3' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -73.48 130.13 84.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.247 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HD2' ' HG3' ' A' ' 115' ' ' ARG . 77.4 Cg_exo -50.96 169.94 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.224 1.949 . . . . 0.0 111.937 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 87' ' ' TYR . 9.8 p -132.95 114.48 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.414 . . . . 0.0 111.612 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -74.59 78.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.996 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -132.55 -158.52 8.93 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.332 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 120' ' ' LEU . 1.4 mt -116.91 131.98 56.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.362 . . . . 0.0 111.065 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.734 ' HG ' HG23 ' A' ' 123' ' ' VAL . 49.5 tp -91.42 102.54 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.446 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 1.1 t-80 -74.53 83.59 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.597 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.734 HG23 ' HG ' ' A' ' 121' ' ' LEU . 84.1 t -89.25 115.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.47 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.9 33.38 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 45.52 45.13 11.91 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.563 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.583 ' C ' HG22 ' A' ' 144' ' ' ILE . 2.0 t0 -168.15 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -157.84 115.16 0.65 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 162' ' ' TYR . 4.5 mt -81.05 78.39 7.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 122' ' ' HIS . 71.6 mtm-85 -85.03 107.8 17.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 139' ' ' ILE . 2.7 p -92.7 108.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 110.967 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.422 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 21.8 t -94.65 134.03 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.997 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.434 ' OD1' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -80.37 131.27 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.435 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 28.8 t0 -79.62 3.4 19.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.05 -24.74 14.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.75 0.309 . . . . 0.0 110.936 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 53.7 p -151.33 19.29 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.337 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.415 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER 44.58 28.54 0.33 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.985 0.421 . . . . 0.0 111.307 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.55 138.21 16.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.314 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.446 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 5.0 tp -86.7 124.28 32.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 117' ' ' VAL . 8.6 mt -95.37 -54.74 6.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.562 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.61 83.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 111.461 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.446 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 7.2 t0 -93.85 73.86 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.192 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -141.89 137.07 31.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.279 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.44 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 23.9 m -60.52 135.28 57.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.583 HG22 ' C ' ' A' ' 126' ' ' ASP . 19.3 tt -59.48 -34.19 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.696 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -73.81 -22.75 59.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.249 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -97.09 26.55 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.193 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.935 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -121.82 176.9 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.607 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 147' ' ' VAL . 2.5 t -90.09 17.36 7.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 73.83 -167.45 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.988 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 25.0 p -123.51 176.3 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -171.42 103.6 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.7 123.67 12.75 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.4 2.066 . . . . 0.0 112.466 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.614 ' OD2' HD13 ' A' ' 106' ' ' LEU . 3.9 m-20 -58.66 -156.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.526 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -98.8 22.4 10.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 110.854 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 156' ' ' HIS . 1.9 m120 -57.11 -20.21 24.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.29 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 155' ' ' ASN . 6.9 t-160 91.56 -34.24 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.479 0.712 . . . . 0.0 111.866 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 158' ' ' ARG . 0.0 OUTLIER 176.6 70.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 111.845 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 5.8 ptp180 165.23 -33.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.114 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -81.21 114.73 3.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.109 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.795 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 8.9 m-85 -120.42 166.44 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.87 112.77 0.48 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 111.35 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.68 ' OH ' HG21 ' A' ' 191' ' ' VAL . 2.5 m-30 -88.58 -178.68 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.572 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.935 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -158.39 145.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.785 0.326 . . . . 0.0 111.324 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.449 ' HB3' HG13 ' A' ' 147' ' ' VAL . 17.0 p -135.09 148.59 49.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.565 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -106.85 83.17 1.8 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.587 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 43.91 -173.61 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.518 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.94 -55.95 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.962 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.64 25.52 3.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.451 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -76.33 0.36 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.97 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.45 -78.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -133.68 -153.67 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.944 179.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.572 ' O ' HG22 ' A' ' 93' ' ' VAL . 15.5 m95 -60.23 83.9 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.897 0.379 . . . . 0.0 109.992 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.6 OUTLIER -90.75 120.66 31.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.355 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.581 ' SG ' HG21 ' A' ' 93' ' ' VAL . 1.3 m -92.39 159.25 15.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.932 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -136.62 119.44 16.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.834 0.349 . . . . 0.0 111.309 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -92.8 110.89 3.99 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.951 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 162' ' ' TYR . 2.3 m-85 -108.42 119.51 39.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.116 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.7 108.28 16.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.795 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -51.99 141.01 18.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.314 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 31.5 t -63.37 -53.48 51.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.41 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.39 -22.12 63.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.748 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.65 71.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.974 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 p -166.53 27.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.792 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.72 26.67 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.925 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.68 54.33 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.656 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.1 tpt180 -175.72 -37.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.947 HD21 ' HB ' ' A' ' 85' ' ' VAL . 8.6 mp -120.52 -39.78 2.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.908 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 45.7 t -52.9 -55.72 21.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 193' ' ' CYS . 0.0 OUTLIER -76.03 -31.64 58.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.771 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -66.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.68 HG21 ' OH ' ' A' ' 162' ' ' TYR . 39.8 t -56.0 -54.63 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.36 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.39 31.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.478 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 4.7 t -67.98 -27.48 66.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.488 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -54.49 -41.49 69.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.622 ' O ' HD12 ' A' ' 199' ' ' LEU . 96.2 m-85 -63.37 -21.89 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.852 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -47.77 -28.3 2.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.27 -31.54 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.575 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -56.72 -41.36 77.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.137 178.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -99.1 -34.91 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 200' ' ' GLU . 30.1 tt0 58.81 20.03 7.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.779 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 176.54 35.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.304 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm 41.55 37.65 0.74 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.854 0.359 . . . . 0.0 111.365 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.09 -32.77 7.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.2 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.725 ' HG2' HD22 ' B' ' 7' ' ' LEU . 0.0 OUTLIER 42.48 62.67 1.63 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.546 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -51.1 115.09 1.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.978 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.518 HG21 HD23 ' B' ' 7' ' ' LEU . 40.5 p -146.78 25.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.09 -58.32 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -149.99 -76.34 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.024 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 60.88 154.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.058 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.065 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.594 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.796 0.331 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -176.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.361 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.487 ' H ' HD12 ' B' ' 3' ' ' ILE . 3.8 mp -46.19 -26.1 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.073 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.04 -85.61 0.02 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.918 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.594 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 32.0 Cg_exo -61.22 109.91 0.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.544 2.163 . . . . 0.0 110.112 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.446 ' CG ' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.725 HD22 ' HG2' ' A' ' 204' ' ' ARG . 3.0 mt . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.864 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.83 0.347 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -114.71 69.89 2.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.005 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.62 56.65 4.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.561 2.174 . . . . 0.0 112.548 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -141.81 -58.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.711 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -105.1 -40.74 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.516 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -61.85 -45.0 95.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.692 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 6.9 pt20 -49.64 -35.42 21.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.979 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -76.7 -67.88 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.368 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -46.96 -45.36 20.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.307 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -49.45 -37.2 24.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.822 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -86.54 -35.4 19.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.757 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.492 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -52.54 -59.67 4.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 193' ' ' CYS . 27.5 m -52.31 -36.82 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -48.07 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.422 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.06 17.65 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . 54.72 92.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.662 0.268 . . . . 0.0 111.313 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 t 174.43 46.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.29 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -121.01 152.27 38.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 1.8 m -157.7 144.48 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.922 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.729 ' CE2' HG21 ' A' ' 123' ' ' VAL . 3.5 p90 -146.83 172.14 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 111.247 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.08 154.49 23.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.828 ' HB ' HD21 ' A' ' 187' ' ' LEU . 11.4 p -174.2 160.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.738 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.545 ' N ' HG22 ' A' ' 85' ' ' VAL . 4.1 mmtt -117.24 75.65 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.655 ' CD1' HG21 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -56.69 115.56 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.402 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.829 HD13 ' HA ' ' A' ' 177' ' ' PHE . 7.7 mp -64.91 -37.54 87.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.58 -129.07 3.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.532 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.551 ' N ' HD11 ' A' ' 109' ' ' LEU . 3.7 p -171.02 124.12 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.506 HG13 HD13 ' A' ' 109' ' ' LEU . 26.8 m -116.61 129.68 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.365 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -57.47 155.55 9.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 172' ' ' TRP . 19.5 m -150.6 177.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.195 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -94.68 -11.17 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.44 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.82 136.25 46.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.823 0.344 . . . . 0.0 110.921 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.3 p -101.32 23.02 11.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.767 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.54 -167.97 2.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.02 109.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -28.38 8.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.42 -45.5 94.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.637 HG12 ' SG ' ' A' ' 174' ' ' CYS . 38.7 t -51.41 -32.56 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -42.9 59.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.761 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -45.35 74.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.43 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.3 pt-20 -75.96 -38.07 57.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -54.83 -45.04 74.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.472 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp -56.8 -42.42 79.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.3 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -42.47 95.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.344 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.4 t -66.26 -40.55 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.011 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.551 HD11 ' N ' ' A' ' 90' ' ' CYS . 1.5 mm? -52.08 -23.19 4.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.25 -50.23 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.536 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.434 ' CG ' ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.68 -22.48 66.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.553 -178.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -88.65 165.8 14.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.31 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -21.5 13.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -41.75 114.97 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.48 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 139.33 20.01 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.39 154.04 43.78 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.627 2.218 . . . . 0.0 112.789 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.945 HG21 HD11 ' A' ' 139' ' ' ILE . 3.4 p -110.97 170.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.55 ' H ' HG22 ' A' ' 117' ' ' VAL . 5.9 ttt85 -137.82 88.29 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.538 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.71 -150.94 5.53 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.739 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.648 HD23 ' C ' ' A' ' 83' ' ' PHE . 10.6 mt -123.04 151.22 42.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.487 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.532 ' CB ' ' CE1' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -99.04 106.88 19.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 129' ' ' ARG . 41.7 m-70 -71.57 63.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 194' ' ' ALA . 70.9 t -66.96 107.45 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.7 m -131.69 31.83 4.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.448 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 48.0 29.09 6.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.565 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' C ' HG22 ' A' ' 144' ' ' ILE . 24.0 t0 -140.97 -43.25 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -159.39 122.18 1.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.977 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.742 ' CD1' HD12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -73.04 82.98 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.76 0.314 . . . . 0.0 110.558 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 48.0 mtt85 -95.73 81.71 3.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.313 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 87' ' ' TYR . 2.0 p -73.55 88.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.21 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 132' ' ' ASP . 72.8 t -76.5 156.26 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.093 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -100.42 122.54 43.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.22 0.33 22.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.72 -32.21 8.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.5 p -119.82 -36.52 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.964 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.9 OUTLIER 67.02 44.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -109.83 16.65 30.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.095 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 137' ' ' GLY . 6.9 tp 46.23 107.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.361 0.601 . . . . 0.0 111.673 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.945 HD11 HG21 ' A' ' 117' ' ' VAL . 32.4 mt -72.94 -61.62 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.908 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.2 t -104.58 97.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -98.92 71.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.18 172.67 12.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 145' ' ' GLU . 12.1 m -92.37 147.91 22.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.629 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.742 HD12 ' CD1' ' A' ' 128' ' ' LEU . 19.4 tt -81.12 -19.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.786 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.602 ' H ' HG22 ' A' ' 143' ' ' THR . 1.5 mt-10 -84.88 -36.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.212 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -43.17 14.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 148' ' ' SER . 10.4 p -46.03 164.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.314 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -70.85 -2.54 15.3 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.0 m-85 84.22 166.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.887 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 29.0 p -87.43 -173.02 4.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.613 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 173.74 101.53 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.444 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 52.0 Cg_endo -69.65 129.79 18.33 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.594 2.196 . . . . 0.0 112.934 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -60.65 -150.34 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.209 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -107.97 19.66 19.73 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.625 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.457 ' ND2' ' HA3' ' A' ' 159' ' ' GLY . 1.5 m-80 -55.77 -21.97 21.81 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.234 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' CB ' ' O ' ' A' ' 155' ' ' ASN . 4.0 t-80 90.49 -30.84 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.32 0.648 . . . . 0.0 111.47 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.06 71.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.706 0.288 . . . . 0.0 111.505 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.41 ' CD ' ' OD2' ' A' ' 182' ' ' ASP . 7.2 ptt180 167.82 -29.69 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.809 0.337 . . . . 0.0 111.225 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 160' ' ' PHE . . . -104.69 127.55 9.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.644 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 6.1 m-85 -139.06 177.64 7.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 p -175.3 125.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.756 ' OH ' HG21 ' A' ' 191' ' ' VAL . 4.9 m-30 -98.1 -171.75 2.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -156.97 155.18 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 22.9 p -146.12 143.22 29.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.952 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 79.34 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.061 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 168' ' ' THR . 37.9 t0 59.36 -88.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.761 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.98 -83.11 0.01 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.431 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 166' ' ' ASP . 1.8 m -139.72 22.34 2.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 92.8 m -111.36 -82.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -158.03 -70.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.683 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -150.05 -155.51 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.977 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.622 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -65.46 76.23 0.06 Allowed 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.01 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -92.41 121.14 33.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.081 -177.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.637 ' SG ' HG12 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.16 142.54 28.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -114.49 118.7 34.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.998 0.428 . . . . 0.0 111.161 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' LEU . . . -115.45 151.88 18.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.833 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.829 ' HA ' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -178.62 176.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 111.956 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.28 139.82 35.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.153 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 187' ' ' LEU . . . -64.25 138.71 58.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 0.0 111.615 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 186' ' ' ARG . 21.9 mmtt -76.81 -27.78 55.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.656 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.41 ' OD2' ' CD ' ' A' ' 158' ' ' ARG . 1.4 t70 60.31 36.92 20.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.464 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.4 p -151.56 19.09 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.674 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.88 26.53 1.19 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.263 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.76 24.14 13.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.552 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -179.34 37.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.086 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 1.002 HD13 ' HB1' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -167.52 -52.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.469 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 2.9 t -73.75 -66.64 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -52.41 -36.81 55.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.478 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.954 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.756 HG21 ' OH ' ' A' ' 162' ' ' TYR . 38.9 t -50.37 -48.86 25.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.994 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.03 -27.26 21.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.885 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.671 ' HB3' HG21 ' A' ' 76' ' ' VAL . 60.8 m -87.24 -28.32 22.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.94 0.4 . . . . 0.0 110.52 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.816 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -51.31 -51.31 55.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.461 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.712 ' O ' HD12 ' A' ' 199' ' ' LEU . 86.5 m-85 -55.06 -23.95 22.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.256 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -46.53 -49.88 18.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.856 0.36 . . . . 0.0 111.202 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 76' ' ' VAL . 86.2 t -58.75 -38.93 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 30.4 t -65.15 -30.78 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.201 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 195' ' ' PHE . 1.2 mp -130.32 57.4 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.296 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -48.22 -26.82 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -121.31 25.18 9.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.524 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.465 ' NZ ' HD11 ' B' ' 3' ' ' ILE . 1.7 mmtp 48.07 45.36 19.43 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.081 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -71.56 66.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.848 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.412 ' CG ' ' O ' ' A' ' 204' ' ' ARG . 0.3 OUTLIER -76.71 76.93 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.986 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -82.83 65.29 7.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.449 HG21 ' CA ' ' B' ' 7' ' ' LEU . 7.1 p -92.09 170.35 9.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -57.53 138.97 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 55.9 92.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -74.3 152.49 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.136 179.78 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.35 -87.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.723 ' HA ' HD13 ' B' ' 7' ' ' LEU . 28.7 mm -116.01 -51.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.867 0.365 . . . . 0.0 111.094 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 149' ' ' PHE . . . -50.98 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.361 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 32.3 Cg_exo -57.78 -34.41 98.19 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.723 HD13 ' HA ' ' B' ' 3' ' ' ILE . 6.2 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.855 0.36 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.483 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 1.7 ptpt -137.69 47.32 1.63 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.357 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 65' ' ' LYS . 10.0 Cg_endo -51.18 -70.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.654 2.236 . . . . 0.0 112.189 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -136.74 -83.03 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.775 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.62 -28.78 65.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.759 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.424 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m0 -55.86 -46.41 78.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.07 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 2.0 pp0? -49.59 -33.48 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.004 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.33 -70.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.67 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 76' ' ' VAL . 11.5 m-20 -47.39 -32.04 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.489 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -65.21 -25.66 67.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 110.959 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 13.4 mt-10 -102.28 -35.91 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -53.91 -55.44 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 193' ' ' CYS . 28.7 m -55.14 -38.51 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -34.8 73.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 23.2 t -88.66 -12.13 43.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.198 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 78' ' ' SER . . . 75.28 73.16 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.841 0.353 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -179.24 50.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -112.84 -179.35 3.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB2' HD11 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -174.15 122.69 0.3 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.503 0.668 . . . . 0.0 111.096 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -127.77 130.15 48.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.511 -177.165 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -60.68 160.41 9.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.935 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.5 p -177.77 159.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 111.923 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.518 ' N ' HG22 ' A' ' 85' ' ' VAL . 10.7 mttt -107.91 62.48 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.211 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.748 ' O ' HG12 ' A' ' 117' ' ' VAL . 31.6 t80 -55.6 119.86 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.472 -178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 109' ' ' LEU . 9.0 mp -60.83 -43.04 98.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.041 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 136.17 -159.02 24.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.975 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -115.51 145.8 42.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.023 0.44 . . . . 0.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -137.27 174.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.401 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.475 ' N ' HG13 ' A' ' 91' ' ' VAL . 2.8 pm0 -101.16 146.7 27.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.305 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 172' ' ' TRP . 4.5 m -144.55 163.85 13.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.027 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -84.79 -3.95 58.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.899 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG11 ' A' ' 101' ' ' VAL . 22.7 mm-40 -153.29 126.71 8.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.847 0.356 . . . . 0.0 110.912 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 3.0 p -95.72 27.08 3.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.604 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -151.03 149.46 29.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.0 -147.06 18.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.96 -46.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -26.93 15.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 95' ' ' GLU . 48.5 t -68.14 -36.73 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.782 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 53.7 m -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -39.23 87.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.53 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.0 pt-20 -82.4 -34.09 28.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.29 13.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.678 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -49.4 -43.35 44.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.22 77.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.29 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.7 t -67.54 -43.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.917 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' A' ' 88' ' ' LEU . 3.1 mm? -53.14 -22.36 6.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -47.0 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.389 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -9.1 58.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.014 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.23 172.35 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.198 -179.437 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.37 6.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.666 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.648 ' HG3' HD13 ' A' ' 109' ' ' LEU . 2.4 mmt180 -43.18 113.38 0.48 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.441 ' CG ' ' HD2' ' A' ' 116' ' ' PRO . 60.8 ttt180 -118.66 144.97 36.53 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.321 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 115' ' ' ARG . 75.3 Cg_exo -50.34 155.39 4.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.813 2.342 . . . . 0.0 112.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 139' ' ' ILE . 10.7 p -126.39 109.55 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.252 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 133' ' ' ASP . 2.6 ttt180 -69.33 70.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.124 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.94 -165.26 11.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.232 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.625 HD13 ' C ' ' A' ' 120' ' ' LEU . 1.9 tm? -120.75 119.23 32.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.6 tp -77.38 83.7 3.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.075 0.464 . . . . 0.0 110.15 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.499 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -66.03 82.61 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.827 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 81' ' ' CYS . 1.8 m -70.78 178.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 p -178.01 31.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.86 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.636 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 40.93 32.55 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.722 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -172.12 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.553 0.216 . . . . 0.0 111.398 -178.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -153.75 117.12 0.78 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.879 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.527 HD21 HD12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -90.13 130.02 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.748 0.309 . . . . 0.0 110.569 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.55 ' HB3' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -135.01 90.67 2.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.901 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 130' ' ' VAL . 3.9 p -72.72 102.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.0 t -91.96 135.91 25.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.36 137.59 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 118' ' ' ARG . 11.3 t0 -87.83 16.12 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -117.43 -35.0 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 43.3 p -119.26 -15.88 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.649 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.92 36.07 7.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.91 -164.79 24.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.873 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -122.5 132.01 54.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.846 HD11 HG21 ' A' ' 117' ' ' VAL . 4.3 mt -100.12 -23.52 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 140' ' ' VAL . 22.0 t -143.77 60.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.195 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.457 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 20.3 p-10 -67.74 73.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.484 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -145.13 151.37 38.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 111.407 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -60.62 179.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.746 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 126' ' ' ASP . 16.4 tt -108.07 -23.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -86.89 -24.18 24.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.879 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -94.76 21.33 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.0 OUTLIER -115.12 178.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.419 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.488 ' OG ' HD12 ' A' ' 163' ' ' ILE . 23.1 t -87.23 13.96 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 76.79 -177.61 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.771 0.319 . . . . 0.0 111.045 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 3.9 m -111.33 163.17 14.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 111.281 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -174.75 98.45 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.866 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 34.1 Cg_endo -64.34 159.44 43.8 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.182 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 22.4 m-20 -78.33 57.3 1.88 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.43 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 153' ' ' ASP . 1.3 ttt180 82.02 6.43 1.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.023 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 40.39 30.68 0.08 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.78 0.324 . . . . 0.0 111.716 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.99 -15.17 52.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.796 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.68 29.23 2.14 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.473 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.0 OUTLIER 60.48 40.58 16.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.961 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.05 110.71 2.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.593 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.683 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 5.9 m-85 -91.82 170.28 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -164.18 107.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.786 ' OH ' HG11 ' A' ' 191' ' ' VAL . 4.0 m-30 -88.94 -179.5 5.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.325 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -159.32 148.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.404 ' HB3' ' CG1' ' A' ' 147' ' ' VAL . 19.6 p -139.21 157.84 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.752 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 87.32 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.885 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' THR . 3.1 p-10 47.62 26.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.169 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.72 80.04 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.417 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 166' ' ' ASP . 17.1 p 55.0 25.7 7.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.678 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -119.22 -78.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -158.79 -81.66 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 111.112 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -143.42 -148.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.891 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.638 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -66.76 74.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.171 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.452 ' HE3' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.29 118.1 27.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.352 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.42 168.08 17.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.091 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -140.58 90.54 2.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.783 0.325 . . . . 0.0 111.407 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -69.46 107.01 1.96 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -104.99 138.67 40.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 179' ' ' ALA . 2.8 tm? -135.37 108.4 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.388 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.683 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -44.88 145.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.713 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.02 -59.7 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -68.31 -27.44 66.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD1' HD21 ' A' ' 178' ' ' LEU . 0.5 OUTLIER 59.17 82.43 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.172 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.438 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 8.3 t -168.6 29.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.06 27.89 1.17 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.898 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.0 49.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.0 110.79 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.55 ' C ' HD12 ' A' ' 187' ' ' LEU . 25.3 mmt180 -149.84 -46.5 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.486 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.935 HD21 ' HB ' ' A' ' 85' ' ' VAL . 2.6 mp -119.66 -36.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.122 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -58.42 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -18.46 47.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.543 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 193' ' ' CYS . . . -87.83 -74.25 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.272 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 187' ' ' LEU . 3.4 p -52.09 -29.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.117 0.484 . . . . 0.0 110.119 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.13 -30.45 60.98 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.832 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -71.0 -32.04 68.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.139 0.495 . . . . 0.0 109.667 177.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.636 ' HB1' ' HA2' ' A' ' 125' ' ' GLY . . . -50.95 -33.6 25.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.564 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.785 ' O ' HD12 ' A' ' 199' ' ' LEU . 17.6 m-85 -61.45 -24.88 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.731 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.02 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.292 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.63 -34.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 31.9 t -52.16 -28.33 17.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.656 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -121.43 -38.41 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 201' ' ' ARG . 0.8 OUTLIER 63.2 105.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.043 -178.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.414 ' CB ' ' O ' ' A' ' 200' ' ' GLU . 1.1 ttt85 79.4 20.0 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.711 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm 47.45 47.89 16.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.322 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -58.56 -30.6 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.57 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.28 145.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.107 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -93.41 21.66 5.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.189 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' O ' ' B' ' 7' ' ' LEU . 7.7 p -85.52 -165.33 1.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.31 74.23 1.85 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.817 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -48.96 -45.06 41.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.217 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 48.9 39.67 14.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.169 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.037 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.428 ' C ' ' CG ' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.643 0.259 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.789 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER 178.43 -92.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.069 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.789 HD13 ' O ' ' B' ' 2' ' ' TYR . 5.1 mm -135.39 64.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.115 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.46 -78.63 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.457 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.4 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 75.9 Cg_exo -47.16 -42.22 26.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.531 2.154 . . . . 0.0 112.139 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.417 ' CD1' ' N ' ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' B' ' 7' ' ' LEU . 4.0 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.691 0.282 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 8.0 mtmt 51.8 51.07 9.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 110.765 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' LYS . 10.6 Cg_endo -53.37 -82.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.75 2.3 . . . . 0.0 112.241 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -141.62 -69.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 110.183 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.95 -28.91 40.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.081 0.467 . . . . 0.0 109.778 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.425 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 1.2 m0 -81.77 -33.9 30.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.168 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -24.13 65.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.965 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.66 -46.97 6.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.02 -46.04 65.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.08 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 69' ' ' TRP . 5.3 tt0 -50.57 -41.8 54.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.39 -23.23 35.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -63.57 -53.04 57.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.874 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -58.41 -43.64 87.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.266 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -53.42 -45.5 69.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.468 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 17.0 12.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.101 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . 56.56 85.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.646 0.26 . . . . 0.0 111.303 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.639 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.6 t 174.24 51.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -119.81 166.7 12.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.763 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.914 ' HB3' HD21 ' A' ' 120' ' ' LEU . 2.0 m -166.48 160.21 15.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.048 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.469 ' CG ' ' O ' ' A' ' 82' ' ' SER . 21.2 m-85 -167.99 141.35 3.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 120' ' ' LEU . 8.2 t -59.37 158.74 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.893 ' HB ' HD21 ' A' ' 187' ' ' LEU . 14.9 p -175.47 160.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 111.952 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 85' ' ' VAL . 8.5 mttt -114.56 57.97 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.703 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.765 ' O ' HG22 ' A' ' 117' ' ' VAL . 26.7 t80 -47.67 134.38 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 109' ' ' LEU . 7.4 mp -79.21 -58.08 3.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.906 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.576 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 151.06 -155.34 26.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.543 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 20.0 p -121.26 144.03 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 109' ' ' LEU . 7.5 m -134.78 142.59 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.1 124.63 24.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 172' ' ' TRP . 15.4 m -127.25 176.92 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.985 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.22 2.9 53.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.886 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.5 mm-40 -153.85 164.97 37.49 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.974 0.416 . . . . 0.0 111.073 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.503 ' HG ' ' HE3' ' A' ' 172' ' ' TRP . 83.7 p -132.95 23.93 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.669 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.78 168.63 19.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.15 154.38 24.21 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -24.09 24.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.03 -42.5 97.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.044 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 45.5 t -64.73 -30.5 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -70.81 -58.08 3.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.037 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -48.27 -37.57 16.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.7 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.3 pt-20 -83.86 -42.17 16.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.817 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 101' ' ' VAL . . . -50.4 -48.76 55.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HB3' ' NH1' ' A' ' 154' ' ' ARG . 0.3 OUTLIER -53.82 -51.47 63.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -51.11 -42.45 60.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.468 178.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -66.27 -35.67 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.119 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.627 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -53.76 -39.57 65.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -52.6 8.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.04 -36.33 28.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.045 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.04 -167.0 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 31.15 3.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.471 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -90.56 79.41 6.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.631 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -58.35 128.35 82.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.16 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.53 159.44 32.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.448 2.098 . . . . 0.0 112.435 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.933 HG11 HD11 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -104.88 -178.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.404 ' HG3' ' HE3' ' A' ' 86' ' ' LYS . 12.1 ttt180 -149.54 70.64 1.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.581 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.8 -130.09 2.66 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.721 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' A' ' 82' ' ' SER . 1.4 tp -136.77 139.44 41.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.936 0.398 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 85' ' ' VAL . 20.1 tp -92.93 124.66 37.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.392 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 129' ' ' ARG . 12.1 m170 -85.24 103.35 14.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.014 HG21 HG22 ' A' ' 191' ' ' VAL . 96.1 t -109.48 105.97 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -128.73 39.76 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.454 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 39.35 48.36 2.87 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.216 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.642 ' O ' HG22 ' A' ' 144' ' ' ILE . 4.4 t70 -160.62 -41.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.79 117.8 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.546 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.723 HD11 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.6 133.78 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 0.0 110.97 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 14.5 mtm-85 -139.42 87.79 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.593 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.504 HG13 ' HB ' ' A' ' 139' ' ' ILE . 7.4 p -77.62 140.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.581 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 136' ' ' LYS . 5.2 t -135.26 152.7 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.478 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.5 t0 -95.82 149.49 21.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.781 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t70 -91.77 19.96 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.351 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -127.27 -40.9 1.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 110.752 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 p -114.06 -19.59 11.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.125 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HA ' HG12 ' A' ' 131' ' ' VAL . 5.4 mmtp 59.3 22.34 10.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 110.784 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.38 120.21 5.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.423 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.456 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 2.0 tp -55.75 133.52 50.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.68 0.276 . . . . 0.0 110.608 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.933 HD11 HG11 ' A' ' 117' ' ' VAL . 6.0 mt -108.12 -43.25 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.08 86.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.529 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.456 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 26.8 t0 -98.09 69.44 2.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.758 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -124.54 179.12 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -91.82 171.67 8.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.649 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.723 HD12 HD11 ' A' ' 128' ' ' LEU . 10.1 tt -107.64 -16.7 8.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.404 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.94 -38.32 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 111.022 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -81.15 -24.79 37.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 163' ' ' ILE . 11.6 p -70.64 164.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.651 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.1 m -72.91 -2.19 19.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.8 m-85 80.58 -167.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.1 p -129.8 -171.62 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.961 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB1' ' HG3' ' B' ' 5' ' ' PRO . . . -164.07 58.31 0.66 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.425 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 50.1 Cg_exo -52.87 113.41 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.361 2.041 . . . . 0.0 111.807 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -172.57 95.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 0.0 111.817 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 106' ' ' LEU . 8.4 ptt180 -179.37 111.38 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.587 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -72.33 -3.82 26.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.462 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -43.57 -65.56 0.48 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -157.15 40.76 0.32 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.828 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 60.55 62.7 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.732 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.83 147.6 17.19 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.541 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 1.5 m-85 -131.06 151.07 51.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.04 125.91 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.881 0.372 . . . . 0.0 111.689 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.669 ' O ' HG23 ' A' ' 163' ' ' ILE . 4.4 m-30 -94.94 -172.48 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.198 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -165.87 159.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.964 0.411 . . . . 0.0 111.379 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.47 ' HB3' HG23 ' A' ' 147' ' ' VAL . 24.0 p -157.56 157.66 34.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.514 ' HG3' ' CZ3' ' A' ' 172' ' ' TRP . 0.1 OUTLIER -116.03 85.09 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.3 p30 46.48 -163.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.76 -42.77 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.218 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.4 p -153.32 24.92 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.948 0.404 . . . . 0.0 110.734 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.68 -72.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.034 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.418 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER 179.81 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.759 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' MET . 6.2 ptt180 -131.05 -152.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.149 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 4.4 m95 -60.87 82.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -90.18 112.68 24.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.81 -177.151 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' A' ' 93' ' ' VAL . 1.2 m -82.29 171.41 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.974 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -146.3 118.83 8.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.92 0.391 . . . . 0.0 111.561 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 87' ' ' TYR . . . -92.32 124.19 7.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.74 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 4.7 m-85 -122.89 136.33 54.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.391 . . . . 0.0 111.327 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.79 108.59 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.438 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.597 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -50.1 134.38 22.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 111.177 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -60.38 3.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.79 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -57.6 -33.81 68.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.649 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.2 80.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.02 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.37 30.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.58 37.56 0.15 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 113.879 0.312 . . . . 0.0 113.879 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -147.58 49.4 1.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.019 0.438 . . . . 0.0 111.496 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.08 -42.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.0 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.893 HD21 ' HB ' ' A' ' 85' ' ' VAL . 5.7 mp -111.47 -44.47 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.4 p -53.9 -60.2 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -71.03 -28.1 64.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -71.94 -68.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.865 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 1.014 HG22 HG21 ' A' ' 123' ' ' VAL . 2.7 t -60.6 -41.37 87.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.28 -39.85 36.37 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.782 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 1.7 m -76.13 -27.76 57.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.061 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.619 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -60.58 -41.96 95.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.542 ' CD2' HD11 ' A' ' 144' ' ' ILE . 42.4 m-85 -59.99 -35.51 75.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -51.45 -27.06 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.6 t -71.77 -31.6 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.45 ' HB3' HD23 ' A' ' 199' ' ' LEU . 38.9 t -48.25 -52.74 19.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.731 HD21 HG21 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -100.43 -33.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 5.2 tt0 45.62 35.3 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.674 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 178.69 34.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.25 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.432 ' HA ' HD12 ' A' ' 199' ' ' LEU . 2.2 mptp? 44.05 31.38 0.52 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.875 0.369 . . . . 0.0 111.267 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -59.56 -15.77 20.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.034 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.923 ' HD3' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -38.71 151.33 0.03 OUTLIER 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.589 0.356 . . . . 0.0 111.821 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 64.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.485 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . 1.017 ' CG2' HD21 ' B' ' 7' ' ' LEU . 3.4 p -96.91 -48.91 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.241 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -148.22 118.87 7.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 55.51 167.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -145.71 99.26 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.043 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 117.938 -1.029 . . . . 0.0 111.149 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.736 0.303 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 179.77 74.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.923 HG23 ' HD3' ' A' ' 204' ' ' ARG . 4.8 mp 47.54 45.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.43 ' CA ' ' C ' ' B' ' 5' ' ' PRO . . . 127.44 87.65 0.59 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.514 ' HG3' ' HB1' ' A' ' 151' ' ' ALA . 41.3 Cg_exo -49.69 140.8 5.57 Favored 'Cis proline' 0 N--CA 1.482 0.801 0 CA-C-N 118.699 1.249 . . . . 0.0 114.922 6.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.458 ' C ' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 1.017 HD21 ' CG2' ' A' ' 206' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.843 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.84 0.352 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' CG ' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER 59.67 170.15 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 179.344 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 65' ' ' LYS . 37.5 Cg_endo -66.1 61.63 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.551 2.167 . . . . 0.0 112.393 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -148.5 -57.33 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.198 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.73 -46.83 9.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.009 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -58.97 -36.59 75.11 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.378 0.608 . . . . 0.0 110.05 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -13.68 40.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.232 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.79 -27.32 6.26 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 4.7 p30 -90.34 -25.92 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.662 0.267 . . . . 0.0 111.504 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 49.4 mt-10 -61.31 -27.0 68.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.976 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -102.04 -24.64 13.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' THR . . . -46.29 -37.6 7.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 194' ' ' ALA . 40.0 t -63.67 -50.47 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HA ' ' CG2' ' A' ' 197' ' ' VAL . 3.8 mtp180 -49.86 -48.63 51.12 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.107 0.479 . . . . 0.0 110.577 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.91 14.33 10.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.246 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 50.42 81.04 0.07 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.65 0.262 . . . . 0.0 111.116 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.8 t -171.96 29.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.586 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.57 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -97.59 157.87 15.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -171.43 144.81 2.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 54.1 m-85 -154.73 146.04 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.507 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -58.11 162.88 3.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.523 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.632 HG13 ' CD2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -159.63 172.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.208 0.528 . . . . 0.0 111.727 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.432 ' H ' HG12 ' A' ' 85' ' ' VAL . 4.4 mttt -125.42 42.4 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.965 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.496 ' N ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -38.98 122.33 1.18 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.388 -178.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.723 HD23 ' HB3' ' A' ' 109' ' ' LEU . 8.9 mp -67.59 -44.52 77.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.214 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.515 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 145.37 -135.09 5.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.442 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.404 ' N ' HD11 ' A' ' 109' ' ' LEU . 25.3 p -139.65 148.75 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.865 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 174' ' ' CYS . 12.5 m -139.15 127.78 28.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.51 128.01 35.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.069 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 172' ' ' TRP . 32.9 m -126.15 -174.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.687 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.93 24.93 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.618 ' HB2' HG21 ' A' ' 101' ' ' VAL . 28.5 mp0 -141.96 -81.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.172 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m 60.36 22.73 12.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.783 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 24.89 2.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -166.42 10.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.64 -39.35 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -59.54 -47.56 85.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.966 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' A' ' 95' ' ' GLU . 62.0 t -49.65 -26.67 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.07 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.6 m -66.88 -44.23 81.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.84 -53.81 43.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 pt-20 -76.81 -36.93 56.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.776 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.597 ' O ' HD23 ' A' ' 109' ' ' LEU . . . -48.9 -25.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tt -81.8 -43.54 18.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.07 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 6.8 pttt -60.76 -35.18 75.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.321 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -68.16 -35.69 72.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.583 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.723 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -54.37 -27.82 38.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -47.39 6.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.079 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -23.48 5.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.795 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.73 177.95 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -12.7 58.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.303 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.702 ' HG2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -43.23 108.91 0.12 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 0.0 111.537 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.2 ptt180 -98.92 144.76 28.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.8 160.37 12.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.461 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.984 HG21 HD11 ' A' ' 139' ' ' ILE . 1.6 p -115.92 176.18 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.599 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -147.69 79.88 1.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.12 5.35 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.008 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 120' ' ' LEU . 3.4 mt -121.1 131.19 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.475 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -88.04 104.89 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -72.09 69.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.261 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.849 HG21 HG22 ' A' ' 191' ' ' VAL . 93.9 t -77.84 97.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.371 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 24.9 p -119.62 42.62 2.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.459 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 42.99 41.91 4.83 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.708 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.764 ' O ' HG22 ' A' ' 144' ' ' ILE . 9.8 t0 -163.39 -43.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.613 0.244 . . . . 0.0 111.286 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -148.14 127.56 2.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.283 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 191' ' ' VAL . 0.2 OUTLIER -87.03 71.41 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.667 0.27 . . . . 0.0 110.886 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.48 89.84 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.8 0.334 . . . . 0.0 111.176 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.864 HG13 ' HB ' ' A' ' 139' ' ' ILE . 5.8 p -85.93 90.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.952 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 132' ' ' ASP . 7.2 p -86.2 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -99.62 147.68 25.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -100.66 14.41 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.676 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.89 -43.77 3.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 58.7 p -111.31 -19.96 12.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 38.45 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.049 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.41 139.99 15.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.103 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 139' ' ' ILE . 2.6 tp -73.39 110.81 7.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.984 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 117' ' ' VAL . 38.2 mt -68.38 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.31 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 138' ' ' LEU . 66.2 t -110.28 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.075 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.442 ' HA ' HD21 ' A' ' 138' ' ' LEU . 26.6 t70 -93.89 73.25 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.497 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.2 170.37 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 145' ' ' GLU . 87.9 m -103.64 141.8 35.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.545 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.889 HD11 ' CE1' ' A' ' 195' ' ' PHE . 13.0 tt -70.66 -27.09 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.014 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.68 ' H ' HG22 ' A' ' 143' ' ' THR . 0.4 OUTLIER -81.79 -30.92 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.772 178.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -91.42 -41.7 10.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.943 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 163' ' ' ILE . 14.3 p -47.4 161.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.074 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.536 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.4 m -52.7 -50.95 62.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 1.061 ' CE1' HD11 ' A' ' 163' ' ' ILE . 3.0 p90 150.75 -176.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.673 0.789 . . . . 0.0 109.971 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 15.9 p -114.91 151.48 33.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.425 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -177.05 102.09 0.23 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.129 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 45.5 Cg_endo -67.31 159.11 53.82 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.332 2.022 . . . . 0.0 111.963 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.63 -59.82 2.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.28 33.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.197 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 41.56 30.97 0.16 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.662 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -104.88 16.58 25.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.588 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -169.8 29.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.671 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.409 ' CD ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER 53.2 26.12 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.73 0.3 . . . . 0.0 111.232 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -110.81 154.14 16.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.594 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 0.3 OUTLIER -139.29 -175.46 4.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.75 0.309 . . . . 0.0 110.728 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.6 t -177.31 136.02 0.2 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.878 0.37 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.645 ' OH ' HG11 ' A' ' 191' ' ' VAL . 60.5 m-85 -105.06 -171.49 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.365 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.061 HD11 ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -165.31 142.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 111.474 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 20.0 p -132.98 142.58 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.466 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 172' ' ' TRP . 4.5 ptt180 -108.51 83.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.429 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 170' ' ' ARG . 2.9 p30 45.45 -162.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.415 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.52 -64.06 4.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.664 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -44.35 5.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.353 . . . . 0.0 111.127 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 79.9 m -86.18 -88.29 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.91 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 166' ' ' ASP . 18.2 mmm180 -154.81 -81.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 110.372 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 3.3 ptp180 -127.59 -152.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.492 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.804 ' O ' HG22 ' A' ' 93' ' ' VAL . 19.5 m95 -67.3 71.53 0.11 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -88.39 119.01 28.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.596 ' SG ' HG11 ' A' ' 93' ' ' VAL . 15.2 m -89.19 157.9 18.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.333 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -135.62 99.11 4.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.649 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -94.28 134.1 11.89 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.92 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.5 p90 -154.93 148.74 25.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 111.482 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.537 HD11 ' OD2' ' A' ' 182' ' ' ASP . 8.2 tp -118.52 132.7 56.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.396 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -49.29 140.43 9.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -61.35 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.685 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -68.21 -32.84 73.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.537 ' OD2' HD11 ' A' ' 178' ' ' LEU . 10.6 t70 67.24 73.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.062 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.4 23.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.624 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 41.15 30.87 0.47 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.42 ' O ' ' NE ' ' A' ' 186' ' ' ARG . 2.0 mt-10 -136.92 41.43 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.669 0.271 . . . . 0.0 111.191 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.487 ' HD3' ' CE1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -154.64 -45.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.911 0.386 . . . . 0.0 110.768 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 191' ' ' VAL . 9.3 mp -113.54 -43.91 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.836 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 20.4 t -56.7 -61.16 2.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -67.3 -21.01 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.259 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.57 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -83.68 -60.92 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.176 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.849 HG22 HG21 ' A' ' 123' ' ' VAL . 2.2 t -66.74 -31.78 55.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.799 0.333 . . . . 0.0 110.553 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.21 -26.01 12.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.56 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 44.5 t -99.08 -23.02 15.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.439 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.619 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -50.07 -28.33 6.97 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.889 ' CE1' HD11 ' A' ' 144' ' ' ILE . 53.4 m-85 -84.87 -22.07 29.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -60.61 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.774 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 77' ' ' ARG . 79.8 t -55.49 -39.09 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 34.9 t -57.61 -48.71 78.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.058 HD21 HG21 ' B' ' 3' ' ' ILE . 1.2 pt? -129.93 56.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.167 0.508 . . . . 0.0 110.754 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 29.3 tt0 -45.1 -28.01 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.709 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -96.47 31.35 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 199' ' ' LEU . 6.0 mptt 47.84 35.08 4.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.005 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -69.65 65.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.432 ' HD2' ' CD1' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -127.16 45.42 2.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.19 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 51.83 25.56 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.82 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.4 t -116.9 103.62 10.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 65.79 133.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 61.58 49.33 5.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.237 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -168.49 35.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.247 -179.646 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.819 0.342 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.628 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -134.48 -78.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 1.058 HG21 HD21 ' A' ' 199' ' ' LEU . 8.1 mm -134.91 -42.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.21 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.03 -77.78 0.11 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.643 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' B' ' 7' ' ' LEU . 83.5 Cg_exo -47.34 140.86 14.73 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.683 2.256 . . . . 0.0 112.213 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.419 ' CD1' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' B' ' 5' ' ' PRO . 5.2 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.326 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.85 0.357 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 19.5 pttt -148.74 165.2 18.51 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.786 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 65' ' ' LYS . 83.2 Cg_exo -45.59 161.93 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.458 2.105 . . . . 0.0 112.456 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.9 m80 71.85 -68.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -69.1 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.739 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -32.6 67.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.699 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.14 -21.83 65.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.28 -62.84 1.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.408 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.9 p30 -53.14 -29.52 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.007 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.0 mm-40 -69.19 -36.0 76.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 0.0 110.522 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.8 -23.87 25.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.681 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.759 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -59.22 -57.37 13.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.677 HG13 ' HA ' ' A' ' 194' ' ' ALA . 1.2 t -50.59 -48.11 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.255 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -42.84 62.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.519 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.0 p -94.49 18.92 10.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.079 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.02 82.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -179.4 49.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.145 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -116.0 173.24 6.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.05 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 29.4 p 176.84 151.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' C ' HD23 ' A' ' 120' ' ' LEU . 53.3 m-85 -160.51 138.25 9.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.784 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.8 t -49.23 167.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.692 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 86' ' ' LYS . 8.5 p -174.48 162.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 111.993 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.526 ' N ' HG22 ' A' ' 85' ' ' VAL . 12.5 mtmm -111.96 56.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.617 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.616 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -47.7 176.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 116' ' ' PRO . 11.0 mt -137.48 -42.4 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.151 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.68 -144.67 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.485 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.5 m -136.58 155.93 49.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.586 HG13 HD13 ' A' ' 109' ' ' LEU . 2.8 m -134.61 128.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.873 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.67 124.28 20.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.852 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 172' ' ' TRP . 28.7 m -126.59 164.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -93.56 17.78 11.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.193 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HB2' HG21 ' A' ' 101' ' ' VAL . 38.3 mt-10 -159.0 114.38 2.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.05 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -93.62 21.35 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -151.84 130.9 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.63 130.34 3.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.457 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.43 ' HE1' ' O ' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -65.04 -32.81 74.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.751 0.31 . . . . 0.0 111.066 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -43.83 91.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 95' ' ' GLU . 59.6 t -61.98 -28.48 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.049 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.4 m -69.08 -48.02 63.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.013 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -52.41 -59.01 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.912 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -62.56 -30.78 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -62.96 -57.42 10.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.02 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -50.52 -44.44 56.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.528 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.79 -39.75 71.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.399 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 104' ' ' GLU . 15.0 t -64.24 -42.97 97.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.437 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.586 HD13 HG13 ' A' ' 91' ' ' VAL . 2.6 mm? -52.33 -22.42 4.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.228 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 -54.18 3.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.355 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 1.5 pp0? -61.16 -30.98 70.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.486 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -84.32 172.39 11.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -22.36 11.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HG3' HD13 ' A' ' 109' ' ' LEU . 1.1 mmt180 -45.26 102.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 141.36 24.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.714 ' HA ' HD23 ' A' ' 88' ' ' LEU . 36.2 Cg_exo -59.82 152.25 65.11 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.481 2.12 . . . . 0.0 112.441 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 118' ' ' ARG . 3.1 p -114.23 177.87 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.403 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.622 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -146.19 74.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.454 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -128.57 -144.87 5.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.282 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -122.2 130.5 53.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.678 0.275 . . . . 0.0 111.281 -178.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.727 ' HG ' HG23 ' A' ' 123' ' ' VAL . 41.8 tp -84.97 100.01 11.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -73.61 87.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.684 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.954 HG21 HG22 ' A' ' 191' ' ' VAL . 94.0 t -101.87 112.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.91 42.73 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.576 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 47.19 25.0 2.48 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.718 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -174.38 27.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 156.43 121.92 0.72 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.14 -1.029 . . . . 0.0 113.468 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.922 HD13 ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -106.85 110.18 22.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 110.419 178.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -124.48 106.29 10.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 87' ' ' TYR . 10.2 p -86.98 112.45 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 136' ' ' LYS . 77.3 t -116.31 120.24 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -54.58 146.65 15.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -94.14 20.67 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -126.06 -42.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.66 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 39.8 p -110.45 -24.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.906 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.461 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER 68.43 25.27 6.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.38 123.41 6.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.364 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 141' ' ' ASP . 14.6 tp -63.48 118.37 8.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 0.0 111.02 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' A' ' 130' ' ' VAL . 3.7 mt -92.67 -50.63 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.41 HG21 ' OH ' ' A' ' 87' ' ' TYR . 11.7 t -120.09 123.08 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.529 ' HB3' HD21 ' A' ' 138' ' ' LEU . 2.2 p-10 -116.94 65.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.169 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.27 165.55 11.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.683 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.81 ' O ' HG22 ' A' ' 144' ' ' ILE . 1.9 t -111.28 2.75 17.87 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.857 HD12 HD21 ' A' ' 128' ' ' LEU . 3.1 tt 72.63 -3.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.403 ' HB3' HG23 ' A' ' 143' ' ' THR . 25.9 tt0 -110.86 -37.53 5.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -30.69 27.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.574 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 148' ' ' SER . 10.7 p -51.46 164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.915 ' CB ' HD12 ' A' ' 163' ' ' ILE . 66.1 m -53.01 -53.91 43.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.323 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 163' ' ' ILE . 0.1 OUTLIER 155.84 -15.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.862 0.726 . . . . 0.0 112.212 178.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 0.5 OUTLIER 90.75 172.2 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.292 0.637 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 166.55 107.0 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 46.0 Cg_endo -68.49 140.33 47.51 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.364 2.043 . . . . 0.0 112.089 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.43 ' O ' ' HE1' ' A' ' 99' ' ' MET . 0.1 OUTLIER -44.95 -85.29 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.361 -179.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -149.76 22.43 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.3 m120 45.82 34.48 1.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.295 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -91.28 -18.41 24.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.409 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -142.47 15.8 2.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.703 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.26 51.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.321 . . . . 0.0 110.891 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -129.54 146.31 17.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.567 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 177' ' ' PHE . 2.0 m-85 -111.63 -176.31 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.702 0.287 . . . . 0.0 110.718 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.429 ' OG ' HD12 ' A' ' 106' ' ' LEU . 1.7 m -168.41 106.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.893 0.378 . . . . 0.0 111.276 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.922 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 42.8 m-85 -85.12 -173.16 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.915 HD12 ' CB ' ' A' ' 148' ' ' SER . 0.0 OUTLIER -167.09 132.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 38.5 t -131.42 156.69 45.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.859 0.361 . . . . 0.0 111.033 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -113.99 80.53 1.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.001 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 t0 52.47 -161.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 168' ' ' THR . . . 100.21 -22.28 40.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.325 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 167' ' ' GLY . 18.9 p -161.75 -42.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -75.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.05 -42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.1 ptp85 -166.67 -150.78 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.954 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.739 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.27 74.42 0.09 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 71.0 mmm -89.19 117.9 28.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.651 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.54 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 0.8 OUTLIER -79.68 165.05 23.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.713 177.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -131.89 120.87 23.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 111.29 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.411 ' HA2' ' HG ' ' A' ' 106' ' ' LEU . . . -116.3 113.68 2.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.432 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.571 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -143.65 162.2 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -137.53 131.15 31.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.983 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 187' ' ' LEU . . . -47.85 138.94 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.375 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -56.41 11.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.885 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.21 -33.67 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 110.455 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.9 t70 66.17 69.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.28 25.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.901 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.18 37.81 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 113.985 0.354 . . . . 0.0 113.985 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -148.69 23.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.846 0.323 . . . . 0.0 111.585 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.74 21.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.394 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.912 ' O ' HG23 ' A' ' 191' ' ' VAL . 0.6 OUTLIER 179.59 -38.92 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.539 ' N ' HD23 ' A' ' 187' ' ' LEU . 70.5 m -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.482 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -55.81 -28.13 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.093 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 76' ' ' VAL . . . -59.0 -49.75 76.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.534 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.954 HG22 HG21 ' A' ' 123' ' ' VAL . 2.5 t -73.74 -38.82 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.531 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.09 -40.95 45.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.951 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -79.23 -29.53 42.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.288 178.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.677 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -56.84 -43.02 80.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.519 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 144' ' ' ILE . 6.8 m-85 -58.09 -28.37 64.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.212 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -51.14 47.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.013 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 64.7 t -50.78 -37.71 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.867 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.1 t -61.8 -35.97 79.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.576 HD11 HD11 ' B' ' 3' ' ' ILE . 1.2 pt? -140.13 64.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 196' ' ' ALA . 1.3 pt-20 -50.29 -30.09 11.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.469 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.73 24.94 3.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.039 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.53 33.97 11.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.44 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -67.74 82.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.268 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -106.02 17.44 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.117 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -23.53 14.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.744 0.307 . . . . 0.0 111.069 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.562 HG23 HD21 ' B' ' 7' ' ' LEU . 5.1 t -48.03 167.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.232 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.23 -75.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.298 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.37 169.87 10.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.349 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 64.12 168.87 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.174 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.971 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.699 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -161.34 -96.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' B' ' 2' ' ' TYR . 4.8 mp -102.71 -47.67 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.456 ' HA2' ' CD1' ' A' ' 149' ' ' PHE . . . -51.09 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' B' ' 1' ' ' ALA . 16.2 Cg_exo -68.59 161.2 46.17 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.692 2.262 . . . . 0.0 111.61 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.407 ' CD1' ' N ' ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 206' ' ' THR . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -129.12 150.62 75.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.54 159.8 28.69 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.632 2.221 . . . . 0.0 112.626 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' TRP . 12.6 m80 63.1 112.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.149 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.66 -73.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.201 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.417 ' N ' ' O ' ' A' ' 67' ' ' HIS . 3.1 m0 -46.3 -34.45 4.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.201 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -62.92 -34.8 78.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.633 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.27 -55.84 4.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.129 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 15.9 t70 -49.42 -49.17 46.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -49.69 -41.58 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -86.21 -23.38 26.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.764 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB1' HG23 ' A' ' 80' ' ' THR . . . -72.7 -66.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 110.709 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.653 ' CG2' ' HB2' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -48.27 -37.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.832 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -45.68 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.038 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -90.78 18.57 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.411 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 55.71 96.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.835 0.35 . . . . 0.0 111.103 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.574 HG23 ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -178.8 -30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.92 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.571 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 0.7 OUTLIER -41.12 158.21 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 111.278 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 175.49 145.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.103 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' CD1' ' HG2' ' A' ' 186' ' ' ARG . 89.6 m-85 -160.59 148.01 15.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 120' ' ' LEU . 32.3 t -47.32 166.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.615 ' HB ' HD11 ' A' ' 187' ' ' LEU . 8.8 p -173.9 159.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.979 0.418 . . . . 0.0 111.724 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.441 ' N ' HG22 ' A' ' 85' ' ' VAL . 32.0 mttm -121.18 65.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.754 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.489 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.6 t80 -56.68 121.13 9.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.269 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.66 -41.21 94.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.474 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 141.9 -178.43 20.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.231 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.41 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 38.1 m -100.86 142.57 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.453 ' O ' ' HE1' ' A' ' 173' ' ' MET . 0.4 OUTLIER -136.51 172.42 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.893 -178.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' CG ' ' HD2' ' A' ' 171' ' ' ARG . 4.0 tt0 -109.83 148.43 31.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.165 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 172' ' ' TRP . 12.9 m -148.73 173.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.426 ' O ' ' CD1' ' A' ' 172' ' ' TRP . 22.5 m-85 -87.94 -24.07 23.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.658 ' HB2' HG21 ' A' ' 101' ' ' VAL . 4.5 mp0 -133.09 145.36 50.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 111.197 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 25.31 5.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.47 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.406 ' HG2' ' HD3' ' A' ' 165' ' ' ARG . 28.3 mtm180 -136.97 24.15 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.89 128.47 4.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.478 ' HG3' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -57.92 -37.89 74.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -55.12 -34.4 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 95' ' ' GLU . 82.2 t -64.86 -30.78 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.884 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 91.8 m -66.39 -43.68 85.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.21 -46.73 79.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.8 pt-20 -76.03 -32.14 59.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.984 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' O ' HD23 ' A' ' 109' ' ' LEU . . . -63.08 -59.79 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.507 HD13 ' OD2' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -46.31 -36.18 6.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -40.58 88.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.4 t -67.49 -32.42 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.615 HD13 ' HG3' ' A' ' 114' ' ' ARG . 4.0 mm? -60.36 -18.63 51.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.086 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -97.17 -45.31 6.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -64.35 -30.42 71.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.73 171.99 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -21.61 14.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD13 ' A' ' 109' ' ' LEU . 4.7 mmt180 -45.43 114.21 0.71 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.6 ptt-85 -124.51 148.15 57.74 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.292 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.1 156.64 2.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.785 2.324 . . . . 0.0 112.632 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 117' ' ' VAL . 10.6 p -129.08 114.34 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.907 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.97 63.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.681 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -117.65 -139.29 6.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.478 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.646 HD23 ' ND1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -144.27 137.79 27.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.985 0.421 . . . . 0.0 111.2 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.623 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -88.8 104.0 16.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.486 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.646 ' ND1' HD23 ' A' ' 120' ' ' LEU . 21.2 m80 -72.01 117.16 13.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.785 HG21 HG22 ' A' ' 191' ' ' VAL . 65.8 t -131.65 88.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.416 ' HB3' ' N ' ' A' ' 80' ' ' THR . 5.5 m -119.26 46.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.89 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 197' ' ' VAL . . . 35.23 61.37 0.66 Allowed Glycine 0 CA--C 1.521 0.456 0 O-C-N 123.415 0.447 . . . . 0.0 113.855 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.708 ' C ' HG22 ' A' ' 144' ' ' ILE . 6.2 t70 -178.94 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.65 122.35 0.95 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.56 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 162' ' ' TYR . 12.8 mt -78.78 146.44 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -154.16 96.17 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.737 HG13 ' HB ' ' A' ' 139' ' ' ILE . 3.5 p -86.89 115.46 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.707 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.16 136.22 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 42.1 t0 -68.5 152.64 45.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 7.0 t0 -97.4 21.55 9.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.23 -46.12 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 110.654 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.3 p -102.17 -25.37 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 66.02 32.09 8.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.03 124.42 8.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.353 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 11.7 tp -55.89 118.17 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.737 ' HB ' HG13 ' A' ' 130' ' ' VAL . 8.6 mt -87.81 -50.51 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.262 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.496 HG23 ' CG1' ' A' ' 130' ' ' VAL . 57.3 t -112.69 79.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.147 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.452 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.3 p-10 -82.74 68.91 9.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -174.33 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.5 m -105.48 169.86 8.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.708 HG22 ' C ' ' A' ' 126' ' ' ASP . 11.5 tt -99.62 -26.04 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.9 -42.32 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -45.65 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 163' ' ' ILE . 14.7 p -48.04 164.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -80.67 7.84 9.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.449 ' H ' HG13 ' A' ' 147' ' ' VAL . 1.5 m-85 80.58 -161.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 110.933 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.48 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.3 p -143.75 163.46 33.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 99' ' ' MET . . . -154.91 110.3 2.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.707 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 25.5 Cg_endo -61.68 132.32 39.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.268 1.979 . . . . 0.0 112.1 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.507 ' OD2' HD13 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -43.31 -54.56 4.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.277 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 177.99 35.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.261 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 42.15 35.26 0.56 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.455 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -78.35 -13.82 59.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.884 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.04 24.48 0.13 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.894 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 64.0 48.07 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 111.045 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.59 128.13 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.326 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -113.78 174.89 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.931 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 t -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.831 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.623 ' OH ' HD11 ' A' ' 121' ' ' LEU . 4.5 m-30 -93.82 -178.15 4.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.625 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.6 pt -163.93 136.97 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.13 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.513 ' SG ' HG23 ' A' ' 147' ' ' VAL . 3.0 m -131.22 160.15 35.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.411 ' HB2' ' NH1' ' A' ' 165' ' ' ARG . 23.5 mtm105 -119.28 85.1 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.075 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 46.58 -161.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.26 -82.24 1.06 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.304 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 24.13 11.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.332 . . . . 0.0 111.015 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.9 -82.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.248 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.5 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.428 ' HD2' ' CG ' ' A' ' 92' ' ' GLU . 4.6 ptp180 -133.27 -151.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.125 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.51 ' O ' HG22 ' A' ' 93' ' ' VAL . 12.2 m95 -63.15 82.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.453 ' HE1' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -86.68 121.09 28.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.559 -178.109 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 155.09 17.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.067 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -137.16 123.21 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.757 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -98.69 112.04 4.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.532 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.476 ' CE2' ' CD2' ' A' ' 162' ' ' TYR . 22.0 m-85 -109.0 158.7 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.751 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 178' ' ' LEU . 0.4 OUTLIER -149.84 99.29 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.299 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 85' ' ' VAL . . . -42.32 141.23 0.99 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.436 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 34.7 t -63.94 -66.22 0.57 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.308 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -29.38 49.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.138 0.494 . . . . 0.0 109.907 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.76 75.19 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.223 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.06 30.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.428 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.454 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 39.1 30.25 0.12 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.421 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -133.71 49.63 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.502 ' HG2' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 169.71 -32.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.673 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.615 HD11 ' HB ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER -112.11 -30.33 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.905 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.454 ' CB ' ' HA2' ' A' ' 184' ' ' GLY . 11.1 t -87.65 -66.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.149 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -30.34 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.571 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -68.04 -68.87 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.996 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.785 HG22 HG21 ' A' ' 123' ' ' VAL . 29.7 t -52.87 -48.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.77 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.76 -35.18 23.27 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.716 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.413 ' HB3' HG11 ' A' ' 76' ' ' VAL . 14.5 t -86.46 -32.77 20.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.165 0.507 . . . . 0.0 109.884 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.653 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . . . -52.38 -33.85 45.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.894 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.525 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 32.6 m-85 -71.9 -18.86 62.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.104 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -44.85 -59.32 2.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.576 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 198' ' ' CYS . 34.4 m -50.47 -47.0 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.179 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.571 ' N ' HG23 ' A' ' 197' ' ' VAL . 41.0 t -54.41 -29.26 48.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 109.784 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.769 HD13 HG12 ' B' ' 3' ' ' ILE . 4.6 mp -123.28 43.29 2.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.521 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -44.93 -28.17 0.63 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.169 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 26.23 9.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 199' ' ' LEU . 15.8 mmtm 49.76 47.6 22.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -87.72 50.84 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.29 119.4 12.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.811 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -94.18 78.91 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.999 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.59 HG21 ' HB2' ' B' ' 7' ' ' LEU . 1.2 t -120.49 104.78 10.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.985 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 71.15 -63.96 0.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.071 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 209' ' ' ALA . . . -152.59 -84.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 208' ' ' ALA . . . 177.01 46.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.104 179.899 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.443 ' HB1' ' CE1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.666 0.27 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.735 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -176.1 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.986 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.769 HG12 HD13 ' A' ' 199' ' ' LEU . 4.2 mp -140.24 54.09 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.163 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.486 ' N ' ' CD1' ' B' ' 7' ' ' LEU . . . -165.9 -67.1 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.418 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.24 1.88 8.55 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.139 2.56 . . . . 0.0 112.664 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.872 ' C ' HD22 ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.872 HD22 ' C ' ' B' ' 6' ' ' PTR . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.04 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.7 mttt 50.43 58.16 17.27 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.712 0.291 . . . . 0.0 111.067 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -44.38 -61.92 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.555 2.17 . . . . 0.0 112.474 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.89 -68.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.762 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -70.98 -23.59 62.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.598 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -33.26 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.006 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -67.31 -40.27 85.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.27 65.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.81 -41.02 94.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -30.47 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.597 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -87.84 -25.61 23.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.662 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -56.01 -50.21 71.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -61.12 -43.87 97.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.6 -179.374 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.8 83.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.448 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -95.05 19.85 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.046 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB1' ' CB ' ' A' ' 124' ' ' SER . . . 49.22 84.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.238 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 3.4 t 178.56 47.51 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.645 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 123' ' ' VAL . 9.7 t -120.83 114.27 21.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.434 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.89 142.79 51.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.866 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.489 ' HB2' HD11 ' A' ' 187' ' ' LEU . 49.0 m-85 -152.02 142.84 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.678 ' HA ' HD23 ' A' ' 120' ' ' LEU . 5.0 m -54.98 164.32 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 121' ' ' LEU . 4.8 p 176.6 161.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 85' ' ' VAL . 10.7 mtmm -113.11 79.33 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 139' ' ' ILE . 12.6 t80 -65.39 99.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.82 HD23 ' HG3' ' A' ' 116' ' ' PRO . 49.9 mt -46.47 -49.57 18.11 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA2' ' CE2' ' A' ' 87' ' ' TYR . . . 147.01 -169.18 28.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.228 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 21.1 p -123.96 129.25 50.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 110.962 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -117.88 147.24 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.999 -178.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.5 136.77 45.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 172' ' ' TRP . 27.4 m -132.76 178.92 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -116.48 26.87 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.674 ' CB ' HG21 ' A' ' 101' ' ' VAL . 3.9 mt-10 -145.0 -82.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.315 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.0 m 63.42 28.25 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 21.45 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.9 168.01 30.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.565 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -32.01 22.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.0 110.894 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -63.51 -17.02 62.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.326 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.674 HG21 ' CB ' ' A' ' 95' ' ' GLU . 25.8 t -87.5 -21.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.602 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.5 p -69.56 -37.0 76.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.62 -59.58 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.478 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.916 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.4 pt-20 -64.35 -32.92 74.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.611 ' HB1' ' CB ' ' A' ' 174' ' ' CYS . . . -67.63 -23.93 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.793 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.671 HD13 ' OD1' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -92.56 -24.14 18.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.874 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.412 ' C ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -81.61 -38.58 25.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.221 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.916 HG23 ' O ' ' A' ' 104' ' ' GLU . 70.9 t -53.14 -55.41 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.262 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.681 ' CD2' HG13 ' A' ' 91' ' ' VAL . 13.9 mt -56.45 -25.31 50.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -82.91 -27.57 30.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.459 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -89.87 -10.39 45.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.259 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.0 p -106.36 -165.67 1.11 Allowed 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -83.65 -21.95 32.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.865 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -48.36 91.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -84.77 159.62 57.48 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.202 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.82 ' HG3' HD23 ' A' ' 88' ' ' LEU . 4.4 Cg_exo -71.81 161.53 44.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.703 2.269 . . . . 0.0 111.962 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.736 HG12 ' HB3' ' A' ' 87' ' ' TYR . 9.6 p -117.64 118.19 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.44 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 64.93 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.349 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -122.34 -159.2 10.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.77 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' ' 84' ' ' SER . 5.3 mt -116.66 126.49 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.137 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.64 ' HB2' HG11 ' A' ' 85' ' ' VAL . 5.9 tp -86.82 100.36 12.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.436 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -76.45 103.61 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.538 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.59 HG21 HG22 ' A' ' 191' ' ' VAL . 58.6 t -104.5 133.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.456 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.461 ' CB ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -145.91 29.06 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.722 -178.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 48.08 23.62 2.83 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.596 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HA ' HG22 ' A' ' 144' ' ' ILE . 41.5 t0 -165.03 22.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 143' ' ' THR . . . 152.36 112.07 0.5 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' A' ' 162' ' ' TYR . 1.4 mt -91.88 101.41 13.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 110.523 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -104.49 89.88 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.689 HG13 ' HB ' ' A' ' 139' ' ' ILE . 7.6 p -83.69 112.96 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.67 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 137' ' ' GLY . 7.0 p -122.76 138.86 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.212 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 36.8 t0 -63.83 144.59 56.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 28.5 t70 -93.52 14.62 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.42 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -120.61 -39.28 2.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.778 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.7 p -104.85 -24.42 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.839 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.15 35.0 4.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -103.99 134.03 11.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.612 HD21 ' CG ' ' A' ' 141' ' ' ASP . 10.8 tp -67.02 120.95 14.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.398 . . . . 0.0 111.061 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.746 HG21 ' CE2' ' A' ' 87' ' ' TYR . 7.8 mt -90.55 -59.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.56 114.83 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.874 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.612 ' CG ' HD21 ' A' ' 138' ' ' LEU . 20.3 t0 -111.28 96.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.73 -163.93 1.49 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.682 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.816 ' O ' HG22 ' A' ' 144' ' ' ILE . 5.1 t -135.93 8.91 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 143' ' ' THR . 4.7 tt 65.59 7.01 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 143' ' ' THR . 0.7 OUTLIER -112.6 -36.23 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.132 0.491 . . . . 0.0 110.397 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -83.98 -19.85 33.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.37 177.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 148' ' ' SER . 8.3 p -66.62 164.0 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.784 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.53 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -85.75 16.27 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' A' ' 148' ' ' SER . 15.4 m-85 82.58 -179.45 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.871 0.367 . . . . 0.0 110.957 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 26.6 p -114.53 -178.76 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.456 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 172.64 100.45 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.387 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' B' ' 5' ' ' PRO . 44.8 Cg_endo -68.9 143.83 56.52 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.507 2.138 . . . . 0.0 112.894 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.671 ' OD1' HD13 ' A' ' 106' ' ' LEU . 0.4 OUTLIER -66.43 -153.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.14 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -98.78 24.04 8.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.813 0.339 . . . . 0.0 110.683 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 156' ' ' HIS . 2.4 m120 -58.05 -18.83 27.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.574 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 155' ' ' ASN . 3.0 t60 86.19 -51.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.571 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -168.64 75.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 111.427 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER 165.72 -28.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 179.218 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -96.86 122.03 7.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.844 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.499 ' HB3' ' CE1' ' A' ' 177' ' ' PHE . 5.6 m-85 -134.61 159.64 40.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.3 t -159.88 138.24 10.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.44 . . . . 0.0 111.636 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.84 ' CE2' HD13 ' A' ' 128' ' ' LEU . 6.0 m-85 -105.69 -173.23 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.1 pt -160.94 135.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.04 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 3.4 m -126.48 100.04 6.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.984 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 -65.04 80.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 168' ' ' THR . 34.4 t0 60.79 -87.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.747 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 49.06 -88.99 0.01 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.765 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 166' ' ' ASP . 2.6 m -116.54 -33.47 4.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.751 0.31 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 81.4 m -59.15 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.034 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 169' ' ' THR . 58.5 mtp180 -163.92 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -136.04 -154.72 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.762 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.75 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -64.27 78.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -99.71 120.96 40.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.153 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.611 ' CB ' ' HB1' ' A' ' 105' ' ' ALA . 86.5 m -91.26 159.22 16.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -129.95 94.67 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.305 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.64 126.32 8.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.366 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.527 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -149.29 152.95 36.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.819 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.464 HD21 ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -130.61 120.89 24.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -40.88 147.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.994 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -42.25 73.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.53 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -76.1 -34.68 59.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.498 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' HD21 ' A' ' 178' ' ' LEU . 3.9 m-20 67.07 64.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.332 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -162.22 24.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.584 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 42.33 27.81 0.5 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.257 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 1.9 mt-10 -125.4 43.4 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.889 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.584 ' C ' HD12 ' A' ' 187' ' ' LEU . 16.5 mmt-85 -158.51 -44.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 191' ' ' VAL . 4.3 mp -115.2 -36.11 4.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.734 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 12.3 t -58.92 -65.87 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 186' ' ' ARG . 10.5 p80 -61.29 -35.68 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.89 -73.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.016 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 187' ' ' LEU . 6.6 t -51.39 -43.57 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.631 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.65 -34.84 36.67 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.484 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 56.5 m -91.14 -27.39 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.073 177.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.618 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -49.53 -45.47 47.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.99 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.603 ' O ' HD12 ' A' ' 199' ' ' LEU . 33.5 m-85 -57.2 -22.52 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.984 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -41.43 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.42 -34.38 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.819 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.97 -23.41 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.767 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 195' ' ' PHE . 5.3 mp -113.8 -45.73 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.824 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 201' ' ' ARG . 60.7 tt0 60.95 115.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.407 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.406 ' CB ' ' O ' ' A' ' 200' ' ' GLU . 3.8 ttm180 78.74 0.95 2.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.391 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.12 52.19 2.58 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.065 0.459 . . . . 0.0 110.961 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -76.97 59.92 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.817 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.473 ' HD2' HD11 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -68.73 104.56 2.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -73.86 61.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.0 t -154.78 38.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -145.16 -52.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -99.3 88.5 3.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.034 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -108.9 165.06 11.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.087 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.171 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 174.73 87.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.897 0.38 . . . . 0.0 111.366 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.582 HG22 ' O ' ' B' ' 3' ' ' ILE . 4.1 mp 42.42 48.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.155 0.502 . . . . 0.0 111.753 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.17 86.27 1.7 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.853 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' B' ' 1' ' ' ALA . 32.5 Cg_exo -71.47 114.09 2.3 Favored 'Cis proline' 0 N--CA 1.481 0.793 0 CA-C-N 118.137 0.969 . . . . 0.0 114.041 4.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.418 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.51 ' CD1' HG23 ' B' ' 3' ' ' ILE . 12.0 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.945 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 3.5 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.781 0.324 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -104.84 83.74 0.86 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.327 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 68' ' ' GLN . 58.6 Cg_endo -71.95 74.28 2.38 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.586 2.191 . . . . 0.0 112.521 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 64.34 -72.83 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.201 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -46.06 -39.24 8.96 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.488 ' CB ' ' HA ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -81.94 -31.32 31.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.478 179.128 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.79 -28.38 68.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -85.24 -37.33 20.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.863 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.561 ' O ' HG22 ' A' ' 76' ' ' VAL . 6.8 t0 -56.46 -49.65 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.66 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -58.15 4.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.354 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -29.15 53.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -51.16 -68.49 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.877 HG21 ' HB3' ' A' ' 193' ' ' CYS . 3.3 m -49.48 -27.43 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -52.14 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 m -95.37 15.94 18.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.152 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 61.97 84.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.036 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.592 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.7 t 175.67 54.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.415 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.712 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 19.5 t -122.28 71.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.371 . . . . 0.0 110.65 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 122' ' ' HIS . 13.0 p -92.91 148.71 21.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.078 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.662 ' C ' HD12 ' A' ' 120' ' ' LEU . 29.4 m-85 -151.52 139.63 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -53.54 139.47 31.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 86' ' ' LYS . 11.9 p -151.68 159.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.55 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.527 ' N ' HG22 ' A' ' 85' ' ' VAL . 23.9 mtpp -114.81 61.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.797 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.543 ' HB3' HG12 ' A' ' 117' ' ' VAL . 23.3 t80 -47.55 119.22 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 109' ' ' LEU . 10.1 mp -56.49 -46.67 80.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.69 ' O ' HD11 ' A' ' 109' ' ' LEU . . . 148.64 -176.38 27.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.99 130.43 51.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 111.372 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.568 HG13 HD13 ' A' ' 109' ' ' LEU . 7.0 m -121.72 174.35 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.09 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 93' ' ' VAL . 2.9 pt-20 -105.7 154.41 20.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.087 0.47 . . . . 0.0 111.616 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.736 HG11 ' SG ' ' A' ' 174' ' ' CYS . 16.0 m -157.65 -175.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.25 20.02 2.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.602 0.239 . . . . 0.0 111.39 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HB2' HG21 ' A' ' 101' ' ' VAL . 1.2 mm-40 -115.76 -68.01 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.176 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 53.0 p 50.1 24.99 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.631 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -148.67 32.72 0.78 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.43 125.23 1.68 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.578 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -34.51 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -63.35 -25.97 68.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.695 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.659 HG21 ' HB2' ' A' ' 95' ' ' GLU . 43.3 t -62.67 -35.42 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -70.82 -34.88 72.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.48 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -64.18 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.2 pt-20 -85.14 -39.21 18.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.422 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.15 75.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 160' ' ' PHE . 33.0 tp -51.6 -33.48 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -43.47 28.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 104' ' ' GLU . 13.2 t -58.11 -33.31 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.69 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.7 OUTLIER -54.38 -31.07 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.215 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -50.43 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.539 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -54.09 -25.72 23.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.638 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.4 p -82.75 -177.85 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -3.73 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.407 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.433 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 11.9 mmp_? -48.54 177.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.774 0.321 . . . . 0.0 111.127 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.19 135.49 4.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.033 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 152.04 4.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.314 2.009 . . . . 0.0 112.099 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 139' ' ' ILE . 7.1 p -123.48 113.6 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.423 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 64.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.557 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -117.0 -150.17 9.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.91 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 83' ' ' PHE . 13.1 tp -137.42 128.21 27.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.773 0.321 . . . . 0.0 110.793 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -78.02 90.14 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -72.64 94.02 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.225 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.822 HG13 HD23 ' A' ' 128' ' ' LEU . 4.2 t -100.34 160.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.72 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -166.54 34.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.501 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 45.93 44.84 13.84 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.536 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -171.19 -43.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.679 0.276 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.53 114.4 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.286 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.918 HD13 ' CE2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -84.33 120.17 25.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 110.169 177.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -132.66 98.68 4.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.036 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 139' ' ' ILE . 5.7 p -83.26 129.45 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.846 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.499 HG23 ' H ' ' A' ' 138' ' ' LEU . 6.1 p -133.71 132.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.052 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.423 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 40.3 t0 -65.8 148.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.919 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -97.74 20.11 12.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -125.54 -42.15 1.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.3 p -104.27 -27.73 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.671 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tptm 49.35 49.9 18.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -113.69 14.03 22.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.076 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.736 HD12 ' H ' ' A' ' 139' ' ' ILE . 8.7 tp 59.36 148.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 111.248 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.996 HD11 HG21 ' A' ' 117' ' ' VAL . 3.3 mt -127.85 -51.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.493 ' O ' HD11 ' A' ' 138' ' ' LEU . 21.9 t -114.16 136.78 49.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.038 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -143.06 58.96 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -113.07 162.06 16.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.958 ' O ' HG23 ' A' ' 147' ' ' VAL . 63.4 m -97.67 122.73 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.603 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.94 HD11 ' CD1' ' A' ' 195' ' ' PHE . 7.3 tt -54.22 -31.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 143' ' ' THR . 24.3 tt0 -72.97 -25.25 60.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.444 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.2 OUTLIER -96.05 -39.55 9.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.499 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 143' ' ' THR . 17.8 t -49.76 144.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.272 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.476 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 9.1 m -50.51 -41.19 53.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.976 ' CE1' HD11 ' A' ' 163' ' ' ILE . 2.7 p90 155.77 -175.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.616 0.572 . . . . 0.0 110.074 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 19.5 p -121.23 140.13 52.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.738 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -167.94 133.06 1.54 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.803 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.423 ' CB ' ' O ' ' A' ' 159' ' ' GLY . 98.3 Cg_endo -82.0 -96.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.482 2.122 . . . . 0.0 112.298 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -159.06 -62.83 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.874 0.369 . . . . 0.0 110.393 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -162.76 26.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.994 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 56.6 t30 45.18 48.69 9.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.284 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.98 -1.33 7.81 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.73 11.13 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.371 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER 58.84 37.17 24.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.029 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 152' ' ' PRO . . . -122.05 141.3 14.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.569 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.473 ' O ' HD13 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -105.51 -163.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 0.0 110.83 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.8 t 172.5 129.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.736 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.918 ' CE2' HD13 ' A' ' 128' ' ' LEU . 3.9 m-30 -110.86 -179.56 3.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.976 HD11 ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -163.83 143.24 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.446 ' HB3' HG13 ' A' ' 147' ' ' VAL . 1.8 p -169.1 133.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.579 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.502 ' HG3' ' CZ2' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -67.63 84.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.979 177.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 169' ' ' THR . 97.8 m-20 -66.6 110.13 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.5 -20.72 59.64 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.467 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -48.56 3.33 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.473 ' CB ' ' HB3' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -50.2 -64.19 0.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.374 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 171' ' ' ARG . 53.7 mtp180 -164.54 -46.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.108 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 165.0 -145.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.502 ' CZ2' ' HG3' ' A' ' 165' ' ' ARG . 1.7 m-90 -64.17 81.7 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.489 ' HE2' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.81 134.9 39.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.333 0.587 . . . . 0.0 111.764 -176.028 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.736 ' SG ' HG11 ' A' ' 93' ' ' VAL . 1.2 m -101.89 169.03 9.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.978 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 39.8 m-70 -146.79 123.42 11.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 111.549 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -101.76 114.6 5.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.877 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.424 ' HD1' HG21 ' A' ' 85' ' ' VAL . 6.8 m-85 -104.96 146.04 29.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.124 0.488 . . . . 0.0 111.623 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.706 HD13 ' O ' ' A' ' 179' ' ' ALA . 3.1 tm? -145.76 110.46 5.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.706 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -42.39 143.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.858 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.8 t -71.91 -48.67 43.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.801 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -78.57 -25.13 45.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.99 77.84 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.462 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 39.9 t -169.9 28.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.503 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.05 34.99 0.62 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.144 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -136.21 47.54 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.546 ' CB ' HD13 ' A' ' 187' ' ' LEU . 1.6 mpt_? -153.47 -57.74 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.131 0.491 . . . . 0.0 110.158 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.49 -0.97 4.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.867 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.428 ' HA ' ' CE2' ' A' ' 160' ' ' PHE . 70.1 m -80.44 -44.08 19.87 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.076 0.465 . . . . 0.0 110.228 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CG ' ' CZ2' ' A' ' 69' ' ' TRP . 1.3 t60 -94.84 -18.86 20.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.67 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.712 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -78.74 -63.07 1.5 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.539 HG21 ' OH ' ' A' ' 162' ' ' TYR . 54.4 t -48.41 -46.52 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.8 -24.22 57.2 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.792 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.877 ' HB3' HG21 ' A' ' 76' ' ' VAL . 56.1 m -85.84 -31.3 22.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.497 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.547 ' HB2' HG11 ' A' ' 123' ' ' VAL . . . -52.68 -42.39 64.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.94 ' CD1' HD11 ' A' ' 144' ' ' ILE . 45.3 m-85 -65.44 -25.88 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.876 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -43.44 -42.05 4.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.908 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.607 ' HB3' HD23 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -43.03 -46.4 5.56 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.811 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 202' ' ' LYS . 0.2 OUTLIER -106.67 -27.28 10.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.096 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 72.84 -63.54 0.43 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.139 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -90.55 29.95 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.757 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.695 ' HA ' HD12 ' A' ' 199' ' ' LEU . 3.7 mmmt 45.95 36.42 2.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.147 0.498 . . . . 0.0 110.388 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -102.59 73.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.473 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.653 ' HG2' HD12 ' B' ' 7' ' ' LEU . 0.1 OUTLIER -86.4 -73.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.321 178.63 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.64 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.922 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.434 HG23 HD23 ' B' ' 7' ' ' LEU . 0.0 OUTLIER -167.24 108.62 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.971 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -74.82 160.59 30.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.09 98.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.06 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -175.3 -75.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.05 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.074 -179.948 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.95 ' HB3' ' HG3' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -157.41 68.44 0.53 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.209 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.678 HD12 ' N ' ' B' ' 3' ' ' ILE . 2.0 mp 66.41 -65.19 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.353 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 149' ' ' PHE . . . -40.49 -61.91 1.72 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.398 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.95 ' HG3' ' HB3' ' B' ' 1' ' ' ALA . 85.2 Cg_endo -76.43 -23.46 11.5 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.908 2.405 . . . . 0.0 112.533 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PTR . . . . . 0.722 ' C ' HD13 ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.722 HD13 ' C ' ' B' ' 6' ' ' PTR . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.711 0.291 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -153.79 146.54 17.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.046 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.07 41.2 0.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.866 2.377 . . . . 0.0 112.8 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -138.95 -63.53 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.49 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -79.26 -56.4 4.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.057 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -58.94 -38.6 79.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.155 0.503 . . . . 0.0 109.89 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -53.16 -24.42 10.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.332 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.57 23.1 13.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.994 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -131.45 -48.19 0.98 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.064 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.01 -37.97 22.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.899 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.08 -26.08 39.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -52.01 -65.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 197' ' ' VAL . 2.7 m -51.45 -31.58 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -47.78 73.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.758 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -94.04 21.56 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.006 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 49.06 85.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.174 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -176.8 41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -109.2 161.84 14.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.899 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 78.7 p 178.66 155.16 0.42 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' SER . 49.5 m-85 -164.69 141.61 6.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 t -51.84 149.92 4.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.352 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 187' ' ' LEU . 1.7 t -146.66 167.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.231 0.539 . . . . 0.0 112.324 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' H ' HG12 ' A' ' 85' ' ' VAL . 17.7 mmtt -121.52 48.07 1.75 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.995 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.936 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -38.8 150.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.066 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 116' ' ' PRO . 75.1 mt -106.54 -38.82 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.643 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.43 169.52 12.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.192 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 9.2 p -101.58 144.3 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 110.914 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -127.32 176.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.873 -178.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.5 ' N ' HG13 ' A' ' 91' ' ' VAL . 2.5 pt-20 -95.92 145.57 25.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.909 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 172' ' ' TRP . 13.6 m -146.0 166.91 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.87 0.367 . . . . 0.0 111.274 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -93.61 20.65 7.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.307 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 94' ' ' PHE . 9.9 mt-10 -167.2 150.05 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.031 0.443 . . . . 0.0 110.906 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 96.3 p -125.32 20.61 8.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.16 74.19 1.02 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.785 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -164.56 117.6 0.76 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.444 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.642 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -56.9 -26.76 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -27.98 36.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.416 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 58.4 t -62.11 -48.3 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.779 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.1 m -60.57 -37.63 81.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.633 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.43 -42.31 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.0 pt-20 -79.45 -35.53 40.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.503 ' O ' HD22 ' A' ' 109' ' ' LEU . . . -55.44 -53.22 58.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.453 ' CD1' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -47.18 -46.2 23.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -42.68 86.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 104' ' ' GLU . 25.2 t -57.66 -47.52 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.808 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.572 HD13 ' HG3' ' A' ' 114' ' ' ARG . 2.7 mm? -53.15 -23.31 7.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.92 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -59.99 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.408 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 1.3 pp0? -53.15 -31.18 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -85.04 -171.96 3.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.955 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 25.44 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.572 ' HG3' HD13 ' A' ' 109' ' ' LEU . 8.5 mmt180 -65.04 76.53 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.41 135.07 5.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.508 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.708 ' HB3' HD23 ' A' ' 88' ' ' LEU . 92.8 Cg_endo -82.4 164.93 16.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.574 2.183 . . . . 0.0 112.068 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.936 HG12 ' CB ' ' A' ' 87' ' ' TYR . 1.5 p -114.56 176.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.014 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.58 ' H ' HG22 ' A' ' 117' ' ' VAL . 3.0 ttt180 -152.65 89.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.455 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -149.59 -137.73 2.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.846 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -122.75 121.72 36.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.646 0.26 . . . . 0.0 111.219 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.636 ' HB2' HG21 ' A' ' 85' ' ' VAL . 8.6 tp -87.61 104.21 16.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.437 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -74.22 110.75 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.717 ' CG1' ' HB2' ' A' ' 194' ' ' ALA . 68.3 t -114.04 105.75 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.2 p -118.17 16.13 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.739 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 62.09 11.49 32.39 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.964 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -149.33 16.13 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.698 0.249 . . . . 0.0 111.282 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 161.06 96.88 0.11 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.812 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.867 HD13 ' CE2' ' A' ' 162' ' ' TYR . 1.6 mt -77.03 111.7 12.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.695 0.283 . . . . 0.0 110.501 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.35 86.76 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.312 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 139' ' ' ILE . 6.2 p -77.93 100.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.602 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 132' ' ' ASP . 65.2 t -99.72 154.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.562 ' OD2' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -91.85 139.49 30.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.425 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 38.7 t70 -87.82 14.33 8.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.524 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.4 OUTLIER -111.44 -30.62 7.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.05 0.452 . . . . 0.0 110.526 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.435 ' N ' ' HG3' ' A' ' 134' ' ' GLU . 67.0 p -139.12 8.64 2.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.512 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER 42.02 44.15 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.484 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.12 143.61 15.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.096 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.43 112.06 12.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.87 0.367 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.799 HD11 HG21 ' A' ' 117' ' ' VAL . 10.2 mt -81.18 -51.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.438 ' HB ' HG12 ' A' ' 130' ' ' VAL . 58.8 t -120.12 101.29 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -95.54 90.85 5.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.178 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 147' ' ' VAL . 19.2 mt-30 -142.13 161.36 38.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.65 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.702 ' O ' HG22 ' A' ' 144' ' ' ILE . 2.0 t -100.21 5.54 44.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 143' ' ' THR . 2.1 tt 84.66 -39.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.122 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -86.45 -25.16 25.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.918 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -78.59 -18.43 54.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.257 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.957 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -79.08 -177.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.607 ' HB3' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -98.01 22.3 9.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.38 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.436 ' CB ' ' O ' ' A' ' 148' ' ' SER . 18.5 m-85 85.62 -171.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 20.4 p -134.4 168.05 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.733 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.642 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -175.49 110.44 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 25.8 Cg_endo -62.14 158.95 36.81 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.462 2.108 . . . . 0.0 112.919 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 26.6 t0 -95.9 53.56 1.41 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.036 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER 88.65 93.66 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.985 -178.238 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -52.66 -20.85 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.368 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 -23.49 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.685 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -109.92 1.14 18.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.466 -0.493 . . . . 0.0 112.214 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 70.33 50.96 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.702 0.287 . . . . 0.0 111.073 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.06 129.5 5.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.799 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 177' ' ' PHE . 0.5 OUTLIER -104.77 -174.53 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 110.591 178.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER 179.68 126.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 111.426 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.867 ' CE2' HD13 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -97.77 -173.78 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.61 179.099 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.957 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -159.07 133.36 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.622 ' HB2' HG13 ' A' ' 147' ' ' VAL . 35.4 t -131.5 152.45 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.009 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.89 96.93 5.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.03 -166.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.719 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.76 -86.74 1.2 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.68 29.73 6.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.683 0.277 . . . . 0.0 110.883 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 -84.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 173' ' ' MET . 9.3 ptm180 -179.21 -47.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -150.45 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.99 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.623 ' O ' HG22 ' A' ' 93' ' ' VAL . 5.7 m95 -68.31 72.86 0.21 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.468 ' HE3' ' O ' ' A' ' 91' ' ' VAL . 75.3 mmm -89.23 118.02 28.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.293 0.568 . . . . 0.0 111.772 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 161.64 26.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.135 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -133.64 109.52 9.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.42 125.8 7.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 1.7 p90 -144.5 144.6 31.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.642 HD12 ' OD2' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -110.34 140.51 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.841 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 182' ' ' ASP . . . -62.51 140.47 58.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.149 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.39 -62.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -74.8 -26.7 59.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.642 ' OD2' HD12 ' A' ' 178' ' ' LEU . 0.3 OUTLIER 62.48 81.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.088 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.52 33.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.447 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 46.15 39.66 9.58 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.594 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.84 4.58 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.574 ' CB ' HD13 ' A' ' 187' ' ' LEU . 14.1 mmt180 -114.76 -64.51 1.3 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.81 0.338 . . . . 0.0 110.743 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.844 HD12 HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -143.37 15.77 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.652 178.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.476 ' O ' ' CE1' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -96.38 -34.26 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 178.282 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.39 -21.42 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.52 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.18 -58.76 3.08 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 123' ' ' VAL . 33.2 t -49.73 -49.75 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.106 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.38 -33.89 12.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.354 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 2.9 t -76.41 -28.56 56.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.544 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.739 ' HB1' ' HA2' ' A' ' 125' ' ' GLY . . . -57.92 -47.02 84.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.787 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -53.56 -26.63 22.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.37 -29.07 9.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 76' ' ' VAL . 86.5 t -84.97 -31.32 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.505 ' HB3' HD23 ' A' ' 199' ' ' LEU . 11.5 t -53.94 -48.0 70.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.325 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 198' ' ' CYS . 0.1 OUTLIER -95.65 -24.5 16.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER 53.57 120.76 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.287 0.565 . . . . 0.0 111.733 179.077 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER 78.07 25.39 0.63 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.905 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 204' ' ' ARG . 8.8 mmmt 49.85 44.31 25.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.231 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -66.49 70.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.78 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.949 ' HG3' HD21 ' B' ' 7' ' ' LEU . 0.2 OUTLIER -66.3 112.47 4.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.191 -179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.505 ' H ' HD13 ' B' ' 7' ' ' LEU . 0.0 OUTLIER -77.11 106.01 8.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.977 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 33.7 p -154.4 64.82 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -57.23 10.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.057 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 60.77 82.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.039 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.27 79.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.002 -0.999 . . . . 0.0 111.082 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.742 ' HB3' ' CG ' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.47 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -130.65 -82.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.928 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.839 HG23 HD11 ' B' ' 7' ' ' LEU . 3.7 mp -132.23 -58.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' B' ' 5' ' ' PRO . . . -45.59 -50.48 10.81 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.742 ' CG ' ' HB3' ' B' ' 1' ' ' ALA . 52.5 Cg_endo -88.02 -28.83 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.332 2.688 . . . . 0.0 112.732 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.949 HD21 ' HG3' ' A' ' 204' ' ' ARG . 11.8 mt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.357 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.403 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.92 0.39 . . . . 0.0 110.5 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -66.47 -29.29 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.17 -56.65 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 1.5 p30 -58.5 -36.88 74.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.958 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 17.4 tt0 -60.19 -27.22 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.489 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 -30.5 14.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.863 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.757 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -52.21 -50.72 61.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' O ' HG21 ' A' ' 197' ' ' VAL . 59.3 t -58.26 -38.75 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.422 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -39.9 70.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.561 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.78 1.41 55.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 124' ' ' SER . . . 65.92 78.51 0.27 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.829 0.347 . . . . 0.0 111.081 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 79' ' ' ALA . 2.9 t 176.19 60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -118.2 -172.75 2.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.912 ' HB3' HD21 ' A' ' 120' ' ' LEU . 2.1 m 174.16 153.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.997 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.489 ' C ' HD12 ' A' ' 120' ' ' LEU . 32.4 m-85 -162.1 139.78 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.686 ' N ' HD12 ' A' ' 120' ' ' LEU . 23.3 t -60.76 157.23 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.735 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.887 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.1 p 178.67 160.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.987 0.422 . . . . 0.0 111.915 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.551 ' N ' HG22 ' A' ' 85' ' ' VAL . 1.7 mttp -111.31 71.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.636 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.607 ' CB ' HG21 ' A' ' 130' ' ' VAL . 41.4 t80 -55.02 107.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.996 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.923 HD23 ' HB3' ' A' ' 109' ' ' LEU . 6.9 mp -48.5 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA2' ' CE1' ' A' ' 87' ' ' TYR . . . 176.18 -133.32 2.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.419 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.95 151.14 38.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.954 0.407 . . . . 0.0 111.002 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 109' ' ' LEU . 6.7 m -139.55 167.05 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.832 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.14 142.6 27.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 172' ' ' TRP . 2.1 m -145.49 173.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.223 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -116.26 25.56 10.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' HG21 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -144.84 -74.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.253 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m 59.45 19.48 7.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.24 66.54 1.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.59 -161.03 27.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.344 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.496 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -119.57 -36.26 3.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 111.06 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -61.58 -25.9 67.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.405 HG21 ' CB ' ' A' ' 95' ' ' GLU . 15.8 t -76.06 -30.44 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.31 -38.75 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.2 -37.72 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.5 pt-20 -88.31 -34.8 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -54.31 -51.31 65.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -45.52 62.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.595 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -39.12 73.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.399 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 104' ' ' GLU . 6.3 t -65.66 -39.65 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.757 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.923 ' HB3' HD23 ' A' ' 88' ' ' LEU . 1.5 mm? -55.64 -26.26 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -86.21 -61.29 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.044 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -48.4 -33.44 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.034 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -165.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.41 42.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.44 ' HG3' HD13 ' A' ' 109' ' ' LEU . 1.7 mmp_? -93.1 70.39 4.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.825 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 133.84 19.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HB3' HD12 ' A' ' 88' ' ' LEU . 71.7 Cg_endo -79.37 141.49 16.01 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.476 2.117 . . . . 0.0 112.63 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.683 HG11 HD11 ' A' ' 139' ' ' ILE . 12.0 m -78.35 173.99 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.37 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -135.95 72.9 1.44 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.246 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -141.17 -130.4 2.58 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.852 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.912 HD21 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -145.25 140.94 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.878 0.37 . . . . 0.0 111.433 -178.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -85.68 116.22 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -81.05 84.25 6.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.968 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 191' ' ' VAL . 38.0 t -94.89 125.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.506 ' O ' ' HB1' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -142.82 44.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.499 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 41.35 51.91 4.42 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.949 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.786 ' O ' HG22 ' A' ' 144' ' ' ILE . 20.9 t70 -164.94 -40.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.673 0.273 . . . . 0.0 111.072 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.433 ' HA2' ' N ' ' A' ' 144' ' ' ILE . . . -176.52 118.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.459 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.802 HD11 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.6 115.81 6.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.736 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -117.99 78.94 1.3 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.607 HG21 ' CB ' ' A' ' 87' ' ' TYR . 5.8 p -68.14 132.79 32.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.081 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.31 139.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -75.95 163.05 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.415 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 48.6 t0 -103.17 15.68 28.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.327 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.03 -60.26 1.82 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.883 0.373 . . . . 0.0 110.579 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 42.9 p -82.01 -27.91 32.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.7 48.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -126.54 142.38 13.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.1 tp -69.45 132.63 46.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.745 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.683 HD11 HG11 ' A' ' 117' ' ' VAL . 8.8 mt -100.63 -53.26 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.395 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 130' ' ' VAL . 13.9 t -111.48 67.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.21 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.459 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.6 p-10 -72.97 67.59 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.51 152.57 48.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 145' ' ' GLU . 64.5 m -78.71 145.06 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.69 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.802 HD12 HD11 ' A' ' 128' ' ' LEU . 7.0 tt -71.89 -30.71 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.897 0.38 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.631 ' H ' HG22 ' A' ' 143' ' ' THR . 8.6 tt0 -75.5 -28.94 59.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.283 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.1 mttm -90.91 -39.23 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.368 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 148' ' ' SER . 9.9 p -58.9 163.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.038 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.516 ' N ' HG22 ' A' ' 147' ' ' VAL . 12.9 t -76.06 1.95 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' HA ' ' CE1' ' A' ' 195' ' ' PHE . 1.4 m-85 80.86 174.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.044 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.459 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 2.9 t -108.92 164.99 11.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -155.17 97.67 2.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.404 ' HG2' ' OH ' ' B' ' 2' ' ' TYR . 53.2 Cg_exo . . . . . 0 C--N 1.345 0.352 0 C-N-CA 122.256 1.971 . . . . 0.0 111.789 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 178' ' ' LEU . 2.6 mmp_? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.704 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -109.87 144.97 16.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.39 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 3.5 m-85 -143.97 178.26 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.607 0.241 . . . . 0.0 110.852 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.409 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 1.8 m -172.26 134.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 111.554 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.577 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 98.2 m-85 -94.55 -174.31 3.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.486 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -165.99 137.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.607 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.72 125.69 24.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.0 OUTLIER -76.89 87.48 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.046 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 168' ' ' THR . 23.1 t0 50.84 -90.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.234 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 165' ' ' ARG . . . 59.47 -82.35 0.01 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -140.96 25.15 2.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.481 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.681 HG22 ' SD ' ' A' ' 173' ' ' MET . 4.2 m -122.25 23.62 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.488 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 169' ' ' THR . 12.3 mtp180 86.74 -72.29 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.487 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -146.6 -164.33 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 0.0 111.02 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.423 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 m95 -56.01 90.17 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.681 ' SD ' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -98.07 110.74 23.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.828 -177.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.495 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 0.6 OUTLIER -82.03 148.19 28.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.735 177.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 173' ' ' MET . 24.6 m-70 -128.66 158.58 38.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.857 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.409 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -144.63 138.53 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.845 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.577 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -153.98 115.06 4.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.178 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.704 HD22 ' HA2' ' A' ' 159' ' ' GLY . 0.1 OUTLIER -90.25 122.33 33.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.821 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -46.1 135.44 7.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -67.08 0.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -33.3 65.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.343 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' CD1' ' A' ' 178' ' ' LEU . 1.4 m-20 63.27 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.268 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.22 28.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.863 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.43 29.22 0.22 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.23 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 186' ' ' ARG . 18.0 mt-10 -138.61 47.7 1.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.027 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.5 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -159.63 -42.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.887 HD21 ' HB ' ' A' ' 85' ' ' VAL . 5.9 mp -114.65 -37.65 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 t -56.95 -59.95 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -75.58 -26.46 57.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -67.26 -66.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 187' ' ' LEU . 1.5 t -70.66 -29.45 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -53.12 -28.79 34.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.218 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 47.5 t -95.86 -22.61 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.302 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.501 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -47.42 -38.61 13.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 199' ' ' LEU . 61.5 m-85 -79.07 -26.99 43.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -47.16 -43.87 21.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.127 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 76' ' ' VAL . 54.2 t -67.05 -30.06 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.738 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.8 t -66.9 -58.87 4.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.779 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.943 HD21 HG21 ' B' ' 3' ' ' ILE . 2.1 pt? -117.54 51.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.547 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.423 ' CA ' ' O ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.721 0.296 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -163.34 -89.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.129 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.943 HG21 HD21 ' A' ' 199' ' ' LEU . 2.6 mm -109.17 -52.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.35 -74.97 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.473 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 CA--C 1.53 0.299 0 C-N-CA 123.159 2.573 . . . . 0.0 113.34 -179.042 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.711 0.291 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.92 -34.74 78.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.52 -51.42 8.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.991 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -58.71 -42.46 88.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.34 -36.91 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.691 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -86.11 -29.79 23.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.708 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -53.55 -57.59 10.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.793 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.741 HG21 ' SG ' ' A' ' 193' ' ' CYS . 0.3 OUTLIER -49.4 -38.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -49.65 74.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.448 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.4 20.64 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 49.21 90.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t 179.5 44.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -112.62 162.27 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.769 ' OG ' HD22 ' A' ' 120' ' ' LEU . 32.4 t -172.64 154.0 2.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.526 ' CB ' HD11 ' A' ' 187' ' ' LEU . 91.2 m-85 -160.34 141.1 11.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -58.14 151.07 19.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.112 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.986 HG22 HD21 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -152.18 171.81 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 112.115 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.578 ' H ' HG12 ' A' ' 85' ' ' VAL . 1.3 mttm -128.11 40.11 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.966 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.523 ' CD1' ' HB3' ' A' ' 177' ' ' PHE . 6.0 t80 -44.57 123.91 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.608 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.63 HD23 ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.55 -60.31 2.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . 159.31 -160.28 31.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.393 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.21 146.49 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.059 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.622 HG22 HD21 ' A' ' 109' ' ' LEU . 2.8 m -133.78 135.47 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.12 120.66 18.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 172' ' ' TRP . 10.7 m -120.96 177.27 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.086 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.22 -22.92 18.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.194 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HB2' HG21 ' A' ' 101' ' ' VAL . 19.5 mp0 -123.61 153.52 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.1 p -133.25 21.78 4.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.009 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.3 23.9 1.03 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.67 131.97 9.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.607 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -51.69 60.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.36 -26.75 8.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 95' ' ' GLU . 47.1 t -65.49 -33.13 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -72.98 -41.39 64.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.68 -33.7 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.576 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.6 pt-20 -87.64 -40.34 14.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -57.39 -58.88 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.61 HD13 ' C ' ' A' ' 106' ' ' LEU . 2.4 tm? -46.36 -40.56 12.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.899 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -64.55 -45.52 86.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 178.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.1 t -63.92 -30.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.883 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.63 ' HB3' HD23 ' A' ' 88' ' ' LEU . 3.5 mm? -59.04 -23.67 62.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.512 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -93.38 -36.23 12.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -72.97 -21.73 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.306 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.26 172.0 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -53.67 -22.73 9.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HG3' HD13 ' A' ' 109' ' ' LEU . 7.4 mmp_? -46.05 92.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -94.96 150.42 37.74 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.416 ' HB3' ' HB3' ' A' ' 86' ' ' LYS . 52.7 Cg_exo -53.23 166.26 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.767 2.311 . . . . 0.0 112.466 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 139' ' ' ILE . 7.0 p -137.9 119.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.356 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -80.85 97.91 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.46 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.69 -169.08 18.96 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.769 HD22 ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -109.87 124.43 51.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.388 . . . . 0.0 111.122 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.731 ' HG ' HG23 ' A' ' 123' ' ' VAL . 6.9 tp -88.88 99.32 12.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.882 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.05 96.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.408 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.731 HG23 ' HG ' ' A' ' 121' ' ' LEU . 95.1 t -102.73 117.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.512 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -136.86 28.99 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.116 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 49.69 24.41 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.759 ' O ' HG22 ' A' ' 144' ' ' ILE . 12.3 t70 -133.92 -44.3 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.27 116.69 0.71 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.71 HD13 ' CE2' ' A' ' 162' ' ' TYR . 8.5 mt -71.57 133.98 46.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -141.49 98.08 3.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 139' ' ' ILE . 4.8 p -89.21 104.47 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 136' ' ' LYS . 14.3 t -107.07 132.62 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.076 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 136' ' ' LYS . 41.3 t0 -70.17 133.28 46.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -79.08 -6.59 56.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -97.57 -24.49 15.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.9 p -123.61 -35.17 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.539 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.1 OUTLIER 75.54 25.25 1.24 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.54 123.83 8.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.262 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.5 tp -50.81 131.52 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.991 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.696 ' HB ' HG13 ' A' ' 130' ' ' VAL . 9.6 mt -105.11 -54.13 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.269 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 140' ' ' VAL . 59.7 t -111.11 65.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.464 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 35.7 p-10 -68.16 66.92 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 140' ' ' VAL . 19.2 mt-30 -138.34 134.59 34.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -54.19 -176.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 126' ' ' ASP . 18.1 tt -108.76 -15.83 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.767 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -99.6 -26.99 13.9 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.0 OUTLIER -110.24 -171.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.289 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.39 14.78 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.475 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HB3' ' HA2' ' B' ' 4' ' ' GLY . 2.5 m-85 73.66 149.56 0.1 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.874 0.369 . . . . 0.0 110.988 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 24.6 p -72.36 -178.56 2.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 171.75 80.83 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.79 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 10.7 Cg_endo . . . . . 0 C--N 1.344 0.31 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.453 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.739 0.304 . . . . 0.0 111.181 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 178' ' ' LEU . . . -126.63 141.18 12.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.899 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.527 ' CE1' ' CB ' ' A' ' 188' ' ' SER . 4.9 m-85 -118.34 -174.27 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.9 m -166.07 134.81 3.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.528 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.71 ' CE2' HD13 ' A' ' 128' ' ' LEU . 7.5 m-30 -102.34 175.28 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.286 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.891 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -159.21 150.96 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.964 0.411 . . . . 0.0 111.425 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.3 166.3 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.539 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.82 79.18 1.54 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.132 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 46.62 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.183 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.03 -34.17 6.0 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.107 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 94.7 m -150.75 -44.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -72.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.92 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -178.21 -79.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.629 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 173' ' ' MET . 1.6 ptp180 -131.81 -153.47 0.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.91 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.607 ' O ' HG22 ' A' ' 93' ' ' VAL . 11.5 m95 -62.83 80.09 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 171' ' ' ARG . 1.2 mmt -85.36 121.57 28.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.74 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.32 156.94 16.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.749 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.68 105.61 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.749 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.96 104.83 2.89 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.468 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.601 ' HD2' HG11 ' A' ' 85' ' ' VAL . 3.3 p90 -121.16 132.64 54.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.415 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.669 ' O ' HG12 ' A' ' 85' ' ' VAL . 10.6 tp -102.26 147.24 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.688 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -68.22 140.09 56.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.175 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.424 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 35.8 t -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.753 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -36.24 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.9 66.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.453 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 2.6 p -148.98 16.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.733 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 43.33 34.71 2.43 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.861 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -144.82 50.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.475 ' C ' HD12 ' A' ' 187' ' ' LEU . 33.0 mtt-85 -168.8 -42.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.74 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.986 HD21 HG22 ' A' ' 85' ' ' VAL . 9.8 mp -113.32 -42.44 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.527 ' CB ' ' CE1' ' A' ' 160' ' ' PHE . 23.2 p -53.36 -65.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -66.91 -25.44 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -69.44 -60.03 2.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 187' ' ' LEU . 17.6 t -61.21 -40.5 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.881 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.73 -41.56 95.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.141 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.741 ' SG ' HG21 ' A' ' 76' ' ' VAL . 14.0 p -73.89 -34.0 64.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 110.332 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.437 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -56.41 -44.82 80.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -51.05 -26.29 6.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.72 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.57 -32.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.621 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.474 ' HB3' HD23 ' A' ' 199' ' ' LEU . 46.6 t -49.85 -36.17 25.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.548 HD11 HG12 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -118.91 -36.37 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.451 178.222 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.415 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.803 0.335 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.46 -97.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.548 HG12 HD11 ' A' ' 199' ' ' LEU . 2.7 mp -112.63 -29.85 2.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 149' ' ' PHE . . . -55.74 -85.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.541 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 49.1 Cg_exo . . . . . 0 N--CA 1.464 -0.236 0 C-N-CA 122.467 2.112 . . . . 0.0 110.826 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.933 0.397 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -68.99 -33.4 73.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.632 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.02 -63.13 1.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.084 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.47 -47.53 57.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -29.77 11.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.4 -24.69 15.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 81' ' ' CYS . . . -59.17 -64.82 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.76 HG21 ' HB3' ' A' ' 193' ' ' CYS . 2.3 m -50.03 -32.68 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -59.66 -52.55 65.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.463 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 23.44 5.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.833 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 48.65 85.27 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -176.64 34.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.325 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.505 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 4.6 t -98.75 156.28 16.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.053 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' HD22 ' A' ' 120' ' ' LEU . 2.6 t -174.8 152.02 1.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.763 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.486 ' CG ' ' HB3' ' A' ' 186' ' ' ARG . 72.3 m-85 -162.18 147.68 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 44.6 t -55.31 151.88 9.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.905 HG22 HD21 ' A' ' 187' ' ' LEU . 1.6 t -152.68 168.35 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.107 0.48 . . . . 0.0 111.618 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.521 ' H ' HG12 ' A' ' 85' ' ' VAL . 2.5 mttt -128.11 48.2 2.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.929 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.641 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.4 t80 -39.57 114.98 0.46 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.871 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 116' ' ' PRO . 54.9 mt -66.89 -26.93 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.651 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 126.01 -152.91 18.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.222 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 2.8 m -126.95 150.45 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.014 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.576 HG13 HD13 ' A' ' 109' ' ' LEU . 13.8 m -133.87 134.91 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.33 133.06 46.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.728 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.727 HG22 ' O ' ' A' ' 172' ' ' TRP . 23.9 m -138.64 169.4 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 111.361 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.5 16.0 16.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -157.34 119.46 3.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 1.7 p -95.83 24.18 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -165.16 123.43 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.751 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 148.72 113.07 0.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -49.71 -36.61 25.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.087 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.22 -41.28 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.35 -33.68 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.081 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -70.36 -39.04 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.05 -32.56 68.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.8 pt-20 -93.79 -36.51 12.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -50.11 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.895 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -50.09 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.686 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -44.06 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.01 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.5 t -65.68 -34.38 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.717 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.651 HD11 ' C ' ' A' ' 89' ' ' GLY . 1.1 mm? -52.03 -28.49 17.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 0.0 110.196 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.0 -27.84 18.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.561 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.72 20.43 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.174 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -120.6 147.63 44.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.69 4.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.64 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HG3' ' HB3' ' A' ' 112' ' ' SER . 0.0 OUTLIER -45.28 171.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.366 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -138.62 151.74 69.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.037 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.732 ' HB3' HD23 ' A' ' 88' ' ' LEU . 89.1 Cg_endo -80.2 -179.9 5.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.636 2.224 . . . . 0.0 112.392 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -141.26 -173.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.616 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.617 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -166.6 96.24 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -158.7 -131.44 1.27 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.771 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.533 HD22 ' OG ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -124.72 129.75 51.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.075 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.622 HD12 ' CE1' ' A' ' 177' ' ' PHE . 10.5 tt -100.88 113.02 25.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.187 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -76.95 111.57 12.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.911 ' CG1' ' HB2' ' A' ' 194' ' ' ALA . 82.1 t -110.78 96.74 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.32 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.443 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -111.79 27.58 9.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.378 . . . . 0.0 111.292 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.77 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 47.62 26.37 3.83 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.274 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.813 ' O ' HG22 ' A' ' 144' ' ' ILE . 24.5 t0 -140.15 -42.91 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.946 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -158.4 119.53 0.9 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.524 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -73.64 123.64 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.42 ' HD2' HD21 ' A' ' 138' ' ' LEU . 5.4 mmm-85 -135.31 100.91 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 139' ' ' ILE . 9.2 p -90.59 128.39 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.47 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 132' ' ' ASP . 54.6 t -116.1 154.87 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.693 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 131' ' ' VAL . 54.5 t0 -102.79 135.72 43.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.5 -0.41 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.714 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -103.48 -31.16 10.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.867 0.365 . . . . 0.0 110.996 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 p -116.64 -29.09 6.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 66.93 29.62 8.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 131' ' ' VAL . . . -95.54 -128.89 5.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.595 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 7.5 tp -156.97 134.63 10.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.773 0.32 . . . . 0.0 110.796 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 117' ' ' VAL . 4.3 mt -108.07 -54.85 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 130' ' ' VAL . 7.6 t -109.09 71.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 111.24 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.455 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 14.9 p-10 -78.58 59.91 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.12 163.11 25.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.389 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.7 m -78.02 174.14 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.713 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 126' ' ' ASP . 4.1 tt -97.64 -21.29 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -91.05 -39.52 12.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.835 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -72.66 -29.23 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 148' ' ' SER . 8.3 p -74.82 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.804 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.541 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -72.55 -0.86 13.95 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.6 m-85 79.11 179.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 25.5 p -98.94 177.34 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HA ' ' HG3' ' B' ' 5' ' ' PRO . . . -171.24 101.01 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.081 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.368 2.045 . . . . 0.0 111.977 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.845 0.355 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.18 106.31 1.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 0.1 OUTLIER -96.41 -177.22 3.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.439 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.83 122.72 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.948 0.404 . . . . 0.0 111.301 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.572 ' OH ' HG11 ' A' ' 191' ' ' VAL . 1.8 m-30 -95.73 -160.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.495 ' O ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -169.89 148.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -135.72 163.32 30.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -129.06 81.07 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 167' ' ' GLY . 2.0 p30 46.55 -161.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 166' ' ' ASP . . . 95.45 -57.08 1.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.137 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.39 19.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 170' ' ' ARG . 49.4 m -137.67 -86.03 0.29 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.673 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 169' ' ' THR . 4.9 mtt180 -164.08 -82.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.906 0.384 . . . . 0.0 111.008 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.6 ptp180 -138.12 -150.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.129 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.727 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.1 m95 -68.6 67.78 0.14 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.416 ' HE3' ' C ' ' A' ' 91' ' ' VAL . 20.4 mmm -89.73 119.97 30.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.39 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HB2' HG23 ' A' ' 91' ' ' VAL . 6.9 m -76.77 166.21 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.753 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 174' ' ' CYS . 17.0 m-70 -138.43 93.09 2.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.407 ' HA3' ' HG ' ' A' ' 109' ' ' LEU . . . -75.89 118.74 5.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.602 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.622 ' CE1' HD12 ' A' ' 121' ' ' LEU . 4.2 m-85 -114.75 108.21 16.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 178' ' ' LEU . 10.7 mt -88.88 98.52 11.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.46 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.859 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -47.18 135.98 9.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.443 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.0 t -54.15 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -55.81 -29.93 60.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.382 . . . . 0.0 110.589 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.93 67.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.116 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.77 21.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.349 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 188' ' ' SER . . . 40.96 34.42 0.8 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.337 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.3 -6.64 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.777 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -124.66 -10.82 7.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.905 HD21 HG22 ' A' ' 85' ' ' VAL . 7.9 mp -136.04 -46.54 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.499 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 14.9 t -61.11 -52.01 66.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.75 -30.19 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -76.75 -69.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 187' ' ' LEU . 21.4 t -48.97 -48.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -61.1 -26.93 66.49 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.802 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.76 ' HB3' HG21 ' A' ' 76' ' ' VAL . 1.2 m -78.31 -33.0 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.46 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.911 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -51.46 -44.3 62.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CE2' ' CG1' ' A' ' 144' ' ' ILE . 93.8 m-85 -58.62 -22.44 56.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -47.48 -48.53 26.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.011 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 194' ' ' ALA . 2.4 m -73.58 -35.79 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.146 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 35.4 t -44.07 -45.03 7.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.178 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.431 HD22 HG21 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -105.18 -29.8 10.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.471 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.506 179.149 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.696 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.71 80.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.568 ' N ' HD13 ' B' ' 3' ' ' ILE . 1.6 mm 70.43 -64.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.64 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.58 -79.07 0.07 OUTLIER Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.816 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.696 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 38.2 Cg_exo . . . . . 0 C--N 1.342 0.218 0 C-N-CA 122.771 2.314 . . . . 0.0 111.943 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 121.189 0.519 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 7.0 pt20 -48.06 -36.52 13.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.088 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -82.77 -58.5 2.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.434 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -46.88 -29.73 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.45 -40.77 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.29 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -93.98 -14.37 25.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 178.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -60.21 -41.72 93.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 194' ' ' ALA . 46.1 t -65.49 -49.55 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.514 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 19.9 mtm-85 -50.49 -53.47 29.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.733 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.28 -0.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.516 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 64.77 80.58 0.23 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.706 0.289 . . . . 0.0 111.07 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 t -179.32 44.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -106.9 163.51 12.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.739 0.304 . . . . 0.0 110.757 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.56 146.18 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.512 ' C ' HD23 ' A' ' 120' ' ' LEU . 81.2 m-85 -157.43 129.42 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -52.38 159.1 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.524 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.846 ' HB ' HD21 ' A' ' 187' ' ' LEU . 13.0 p -172.92 160.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 111.691 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.522 ' N ' HG22 ' A' ' 85' ' ' VAL . 7.3 mmtt -108.02 65.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.735 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.557 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -60.36 126.05 26.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.414 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 88' ' ' LEU . 6.2 mp -77.92 -31.58 51.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.586 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.79 -164.13 15.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.254 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.426 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 20.2 m -105.19 147.59 27.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.992 0.425 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 174' ' ' CYS . 0.4 OUTLIER -126.68 171.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.045 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 1.6 pt-20 -90.63 140.8 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 92' ' ' GLU . 34.3 m -158.41 179.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.839 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.07 18.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.46 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HB2' HG21 ' A' ' 101' ' ' VAL . 58.0 mp0 -152.72 112.99 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.414 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.469 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -106.67 25.11 11.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.901 177.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.64 33.66 2.23 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.982 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.27 106.82 0.56 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -25.69 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 110.871 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -76.31 -26.26 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.859 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 95' ' ' GLU . 23.6 t -67.44 -39.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.967 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.3 m -72.15 -48.09 46.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.345 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -52.95 -38.24 61.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.349 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.5 pt-20 -85.83 -42.13 14.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.768 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 101' ' ' VAL . . . -49.78 -48.12 50.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 160' ' ' PHE . 6.5 tt -50.87 -46.12 60.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -40.83 90.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.062 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' SER . 41.3 t -61.77 -31.19 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.058 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.606 HD13 ' HG3' ' A' ' 114' ' ' ARG . 3.2 mm? -67.54 -21.46 65.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -89.11 -50.38 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -24.08 64.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 96.2 p -79.17 170.82 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.27 -22.55 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.417 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.606 ' HG3' HD13 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -46.36 159.61 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.107 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -150.09 153.49 35.48 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.82 0.343 . . . . 0.0 111.418 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.5 Cg_exo -60.53 163.2 15.85 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.801 2.334 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 117' ' ' VAL . 7.4 p -133.82 110.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -74.85 74.31 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.439 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 131' ' ' VAL . . . -134.48 -156.73 7.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -123.92 125.54 44.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 111.43 -178.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.473 ' HG ' HG23 ' A' ' 123' ' ' VAL . 42.8 tp -83.91 105.67 14.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.264 177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -76.84 98.44 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.424 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.934 HG21 HG22 ' A' ' 191' ' ' VAL . 97.0 t -101.96 108.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 48.1 p -125.85 40.57 3.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.116 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.451 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 40.58 35.56 0.87 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.211 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 144' ' ' ILE . 19.7 t0 -158.21 -40.5 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.551 0.215 . . . . 0.0 111.452 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -147.63 121.24 1.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.991 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.772 HD11 ' CG1' ' A' ' 191' ' ' VAL . 0.0 OUTLIER -83.56 91.37 7.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.817 0.341 . . . . 0.0 110.427 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.832 ' HB3' HD11 ' A' ' 138' ' ' LEU . 3.5 mtt85 -107.28 98.45 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 139' ' ' ILE . 4.4 p -90.11 106.26 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 132' ' ' ASP . 4.1 t -93.32 163.84 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 131' ' ' VAL . 46.1 t0 -109.96 136.8 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.43 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 118' ' ' ARG . 49.4 t0 -79.18 3.06 18.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.97 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -116.03 -32.42 5.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.7 p -115.91 -23.05 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.359 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.5 OUTLIER 62.14 18.37 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.129 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.67 125.42 8.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.062 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -59.05 126.4 27.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.664 ' HB ' HG13 ' A' ' 130' ' ' VAL . 6.0 mt -89.73 -24.07 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.706 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.409 HG23 ' CG1' ' A' ' 130' ' ' VAL . 3.5 t -144.09 63.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.444 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 9.4 p-10 -73.32 61.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.554 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -131.89 159.84 37.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 145' ' ' GLU . 91.5 m -75.88 143.17 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.712 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 126' ' ' ASP . 7.9 tt -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.72 ' H ' HG22 ' A' ' 143' ' ' THR . 4.3 tt0 -77.07 -30.19 55.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.707 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -76.44 -20.3 57.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.908 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.6 OUTLIER -78.07 169.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.61 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.438 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -83.92 8.8 13.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.85 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.411 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.9 m-85 78.97 139.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.238 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.511 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 29.4 p -74.38 -174.42 2.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.767 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.483 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . -166.23 55.5 0.36 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.691 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 151' ' ' ALA . 50.9 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 122.205 1.937 . . . . 0.0 111.374 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 183' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.838 0.352 . . . . 0.0 110.533 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.34 149.27 18.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.718 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.492 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 0.1 OUTLIER -139.83 172.82 12.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 40.7 t -165.25 134.93 3.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.592 ' CE2' HD23 ' A' ' 128' ' ' LEU . 2.7 m-30 -89.54 -165.28 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.502 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.908 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -164.77 158.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.392 . . . . 0.0 111.668 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 42.6 t -159.89 127.95 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.465 ' HG3' ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.71 87.61 7.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.103 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 45.3 -158.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.03 -71.67 0.26 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.109 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 168' ' ' THR . 26.1 m -130.3 17.19 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 0.0 111.084 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.603 HG22 ' SD ' ' A' ' 173' ' ' MET . 18.6 m -131.07 23.83 4.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 169' ' ' THR . 11.5 mmm180 84.95 -71.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.456 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 -158.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.985 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -65.77 94.67 0.22 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.603 ' SD ' HG22 ' A' ' 169' ' ' THR . 0.3 OUTLIER -110.61 158.37 18.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 111.702 -177.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.562 ' HB2' HG12 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -111.94 174.98 5.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.878 178.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -137.67 74.62 1.49 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.96 0.41 . . . . 0.0 110.774 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -76.55 129.22 9.76 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.92 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.529 ' CG ' ' CE2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -153.92 160.11 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.529 HD21 ' OD2' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -132.91 127.1 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.832 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.498 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -47.73 134.78 12.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.504 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -63.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -62.16 -29.27 70.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.556 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.529 ' OD2' HD21 ' A' ' 178' ' ' LEU . 0.3 OUTLIER 60.45 80.16 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.178 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.419 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -170.65 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.462 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.25 29.96 0.25 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.201 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.02 56.55 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -169.17 -41.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.987 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.846 HD21 ' HB ' ' A' ' 85' ' ' VAL . 6.5 mp -115.65 -45.56 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.688 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -49.37 67.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.807 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -82.75 -27.98 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.813 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -70.06 -57.6 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.883 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 123' ' ' VAL . 1.2 t -76.52 -26.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.69 -32.69 32.93 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.555 ' HB3' HG11 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -90.62 -20.76 22.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.648 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.661 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -46.58 -37.99 8.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.142 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -77.09 -23.59 51.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.005 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.71 -35.34 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.825 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.93 -30.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.621 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 50.2 t -51.75 -39.84 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.308 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.406 HD11 HD11 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -107.06 -26.89 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.474 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -177.15 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.494 ' H ' HD12 ' B' ' 3' ' ' ILE . 3.7 mp -45.14 -27.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.85 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.56 -82.66 0.03 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.968 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 32.9 Cg_exo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 123.026 2.484 . . . . 0.0 112.085 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 3.0 m0 . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.862 0.363 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -47.69 -33.39 6.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.25 -61.01 1.87 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.304 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -48.38 -32.14 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.186 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -61.99 -28.93 69.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -99.45 -29.26 12.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.859 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -48.26 -35.84 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.938 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -61.91 -34.27 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.004 0.43 . . . . 0.0 110.512 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.8 mtm180 -64.39 -56.49 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.23 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -68.6 -10.49 56.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.342 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 78' ' ' SER . . . 73.18 76.47 0.14 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.733 0.302 . . . . 0.0 111.055 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t -177.58 47.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.859 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -108.7 173.14 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.699 178.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 12.5 m -171.45 150.77 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 82' ' ' SER . 85.8 m-85 -161.56 136.91 7.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.834 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.73 163.8 1.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.947 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.4 p 178.88 155.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 111.512 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 85' ' ' VAL . 1.8 mtpp -109.93 62.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.332 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.639 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.4 t80 -47.26 111.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.487 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.937 HD23 ' CB ' ' A' ' 109' ' ' LEU . 3.5 mp -55.22 -44.08 75.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.567 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 132.67 -157.96 22.82 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.461 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 25.9 p -116.68 156.08 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.496 HG11 HD22 ' A' ' 109' ' ' LEU . 27.5 m -152.28 135.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.022 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 139.36 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.581 HG21 ' SG ' ' A' ' 174' ' ' CYS . 11.0 m -142.02 169.49 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.68 -24.15 27.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.617 ' O ' HG11 ' A' ' 101' ' ' VAL . 23.6 mm-40 -133.93 126.18 29.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.869 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.527 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -97.28 21.52 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.831 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.54 130.89 4.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.01 136.74 5.29 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.753 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 178.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 71.39 -61.63 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 110.355 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 95' ' ' GLU . 86.0 t -52.28 -44.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.292 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.9 p -63.26 -39.18 93.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.216 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -60.69 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.141 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.624 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.9 pt-20 -64.52 -38.54 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.052 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 174' ' ' CYS . . . -53.39 -24.77 13.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.088 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -45.24 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.17 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 5.5 pttt -57.12 -34.15 68.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 104' ' ' GLU . 41.1 t -59.98 -37.64 73.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.03 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.937 ' CB ' HD23 ' A' ' 88' ' ' LEU . 4.6 mm? -54.91 -25.99 32.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.938 0.399 . . . . 0.0 110.001 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.88 -51.56 4.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 6.0 mm-40 -49.5 -26.36 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.518 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 114' ' ' ARG . 0.3 OUTLIER -99.41 -163.36 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.729 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.38 26.22 6.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.286 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -78.18 81.46 4.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.735 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.433 ' HG3' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -73.48 130.13 84.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.247 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HD2' ' HG3' ' A' ' 115' ' ' ARG . 77.4 Cg_exo -50.96 169.94 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.224 1.949 . . . . 0.0 111.937 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 87' ' ' TYR . 9.8 p -132.95 114.48 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.414 . . . . 0.0 111.612 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -74.59 78.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.996 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -132.55 -158.52 8.93 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.332 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 120' ' ' LEU . 1.4 mt -116.91 131.98 56.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.362 . . . . 0.0 111.065 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.734 ' HG ' HG23 ' A' ' 123' ' ' VAL . 49.5 tp -91.42 102.54 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.446 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 1.1 t-80 -74.53 83.59 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.597 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.734 HG23 ' HG ' ' A' ' 121' ' ' LEU . 84.1 t -89.25 115.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.47 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.9 33.38 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 45.52 45.13 11.91 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.563 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.583 ' C ' HG22 ' A' ' 144' ' ' ILE . 2.0 t0 -168.15 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -157.84 115.16 0.65 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 162' ' ' TYR . 4.5 mt -81.05 78.39 7.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 122' ' ' HIS . 71.6 mtm-85 -85.03 107.8 17.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 139' ' ' ILE . 2.7 p -92.7 108.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 110.967 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.422 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 21.8 t -94.65 134.03 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.997 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.434 ' OD1' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -80.37 131.27 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.435 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 28.8 t0 -79.62 3.4 19.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.05 -24.74 14.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.75 0.309 . . . . 0.0 110.936 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 53.7 p -151.33 19.29 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.337 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.415 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER 44.58 28.54 0.33 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.985 0.421 . . . . 0.0 111.307 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.55 138.21 16.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.314 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.446 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 5.0 tp -86.7 124.28 32.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 117' ' ' VAL . 8.6 mt -95.37 -54.74 6.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.562 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.61 83.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 111.461 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.446 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 7.2 t0 -93.85 73.86 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.192 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -141.89 137.07 31.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.279 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.44 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 23.9 m -60.52 135.28 57.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.583 HG22 ' C ' ' A' ' 126' ' ' ASP . 19.3 tt -59.48 -34.19 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.696 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -73.81 -22.75 59.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.249 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -97.09 26.55 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.193 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.935 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -121.82 176.9 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.607 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 147' ' ' VAL . 2.5 t -90.09 17.36 7.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 73.83 -167.45 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.988 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 25.0 p -123.51 176.3 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -171.42 103.6 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 C--N 1.345 0.385 0 C-N-CA 122.4 2.066 . . . . 0.0 112.466 -179.174 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -81.21 114.73 3.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.109 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.795 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 8.9 m-85 -120.42 166.44 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.87 112.77 0.48 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 111.35 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.68 ' OH ' HG21 ' A' ' 191' ' ' VAL . 2.5 m-30 -88.58 -178.68 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.572 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.935 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -158.39 145.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.785 0.326 . . . . 0.0 111.324 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.449 ' HB3' HG13 ' A' ' 147' ' ' VAL . 17.0 p -135.09 148.59 49.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.565 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -106.85 83.17 1.8 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.587 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 43.91 -173.61 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.518 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.94 -55.95 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.962 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.64 25.52 3.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.451 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -76.33 0.36 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.97 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.45 -78.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -133.68 -153.67 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.944 179.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.572 ' O ' HG22 ' A' ' 93' ' ' VAL . 15.5 m95 -60.23 83.9 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.897 0.379 . . . . 0.0 109.992 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.6 OUTLIER -90.75 120.66 31.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.355 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.581 ' SG ' HG21 ' A' ' 93' ' ' VAL . 1.3 m -92.39 159.25 15.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.932 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -136.62 119.44 16.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.834 0.349 . . . . 0.0 111.309 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -92.8 110.89 3.99 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.951 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 162' ' ' TYR . 2.3 m-85 -108.42 119.51 39.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.116 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.7 108.28 16.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.795 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -51.99 141.01 18.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.314 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 31.5 t -63.37 -53.48 51.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.41 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.39 -22.12 63.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.748 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.65 71.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.974 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 p -166.53 27.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.792 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.72 26.67 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.925 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.68 54.33 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.656 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.1 tpt180 -175.72 -37.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.947 HD21 ' HB ' ' A' ' 85' ' ' VAL . 8.6 mp -120.52 -39.78 2.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.908 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 45.7 t -52.9 -55.72 21.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 193' ' ' CYS . 0.0 OUTLIER -76.03 -31.64 58.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.771 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -66.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.68 HG21 ' OH ' ' A' ' 162' ' ' TYR . 39.8 t -56.0 -54.63 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.36 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.39 31.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.478 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 4.7 t -67.98 -27.48 66.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.488 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -54.49 -41.49 69.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.622 ' O ' HD12 ' A' ' 199' ' ' LEU . 96.2 m-85 -63.37 -21.89 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.852 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -47.77 -28.3 2.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.27 -31.54 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.575 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -56.72 -41.36 77.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.137 178.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -99.1 -34.91 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 200' ' ' GLU . 30.1 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.779 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.594 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.796 0.331 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -176.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.361 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.487 ' H ' HD12 ' B' ' 3' ' ' ILE . 3.8 mp -46.19 -26.1 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.073 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.04 -85.61 0.02 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.918 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.594 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 32.0 Cg_exo . . . . . 0 N--CA 1.462 -0.341 0 C-N-CA 122.544 2.163 . . . . 0.0 110.112 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 m0 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.938 0.399 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 6.9 pt20 -49.64 -35.42 21.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.979 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -76.7 -67.88 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.368 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -46.96 -45.36 20.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.307 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -49.45 -37.2 24.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.822 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -86.54 -35.4 19.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.757 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.492 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -52.54 -59.67 4.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 193' ' ' CYS . 27.5 m -52.31 -36.82 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -48.07 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.422 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.06 17.65 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . 54.72 92.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.662 0.268 . . . . 0.0 111.313 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 t 174.43 46.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.29 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -121.01 152.27 38.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 1.8 m -157.7 144.48 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.922 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.729 ' CE2' HG21 ' A' ' 123' ' ' VAL . 3.5 p90 -146.83 172.14 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 111.247 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.08 154.49 23.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.828 ' HB ' HD21 ' A' ' 187' ' ' LEU . 11.4 p -174.2 160.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.738 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.545 ' N ' HG22 ' A' ' 85' ' ' VAL . 4.1 mmtt -117.24 75.65 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.655 ' CD1' HG21 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -56.69 115.56 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.402 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.829 HD13 ' HA ' ' A' ' 177' ' ' PHE . 7.7 mp -64.91 -37.54 87.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.58 -129.07 3.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.532 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.551 ' N ' HD11 ' A' ' 109' ' ' LEU . 3.7 p -171.02 124.12 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.506 HG13 HD13 ' A' ' 109' ' ' LEU . 26.8 m -116.61 129.68 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.365 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -57.47 155.55 9.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 172' ' ' TRP . 19.5 m -150.6 177.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.195 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -94.68 -11.17 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.44 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.82 136.25 46.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.823 0.344 . . . . 0.0 110.921 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.3 p -101.32 23.02 11.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.767 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.54 -167.97 2.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.02 109.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -28.38 8.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.42 -45.5 94.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.637 HG12 ' SG ' ' A' ' 174' ' ' CYS . 38.7 t -51.41 -32.56 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -42.9 59.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.761 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -45.35 74.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.43 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.3 pt-20 -75.96 -38.07 57.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -54.83 -45.04 74.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.472 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp -56.8 -42.42 79.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.3 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -42.47 95.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.344 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.4 t -66.26 -40.55 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.011 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.551 HD11 ' N ' ' A' ' 90' ' ' CYS . 1.5 mm? -52.08 -23.19 4.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.25 -50.23 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.536 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.434 ' CG ' ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.68 -22.48 66.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.553 -178.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -88.65 165.8 14.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.31 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -21.5 13.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -41.75 114.97 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.48 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 139.33 20.01 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.39 154.04 43.78 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.627 2.218 . . . . 0.0 112.789 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.945 HG21 HD11 ' A' ' 139' ' ' ILE . 3.4 p -110.97 170.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.55 ' H ' HG22 ' A' ' 117' ' ' VAL . 5.9 ttt85 -137.82 88.29 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.538 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.71 -150.94 5.53 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.739 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.648 HD23 ' C ' ' A' ' 83' ' ' PHE . 10.6 mt -123.04 151.22 42.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.487 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.532 ' CB ' ' CE1' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -99.04 106.88 19.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 129' ' ' ARG . 41.7 m-70 -71.57 63.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 194' ' ' ALA . 70.9 t -66.96 107.45 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.7 m -131.69 31.83 4.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.448 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 48.0 29.09 6.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.565 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.562 ' C ' HG22 ' A' ' 144' ' ' ILE . 24.0 t0 -140.97 -43.25 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -159.39 122.18 1.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.977 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.742 ' CD1' HD12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -73.04 82.98 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.76 0.314 . . . . 0.0 110.558 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 48.0 mtt85 -95.73 81.71 3.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.313 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 87' ' ' TYR . 2.0 p -73.55 88.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.21 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 132' ' ' ASP . 72.8 t -76.5 156.26 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.093 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -100.42 122.54 43.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.22 0.33 22.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.72 -32.21 8.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.5 p -119.82 -36.52 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.964 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.9 OUTLIER 67.02 44.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -109.83 16.65 30.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.095 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 137' ' ' GLY . 6.9 tp 46.23 107.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.361 0.601 . . . . 0.0 111.673 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.945 HD11 HG21 ' A' ' 117' ' ' VAL . 32.4 mt -72.94 -61.62 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.908 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.2 t -104.58 97.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -98.92 71.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.18 172.67 12.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 145' ' ' GLU . 12.1 m -92.37 147.91 22.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.629 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.742 HD12 ' CD1' ' A' ' 128' ' ' LEU . 19.4 tt -81.12 -19.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.786 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.602 ' H ' HG22 ' A' ' 143' ' ' THR . 1.5 mt-10 -84.88 -36.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.212 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -43.17 14.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 148' ' ' SER . 10.4 p -46.03 164.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.314 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -70.85 -2.54 15.3 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.0 m-85 84.22 166.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.887 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 29.0 p -87.43 -173.02 4.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.613 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 173.74 101.53 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.444 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 52.0 Cg_endo . . . . . 0 C--N 1.346 0.444 0 C-N-CA 122.594 2.196 . . . . 0.0 112.934 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.41 ' CD ' ' OD2' ' A' ' 182' ' ' ASP . 7.2 ptt180 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.809 0.337 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 160' ' ' PHE . . . -104.69 127.55 9.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.644 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 6.1 m-85 -139.06 177.64 7.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 p -175.3 125.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.756 ' OH ' HG21 ' A' ' 191' ' ' VAL . 4.9 m-30 -98.1 -171.75 2.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -156.97 155.18 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 22.9 p -146.12 143.22 29.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.952 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 79.34 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.061 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 168' ' ' THR . 37.9 t0 59.36 -88.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.761 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.98 -83.11 0.01 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.431 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 166' ' ' ASP . 1.8 m -139.72 22.34 2.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 92.8 m -111.36 -82.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -158.03 -70.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.683 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -150.05 -155.51 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.977 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.622 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -65.46 76.23 0.06 Allowed 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -92.41 121.14 33.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.081 -177.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.637 ' SG ' HG12 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.16 142.54 28.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -114.49 118.7 34.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.998 0.428 . . . . 0.0 111.161 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' LEU . . . -115.45 151.88 18.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.833 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.829 ' HA ' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -178.62 176.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 111.956 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.28 139.82 35.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.153 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 187' ' ' LEU . . . -64.25 138.71 58.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 0.0 111.615 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 186' ' ' ARG . 21.9 mmtt -76.81 -27.78 55.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.656 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.41 ' OD2' ' CD ' ' A' ' 158' ' ' ARG . 1.4 t70 60.31 36.92 20.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.464 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.4 p -151.56 19.09 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.674 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.88 26.53 1.19 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.263 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.76 24.14 13.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.552 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -179.34 37.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.086 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 1.002 HD13 ' HB1' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -167.52 -52.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.469 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 2.9 t -73.75 -66.64 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -52.41 -36.81 55.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.478 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.954 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.756 HG21 ' OH ' ' A' ' 162' ' ' TYR . 38.9 t -50.37 -48.86 25.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.994 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.03 -27.26 21.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.885 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.671 ' HB3' HG21 ' A' ' 76' ' ' VAL . 60.8 m -87.24 -28.32 22.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.94 0.4 . . . . 0.0 110.52 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.816 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -51.31 -51.31 55.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.461 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.712 ' O ' HD12 ' A' ' 199' ' ' LEU . 86.5 m-85 -55.06 -23.95 22.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.256 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -46.53 -49.88 18.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.856 0.36 . . . . 0.0 111.202 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 76' ' ' VAL . 86.2 t -58.75 -38.93 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 30.4 t -65.15 -30.78 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.201 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 195' ' ' PHE . 1.2 mp -130.32 57.4 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.296 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.402 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.35 -87.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 199' ' ' LEU . 28.7 mm -116.01 -51.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.867 0.365 . . . . 0.0 111.094 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 149' ' ' PHE . . . -50.98 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.361 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 32.3 Cg_exo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.5 m0 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.838 0.351 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 2.0 pp0? -49.59 -33.48 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.004 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.33 -70.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.67 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 76' ' ' VAL . 11.5 m-20 -47.39 -32.04 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.489 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -65.21 -25.66 67.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 110.959 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 13.4 mt-10 -102.28 -35.91 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -53.91 -55.44 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 193' ' ' CYS . 28.7 m -55.14 -38.51 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -34.8 73.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 23.2 t -88.66 -12.13 43.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.198 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 78' ' ' SER . . . 75.28 73.16 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.841 0.353 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -179.24 50.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -112.84 -179.35 3.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB2' HD11 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -174.15 122.69 0.3 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.503 0.668 . . . . 0.0 111.096 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -127.77 130.15 48.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.511 -177.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -60.68 160.41 9.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.935 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.5 p -177.77 159.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 111.923 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.518 ' N ' HG22 ' A' ' 85' ' ' VAL . 10.7 mttt -107.91 62.48 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.211 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.748 ' O ' HG12 ' A' ' 117' ' ' VAL . 31.6 t80 -55.6 119.86 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.472 -178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 109' ' ' LEU . 9.0 mp -60.83 -43.04 98.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.041 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 136.17 -159.02 24.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.975 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -115.51 145.8 42.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.023 0.44 . . . . 0.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -137.27 174.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.401 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.475 ' N ' HG13 ' A' ' 91' ' ' VAL . 2.8 pm0 -101.16 146.7 27.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.305 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 172' ' ' TRP . 4.5 m -144.55 163.85 13.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.027 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -84.79 -3.95 58.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.899 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG11 ' A' ' 101' ' ' VAL . 22.7 mm-40 -153.29 126.71 8.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.847 0.356 . . . . 0.0 110.912 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 3.0 p -95.72 27.08 3.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.604 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -151.03 149.46 29.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.0 -147.06 18.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.96 -46.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -26.93 15.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 95' ' ' GLU . 48.5 t -68.14 -36.73 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.782 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 53.7 m -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -39.23 87.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.53 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.0 pt-20 -82.4 -34.09 28.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.29 13.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.678 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -49.4 -43.35 44.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.22 77.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.29 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.7 t -67.54 -43.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.917 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' A' ' 88' ' ' LEU . 3.1 mm? -53.14 -22.36 6.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -47.0 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.389 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -9.1 58.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.014 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.23 172.35 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.198 -179.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.37 6.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.666 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.648 ' HG3' HD13 ' A' ' 109' ' ' LEU . 2.4 mmt180 -43.18 113.38 0.48 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.441 ' CG ' ' HD2' ' A' ' 116' ' ' PRO . 60.8 ttt180 -118.66 144.97 36.53 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.321 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 115' ' ' ARG . 75.3 Cg_exo -50.34 155.39 4.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.813 2.342 . . . . 0.0 112.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 139' ' ' ILE . 10.7 p -126.39 109.55 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.252 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 133' ' ' ASP . 2.6 ttt180 -69.33 70.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.124 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.94 -165.26 11.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.232 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.625 HD13 ' C ' ' A' ' 120' ' ' LEU . 1.9 tm? -120.75 119.23 32.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.6 tp -77.38 83.7 3.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.075 0.464 . . . . 0.0 110.15 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.499 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -66.03 82.61 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.827 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 81' ' ' CYS . 1.8 m -70.78 178.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 p -178.01 31.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.86 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.636 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 40.93 32.55 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.722 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -172.12 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.553 0.216 . . . . 0.0 111.398 -178.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -153.75 117.12 0.78 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.879 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.527 HD21 HD12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -90.13 130.02 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.748 0.309 . . . . 0.0 110.569 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.55 ' HB3' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -135.01 90.67 2.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.901 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 130' ' ' VAL . 3.9 p -72.72 102.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.0 t -91.96 135.91 25.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.36 137.59 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 118' ' ' ARG . 11.3 t0 -87.83 16.12 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -117.43 -35.0 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 43.3 p -119.26 -15.88 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.649 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.92 36.07 7.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.91 -164.79 24.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.873 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -122.5 132.01 54.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.846 HD11 HG21 ' A' ' 117' ' ' VAL . 4.3 mt -100.12 -23.52 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 140' ' ' VAL . 22.0 t -143.77 60.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.195 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.457 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 20.3 p-10 -67.74 73.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.484 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -145.13 151.37 38.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 111.407 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -60.62 179.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.746 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 126' ' ' ASP . 16.4 tt -108.07 -23.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -86.89 -24.18 24.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.879 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -94.76 21.33 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.0 OUTLIER -115.12 178.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.419 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.488 ' OG ' HD12 ' A' ' 163' ' ' ILE . 23.1 t -87.23 13.96 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 76.79 -177.61 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.771 0.319 . . . . 0.0 111.045 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 3.9 m -111.33 163.17 14.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 111.281 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -174.75 98.45 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.866 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 34.1 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.182 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.84 0.353 . . . . 0.0 110.961 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.05 110.71 2.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.593 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.683 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 5.9 m-85 -91.82 170.28 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -164.18 107.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.786 ' OH ' HG11 ' A' ' 191' ' ' VAL . 4.0 m-30 -88.94 -179.5 5.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.325 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -159.32 148.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.404 ' HB3' ' CG1' ' A' ' 147' ' ' VAL . 19.6 p -139.21 157.84 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.752 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 87.32 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.885 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' THR . 3.1 p-10 47.62 26.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.169 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.72 80.04 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.417 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 166' ' ' ASP . 17.1 p 55.0 25.7 7.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.678 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -119.22 -78.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -158.79 -81.66 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 111.112 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -143.42 -148.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.891 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.638 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -66.76 74.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.452 ' HE3' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.29 118.1 27.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.352 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.42 168.08 17.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.091 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -140.58 90.54 2.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.783 0.325 . . . . 0.0 111.407 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -69.46 107.01 1.96 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -104.99 138.67 40.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 179' ' ' ALA . 2.8 tm? -135.37 108.4 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.388 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.683 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -44.88 145.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.713 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.02 -59.7 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -68.31 -27.44 66.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD1' HD21 ' A' ' 178' ' ' LEU . 0.5 OUTLIER 59.17 82.43 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.172 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.438 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 8.3 t -168.6 29.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.06 27.89 1.17 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.898 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.0 49.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.0 110.79 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.55 ' C ' HD12 ' A' ' 187' ' ' LEU . 25.3 mmt180 -149.84 -46.5 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.486 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.935 HD21 ' HB ' ' A' ' 85' ' ' VAL . 2.6 mp -119.66 -36.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.122 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -58.42 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -18.46 47.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.543 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 193' ' ' CYS . . . -87.83 -74.25 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.272 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 187' ' ' LEU . 3.4 p -52.09 -29.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.117 0.484 . . . . 0.0 110.119 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.13 -30.45 60.98 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.832 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -71.0 -32.04 68.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.139 0.495 . . . . 0.0 109.667 177.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.636 ' HB1' ' HA2' ' A' ' 125' ' ' GLY . . . -50.95 -33.6 25.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.564 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.785 ' O ' HD12 ' A' ' 199' ' ' LEU . 17.6 m-85 -61.45 -24.88 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.731 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.02 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.292 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.63 -34.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 31.9 t -52.16 -28.33 17.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.656 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -121.43 -38.41 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.043 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.428 ' C ' ' CG ' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.643 0.259 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.789 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER 178.43 -92.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.069 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.789 HD13 ' O ' ' B' ' 2' ' ' TYR . 5.1 mm -135.39 64.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.115 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.46 -78.63 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.457 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.4 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 75.9 Cg_exo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.531 2.154 . . . . 0.0 112.139 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.425 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 1.2 m0 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.011 0.434 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -24.13 65.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.965 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.66 -46.97 6.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.02 -46.04 65.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.08 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 69' ' ' TRP . 5.3 tt0 -50.57 -41.8 54.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.39 -23.23 35.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -63.57 -53.04 57.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.874 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -58.41 -43.64 87.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.266 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -53.42 -45.5 69.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.468 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 17.0 12.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.101 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . 56.56 85.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.646 0.26 . . . . 0.0 111.303 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.639 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.6 t 174.24 51.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -119.81 166.7 12.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.763 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.914 ' HB3' HD21 ' A' ' 120' ' ' LEU . 2.0 m -166.48 160.21 15.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.048 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.469 ' CG ' ' O ' ' A' ' 82' ' ' SER . 21.2 m-85 -167.99 141.35 3.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 120' ' ' LEU . 8.2 t -59.37 158.74 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.893 ' HB ' HD21 ' A' ' 187' ' ' LEU . 14.9 p -175.47 160.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 111.952 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 85' ' ' VAL . 8.5 mttt -114.56 57.97 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.703 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.765 ' O ' HG22 ' A' ' 117' ' ' VAL . 26.7 t80 -47.67 134.38 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 109' ' ' LEU . 7.4 mp -79.21 -58.08 3.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.906 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.576 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 151.06 -155.34 26.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.543 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 20.0 p -121.26 144.03 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 109' ' ' LEU . 7.5 m -134.78 142.59 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.1 124.63 24.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 172' ' ' TRP . 15.4 m -127.25 176.92 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.985 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.22 2.9 53.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.886 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.5 mm-40 -153.85 164.97 37.49 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.974 0.416 . . . . 0.0 111.073 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.503 ' HG ' ' HE3' ' A' ' 172' ' ' TRP . 83.7 p -132.95 23.93 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.669 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.78 168.63 19.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.15 154.38 24.21 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -24.09 24.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.03 -42.5 97.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.044 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 45.5 t -64.73 -30.5 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -70.81 -58.08 3.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.037 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -48.27 -37.57 16.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.7 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.3 pt-20 -83.86 -42.17 16.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.817 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 101' ' ' VAL . . . -50.4 -48.76 55.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HG ' ' HA2' ' A' ' 176' ' ' GLY . 0.3 OUTLIER -53.82 -51.47 63.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -51.11 -42.45 60.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.468 178.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -66.27 -35.67 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.119 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.627 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -53.76 -39.57 65.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -52.6 8.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.04 -36.33 28.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.045 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.04 -167.0 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 31.15 3.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.471 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -90.56 79.41 6.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.631 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -58.35 128.35 82.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.16 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.53 159.44 32.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.448 2.098 . . . . 0.0 112.435 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.933 HG11 HD11 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -104.88 -178.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.404 ' HG3' ' HE3' ' A' ' 86' ' ' LYS . 12.1 ttt180 -149.54 70.64 1.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.581 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.8 -130.09 2.66 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.721 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' A' ' 82' ' ' SER . 1.4 tp -136.77 139.44 41.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.936 0.398 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 85' ' ' VAL . 20.1 tp -92.93 124.66 37.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.392 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 129' ' ' ARG . 12.1 m170 -85.24 103.35 14.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.014 HG21 HG22 ' A' ' 191' ' ' VAL . 96.1 t -109.48 105.97 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -128.73 39.76 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.454 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 39.35 48.36 2.87 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.216 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.642 ' O ' HG22 ' A' ' 144' ' ' ILE . 4.4 t70 -160.62 -41.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.79 117.8 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.546 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.723 HD11 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.6 133.78 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 0.0 110.97 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 14.5 mtm-85 -139.42 87.79 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.593 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.504 HG13 ' HB ' ' A' ' 139' ' ' ILE . 7.4 p -77.62 140.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.581 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 136' ' ' LYS . 5.2 t -135.26 152.7 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.478 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.5 t0 -95.82 149.49 21.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.781 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.422 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t70 -91.77 19.96 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.351 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -127.27 -40.9 1.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 110.752 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 p -114.06 -19.59 11.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.125 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HA ' HG12 ' A' ' 131' ' ' VAL . 5.4 mmtp 59.3 22.34 10.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 110.784 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.38 120.21 5.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.423 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.456 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 2.0 tp -55.75 133.52 50.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.68 0.276 . . . . 0.0 110.608 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.933 HD11 HG11 ' A' ' 117' ' ' VAL . 6.0 mt -108.12 -43.25 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.08 86.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.529 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.456 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 26.8 t0 -98.09 69.44 2.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.758 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -124.54 179.12 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -91.82 171.67 8.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.649 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.723 HD12 HD11 ' A' ' 128' ' ' LEU . 10.1 tt -107.64 -16.7 8.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.404 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.94 -38.32 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 111.022 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -81.15 -24.79 37.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 163' ' ' ILE . 11.6 p -70.64 164.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.651 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.1 m -72.91 -2.19 19.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.8 m-85 80.58 -167.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.1 p -129.8 -171.62 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.961 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB1' ' HG3' ' B' ' 5' ' ' PRO . . . -164.07 58.31 0.66 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.425 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 50.1 Cg_exo . . . . . 0 C--N 1.344 0.291 0 C-N-CA 122.361 2.041 . . . . 0.0 111.807 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 120.909 0.385 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.83 147.6 17.19 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.541 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 1.5 m-85 -131.06 151.07 51.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.04 125.91 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.881 0.372 . . . . 0.0 111.689 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.669 ' O ' HG23 ' A' ' 163' ' ' ILE . 4.4 m-30 -94.94 -172.48 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.198 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -165.87 159.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.964 0.411 . . . . 0.0 111.379 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.47 ' HB3' HG23 ' A' ' 147' ' ' VAL . 24.0 p -157.56 157.66 34.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.514 ' HG3' ' CZ3' ' A' ' 172' ' ' TRP . 0.1 OUTLIER -116.03 85.09 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.3 p30 46.48 -163.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.76 -42.77 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.218 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.4 p -153.32 24.92 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.948 0.404 . . . . 0.0 110.734 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.68 -72.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.034 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.418 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER 179.81 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.759 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' MET . 6.2 ptt180 -131.05 -152.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.149 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 4.4 m95 -60.87 82.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -90.18 112.68 24.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.81 -177.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' A' ' 93' ' ' VAL . 1.2 m -82.29 171.41 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.974 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -146.3 118.83 8.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.92 0.391 . . . . 0.0 111.561 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 87' ' ' TYR . . . -92.32 124.19 7.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.74 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 4.7 m-85 -122.89 136.33 54.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.391 . . . . 0.0 111.327 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.79 108.59 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.438 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.597 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -50.1 134.38 22.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 111.177 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -60.38 3.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.79 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -57.6 -33.81 68.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.649 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.2 80.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.02 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.37 30.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.58 37.56 0.15 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 113.879 0.312 . . . . 0.0 113.879 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -147.58 49.4 1.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.019 0.438 . . . . 0.0 111.496 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.08 -42.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.0 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.893 HD21 ' HB ' ' A' ' 85' ' ' VAL . 5.7 mp -111.47 -44.47 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.4 p -53.9 -60.2 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -71.03 -28.1 64.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -71.94 -68.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.865 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 1.014 HG22 HG21 ' A' ' 123' ' ' VAL . 2.7 t -60.6 -41.37 87.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.28 -39.85 36.37 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.782 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 1.7 m -76.13 -27.76 57.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.061 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.619 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -60.58 -41.96 95.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.542 ' CD2' HD11 ' A' ' 144' ' ' ILE . 42.4 m-85 -59.99 -35.51 75.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -51.45 -27.06 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.6 t -71.77 -31.6 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.45 ' HB3' HD23 ' A' ' 199' ' ' LEU . 38.9 t -48.25 -52.74 19.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.731 HD21 HG21 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -100.43 -33.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 5.2 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.674 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.736 0.303 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 179.77 74.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.731 HG21 HD21 ' A' ' 199' ' ' LEU . 4.8 mp 47.54 45.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.43 ' CA ' ' C ' ' B' ' 5' ' ' PRO . . . 127.44 87.65 0.59 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.514 ' HG3' ' HB1' ' A' ' 151' ' ' ALA . 41.3 Cg_exo . . . . . 0 N--CA 1.482 0.801 0 CA-C-N 118.699 1.249 . . . . 0.0 114.922 6.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 . . . . . 0 CA--C 1.518 -0.255 0 CA-C-O 121.378 0.608 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -13.68 40.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.232 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.79 -27.32 6.26 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 4.7 p30 -90.34 -25.92 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.662 0.267 . . . . 0.0 111.504 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 49.4 mt-10 -61.31 -27.0 68.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.976 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -102.04 -24.64 13.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' THR . . . -46.29 -37.6 7.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 194' ' ' ALA . 40.0 t -63.67 -50.47 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HA ' ' CG2' ' A' ' 197' ' ' VAL . 3.8 mtp180 -49.86 -48.63 51.12 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.107 0.479 . . . . 0.0 110.577 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.91 14.33 10.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.246 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 50.42 81.04 0.07 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.65 0.262 . . . . 0.0 111.116 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.8 t -171.96 29.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.586 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.57 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -97.59 157.87 15.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -171.43 144.81 2.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 54.1 m-85 -154.73 146.04 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.507 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -58.11 162.88 3.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.523 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.632 HG13 ' CD2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -159.63 172.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.208 0.528 . . . . 0.0 111.727 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.432 ' H ' HG12 ' A' ' 85' ' ' VAL . 4.4 mttt -125.42 42.4 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.965 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.496 ' N ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -38.98 122.33 1.18 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.388 -178.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.723 HD23 ' HB3' ' A' ' 109' ' ' LEU . 8.9 mp -67.59 -44.52 77.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.214 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.515 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 145.37 -135.09 5.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.442 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.404 ' N ' HD11 ' A' ' 109' ' ' LEU . 25.3 p -139.65 148.75 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.865 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 174' ' ' CYS . 12.5 m -139.15 127.78 28.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.51 128.01 35.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.069 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 172' ' ' TRP . 32.9 m -126.15 -174.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.687 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.93 24.93 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.618 ' HB2' HG21 ' A' ' 101' ' ' VAL . 28.5 mp0 -141.96 -81.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.172 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m 60.36 22.73 12.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.783 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 24.89 2.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -166.42 10.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.64 -39.35 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -59.54 -47.56 85.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.966 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' A' ' 95' ' ' GLU . 62.0 t -49.65 -26.67 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.07 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.6 m -66.88 -44.23 81.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.84 -53.81 43.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 pt-20 -76.81 -36.93 56.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.776 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.597 ' O ' HD23 ' A' ' 109' ' ' LEU . . . -48.9 -25.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tt -81.8 -43.54 18.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.07 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 6.8 pttt -60.76 -35.18 75.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.321 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -68.16 -35.69 72.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.583 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.723 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -54.37 -27.82 38.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -47.39 6.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.079 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -23.48 5.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.795 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.73 177.95 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -12.7 58.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.303 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.702 ' HG2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -43.23 108.91 0.12 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 0.0 111.537 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.2 ptt180 -98.92 144.76 28.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.8 160.37 12.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.461 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.984 HG21 HD11 ' A' ' 139' ' ' ILE . 1.6 p -115.92 176.18 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.599 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -147.69 79.88 1.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.12 5.35 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.008 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 120' ' ' LEU . 3.4 mt -121.1 131.19 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.475 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -88.04 104.89 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -72.09 69.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.261 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.849 HG21 HG22 ' A' ' 191' ' ' VAL . 93.9 t -77.84 97.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.371 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 24.9 p -119.62 42.62 2.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.459 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 42.99 41.91 4.83 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.708 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.764 ' O ' HG22 ' A' ' 144' ' ' ILE . 9.8 t0 -163.39 -43.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.613 0.244 . . . . 0.0 111.286 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -148.14 127.56 2.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.283 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 191' ' ' VAL . 0.2 OUTLIER -87.03 71.41 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.667 0.27 . . . . 0.0 110.886 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.48 89.84 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.8 0.334 . . . . 0.0 111.176 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.864 HG13 ' HB ' ' A' ' 139' ' ' ILE . 5.8 p -85.93 90.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.952 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 132' ' ' ASP . 7.2 p -86.2 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -99.62 147.68 25.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -100.66 14.41 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.676 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.89 -43.77 3.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 58.7 p -111.31 -19.96 12.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 38.45 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.049 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.41 139.99 15.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.103 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 139' ' ' ILE . 2.6 tp -73.39 110.81 7.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.984 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 117' ' ' VAL . 38.2 mt -68.38 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.31 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 138' ' ' LEU . 66.2 t -110.28 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.075 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.442 ' HA ' HD21 ' A' ' 138' ' ' LEU . 26.6 t70 -93.89 73.25 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.497 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.2 170.37 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 145' ' ' GLU . 87.9 m -103.64 141.8 35.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.545 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.889 HD11 ' CE1' ' A' ' 195' ' ' PHE . 13.0 tt -70.66 -27.09 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.014 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.68 ' H ' HG22 ' A' ' 143' ' ' THR . 0.4 OUTLIER -81.79 -30.92 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.772 178.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -91.42 -41.7 10.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.943 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 163' ' ' ILE . 14.3 p -47.4 161.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.074 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.536 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.4 m -52.7 -50.95 62.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 1.061 ' CE1' HD11 ' A' ' 163' ' ' ILE . 3.0 p90 150.75 -176.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.673 0.789 . . . . 0.0 109.971 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 15.9 p -114.91 151.48 33.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.425 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -177.05 102.09 0.23 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.129 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 45.5 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.332 2.022 . . . . 0.0 111.963 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.409 ' CD ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.73 0.3 . . . . 0.0 111.232 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -110.81 154.14 16.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.594 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 0.3 OUTLIER -139.29 -175.46 4.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.75 0.309 . . . . 0.0 110.728 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.6 t -177.31 136.02 0.2 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.878 0.37 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.645 ' OH ' HG11 ' A' ' 191' ' ' VAL . 60.5 m-85 -105.06 -171.49 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.365 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.061 HD11 ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -165.31 142.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 111.474 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 20.0 p -132.98 142.58 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.466 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 172' ' ' TRP . 4.5 ptt180 -108.51 83.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.429 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 170' ' ' ARG . 2.9 p30 45.45 -162.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.415 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.52 -64.06 4.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.664 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -44.35 5.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.353 . . . . 0.0 111.127 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 79.9 m -86.18 -88.29 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.91 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 166' ' ' ASP . 18.2 mmm180 -154.81 -81.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 110.372 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 3.3 ptp180 -127.59 -152.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.492 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.804 ' O ' HG22 ' A' ' 93' ' ' VAL . 19.5 m95 -67.3 71.53 0.11 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -88.39 119.01 28.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.596 ' SG ' HG11 ' A' ' 93' ' ' VAL . 15.2 m -89.19 157.9 18.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.333 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -135.62 99.11 4.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.649 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -94.28 134.1 11.89 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.92 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.5 p90 -154.93 148.74 25.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 111.482 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.537 HD11 ' OD2' ' A' ' 182' ' ' ASP . 8.2 tp -118.52 132.7 56.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.396 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -49.29 140.43 9.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -61.35 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.685 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -68.21 -32.84 73.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.537 ' OD2' HD11 ' A' ' 178' ' ' LEU . 10.6 t70 67.24 73.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.062 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.4 23.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.624 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 41.15 30.87 0.47 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.42 ' O ' ' NE ' ' A' ' 186' ' ' ARG . 2.0 mt-10 -136.92 41.43 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.669 0.271 . . . . 0.0 111.191 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.487 ' HD3' ' CE1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -154.64 -45.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.911 0.386 . . . . 0.0 110.768 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 191' ' ' VAL . 9.3 mp -113.54 -43.91 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.836 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 20.4 t -56.7 -61.16 2.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -67.3 -21.01 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.259 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.57 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -83.68 -60.92 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.176 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.849 HG22 HG21 ' A' ' 123' ' ' VAL . 2.2 t -66.74 -31.78 55.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.799 0.333 . . . . 0.0 110.553 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.21 -26.01 12.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.56 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 44.5 t -99.08 -23.02 15.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.439 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.619 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -50.07 -28.33 6.97 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.889 ' CE1' HD11 ' A' ' 144' ' ' ILE . 53.4 m-85 -84.87 -22.07 29.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -60.61 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.774 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 77' ' ' ARG . 79.8 t -55.49 -39.09 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 34.9 t -57.61 -48.71 78.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.058 HD21 HG21 ' B' ' 3' ' ' ILE . 1.2 pt? -129.93 56.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.167 0.508 . . . . 0.0 110.754 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 29.3 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.709 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.819 0.342 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.628 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -134.48 -78.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 1.058 HG21 HD21 ' A' ' 199' ' ' LEU . 8.1 mm -134.91 -42.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.21 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.03 -77.78 0.11 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.643 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo . . . . . 0 C--N 1.345 0.352 0 C-N-CA 122.683 2.256 . . . . 0.0 112.213 179.909 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.967 0.413 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.14 -21.83 65.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.28 -62.84 1.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.408 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.9 p30 -53.14 -29.52 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.007 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.0 mm-40 -69.19 -36.0 76.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 0.0 110.522 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.8 -23.87 25.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.681 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.759 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -59.22 -57.37 13.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.677 HG13 ' HA ' ' A' ' 194' ' ' ALA . 1.2 t -50.59 -48.11 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.255 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -42.84 62.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.519 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.0 p -94.49 18.92 10.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.079 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.02 82.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -179.4 49.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.145 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -116.0 173.24 6.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.05 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 29.4 p 176.84 151.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.512 ' C ' HD23 ' A' ' 120' ' ' LEU . 53.3 m-85 -160.51 138.25 9.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.784 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.8 t -49.23 167.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.692 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 86' ' ' LYS . 8.5 p -174.48 162.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 111.993 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.526 ' N ' HG22 ' A' ' 85' ' ' VAL . 12.5 mtmm -111.96 56.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.617 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.616 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -47.7 176.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 116' ' ' PRO . 11.0 mt -137.48 -42.4 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.151 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.68 -144.67 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.485 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.5 m -136.58 155.93 49.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.586 HG13 HD13 ' A' ' 109' ' ' LEU . 2.8 m -134.61 128.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.873 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.67 124.28 20.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.852 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 172' ' ' TRP . 28.7 m -126.59 164.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -93.56 17.78 11.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.193 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HB2' HG21 ' A' ' 101' ' ' VAL . 38.3 mt-10 -159.0 114.38 2.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.05 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -93.62 21.35 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -151.84 130.9 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.63 130.34 3.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.457 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -32.81 74.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.751 0.31 . . . . 0.0 111.066 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -43.83 91.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 95' ' ' GLU . 59.6 t -61.98 -28.48 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.049 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.4 m -69.08 -48.02 63.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.013 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -52.41 -59.01 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.912 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -62.56 -30.78 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -62.96 -57.42 10.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.02 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -50.52 -44.44 56.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.528 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.79 -39.75 71.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.399 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 104' ' ' GLU . 15.0 t -64.24 -42.97 97.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.437 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.586 HD13 HG13 ' A' ' 91' ' ' VAL . 2.6 mm? -52.33 -22.42 4.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.228 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 -54.18 3.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.355 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 1.5 pp0? -61.16 -30.98 70.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.486 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -84.32 172.39 11.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -22.36 11.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HG3' HD13 ' A' ' 109' ' ' LEU . 1.1 mmt180 -45.26 102.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 141.36 24.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.714 ' HA ' HD23 ' A' ' 88' ' ' LEU . 36.2 Cg_exo -59.82 152.25 65.11 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.481 2.12 . . . . 0.0 112.441 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 118' ' ' ARG . 3.1 p -114.23 177.87 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.403 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.622 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -146.19 74.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.454 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -128.57 -144.87 5.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.282 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -122.2 130.5 53.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.678 0.275 . . . . 0.0 111.281 -178.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.727 ' HG ' HG23 ' A' ' 123' ' ' VAL . 41.8 tp -84.97 100.01 11.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -73.61 87.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.684 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.954 HG21 HG22 ' A' ' 191' ' ' VAL . 94.0 t -101.87 112.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.91 42.73 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.576 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 47.19 25.0 2.48 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.718 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -174.38 27.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 156.43 121.92 0.72 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.14 -1.029 . . . . 0.0 113.468 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.922 HD13 ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -106.85 110.18 22.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 110.419 178.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -124.48 106.29 10.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 87' ' ' TYR . 10.2 p -86.98 112.45 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 136' ' ' LYS . 77.3 t -116.31 120.24 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -54.58 146.65 15.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -94.14 20.67 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -126.06 -42.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.66 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 39.8 p -110.45 -24.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.906 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.461 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER 68.43 25.27 6.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.38 123.41 6.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.364 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 141' ' ' ASP . 14.6 tp -63.48 118.37 8.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 0.0 111.02 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' A' ' 130' ' ' VAL . 3.7 mt -92.67 -50.63 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.41 HG21 ' OH ' ' A' ' 87' ' ' TYR . 11.7 t -120.09 123.08 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.529 ' HB3' HD21 ' A' ' 138' ' ' LEU . 2.2 p-10 -116.94 65.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.169 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.27 165.55 11.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.683 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.81 ' O ' HG22 ' A' ' 144' ' ' ILE . 1.9 t -111.28 2.75 17.87 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.857 HD12 HD21 ' A' ' 128' ' ' LEU . 3.1 tt 72.63 -3.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.403 ' HB3' HG23 ' A' ' 143' ' ' THR . 25.9 tt0 -110.86 -37.53 5.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -30.69 27.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.574 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 148' ' ' SER . 10.7 p -51.46 164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.915 ' CB ' HD12 ' A' ' 163' ' ' ILE . 66.1 m -53.01 -53.91 43.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.323 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 163' ' ' ILE . 0.1 OUTLIER 155.84 -15.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.862 0.726 . . . . 0.0 112.212 178.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 0.5 OUTLIER 90.75 172.2 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.292 0.637 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 166.55 107.0 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 46.0 Cg_endo . . . . . 0 C--N 1.345 0.348 0 C-N-CA 122.364 2.043 . . . . 0.0 112.089 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.773 0.321 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -129.54 146.31 17.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.567 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 177' ' ' PHE . 2.0 m-85 -111.63 -176.31 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.702 0.287 . . . . 0.0 110.718 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.429 ' OG ' HD12 ' A' ' 106' ' ' LEU . 1.7 m -168.41 106.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.893 0.378 . . . . 0.0 111.276 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.922 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 42.8 m-85 -85.12 -173.16 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.915 HD12 ' CB ' ' A' ' 148' ' ' SER . 0.0 OUTLIER -167.09 132.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 38.5 t -131.42 156.69 45.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.859 0.361 . . . . 0.0 111.033 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -113.99 80.53 1.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.001 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 t0 52.47 -161.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 168' ' ' THR . . . 100.21 -22.28 40.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.325 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 167' ' ' GLY . 18.9 p -161.75 -42.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -75.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.05 -42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.1 ptp85 -166.67 -150.78 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.954 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.739 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.27 74.42 0.09 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 71.0 mmm -89.19 117.9 28.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.651 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.54 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 0.8 OUTLIER -79.68 165.05 23.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.713 177.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -131.89 120.87 23.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 111.29 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.411 ' HA2' ' HG ' ' A' ' 106' ' ' LEU . . . -116.3 113.68 2.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.432 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.571 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -143.65 162.2 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -137.53 131.15 31.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.983 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 187' ' ' LEU . . . -47.85 138.94 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.375 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -56.41 11.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.885 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.21 -33.67 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 110.455 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.9 t70 66.17 69.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.28 25.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.901 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.18 37.81 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 113.985 0.354 . . . . 0.0 113.985 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -148.69 23.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.846 0.323 . . . . 0.0 111.585 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.74 21.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.394 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.912 ' O ' HG23 ' A' ' 191' ' ' VAL . 0.6 OUTLIER 179.59 -38.92 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.539 ' N ' HD23 ' A' ' 187' ' ' LEU . 70.5 m -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.482 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -55.81 -28.13 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.093 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 76' ' ' VAL . . . -59.0 -49.75 76.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.534 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.954 HG22 HG21 ' A' ' 123' ' ' VAL . 2.5 t -73.74 -38.82 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.531 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.09 -40.95 45.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.951 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -79.23 -29.53 42.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.288 178.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.677 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -56.84 -43.02 80.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.519 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 144' ' ' ILE . 6.8 m-85 -58.09 -28.37 64.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.212 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -51.14 47.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.013 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 64.7 t -50.78 -37.71 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.867 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.1 t -61.8 -35.97 79.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.576 HD11 HD11 ' B' ' 3' ' ' ILE . 1.2 pt? -140.13 64.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 196' ' ' ALA . 1.3 pt-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.469 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.699 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -161.34 -96.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' B' ' 2' ' ' TYR . 4.8 mp -102.71 -47.67 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.456 ' HA2' ' CD1' ' A' ' 149' ' ' PHE . . . -51.09 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' B' ' 1' ' ' ALA . 16.2 Cg_exo . . . . . 0 N--CA 1.463 -0.266 0 C-N-CA 122.692 2.262 . . . . 0.0 111.61 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.1 m0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.867 0.365 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -62.92 -34.8 78.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.633 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.27 -55.84 4.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.129 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 15.9 t70 -49.42 -49.17 46.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -49.69 -41.58 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -86.21 -23.38 26.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.764 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB1' HG23 ' A' ' 80' ' ' THR . . . -72.7 -66.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 110.709 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.653 ' CG2' ' HB2' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -48.27 -37.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.832 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -45.68 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.038 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -90.78 18.57 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.411 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 55.71 96.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.835 0.35 . . . . 0.0 111.103 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.574 HG23 ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -178.8 -30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.92 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.571 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 0.7 OUTLIER -41.12 158.21 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 111.278 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 175.49 145.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.103 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.502 ' CD1' ' HG2' ' A' ' 186' ' ' ARG . 89.6 m-85 -160.59 148.01 15.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 120' ' ' LEU . 32.3 t -47.32 166.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.615 ' HB ' HD11 ' A' ' 187' ' ' LEU . 8.8 p -173.9 159.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.979 0.418 . . . . 0.0 111.724 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.441 ' N ' HG22 ' A' ' 85' ' ' VAL . 32.0 mttm -121.18 65.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.754 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.489 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.6 t80 -56.68 121.13 9.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.269 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.66 -41.21 94.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.474 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 141.9 -178.43 20.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.231 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.41 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 38.1 m -100.86 142.57 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.453 ' O ' ' HE1' ' A' ' 173' ' ' MET . 0.4 OUTLIER -136.51 172.42 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.893 -178.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' CG ' ' HD2' ' A' ' 171' ' ' ARG . 4.0 tt0 -109.83 148.43 31.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.165 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 172' ' ' TRP . 12.9 m -148.73 173.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.426 ' O ' ' CD1' ' A' ' 172' ' ' TRP . 22.5 m-85 -87.94 -24.07 23.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.658 ' HB2' HG21 ' A' ' 101' ' ' VAL . 4.5 mp0 -133.09 145.36 50.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 111.197 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 25.31 5.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.47 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.406 ' HG2' ' HD3' ' A' ' 165' ' ' ARG . 28.3 mtm180 -136.97 24.15 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.89 128.47 4.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.478 ' HG3' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -57.92 -37.89 74.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -55.12 -34.4 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 95' ' ' GLU . 82.2 t -64.86 -30.78 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.884 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 91.8 m -66.39 -43.68 85.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.21 -46.73 79.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.8 pt-20 -76.03 -32.14 59.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.984 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' O ' HD23 ' A' ' 109' ' ' LEU . . . -63.08 -59.79 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.31 -36.18 6.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -40.58 88.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.4 t -67.49 -32.42 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.615 HD13 ' HG3' ' A' ' 114' ' ' ARG . 4.0 mm? -60.36 -18.63 51.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.086 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -97.17 -45.31 6.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -64.35 -30.42 71.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.73 171.99 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -21.61 14.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD13 ' A' ' 109' ' ' LEU . 4.7 mmt180 -45.43 114.21 0.71 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.6 ptt-85 -124.51 148.15 57.74 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.292 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.1 156.64 2.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.785 2.324 . . . . 0.0 112.632 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 117' ' ' VAL . 10.6 p -129.08 114.34 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.907 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.97 63.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.681 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -117.65 -139.29 6.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.478 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.834 HD23 ' CD2' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -144.27 137.79 27.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.985 0.421 . . . . 0.0 111.2 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.623 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -88.8 104.0 16.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.486 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.834 ' CD2' HD23 ' A' ' 120' ' ' LEU . 15.8 m-70 -72.01 117.16 13.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.785 HG21 HG22 ' A' ' 191' ' ' VAL . 65.8 t -131.65 88.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.416 ' HB3' ' N ' ' A' ' 80' ' ' THR . 5.5 m -119.26 46.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.89 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 197' ' ' VAL . . . 35.23 61.37 0.66 Allowed Glycine 0 CA--C 1.521 0.456 0 O-C-N 123.415 0.447 . . . . 0.0 113.855 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.708 ' C ' HG22 ' A' ' 144' ' ' ILE . 6.2 t70 -178.94 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.65 122.35 0.95 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.56 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 162' ' ' TYR . 12.8 mt -78.78 146.44 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 122' ' ' HIS . 29.4 mtt180 -154.16 96.17 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.737 HG13 ' HB ' ' A' ' 139' ' ' ILE . 3.5 p -86.89 115.46 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.707 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.16 136.22 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 42.1 t0 -68.5 152.64 45.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 7.0 t0 -97.4 21.55 9.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.23 -46.12 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 110.654 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.3 p -102.17 -25.37 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 66.02 32.09 8.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.03 124.42 8.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.353 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 11.7 tp -55.89 118.17 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.737 ' HB ' HG13 ' A' ' 130' ' ' VAL . 8.6 mt -87.81 -50.51 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.262 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.496 HG23 ' CG1' ' A' ' 130' ' ' VAL . 57.3 t -112.69 79.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.147 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.452 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.3 p-10 -82.74 68.91 9.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -174.33 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.5 m -105.48 169.86 8.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.708 HG22 ' C ' ' A' ' 126' ' ' ASP . 11.5 tt -99.62 -26.04 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.9 -42.32 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -45.65 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 163' ' ' ILE . 14.7 p -48.04 164.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -80.67 7.84 9.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.449 ' H ' HG13 ' A' ' 147' ' ' VAL . 1.5 m-85 80.58 -161.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 110.933 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.48 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.3 p -143.75 163.46 33.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 99' ' ' MET . . . -154.91 110.3 2.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.707 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 25.5 Cg_endo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.268 1.979 . . . . 0.0 112.1 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.801 0.334 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.59 128.13 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.326 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -113.78 174.89 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.931 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 t -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.831 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.623 ' OH ' HD11 ' A' ' 121' ' ' LEU . 4.5 m-30 -93.82 -178.15 4.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.625 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.6 pt -163.93 136.97 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.13 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.513 ' SG ' HG23 ' A' ' 147' ' ' VAL . 3.0 m -131.22 160.15 35.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.411 ' HB2' ' NH1' ' A' ' 165' ' ' ARG . 23.5 mtm105 -119.28 85.1 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.075 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 46.58 -161.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.26 -82.24 1.06 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.304 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 24.13 11.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.332 . . . . 0.0 111.015 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.9 -82.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.248 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.5 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.428 ' HD2' ' CG ' ' A' ' 92' ' ' GLU . 4.6 ptp180 -133.27 -151.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.125 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.51 ' O ' HG22 ' A' ' 93' ' ' VAL . 12.2 m95 -63.15 82.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.453 ' HE1' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -86.68 121.09 28.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.559 -178.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 155.09 17.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.067 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -137.16 123.21 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.757 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -98.69 112.04 4.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.532 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.476 ' CE2' ' CD2' ' A' ' 162' ' ' TYR . 22.0 m-85 -109.0 158.7 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.751 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 178' ' ' LEU . 0.4 OUTLIER -149.84 99.29 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.299 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 85' ' ' VAL . . . -42.32 141.23 0.99 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.436 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 34.7 t -63.94 -66.22 0.57 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.308 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -29.38 49.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.138 0.494 . . . . 0.0 109.907 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.76 75.19 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.223 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.06 30.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.428 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.454 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 39.1 30.25 0.12 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.421 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -133.71 49.63 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.502 ' HG2' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 169.71 -32.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.673 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.615 HD11 ' HB ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER -112.11 -30.33 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.905 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.454 ' CB ' ' HA2' ' A' ' 184' ' ' GLY . 11.1 t -87.65 -66.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.149 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -30.34 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.571 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -68.04 -68.87 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.996 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.785 HG22 HG21 ' A' ' 123' ' ' VAL . 29.7 t -52.87 -48.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.77 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.76 -35.18 23.27 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.716 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.413 ' HB3' HG11 ' A' ' 76' ' ' VAL . 14.5 t -86.46 -32.77 20.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.165 0.507 . . . . 0.0 109.884 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.653 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . . . -52.38 -33.85 45.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.894 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.525 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 32.6 m-85 -71.9 -18.86 62.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.104 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -44.85 -59.32 2.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.576 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 198' ' ' CYS . 34.4 m -50.47 -47.0 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.179 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.571 ' N ' HG23 ' A' ' 197' ' ' VAL . 41.0 t -54.41 -29.26 48.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 109.784 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.769 HD13 HG12 ' B' ' 3' ' ' ILE . 4.6 mp -123.28 43.29 2.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.521 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.169 179.761 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.443 ' HB1' ' CE1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.666 0.27 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.735 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -176.1 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.986 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.769 HG12 HD13 ' A' ' 199' ' ' LEU . 4.2 mp -140.24 54.09 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.163 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.9 -67.1 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.418 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 123.139 2.56 . . . . 0.0 112.664 179.306 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.832 0.349 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -67.31 -40.27 85.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.27 65.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.81 -41.02 94.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -30.47 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.597 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -87.84 -25.61 23.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.662 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -56.01 -50.21 71.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -61.12 -43.87 97.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.6 -179.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.8 83.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.448 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -95.05 19.85 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.046 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB1' ' CB ' ' A' ' 124' ' ' SER . . . 49.22 84.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.238 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 3.4 t 178.56 47.51 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.645 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 123' ' ' VAL . 9.7 t -120.83 114.27 21.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.434 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.89 142.79 51.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.866 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.489 ' HB2' HD11 ' A' ' 187' ' ' LEU . 49.0 m-85 -152.02 142.84 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.678 ' HA ' HD23 ' A' ' 120' ' ' LEU . 5.0 m -54.98 164.32 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 121' ' ' LEU . 4.8 p 176.6 161.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 85' ' ' VAL . 10.7 mtmm -113.11 79.33 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 139' ' ' ILE . 12.6 t80 -65.39 99.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.82 HD23 ' HG3' ' A' ' 116' ' ' PRO . 49.9 mt -46.47 -49.57 18.11 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA2' ' CE2' ' A' ' 87' ' ' TYR . . . 147.01 -169.18 28.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.228 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 21.1 p -123.96 129.25 50.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 110.962 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -117.88 147.24 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.999 -178.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.5 136.77 45.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 172' ' ' TRP . 27.4 m -132.76 178.92 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -116.48 26.87 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.674 ' CB ' HG21 ' A' ' 101' ' ' VAL . 3.9 mt-10 -145.0 -82.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.315 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.0 m 63.42 28.25 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 21.45 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.9 168.01 30.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.565 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -32.01 22.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.0 110.894 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -63.51 -17.02 62.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.326 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.674 HG21 ' CB ' ' A' ' 95' ' ' GLU . 25.8 t -87.5 -21.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.602 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.5 p -69.56 -37.0 76.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.62 -59.58 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.478 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.916 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.4 pt-20 -64.35 -32.92 74.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.611 ' HB1' ' CB ' ' A' ' 174' ' ' CYS . . . -67.63 -23.93 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.793 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.56 -24.14 18.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.874 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.412 ' C ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -81.61 -38.58 25.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.916 HG23 ' O ' ' A' ' 104' ' ' GLU . 70.9 t -53.14 -55.41 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.262 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.681 ' CD2' HG13 ' A' ' 91' ' ' VAL . 13.9 mt -56.45 -25.31 50.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -82.91 -27.57 30.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.459 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -89.87 -10.39 45.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.259 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.0 p -106.36 -165.67 1.11 Allowed 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -83.65 -21.95 32.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.865 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -48.36 91.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -84.77 159.62 57.48 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.202 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.82 ' HG3' HD23 ' A' ' 88' ' ' LEU . 4.4 Cg_exo -71.81 161.53 44.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.703 2.269 . . . . 0.0 111.962 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.736 HG12 ' HB3' ' A' ' 87' ' ' TYR . 9.6 p -117.64 118.19 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.44 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 64.93 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.349 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -122.34 -159.2 10.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.77 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' ' 84' ' ' SER . 5.3 mt -116.66 126.49 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.137 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.64 ' HB2' HG11 ' A' ' 85' ' ' VAL . 5.9 tp -86.82 100.36 12.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.436 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -76.45 103.61 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.538 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.59 HG21 HG22 ' A' ' 191' ' ' VAL . 58.6 t -104.5 133.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.456 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.461 ' CB ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -145.91 29.06 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.722 -178.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 48.08 23.62 2.83 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.596 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HA ' HG22 ' A' ' 144' ' ' ILE . 41.5 t0 -165.03 22.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 143' ' ' THR . . . 152.36 112.07 0.5 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' A' ' 162' ' ' TYR . 1.4 mt -91.88 101.41 13.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 110.523 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -104.49 89.88 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.689 HG13 ' HB ' ' A' ' 139' ' ' ILE . 7.6 p -83.69 112.96 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.67 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 137' ' ' GLY . 7.0 p -122.76 138.86 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.212 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 36.8 t0 -63.83 144.59 56.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 28.5 t70 -93.52 14.62 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.42 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -120.61 -39.28 2.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.778 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.7 p -104.85 -24.42 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.839 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.15 35.0 4.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -103.99 134.03 11.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.612 HD21 ' CG ' ' A' ' 141' ' ' ASP . 10.8 tp -67.02 120.95 14.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.398 . . . . 0.0 111.061 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.746 HG21 ' CE2' ' A' ' 87' ' ' TYR . 7.8 mt -90.55 -59.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.56 114.83 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.874 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.612 ' CG ' HD21 ' A' ' 138' ' ' LEU . 20.3 t0 -111.28 96.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.73 -163.93 1.49 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.682 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.816 ' O ' HG22 ' A' ' 144' ' ' ILE . 5.1 t -135.93 8.91 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 143' ' ' THR . 4.7 tt 65.59 7.01 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 143' ' ' THR . 0.7 OUTLIER -112.6 -36.23 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.132 0.491 . . . . 0.0 110.397 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -83.98 -19.85 33.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.37 177.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 148' ' ' SER . 8.3 p -66.62 164.0 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.784 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.53 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -85.75 16.27 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' A' ' 148' ' ' SER . 15.4 m-85 82.58 -179.45 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.871 0.367 . . . . 0.0 110.957 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 26.6 p -114.53 -178.76 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.456 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 172.64 100.45 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.387 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' B' ' 5' ' ' PRO . 44.8 Cg_endo . . . . . 0 C--N 1.345 0.374 0 C-N-CA 122.507 2.138 . . . . 0.0 112.894 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -96.86 122.03 7.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.844 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.499 ' HB3' ' CE1' ' A' ' 177' ' ' PHE . 5.6 m-85 -134.61 159.64 40.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.3 t -159.88 138.24 10.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.44 . . . . 0.0 111.636 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.84 ' CE2' HD13 ' A' ' 128' ' ' LEU . 6.0 m-85 -105.69 -173.23 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.1 pt -160.94 135.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.04 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 3.4 m -126.48 100.04 6.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.984 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 -65.04 80.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 168' ' ' THR . 34.4 t0 60.79 -87.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.747 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 49.06 -88.99 0.01 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.765 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 166' ' ' ASP . 2.6 m -116.54 -33.47 4.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.751 0.31 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 81.4 m -59.15 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.034 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 169' ' ' THR . 58.5 mtp180 -163.92 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -136.04 -154.72 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.762 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.75 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -64.27 78.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -99.71 120.96 40.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.153 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.611 ' CB ' ' HB1' ' A' ' 105' ' ' ALA . 86.5 m -91.26 159.22 16.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -129.95 94.67 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.305 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.64 126.32 8.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.366 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.527 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -149.29 152.95 36.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.819 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.464 HD21 ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -130.61 120.89 24.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -40.88 147.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.994 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -42.25 73.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.53 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -76.1 -34.68 59.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.498 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' HD21 ' A' ' 178' ' ' LEU . 3.9 m-20 67.07 64.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.332 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -162.22 24.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.584 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 42.33 27.81 0.5 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.257 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 1.9 mt-10 -125.4 43.4 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.889 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.584 ' C ' HD12 ' A' ' 187' ' ' LEU . 16.5 mmt-85 -158.51 -44.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 191' ' ' VAL . 4.3 mp -115.2 -36.11 4.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.734 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 12.3 t -58.92 -65.87 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 186' ' ' ARG . 10.5 p80 -61.29 -35.68 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.89 -73.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.016 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 187' ' ' LEU . 6.6 t -51.39 -43.57 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.631 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.65 -34.84 36.67 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.484 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 56.5 m -91.14 -27.39 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.073 177.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.618 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -49.53 -45.47 47.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.99 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.603 ' O ' HD12 ' A' ' 199' ' ' LEU . 33.5 m-85 -57.2 -22.52 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.984 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -41.43 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.42 -34.38 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.819 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.97 -23.41 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.767 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 195' ' ' PHE . 5.3 mp -113.8 -45.73 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.824 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.407 -178.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 174.73 87.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.897 0.38 . . . . 0.0 111.366 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.582 HG22 ' O ' ' B' ' 3' ' ' ILE . 4.1 mp 42.42 48.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.155 0.502 . . . . 0.0 111.753 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.17 86.27 1.7 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.853 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' B' ' 1' ' ' ALA . 32.5 Cg_exo . . . . . 0 N--CA 1.481 0.793 0 CA-C-N 118.137 0.969 . . . . 0.0 114.041 4.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.433 ' CZ2' ' CG ' ' A' ' 189' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.985 0.422 . . . . 0.0 110.478 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.79 -28.38 68.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -85.24 -37.33 20.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.863 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.561 ' O ' HG22 ' A' ' 76' ' ' VAL . 6.8 t0 -56.46 -49.65 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.66 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -58.15 4.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.354 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -29.15 53.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -51.16 -68.49 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.877 HG21 ' HB3' ' A' ' 193' ' ' CYS . 3.3 m -49.48 -27.43 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -52.14 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 m -95.37 15.94 18.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.152 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 61.97 84.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.036 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.592 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.7 t 175.67 54.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.415 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.712 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 19.5 t -122.28 71.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.371 . . . . 0.0 110.65 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 122' ' ' HIS . 13.0 p -92.91 148.71 21.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.078 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.662 ' C ' HD12 ' A' ' 120' ' ' LEU . 29.4 m-85 -151.52 139.63 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -53.54 139.47 31.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 86' ' ' LYS . 11.9 p -151.68 159.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.55 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.527 ' N ' HG22 ' A' ' 85' ' ' VAL . 23.9 mtpp -114.81 61.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.797 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.543 ' HB3' HG12 ' A' ' 117' ' ' VAL . 23.3 t80 -47.55 119.22 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 109' ' ' LEU . 10.1 mp -56.49 -46.67 80.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.69 ' O ' HD11 ' A' ' 109' ' ' LEU . . . 148.64 -176.38 27.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.99 130.43 51.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 111.372 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG13 HD13 ' A' ' 109' ' ' LEU . 7.0 m -121.72 174.35 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.09 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 93' ' ' VAL . 2.9 pt-20 -105.7 154.41 20.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.087 0.47 . . . . 0.0 111.616 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.736 HG11 ' SG ' ' A' ' 174' ' ' CYS . 16.0 m -157.65 -175.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.25 20.02 2.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.602 0.239 . . . . 0.0 111.39 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HB2' HG21 ' A' ' 101' ' ' VAL . 1.2 mm-40 -115.76 -68.01 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.176 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 53.0 p 50.1 24.99 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.631 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -148.67 32.72 0.78 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.43 125.23 1.68 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.578 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -34.51 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -63.35 -25.97 68.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.695 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.659 HG21 ' HB2' ' A' ' 95' ' ' GLU . 43.3 t -62.67 -35.42 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -70.82 -34.88 72.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.48 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -64.18 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.2 pt-20 -85.14 -39.21 18.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.422 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.15 75.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 160' ' ' PHE . 33.0 tp -51.6 -33.48 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -43.47 28.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 104' ' ' GLU . 13.2 t -58.11 -33.31 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.69 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.7 OUTLIER -54.38 -31.07 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.215 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -50.43 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.539 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -54.09 -25.72 23.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.638 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.4 p -82.75 -177.85 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -3.73 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.407 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.433 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 11.9 mmp_? -48.54 177.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.774 0.321 . . . . 0.0 111.127 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.19 135.49 4.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.033 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 152.04 4.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.314 2.009 . . . . 0.0 112.099 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 139' ' ' ILE . 7.1 p -123.48 113.6 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.423 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 64.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.557 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -117.0 -150.17 9.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.91 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 83' ' ' PHE . 13.1 tp -137.42 128.21 27.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.773 0.321 . . . . 0.0 110.793 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -78.02 90.14 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -72.64 94.02 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.225 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.822 HG13 HD23 ' A' ' 128' ' ' LEU . 4.2 t -100.34 160.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.72 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -166.54 34.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.501 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 45.93 44.84 13.84 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.536 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -171.19 -43.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.679 0.276 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.53 114.4 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.286 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.918 HD13 ' CE2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -84.33 120.17 25.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 110.169 177.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -132.66 98.68 4.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.036 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 139' ' ' ILE . 5.7 p -83.26 129.45 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.846 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.499 HG23 ' H ' ' A' ' 138' ' ' LEU . 6.1 p -133.71 132.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.052 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.423 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 40.3 t0 -65.8 148.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.919 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -97.74 20.11 12.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -125.54 -42.15 1.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.3 p -104.27 -27.73 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.671 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tptm 49.35 49.9 18.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -113.69 14.03 22.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.076 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.736 HD12 ' H ' ' A' ' 139' ' ' ILE . 8.7 tp 59.36 148.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 111.248 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.996 HD11 HG21 ' A' ' 117' ' ' VAL . 3.3 mt -127.85 -51.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.493 ' O ' HD11 ' A' ' 138' ' ' LEU . 21.9 t -114.16 136.78 49.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.038 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -143.06 58.96 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -113.07 162.06 16.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.958 ' O ' HG23 ' A' ' 147' ' ' VAL . 63.4 m -97.67 122.73 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.603 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.94 HD11 ' CD1' ' A' ' 195' ' ' PHE . 7.3 tt -54.22 -31.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 143' ' ' THR . 24.3 tt0 -72.97 -25.25 60.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.444 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.2 OUTLIER -96.05 -39.55 9.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.499 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 143' ' ' THR . 17.8 t -49.76 144.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.272 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.476 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 9.1 m -50.51 -41.19 53.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.976 ' CE1' HD11 ' A' ' 163' ' ' ILE . 2.7 p90 155.77 -175.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.616 0.572 . . . . 0.0 110.074 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 19.5 p -121.23 140.13 52.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.738 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -167.94 133.06 1.54 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.803 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.423 ' CB ' ' O ' ' A' ' 159' ' ' GLY . 98.3 Cg_endo . . . . . 0 CA--C 1.535 0.534 0 C-N-CA 122.482 2.122 . . . . 0.0 112.298 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.704 0.288 . . . . 0.0 111.029 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 152' ' ' PRO . . . -122.05 141.3 14.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.569 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.473 ' O ' HD13 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -105.51 -163.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 0.0 110.83 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.8 t 172.5 129.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.736 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.918 ' CE2' HD13 ' A' ' 128' ' ' LEU . 3.9 m-30 -110.86 -179.56 3.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.976 HD11 ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -163.83 143.24 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.446 ' HB3' HG13 ' A' ' 147' ' ' VAL . 1.8 p -169.1 133.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.579 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.502 ' HG3' ' CZ2' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -67.63 84.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.979 177.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 169' ' ' THR . 97.8 m-20 -66.6 110.13 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.5 -20.72 59.64 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.467 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -48.56 3.33 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.473 ' CB ' ' HB3' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -50.2 -64.19 0.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.374 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 171' ' ' ARG . 53.7 mtp180 -164.54 -46.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.108 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 165.0 -145.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.502 ' CZ2' ' HG3' ' A' ' 165' ' ' ARG . 1.7 m-90 -64.17 81.7 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.489 ' HE2' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.81 134.9 39.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.333 0.587 . . . . 0.0 111.764 -176.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.736 ' SG ' HG11 ' A' ' 93' ' ' VAL . 1.2 m -101.89 169.03 9.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.978 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 39.8 m-70 -146.79 123.42 11.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 111.549 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -101.76 114.6 5.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.877 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.424 ' HD1' HG21 ' A' ' 85' ' ' VAL . 6.8 m-85 -104.96 146.04 29.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.124 0.488 . . . . 0.0 111.623 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.706 HD13 ' O ' ' A' ' 179' ' ' ALA . 3.1 tm? -145.76 110.46 5.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.706 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -42.39 143.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.858 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.8 t -71.91 -48.67 43.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.801 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -78.57 -25.13 45.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.99 77.84 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.462 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 39.9 t -169.9 28.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.503 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.05 34.99 0.62 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.144 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -136.21 47.54 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.546 ' CB ' HD13 ' A' ' 187' ' ' LEU . 1.6 mpt_? -153.47 -57.74 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.131 0.491 . . . . 0.0 110.158 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.49 -0.97 4.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.867 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.428 ' HA ' ' CE2' ' A' ' 160' ' ' PHE . 70.1 m -80.44 -44.08 19.87 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.076 0.465 . . . . 0.0 110.228 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CG ' ' CZ2' ' A' ' 69' ' ' TRP . 2.1 t-80 -94.84 -18.86 20.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.67 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.712 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -78.74 -63.07 1.5 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.539 HG21 ' OH ' ' A' ' 162' ' ' TYR . 54.4 t -48.41 -46.52 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.8 -24.22 57.2 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.792 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.877 ' HB3' HG21 ' A' ' 76' ' ' VAL . 56.1 m -85.84 -31.3 22.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.497 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.547 ' HB2' HG11 ' A' ' 123' ' ' VAL . . . -52.68 -42.39 64.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.94 ' CD1' HD11 ' A' ' 144' ' ' ILE . 45.3 m-85 -65.44 -25.88 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.876 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -43.44 -42.05 4.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.908 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.607 ' HB3' HD23 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -43.03 -46.4 5.56 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.811 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.64 ' N ' HD23 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -106.67 -27.28 10.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.096 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.139 177.213 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.95 ' HB3' ' HG3' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -157.41 68.44 0.53 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.209 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.678 HD12 ' N ' ' B' ' 3' ' ' ILE . 2.0 mp 66.41 -65.19 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.353 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 149' ' ' PHE . . . -40.49 -61.91 1.72 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.398 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.95 ' HG3' ' HB3' ' B' ' 1' ' ' ALA . 85.2 Cg_endo . . . . . 0 N--CA 1.464 -0.259 0 C-N-CA 122.908 2.405 . . . . 0.0 112.533 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.3 m0 . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.155 0.503 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -53.16 -24.42 10.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.332 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.57 23.1 13.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.994 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -131.45 -48.19 0.98 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.064 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.01 -37.97 22.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.899 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.08 -26.08 39.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -52.01 -65.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 197' ' ' VAL . 2.7 m -51.45 -31.58 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -47.78 73.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.758 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -94.04 21.56 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.006 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 49.06 85.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.174 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -176.8 41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -109.2 161.84 14.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.899 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 78.7 p 178.66 155.16 0.42 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' SER . 49.5 m-85 -164.69 141.61 6.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 t -51.84 149.92 4.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.352 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 187' ' ' LEU . 1.7 t -146.66 167.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.231 0.539 . . . . 0.0 112.324 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.531 ' H ' HG12 ' A' ' 85' ' ' VAL . 17.7 mmtt -121.52 48.07 1.75 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.995 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.936 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -38.8 150.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.066 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 116' ' ' PRO . 75.1 mt -106.54 -38.82 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.643 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.43 169.52 12.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.192 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 9.2 p -101.58 144.3 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 110.914 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -127.32 176.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.873 -178.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.5 ' N ' HG13 ' A' ' 91' ' ' VAL . 2.5 pt-20 -95.92 145.57 25.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.909 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 172' ' ' TRP . 13.6 m -146.0 166.91 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.87 0.367 . . . . 0.0 111.274 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -93.61 20.65 7.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.307 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 94' ' ' PHE . 9.9 mt-10 -167.2 150.05 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.031 0.443 . . . . 0.0 110.906 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 96.3 p -125.32 20.61 8.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.16 74.19 1.02 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.785 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -164.56 117.6 0.76 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.444 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.642 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -56.9 -26.76 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -27.98 36.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.416 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 58.4 t -62.11 -48.3 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.779 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.1 m -60.57 -37.63 81.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.633 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.43 -42.31 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.0 pt-20 -79.45 -35.53 40.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.503 ' O ' HD22 ' A' ' 109' ' ' LEU . . . -55.44 -53.22 58.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.453 ' CD1' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -47.18 -46.2 23.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -42.68 86.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 104' ' ' GLU . 25.2 t -57.66 -47.52 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.808 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.572 HD13 ' HG3' ' A' ' 114' ' ' ARG . 2.7 mm? -53.15 -23.31 7.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.92 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -59.99 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.408 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 1.3 pp0? -53.15 -31.18 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -85.04 -171.96 3.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.955 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 25.44 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.572 ' HG3' HD13 ' A' ' 109' ' ' LEU . 8.5 mmt180 -65.04 76.53 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.41 135.07 5.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.508 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.708 ' HB3' HD23 ' A' ' 88' ' ' LEU . 92.8 Cg_endo -82.4 164.93 16.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.574 2.183 . . . . 0.0 112.068 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.936 HG12 ' CB ' ' A' ' 87' ' ' TYR . 1.5 p -114.56 176.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.014 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.58 ' H ' HG22 ' A' ' 117' ' ' VAL . 3.0 ttt180 -152.65 89.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.455 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -149.59 -137.73 2.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.846 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -122.75 121.72 36.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.646 0.26 . . . . 0.0 111.219 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.636 ' HB2' HG21 ' A' ' 85' ' ' VAL . 8.6 tp -87.61 104.21 16.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.437 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -74.22 110.75 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.717 ' CG1' ' HB2' ' A' ' 194' ' ' ALA . 68.3 t -114.04 105.75 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.2 p -118.17 16.13 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.739 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 62.09 11.49 32.39 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.964 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -149.33 16.13 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.698 0.249 . . . . 0.0 111.282 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 161.06 96.88 0.11 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.812 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.867 HD13 ' CE2' ' A' ' 162' ' ' TYR . 1.6 mt -77.03 111.7 12.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.695 0.283 . . . . 0.0 110.501 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.35 86.76 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.312 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 139' ' ' ILE . 6.2 p -77.93 100.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.602 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 132' ' ' ASP . 65.2 t -99.72 154.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.562 ' OD2' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -91.85 139.49 30.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.425 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 38.7 t70 -87.82 14.33 8.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.524 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.4 OUTLIER -111.44 -30.62 7.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.05 0.452 . . . . 0.0 110.526 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.435 ' N ' ' HG3' ' A' ' 134' ' ' GLU . 67.0 p -139.12 8.64 2.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.512 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER 42.02 44.15 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.484 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.12 143.61 15.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.096 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.43 112.06 12.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.87 0.367 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.799 HD11 HG21 ' A' ' 117' ' ' VAL . 10.2 mt -81.18 -51.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.438 ' HB ' HG12 ' A' ' 130' ' ' VAL . 58.8 t -120.12 101.29 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -95.54 90.85 5.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.178 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 147' ' ' VAL . 19.2 mt-30 -142.13 161.36 38.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.65 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.702 ' O ' HG22 ' A' ' 144' ' ' ILE . 2.0 t -100.21 5.54 44.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 143' ' ' THR . 2.1 tt 84.66 -39.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.122 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -86.45 -25.16 25.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.918 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -78.59 -18.43 54.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.257 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.957 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -79.08 -177.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.607 ' HB3' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -98.01 22.3 9.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.38 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.436 ' CB ' ' O ' ' A' ' 148' ' ' SER . 18.5 m-85 85.62 -171.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 20.4 p -134.4 168.05 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.733 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.642 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -175.49 110.44 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 25.8 Cg_endo . . . . . 0 C--N 1.347 0.471 0 C-N-CA 122.462 2.108 . . . . 0.0 112.919 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.702 0.287 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.06 129.5 5.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.799 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 177' ' ' PHE . 0.5 OUTLIER -104.77 -174.53 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 110.591 178.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER 179.68 126.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 111.426 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.867 ' CE2' HD13 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -97.77 -173.78 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.61 179.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.957 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -159.07 133.36 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.622 ' HB2' HG13 ' A' ' 147' ' ' VAL . 35.4 t -131.5 152.45 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.009 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.89 96.93 5.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.03 -166.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.719 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.76 -86.74 1.2 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.68 29.73 6.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.683 0.277 . . . . 0.0 110.883 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 -84.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 173' ' ' MET . 9.3 ptm180 -179.21 -47.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -150.45 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.99 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.623 ' O ' HG22 ' A' ' 93' ' ' VAL . 5.7 m95 -68.31 72.86 0.21 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.468 ' HE3' ' O ' ' A' ' 91' ' ' VAL . 75.3 mmm -89.23 118.02 28.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.293 0.568 . . . . 0.0 111.772 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 161.64 26.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.135 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -133.64 109.52 9.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.42 125.8 7.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 1.7 p90 -144.5 144.6 31.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.642 HD12 ' OD2' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -110.34 140.51 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.841 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 182' ' ' ASP . . . -62.51 140.47 58.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.149 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.39 -62.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -74.8 -26.7 59.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.642 ' OD2' HD12 ' A' ' 178' ' ' LEU . 0.3 OUTLIER 62.48 81.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.088 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.52 33.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.447 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 46.15 39.66 9.58 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.594 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.84 4.58 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.574 ' CB ' HD13 ' A' ' 187' ' ' LEU . 14.1 mmt180 -114.76 -64.51 1.3 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.81 0.338 . . . . 0.0 110.743 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.844 HD12 HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -143.37 15.77 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.652 178.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.476 ' O ' ' CE1' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -96.38 -34.26 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 178.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.39 -21.42 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.52 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.18 -58.76 3.08 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 123' ' ' VAL . 33.2 t -49.73 -49.75 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.106 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.38 -33.89 12.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.354 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 2.9 t -76.41 -28.56 56.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.544 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.739 ' HB1' ' HA2' ' A' ' 125' ' ' GLY . . . -57.92 -47.02 84.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.787 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -53.56 -26.63 22.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.37 -29.07 9.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 76' ' ' VAL . 86.5 t -84.97 -31.32 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.505 ' HB3' HD23 ' A' ' 199' ' ' LEU . 11.5 t -53.94 -48.0 70.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.325 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 198' ' ' CYS . 0.1 OUTLIER -95.65 -24.5 16.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 121.287 0.565 . . . . 0.0 111.733 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.742 ' HB3' ' CG ' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.47 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -130.65 -82.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.928 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' B' ' 2' ' ' TYR . 3.7 mp -132.23 -58.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' B' ' 5' ' ' PRO . . . -45.59 -50.48 10.81 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.742 ' CG ' ' HB3' ' B' ' 1' ' ' ALA . 52.5 Cg_endo . . . . . 0 N--CA 1.459 -0.508 0 C-N-CA 123.332 2.688 . . . . 0.0 112.732 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.24 175.22 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -44.84 105.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.611 2.208 . . . . 0.0 112.748 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 171.2 -82.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.677 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -96.73 -34.93 11.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.385 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.403 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -61.0 -31.9 71.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -66.47 -29.29 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.17 -56.65 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 1.5 p30 -58.5 -36.88 74.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.958 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 17.4 tt0 -60.19 -27.22 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.489 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 -30.5 14.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.863 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.757 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -52.21 -50.72 61.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' O ' HG21 ' A' ' 197' ' ' VAL . 59.3 t -58.26 -38.75 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.422 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -39.9 70.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.561 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.78 1.41 55.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 124' ' ' SER . . . 65.92 78.51 0.27 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.829 0.347 . . . . 0.0 111.081 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 79' ' ' ALA . 2.9 t 176.19 60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -118.2 -172.75 2.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.912 ' HB3' HD21 ' A' ' 120' ' ' LEU . 2.1 m 174.16 153.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.997 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.489 ' C ' HD12 ' A' ' 120' ' ' LEU . 32.4 m-85 -162.1 139.78 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.686 ' N ' HD12 ' A' ' 120' ' ' LEU . 23.3 t -60.76 157.23 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.735 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.887 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.1 p 178.67 160.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.987 0.422 . . . . 0.0 111.915 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.551 ' N ' HG22 ' A' ' 85' ' ' VAL . 1.7 mttp -111.31 71.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.636 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.607 ' CB ' HG21 ' A' ' 130' ' ' VAL . 41.4 t80 -55.02 107.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.996 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.923 HD23 ' HB3' ' A' ' 109' ' ' LEU . 6.9 mp -48.5 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA2' ' CE1' ' A' ' 87' ' ' TYR . . . 176.18 -133.32 2.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.419 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.95 151.14 38.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.954 0.407 . . . . 0.0 111.002 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 109' ' ' LEU . 6.7 m -139.55 167.05 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.832 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.14 142.6 27.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 172' ' ' TRP . 2.1 m -145.49 173.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.223 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -116.26 25.56 10.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' HG21 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -144.84 -74.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.253 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m 59.45 19.48 7.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.24 66.54 1.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.59 -161.03 27.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.344 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.496 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -119.57 -36.26 3.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 111.06 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -61.58 -25.9 67.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.405 HG21 ' CB ' ' A' ' 95' ' ' GLU . 15.8 t -76.06 -30.44 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.31 -38.75 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.2 -37.72 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.5 pt-20 -88.31 -34.8 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -54.31 -51.31 65.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -45.52 62.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.595 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -39.12 73.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.399 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 104' ' ' GLU . 6.3 t -65.66 -39.65 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.757 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.923 ' HB3' HD23 ' A' ' 88' ' ' LEU . 1.5 mm? -55.64 -26.26 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -86.21 -61.29 1.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.044 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -48.4 -33.44 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.034 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.87 -165.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.41 42.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.44 ' HG3' HD13 ' A' ' 109' ' ' LEU . 1.7 mmp_? -93.1 70.39 4.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.825 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 133.84 19.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HB3' HD12 ' A' ' 88' ' ' LEU . 71.7 Cg_endo -79.37 141.49 16.01 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.476 2.117 . . . . 0.0 112.63 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.683 HG11 HD11 ' A' ' 139' ' ' ILE . 12.0 m -78.35 173.99 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.37 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -135.95 72.9 1.44 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.246 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -141.17 -130.4 2.58 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.852 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.912 HD21 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -145.25 140.94 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.878 0.37 . . . . 0.0 111.433 -178.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -85.68 116.22 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -81.05 84.25 6.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.968 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 191' ' ' VAL . 38.0 t -94.89 125.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.506 ' O ' ' HB1' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -142.82 44.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.499 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 41.35 51.91 4.42 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.949 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.786 ' O ' HG22 ' A' ' 144' ' ' ILE . 20.9 t70 -164.94 -40.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.673 0.273 . . . . 0.0 111.072 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.433 ' HA2' ' N ' ' A' ' 144' ' ' ILE . . . -176.52 118.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.459 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.802 HD11 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.6 115.81 6.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.736 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -117.99 78.94 1.3 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.607 HG21 ' CB ' ' A' ' 87' ' ' TYR . 5.8 p -68.14 132.79 32.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.081 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.31 139.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -75.95 163.05 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.415 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 48.6 t0 -103.17 15.68 28.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.327 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.03 -60.26 1.82 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.883 0.373 . . . . 0.0 110.579 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 42.9 p -82.01 -27.91 32.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.7 48.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -126.54 142.38 13.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.1 tp -69.45 132.63 46.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.745 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.683 HD11 HG11 ' A' ' 117' ' ' VAL . 8.8 mt -100.63 -53.26 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.395 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 130' ' ' VAL . 13.9 t -111.48 67.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.21 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.459 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.6 p-10 -72.97 67.59 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.51 152.57 48.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 145' ' ' GLU . 64.5 m -78.71 145.06 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.69 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.802 HD12 HD11 ' A' ' 128' ' ' LEU . 7.0 tt -71.89 -30.71 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.897 0.38 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.631 ' H ' HG22 ' A' ' 143' ' ' THR . 8.6 tt0 -75.5 -28.94 59.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.283 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.1 mttm -90.91 -39.23 12.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.368 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 148' ' ' SER . 9.9 p -58.9 163.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.038 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.516 ' N ' HG22 ' A' ' 147' ' ' VAL . 12.9 t -76.06 1.95 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' HA ' ' CE1' ' A' ' 195' ' ' PHE . 1.4 m-85 80.86 174.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.044 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.459 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 2.9 t -108.92 164.99 11.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -155.17 97.67 2.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.404 ' HG2' ' OH ' ' B' ' 2' ' ' TYR . 53.2 Cg_exo -49.06 129.79 22.45 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.256 1.971 . . . . 0.0 111.789 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.49 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.416 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -156.67 23.26 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.231 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.6 t30 44.25 29.64 0.38 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.569 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.408 ' HB2' ' HG3' ' A' ' 154' ' ' ARG . 1.1 t-80 -86.84 -17.57 33.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.523 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.33 25.33 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.139 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 178' ' ' LEU . 2.6 mmp_? 69.17 45.46 0.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.953 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.704 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -109.87 144.97 16.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.39 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 3.5 m-85 -143.97 178.26 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.607 0.241 . . . . 0.0 110.852 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.409 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 1.8 m -172.26 134.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 111.554 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.577 ' CE2' ' CZ ' ' A' ' 177' ' ' PHE . 98.2 m-85 -94.55 -174.31 3.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.486 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -165.99 137.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.607 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -136.72 125.69 24.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.0 OUTLIER -76.89 87.48 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.046 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 168' ' ' THR . 23.1 t0 50.84 -90.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.234 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 165' ' ' ARG . . . 59.47 -82.35 0.01 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -140.96 25.15 2.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.481 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.681 HG22 ' SD ' ' A' ' 173' ' ' MET . 4.2 m -122.25 23.62 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.488 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 169' ' ' THR . 12.3 mtp180 86.74 -72.29 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.487 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -146.6 -164.33 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 0.0 111.02 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.423 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 m95 -56.01 90.17 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.681 ' SD ' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -98.07 110.74 23.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.828 -177.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.495 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 0.6 OUTLIER -82.03 148.19 28.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.735 177.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 173' ' ' MET . 24.6 m-70 -128.66 158.58 38.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 111.857 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.409 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -144.63 138.53 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.845 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.577 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -153.98 115.06 4.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.178 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.704 HD22 ' HA2' ' A' ' 159' ' ' GLY . 0.1 OUTLIER -90.25 122.33 33.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.821 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -46.1 135.44 7.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.511 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -67.08 0.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -33.3 65.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.343 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' CD1' ' A' ' 178' ' ' LEU . 1.4 m-20 63.27 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.268 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.22 28.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.863 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.43 29.22 0.22 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.23 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 186' ' ' ARG . 18.0 mt-10 -138.61 47.7 1.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.027 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.5 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -159.63 -42.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.887 HD21 ' HB ' ' A' ' 85' ' ' VAL . 5.9 mp -114.65 -37.65 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 t -56.95 -59.95 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -75.58 -26.46 57.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -67.26 -66.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 187' ' ' LEU . 1.5 t -70.66 -29.45 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -53.12 -28.79 34.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.218 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 47.5 t -95.86 -22.61 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.302 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.501 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -47.42 -38.61 13.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 199' ' ' LEU . 61.5 m-85 -79.07 -26.99 43.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.348 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -47.16 -43.87 21.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.127 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 76' ' ' VAL . 54.2 t -67.05 -30.06 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.738 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.8 t -66.9 -58.87 4.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.779 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.943 HD21 HG21 ' B' ' 3' ' ' ILE . 2.1 pt? -117.54 51.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.547 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.423 ' CA ' ' O ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER -50.56 -33.08 20.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.44 22.07 5.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.695 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm 49.89 44.3 25.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.81 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -58.67 -18.36 30.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.915 ' CD ' HD13 ' A' ' 199' ' ' LEU . 0.6 OUTLIER -48.81 129.02 16.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.062 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.64 81.35 2.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.759 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.476 HG21 ' HA ' ' B' ' 7' ' ' LEU . 0.5 OUTLIER -115.96 -39.82 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.142 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -99.52 -172.04 2.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 209' ' ' ALA . . . -68.8 -50.97 45.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.01 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 208' ' ' ALA . . . 69.06 103.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.034 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 209' ' ' ALA . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.891 -1.052 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.721 0.296 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -163.34 -89.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.129 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.943 HG21 HD21 ' A' ' 199' ' ' LEU . 2.6 mm -109.17 -52.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.35 -74.97 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.473 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' B' ' 6' ' ' PTR . 17.5 Cg_exo -71.28 52.03 1.46 Allowed 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 123.159 2.573 . . . . 0.0 113.34 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.424 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 206' ' ' THR . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.835 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.828 0.347 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.8 mttp 48.44 70.92 1.79 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.275 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.59 -77.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.589 2.193 . . . . 0.0 112.015 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.04 -69.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.54 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.46 -23.91 52.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -29.33 69.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.037 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -62.92 -34.74 78.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.52 -51.42 8.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.991 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -58.71 -42.46 88.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.34 -36.91 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.691 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -86.11 -29.79 23.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.708 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -53.55 -57.59 10.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.793 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.741 HG21 ' SG ' ' A' ' 193' ' ' CYS . 0.3 OUTLIER -49.4 -38.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -49.65 74.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.448 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.4 20.64 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 49.21 90.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t 179.5 44.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -112.62 162.27 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.769 ' OG ' HD22 ' A' ' 120' ' ' LEU . 32.4 t -172.64 154.0 2.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.526 ' CB ' HD11 ' A' ' 187' ' ' LEU . 91.2 m-85 -160.34 141.1 11.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -58.14 151.07 19.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.112 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.986 HG22 HD21 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -152.18 171.81 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 112.115 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.578 ' H ' HG12 ' A' ' 85' ' ' VAL . 1.3 mttm -128.11 40.11 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.966 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.523 ' CD1' ' HB3' ' A' ' 177' ' ' PHE . 6.0 t80 -44.57 123.91 3.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.608 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.63 HD23 ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.55 -60.31 2.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . 159.31 -160.28 31.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.393 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.21 146.49 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.059 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.622 HG22 HD21 ' A' ' 109' ' ' LEU . 2.8 m -133.78 135.47 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.12 120.66 18.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 172' ' ' TRP . 10.7 m -120.96 177.27 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.086 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.22 -22.92 18.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.194 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HB2' HG21 ' A' ' 101' ' ' VAL . 19.5 mp0 -123.61 153.52 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.1 p -133.25 21.78 4.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.009 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.3 23.9 1.03 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.67 131.97 9.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.607 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -51.69 60.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.36 -26.75 8.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 95' ' ' GLU . 47.1 t -65.49 -33.13 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.205 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -72.98 -41.39 64.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 4.1 mt-10 -58.68 -33.7 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.576 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.6 pt-20 -87.64 -40.34 14.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -57.39 -58.88 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.61 HD13 ' C ' ' A' ' 106' ' ' LEU . 2.4 tm? -46.36 -40.56 12.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.899 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -64.55 -45.52 86.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 178.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.1 t -63.92 -30.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.883 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.63 ' HB3' HD23 ' A' ' 88' ' ' LEU . 3.5 mm? -59.04 -23.67 62.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.512 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -93.38 -36.23 12.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -72.97 -21.73 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.306 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.26 172.0 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -53.67 -22.73 9.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HG3' HD13 ' A' ' 109' ' ' LEU . 7.4 mmp_? -46.05 92.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -94.96 150.42 37.74 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.416 ' HB3' ' HB3' ' A' ' 86' ' ' LYS . 52.7 Cg_exo -53.23 166.26 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.767 2.311 . . . . 0.0 112.466 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 139' ' ' ILE . 7.0 p -137.9 119.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.356 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -80.85 97.91 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.46 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.69 -169.08 18.96 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.769 HD22 ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -109.87 124.43 51.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.388 . . . . 0.0 111.122 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.731 ' HG ' HG23 ' A' ' 123' ' ' VAL . 6.9 tp -88.88 99.32 12.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.882 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.05 96.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.408 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.731 HG23 ' HG ' ' A' ' 121' ' ' LEU . 95.1 t -102.73 117.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.512 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -136.86 28.99 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.116 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 49.69 24.41 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.759 ' O ' HG22 ' A' ' 144' ' ' ILE . 12.3 t70 -133.92 -44.3 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.27 116.69 0.71 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.71 HD13 ' CE2' ' A' ' 162' ' ' TYR . 8.5 mt -71.57 133.98 46.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -141.49 98.08 3.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 139' ' ' ILE . 4.8 p -89.21 104.47 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 136' ' ' LYS . 14.3 t -107.07 132.62 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.076 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 136' ' ' LYS . 41.3 t0 -70.17 133.28 46.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -79.08 -6.59 56.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -97.57 -24.49 15.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.9 p -123.61 -35.17 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.539 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.1 OUTLIER 75.54 25.25 1.24 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.54 123.83 8.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.262 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 6.5 tp -50.81 131.52 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.991 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.696 ' HB ' HG13 ' A' ' 130' ' ' VAL . 9.6 mt -105.11 -54.13 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.269 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 140' ' ' VAL . 59.7 t -111.11 65.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.464 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 35.7 p-10 -68.16 66.92 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 140' ' ' VAL . 19.2 mt-30 -138.34 134.59 34.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -54.19 -176.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 178.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 126' ' ' ASP . 18.1 tt -108.76 -15.83 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.767 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -99.6 -26.99 13.9 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.0 OUTLIER -110.24 -171.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.289 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.39 14.78 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.475 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HB3' ' HA2' ' B' ' 4' ' ' GLY . 2.5 m-85 73.66 149.56 0.1 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.874 0.369 . . . . 0.0 110.988 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 24.6 p -72.36 -178.56 2.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.957 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 171.75 80.83 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.79 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 10.7 Cg_endo -53.84 146.61 45.18 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -44.12 -59.66 2.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.416 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.34 31.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.3 m120 42.36 32.23 0.32 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.598 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -108.01 7.35 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.975 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -152.24 19.18 0.66 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.832 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.453 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER 58.84 33.82 23.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.739 0.304 . . . . 0.0 111.181 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 178' ' ' LEU . . . -126.63 141.18 12.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.899 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.527 ' CE1' ' CB ' ' A' ' 188' ' ' SER . 4.9 m-85 -118.34 -174.27 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.9 m -166.07 134.81 3.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.528 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.71 ' CE2' HD13 ' A' ' 128' ' ' LEU . 7.5 m-30 -102.34 175.28 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.286 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.891 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -159.21 150.96 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.964 0.411 . . . . 0.0 111.425 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.3 166.3 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.539 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.82 79.18 1.54 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.132 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 46.62 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.183 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.03 -34.17 6.0 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.107 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 94.7 m -150.75 -44.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -72.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.92 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -178.21 -79.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.629 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 173' ' ' MET . 1.6 ptp180 -131.81 -153.47 0.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.91 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.607 ' O ' HG22 ' A' ' 93' ' ' VAL . 11.5 m95 -62.83 80.09 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 171' ' ' ARG . 1.2 mmt -85.36 121.57 28.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.74 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.32 156.94 16.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.749 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.68 105.61 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.749 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.96 104.83 2.89 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.468 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.601 ' HD2' HG11 ' A' ' 85' ' ' VAL . 3.3 p90 -121.16 132.64 54.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.415 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.669 ' O ' HG12 ' A' ' 85' ' ' VAL . 10.6 tp -102.26 147.24 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.688 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -68.22 140.09 56.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.175 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.424 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 35.8 t -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.753 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.75 -36.24 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.9 66.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.453 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 2.6 p -148.98 16.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.733 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 43.33 34.71 2.43 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.861 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -144.82 50.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.475 ' C ' HD12 ' A' ' 187' ' ' LEU . 33.0 mtt-85 -168.8 -42.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.74 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.986 HD21 HG22 ' A' ' 85' ' ' VAL . 9.8 mp -113.32 -42.44 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.527 ' CB ' ' CE1' ' A' ' 160' ' ' PHE . 23.2 p -53.36 -65.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -66.91 -25.44 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -69.44 -60.03 2.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 187' ' ' LEU . 17.6 t -61.21 -40.5 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.881 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.73 -41.56 95.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.141 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.741 ' SG ' HG21 ' A' ' 76' ' ' VAL . 14.0 p -73.89 -34.0 64.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 110.332 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.437 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -56.41 -44.82 80.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -51.05 -26.29 6.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.72 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.57 -32.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.621 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.474 ' HB3' HD23 ' A' ' 199' ' ' LEU . 46.6 t -49.85 -36.17 25.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 202' ' ' LYS . 0.2 OUTLIER -118.91 -36.37 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 66.88 126.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.451 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 63.22 21.71 12.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.216 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.811 ' HA ' HD12 ' A' ' 199' ' ' LEU . 11.0 mptt 44.8 38.76 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.83 0.348 . . . . 0.0 111.318 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -67.46 -32.49 73.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.989 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.616 ' HD2' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER 38.09 -159.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.611 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mmt-85 -145.26 25.21 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.818 0.342 . . . . 0.0 111.112 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.536 HG21 HD12 ' B' ' 7' ' ' LEU . 0.1 OUTLIER -108.0 -24.44 11.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.797 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -48.93 -40.17 29.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.107 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -118.21 85.04 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.151 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 210' ' ' ALA . . . -77.24 -172.72 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.03 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 209' ' ' ALA . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.999 -1.001 . . . . 0.0 111.012 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.415 ' CB ' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.803 0.335 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.46 -97.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.832 HG23 ' OXT' ' B' ' 7' ' ' LEU . 2.7 mp -112.63 -29.85 2.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 149' ' ' PHE . . . -55.74 -85.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.541 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 49.1 Cg_exo -57.41 89.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.467 2.112 . . . . 0.0 110.826 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.407 ' HB2' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.832 ' OXT' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.91 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.798 0.332 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt 45.28 55.96 14.73 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.237 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -47.64 -59.0 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.849 2.366 . . . . 0.0 112.22 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -170.84 -61.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -80.83 -26.67 36.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.682 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -54.64 -30.18 54.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -68.99 -33.4 73.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.632 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.02 -63.13 1.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.084 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.47 -47.53 57.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -29.77 11.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.4 -24.69 15.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 81' ' ' CYS . . . -59.17 -64.82 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.76 HG21 ' HB3' ' A' ' 193' ' ' CYS . 2.3 m -50.03 -32.68 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -59.66 -52.55 65.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.463 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.81 23.44 5.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.833 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 48.65 85.27 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -176.64 34.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.325 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.505 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 4.6 t -98.75 156.28 16.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.053 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' HD22 ' A' ' 120' ' ' LEU . 2.6 t -174.8 152.02 1.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.763 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.486 ' CG ' ' HB3' ' A' ' 186' ' ' ARG . 72.3 m-85 -162.18 147.68 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 44.6 t -55.31 151.88 9.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.905 HG22 HD21 ' A' ' 187' ' ' LEU . 1.6 t -152.68 168.35 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.107 0.48 . . . . 0.0 111.618 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.521 ' H ' HG12 ' A' ' 85' ' ' VAL . 2.5 mttt -128.11 48.2 2.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.929 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.641 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.4 t80 -39.57 114.98 0.46 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.871 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 116' ' ' PRO . 54.9 mt -66.89 -26.93 67.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.651 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 126.01 -152.91 18.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.222 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 2.8 m -126.95 150.45 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.014 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.576 HG13 HD13 ' A' ' 109' ' ' LEU . 13.8 m -133.87 134.91 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.33 133.06 46.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.728 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.727 HG22 ' O ' ' A' ' 172' ' ' TRP . 23.9 m -138.64 169.4 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 111.361 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.5 16.0 16.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -157.34 119.46 3.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 1.7 p -95.83 24.18 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -165.16 123.43 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.751 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 148.72 113.07 0.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -49.71 -36.61 25.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.087 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.22 -41.28 97.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.35 -33.68 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.081 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -70.36 -39.04 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.05 -32.56 68.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.868 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.8 pt-20 -93.79 -36.51 12.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -50.11 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.895 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -50.09 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.686 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -44.06 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.01 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.5 t -65.68 -34.38 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.717 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.651 HD11 ' C ' ' A' ' 89' ' ' GLY . 1.1 mm? -52.03 -28.49 17.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 0.0 110.196 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.0 -27.84 18.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.561 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.72 20.43 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.174 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -120.6 147.63 44.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -23.69 4.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.64 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HG3' ' HB3' ' A' ' 112' ' ' SER . 0.0 OUTLIER -45.28 171.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.366 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -138.62 151.74 69.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.037 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.732 ' HB3' HD23 ' A' ' 88' ' ' LEU . 89.1 Cg_endo -80.2 -179.9 5.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.636 2.224 . . . . 0.0 112.392 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -141.26 -173.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.616 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.617 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -166.6 96.24 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -158.7 -131.44 1.27 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.771 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.533 HD22 ' OG ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -124.72 129.75 51.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.075 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.622 HD12 ' CE1' ' A' ' 177' ' ' PHE . 10.5 tt -100.88 113.02 25.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.187 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -76.95 111.57 12.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.911 ' CG1' ' HB2' ' A' ' 194' ' ' ALA . 82.1 t -110.78 96.74 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.32 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.443 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -111.79 27.58 9.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.378 . . . . 0.0 111.292 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.77 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 47.62 26.37 3.83 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.274 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.813 ' O ' HG22 ' A' ' 144' ' ' ILE . 24.5 t0 -140.15 -42.91 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.946 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -158.4 119.53 0.9 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.524 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -73.64 123.64 24.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.42 ' HD2' HD21 ' A' ' 138' ' ' LEU . 5.4 mmm-85 -135.31 100.91 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 139' ' ' ILE . 9.2 p -90.59 128.39 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.47 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 132' ' ' ASP . 54.6 t -116.1 154.87 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.693 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 131' ' ' VAL . 54.5 t0 -102.79 135.72 43.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.5 -0.41 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.714 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -103.48 -31.16 10.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.867 0.365 . . . . 0.0 110.996 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 p -116.64 -29.09 6.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 66.93 29.62 8.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.39 . . . . 0.0 110.715 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 131' ' ' VAL . . . -95.54 -128.89 5.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.595 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 7.5 tp -156.97 134.63 10.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.773 0.32 . . . . 0.0 110.796 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 117' ' ' VAL . 4.3 mt -108.07 -54.85 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 130' ' ' VAL . 7.6 t -109.09 71.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.359 . . . . 0.0 111.24 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.455 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 14.9 p-10 -78.58 59.91 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.12 163.11 25.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.389 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.7 m -78.02 174.14 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.713 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 126' ' ' ASP . 4.1 tt -97.64 -21.29 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -91.05 -39.52 12.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.835 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -72.66 -29.23 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 148' ' ' SER . 8.3 p -74.82 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.804 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.541 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -72.55 -0.86 13.95 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.6 m-85 79.11 179.3 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 25.5 p -98.94 177.34 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HA ' ' HG3' ' B' ' 5' ' ' PRO . . . -171.24 101.01 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.081 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.75 120.84 8.08 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.368 2.045 . . . . 0.0 111.977 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -39.03 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.959 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -143.42 21.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.306 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 48.24 26.88 1.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.815 0.34 . . . . 0.0 111.111 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 156' ' ' HIS . 11.8 t-160 -130.94 63.92 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 158' ' ' ARG . 0.5 OUTLIER 166.04 -25.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.515 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER 82.63 26.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.677 -179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.18 106.31 1.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 0.1 OUTLIER -96.41 -177.22 3.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.439 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.83 122.72 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.948 0.404 . . . . 0.0 111.301 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.572 ' OH ' HG11 ' A' ' 191' ' ' VAL . 1.8 m-30 -95.73 -160.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.49 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.495 ' O ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -169.89 148.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 18.6 p -135.72 163.32 30.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -129.06 81.07 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 167' ' ' GLY . 2.0 p30 46.55 -161.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 166' ' ' ASP . . . 95.45 -57.08 1.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.137 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.39 19.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 110.926 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 170' ' ' ARG . 49.4 m -137.67 -86.03 0.29 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.673 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 169' ' ' THR . 4.9 mtt180 -164.08 -82.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.906 0.384 . . . . 0.0 111.008 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.6 ptp180 -138.12 -150.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.129 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.727 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.1 m95 -68.6 67.78 0.14 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.416 ' HE3' ' C ' ' A' ' 91' ' ' VAL . 20.4 mmm -89.73 119.97 30.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.39 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HB2' HG23 ' A' ' 91' ' ' VAL . 6.9 m -76.77 166.21 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.753 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 174' ' ' CYS . 17.0 m-70 -138.43 93.09 2.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.407 ' HA3' ' HG ' ' A' ' 109' ' ' LEU . . . -75.89 118.74 5.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.602 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.622 ' CE1' HD12 ' A' ' 121' ' ' LEU . 4.2 m-85 -114.75 108.21 16.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 178' ' ' LEU . 10.7 mt -88.88 98.52 11.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.46 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.859 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -47.18 135.98 9.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.443 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.0 t -54.15 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -55.81 -29.93 60.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.382 . . . . 0.0 110.589 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.93 67.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.116 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.77 21.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.349 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 188' ' ' SER . . . 40.96 34.42 0.8 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.337 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.3 -6.64 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.777 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -124.66 -10.82 7.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.905 HD21 HG22 ' A' ' 85' ' ' VAL . 7.9 mp -136.04 -46.54 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.499 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 14.9 t -61.11 -52.01 66.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.75 -30.19 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -76.75 -69.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 187' ' ' LEU . 21.4 t -48.97 -48.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -61.1 -26.93 66.49 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.802 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.76 ' HB3' HG21 ' A' ' 76' ' ' VAL . 1.2 m -78.31 -33.0 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.46 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.911 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -51.46 -44.3 62.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CE2' ' CG1' ' A' ' 144' ' ' ILE . 93.8 m-85 -58.62 -22.44 56.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -47.48 -48.53 26.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.011 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 194' ' ' ALA . 2.4 m -73.58 -35.79 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.146 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 35.4 t -44.07 -45.03 7.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.178 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.431 HD22 HG21 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -105.18 -29.8 10.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.471 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 58.91 120.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.506 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 68.41 39.41 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.316 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm 48.54 29.0 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.01 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -80.99 67.03 6.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.118 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.643 ' CG ' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -54.36 -27.77 38.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 62.82 44.34 6.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.461 HG22 HD23 ' B' ' 7' ' ' LEU . 59.9 p -55.82 -44.72 78.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.013 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.26 -54.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.973 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 59.07 105.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.006 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.77 -71.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.012 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.696 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.71 80.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.643 HD12 ' CG ' ' A' ' 204' ' ' ARG . 1.6 mm 70.43 -64.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.64 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.58 -79.07 0.07 OUTLIER Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.816 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.696 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 38.2 Cg_exo -57.45 -33.33 96.16 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.771 2.314 . . . . 0.0 111.943 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.469 ' HD2' ' C ' ' B' ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.461 HD23 HG22 ' A' ' 206' ' ' THR . 1.4 mp . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.841 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 69' ' ' TRP . 0.7 OUTLIER -136.4 95.43 12.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.33 -7.12 19.19 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.632 2.221 . . . . 0.0 112.84 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -110.26 140.66 44.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.715 0.293 . . . . 0.0 110.76 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.62 -64.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.338 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 1.4 m0 -52.86 -46.65 67.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.522 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 7.0 pt20 -48.06 -36.52 13.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.088 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -82.77 -58.5 2.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.434 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -46.88 -29.73 2.15 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.045 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.45 -40.77 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.29 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -93.98 -14.37 25.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 178.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -60.21 -41.72 93.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 194' ' ' ALA . 46.1 t -65.49 -49.55 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.514 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 19.9 mtm-85 -50.49 -53.47 29.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.733 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.28 -0.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.516 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 64.77 80.58 0.23 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.706 0.289 . . . . 0.0 111.07 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 t -179.32 44.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -106.9 163.51 12.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.739 0.304 . . . . 0.0 110.757 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.56 146.18 5.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' C ' HD23 ' A' ' 120' ' ' LEU . 81.2 m-85 -157.43 129.42 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -52.38 159.1 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.524 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.846 ' HB ' HD21 ' A' ' 187' ' ' LEU . 13.0 p -172.92 160.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 111.691 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.522 ' N ' HG22 ' A' ' 85' ' ' VAL . 7.3 mmtt -108.02 65.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.735 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.557 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -60.36 126.05 26.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.414 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 88' ' ' LEU . 6.2 mp -77.92 -31.58 51.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.586 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.79 -164.13 15.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.254 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.426 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 20.2 m -105.19 147.59 27.83 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.992 0.425 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 174' ' ' CYS . 0.4 OUTLIER -126.68 171.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.045 -178.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 1.6 pt-20 -90.63 140.8 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 92' ' ' GLU . 34.3 m -158.41 179.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.839 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.07 18.92 4.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.46 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HB2' HG21 ' A' ' 101' ' ' VAL . 58.0 mp0 -152.72 112.99 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.414 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.469 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -106.67 25.11 11.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.901 177.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.64 33.66 2.23 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.982 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.27 106.82 0.56 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.444 ' CE ' ' HB3' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -49.82 -25.69 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 110.871 179.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -76.31 -26.26 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.859 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 95' ' ' GLU . 23.6 t -67.44 -39.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.967 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.3 m -72.15 -48.09 46.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.345 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -52.95 -38.24 61.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.349 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.5 pt-20 -85.83 -42.13 14.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.768 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 101' ' ' VAL . . . -49.78 -48.12 50.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 160' ' ' PHE . 6.5 tt -50.87 -46.12 60.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -40.83 90.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.062 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 112' ' ' SER . 41.3 t -61.77 -31.19 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.058 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.606 HD13 ' HG3' ' A' ' 114' ' ' ARG . 3.2 mm? -67.54 -21.46 65.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -89.11 -50.38 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -24.08 64.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 96.2 p -79.17 170.82 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.27 -22.55 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.417 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.606 ' HG3' HD13 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -46.36 159.61 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.107 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -150.09 153.49 35.48 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.82 0.343 . . . . 0.0 111.418 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.5 Cg_exo -60.53 163.2 15.85 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.801 2.334 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 117' ' ' VAL . 7.4 p -133.82 110.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -74.85 74.31 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.439 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 131' ' ' VAL . . . -134.48 -156.73 7.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -123.92 125.54 44.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 111.43 -178.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.473 ' HG ' HG23 ' A' ' 123' ' ' VAL . 42.8 tp -83.91 105.67 14.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.264 177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -76.84 98.44 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.424 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.934 HG21 HG22 ' A' ' 191' ' ' VAL . 97.0 t -101.96 108.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 48.1 p -125.85 40.57 3.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.116 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.451 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 40.58 35.56 0.87 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.211 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 144' ' ' ILE . 19.7 t0 -158.21 -40.5 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.551 0.215 . . . . 0.0 111.452 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -147.63 121.24 1.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.991 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.772 HD11 ' CG1' ' A' ' 191' ' ' VAL . 0.0 OUTLIER -83.56 91.37 7.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.817 0.341 . . . . 0.0 110.427 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.832 ' HB3' HD11 ' A' ' 138' ' ' LEU . 3.5 mtt85 -107.28 98.45 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 139' ' ' ILE . 4.4 p -90.11 106.26 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 132' ' ' ASP . 4.1 t -93.32 163.84 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 131' ' ' VAL . 46.1 t0 -109.96 136.8 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.43 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 118' ' ' ARG . 49.4 t0 -79.18 3.06 18.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.97 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -116.03 -32.42 5.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.7 p -115.91 -23.05 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.359 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.5 OUTLIER 62.14 18.37 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.129 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.67 125.42 8.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.062 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -59.05 126.4 27.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.664 ' HB ' HG13 ' A' ' 130' ' ' VAL . 6.0 mt -89.73 -24.07 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.706 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.409 HG23 ' CG1' ' A' ' 130' ' ' VAL . 3.5 t -144.09 63.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.444 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 9.4 p-10 -73.32 61.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.554 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -131.89 159.84 37.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 145' ' ' GLU . 91.5 m -75.88 143.17 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.712 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 126' ' ' ASP . 7.9 tt -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.72 ' H ' HG22 ' A' ' 143' ' ' THR . 4.3 tt0 -77.07 -30.19 55.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.707 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -76.44 -20.3 57.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.908 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.6 OUTLIER -78.07 169.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.61 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.438 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -83.92 8.8 13.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.85 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.411 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.9 m-85 78.97 139.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.238 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.511 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 29.4 p -74.38 -174.42 2.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.767 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.483 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . -166.23 55.5 0.36 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.691 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 151' ' ' ALA . 50.9 Cg_exo -52.2 110.86 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.205 1.937 . . . . 0.0 111.374 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.444 ' HB3' ' CE ' ' A' ' 99' ' ' MET . 29.9 t0 -171.46 79.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.246 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.401 ' NH1' ' O ' ' A' ' 151' ' ' ALA . 6.6 mpt_? -130.62 -43.64 1.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.52 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 46.41 27.76 0.64 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -122.68 -33.98 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.402 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -149.87 18.22 0.89 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.007 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 183' ' ' SER . 0.1 OUTLIER 58.97 57.5 3.54 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.533 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.34 149.27 18.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.718 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.492 ' HB2' ' CE1' ' A' ' 177' ' ' PHE . 0.1 OUTLIER -139.83 172.82 12.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 40.7 t -165.25 134.93 3.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.592 ' CE2' HD23 ' A' ' 128' ' ' LEU . 2.7 m-30 -89.54 -165.28 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.502 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.908 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -164.77 158.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.392 . . . . 0.0 111.668 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 42.6 t -159.89 127.95 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.465 ' HG3' ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.71 87.61 7.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.103 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 45.3 -158.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.03 -71.67 0.26 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.109 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 168' ' ' THR . 26.1 m -130.3 17.19 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 0.0 111.084 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.603 HG22 ' SD ' ' A' ' 173' ' ' MET . 18.6 m -131.07 23.83 4.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 169' ' ' THR . 11.5 mmm180 84.95 -71.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.456 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 -158.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.985 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -65.77 94.67 0.22 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.603 ' SD ' HG22 ' A' ' 169' ' ' THR . 0.3 OUTLIER -110.61 158.37 18.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 111.702 -177.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.562 ' HB2' HG12 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -111.94 174.98 5.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.878 178.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -137.67 74.62 1.49 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.96 0.41 . . . . 0.0 110.774 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -76.55 129.22 9.76 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.92 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.529 ' CG ' ' CE2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -153.92 160.11 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.529 HD21 ' OD2' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -132.91 127.1 33.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.832 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.498 ' HA ' HD22 ' A' ' 187' ' ' LEU . . . -47.73 134.78 12.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.504 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -63.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -62.16 -29.27 70.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.556 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.529 ' OD2' HD21 ' A' ' 178' ' ' LEU . 0.3 OUTLIER 60.45 80.16 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.178 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.419 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -170.65 28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.462 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.25 29.96 0.25 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.201 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.02 56.55 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -169.17 -41.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.987 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.846 HD21 ' HB ' ' A' ' 85' ' ' VAL . 6.5 mp -115.65 -45.56 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.688 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -49.37 67.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.807 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -82.75 -27.98 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.813 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 186' ' ' ARG . . . -70.06 -57.6 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.883 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 123' ' ' VAL . 1.2 t -76.52 -26.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.69 -32.69 32.93 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.555 ' HB3' HG11 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -90.62 -20.76 22.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.648 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.661 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -46.58 -37.99 8.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.142 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -77.09 -23.59 51.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.005 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.71 -35.34 30.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.825 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 99.4 t -79.93 -30.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.621 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 50.2 t -51.75 -39.84 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.308 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -107.06 -26.89 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.25 123.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.28 19.25 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.124 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.567 ' HA ' HD12 ' A' ' 199' ' ' LEU . 2.0 mmmt 46.74 48.76 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.487 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -51.96 -47.34 64.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.87 0.366 . . . . 0.0 110.521 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 42.82 97.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.778 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -69.87 72.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.831 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.808 ' CG2' HD23 ' B' ' 7' ' ' LEU . 40.4 p -113.01 38.97 2.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.034 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -136.57 -60.7 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.031 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -98.95 73.11 1.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.21 -170.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.154 -0.926 . . . . 0.0 111.01 179.936 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.474 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -177.15 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.543 ' HA ' HD12 ' B' ' 7' ' ' LEU . 3.7 mp -45.14 -27.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.85 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 6' ' ' PTR . . . -48.56 -82.66 0.03 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.968 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 32.9 Cg_exo -66.09 60.34 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.026 2.484 . . . . 0.0 112.085 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.437 ' N ' ' O ' ' B' ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.808 HD23 ' CG2' ' A' ' 206' ' ' THR . 4.7 mp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.922 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.906 0.384 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -71.3 142.62 87.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.966 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.56 -178.3 3.63 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.66 2.24 . . . . 0.0 112.295 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.4 -162.93 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -43.22 -36.09 1.64 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.09 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 3.0 m0 -54.03 -43.93 70.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.925 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -47.69 -33.39 6.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.25 -61.01 1.87 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.304 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -48.38 -32.14 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.186 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -61.99 -28.93 69.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -99.45 -29.26 12.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.859 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -48.26 -35.84 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.938 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -61.91 -34.27 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.004 0.43 . . . . 0.0 110.512 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.8 mtm180 -64.39 -56.49 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.23 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -68.6 -10.49 56.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.342 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 78' ' ' SER . . . 73.18 76.47 0.14 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.733 0.302 . . . . 0.0 111.055 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t -177.58 47.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.859 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -108.7 173.14 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.699 178.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 12.5 m -171.45 150.77 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 82' ' ' SER . 85.8 m-85 -161.56 136.91 7.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.834 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.73 163.8 1.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.49 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.947 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.4 p 178.88 155.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 111.512 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 85' ' ' VAL . 1.8 mtpp -109.93 62.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.332 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.639 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.4 t80 -47.26 111.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.487 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.937 HD23 ' CB ' ' A' ' 109' ' ' LEU . 3.5 mp -55.22 -44.08 75.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.567 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 132.67 -157.96 22.82 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.461 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 25.9 p -116.68 156.08 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.496 HG11 HD22 ' A' ' 109' ' ' LEU . 27.5 m -152.28 135.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.022 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 139.36 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.581 HG21 ' SG ' ' A' ' 174' ' ' CYS . 11.0 m -142.02 169.49 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.68 -24.15 27.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.617 ' O ' HG11 ' A' ' 101' ' ' VAL . 23.6 mm-40 -133.93 126.18 29.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.869 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.527 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -97.28 21.52 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.831 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.54 130.89 4.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.01 136.74 5.29 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.753 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 178.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 71.39 -61.63 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 110.355 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 95' ' ' GLU . 86.0 t -52.28 -44.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.292 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.9 p -63.26 -39.18 93.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.216 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -60.69 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.141 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.624 ' O ' HG23 ' A' ' 108' ' ' VAL . 19.9 pt-20 -64.52 -38.54 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.052 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 174' ' ' CYS . . . -53.39 -24.77 13.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.088 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.614 HD13 ' OD2' ' A' ' 153' ' ' ASP . 0.6 OUTLIER -82.15 -45.24 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.17 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 5.5 pttt -57.12 -34.15 68.07 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 104' ' ' GLU . 41.1 t -59.98 -37.64 73.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.03 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.937 ' CB ' HD23 ' A' ' 88' ' ' LEU . 4.6 mm? -54.91 -25.99 32.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.938 0.399 . . . . 0.0 110.001 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.88 -51.56 4.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 6.0 mm-40 -49.5 -26.36 3.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.518 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 114' ' ' ARG . 0.3 OUTLIER -99.41 -163.36 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.729 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.38 26.22 6.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.286 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -78.18 81.46 4.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.735 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.433 ' HG3' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -73.48 130.13 84.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.247 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HD2' ' HG3' ' A' ' 115' ' ' ARG . 77.4 Cg_exo -50.96 169.94 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.224 1.949 . . . . 0.0 111.937 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 87' ' ' TYR . 9.8 p -132.95 114.48 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.414 . . . . 0.0 111.612 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -74.59 78.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.996 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -132.55 -158.52 8.93 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.332 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 120' ' ' LEU . 1.4 mt -116.91 131.98 56.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.362 . . . . 0.0 111.065 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.734 ' HG ' HG23 ' A' ' 123' ' ' VAL . 49.5 tp -91.42 102.54 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.446 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 1.1 t-80 -74.53 83.59 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.597 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.734 HG23 ' HG ' ' A' ' 121' ' ' LEU . 84.1 t -89.25 115.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.47 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.9 33.38 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 45.52 45.13 11.91 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.563 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.583 ' C ' HG22 ' A' ' 144' ' ' ILE . 2.0 t0 -168.15 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -157.84 115.16 0.65 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 162' ' ' TYR . 4.5 mt -81.05 78.39 7.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 122' ' ' HIS . 71.6 mtm-85 -85.03 107.8 17.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 139' ' ' ILE . 2.7 p -92.7 108.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 110.967 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.422 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 21.8 t -94.65 134.03 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.997 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.434 ' OD1' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -80.37 131.27 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.435 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 28.8 t0 -79.62 3.4 19.15 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.05 -24.74 14.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.75 0.309 . . . . 0.0 110.936 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 53.7 p -151.33 19.29 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.337 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.415 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER 44.58 28.54 0.33 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.985 0.421 . . . . 0.0 111.307 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.55 138.21 16.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.314 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.446 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 5.0 tp -86.7 124.28 32.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 117' ' ' VAL . 8.6 mt -95.37 -54.74 6.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.562 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.61 83.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 111.461 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.446 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 7.2 t0 -93.85 73.86 4.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.192 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -141.89 137.07 31.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.279 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.44 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 23.9 m -60.52 135.28 57.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.583 HG22 ' C ' ' A' ' 126' ' ' ASP . 19.3 tt -59.48 -34.19 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.696 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -73.81 -22.75 59.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.249 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -97.09 26.55 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.193 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.935 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -121.82 176.9 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.607 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 147' ' ' VAL . 2.5 t -90.09 17.36 7.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 73.83 -167.45 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.988 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 25.0 p -123.51 176.3 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -171.42 103.6 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.7 123.67 12.75 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.4 2.066 . . . . 0.0 112.466 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.614 ' OD2' HD13 ' A' ' 106' ' ' LEU . 3.9 m-20 -58.66 -156.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.526 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -98.8 22.4 10.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 110.854 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 156' ' ' HIS . 1.9 m120 -57.11 -20.21 24.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.29 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 155' ' ' ASN . 6.9 t-160 91.56 -34.24 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.479 0.712 . . . . 0.0 111.866 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 158' ' ' ARG . 0.0 OUTLIER 176.6 70.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 111.845 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 5.8 ptp180 165.23 -33.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.114 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -81.21 114.73 3.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.109 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.795 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 8.9 m-85 -120.42 166.44 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.87 112.77 0.48 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 111.35 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.68 ' OH ' HG21 ' A' ' 191' ' ' VAL . 2.5 m-30 -88.58 -178.68 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.572 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.935 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -158.39 145.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.785 0.326 . . . . 0.0 111.324 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.449 ' HB3' HG13 ' A' ' 147' ' ' VAL . 17.0 p -135.09 148.59 49.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.565 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -106.85 83.17 1.8 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.587 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 43.91 -173.61 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.518 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.94 -55.95 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.962 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.64 25.52 3.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.451 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -76.33 0.36 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.97 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.45 -78.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -133.68 -153.67 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.944 179.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.572 ' O ' HG22 ' A' ' 93' ' ' VAL . 15.5 m95 -60.23 83.9 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.897 0.379 . . . . 0.0 109.992 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.6 OUTLIER -90.75 120.66 31.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.355 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.581 ' SG ' HG21 ' A' ' 93' ' ' VAL . 1.3 m -92.39 159.25 15.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.932 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -136.62 119.44 16.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.834 0.349 . . . . 0.0 111.309 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -92.8 110.89 3.99 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.951 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 162' ' ' TYR . 2.3 m-85 -108.42 119.51 39.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.116 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.7 108.28 16.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.795 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -51.99 141.01 18.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.314 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 31.5 t -63.37 -53.48 51.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.41 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.39 -22.12 63.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.748 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.65 71.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.974 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 p -166.53 27.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.792 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.72 26.67 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.925 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.68 54.33 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.656 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.1 tpt180 -175.72 -37.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.947 HD21 ' HB ' ' A' ' 85' ' ' VAL . 8.6 mp -120.52 -39.78 2.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.908 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 45.7 t -52.9 -55.72 21.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 193' ' ' CYS . 0.0 OUTLIER -76.03 -31.64 58.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.771 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -66.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.68 HG21 ' OH ' ' A' ' 162' ' ' TYR . 39.8 t -56.0 -54.63 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.36 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.39 31.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.478 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 4.7 t -67.98 -27.48 66.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.488 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -54.49 -41.49 69.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.622 ' O ' HD12 ' A' ' 199' ' ' LEU . 96.2 m-85 -63.37 -21.89 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.852 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -47.77 -28.3 2.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.27 -31.54 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.575 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -56.72 -41.36 77.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.137 178.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -99.1 -34.91 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 200' ' ' GLU . 30.1 tt0 58.81 20.03 7.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.779 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 176.54 35.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.304 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm 41.55 37.65 0.74 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.854 0.359 . . . . 0.0 111.365 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.09 -32.77 7.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.2 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.725 ' HG2' HD22 ' B' ' 7' ' ' LEU . 0.0 OUTLIER 42.48 62.67 1.63 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.546 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -51.1 115.09 1.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.978 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.518 HG21 HD23 ' B' ' 7' ' ' LEU . 40.5 p -146.78 25.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.09 -58.32 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -149.99 -76.34 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.024 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 60.88 154.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.058 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.065 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.594 ' HB3' ' HG2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.796 0.331 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -176.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.361 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.487 ' H ' HD12 ' B' ' 3' ' ' ILE . 3.8 mp -46.19 -26.1 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.073 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.04 -85.61 0.02 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.918 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.594 ' HG2' ' HB3' ' B' ' 1' ' ' ALA . 32.0 Cg_exo -61.22 109.91 0.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.544 2.163 . . . . 0.0 110.112 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.446 ' CG ' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.725 HD22 ' HG2' ' A' ' 204' ' ' ARG . 3.0 mt . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.864 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.83 0.347 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -114.71 69.89 2.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.005 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.62 56.65 4.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.561 2.174 . . . . 0.0 112.548 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -141.81 -58.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.711 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -105.1 -40.74 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.516 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -61.85 -45.0 95.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.692 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 6.9 pt20 -49.64 -35.42 21.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.979 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 70' ' ' GLN . . . -76.7 -67.88 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.368 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -46.96 -45.36 20.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.307 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -49.45 -37.2 24.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.822 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -86.54 -35.4 19.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.757 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.492 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -52.54 -59.67 4.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 193' ' ' CYS . 27.5 m -52.31 -36.82 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -48.07 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.422 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.06 17.65 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . 54.72 92.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.662 0.268 . . . . 0.0 111.313 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 t 174.43 46.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.29 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -121.01 152.27 38.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 1.8 m -157.7 144.48 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.922 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.729 ' CE2' HG21 ' A' ' 123' ' ' VAL . 3.5 p90 -146.83 172.14 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 111.247 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.08 154.49 23.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.828 ' HB ' HD21 ' A' ' 187' ' ' LEU . 11.4 p -174.2 160.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.738 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.545 ' N ' HG22 ' A' ' 85' ' ' VAL . 4.1 mmtt -117.24 75.65 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.655 ' CD1' HG21 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -56.69 115.56 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.402 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.829 HD13 ' HA ' ' A' ' 177' ' ' PHE . 7.7 mp -64.91 -37.54 87.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.58 -129.07 3.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.532 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.551 ' N ' HD11 ' A' ' 109' ' ' LEU . 3.7 p -171.02 124.12 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.506 HG13 HD13 ' A' ' 109' ' ' LEU . 26.8 m -116.61 129.68 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.365 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 0.9 OUTLIER -57.47 155.55 9.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 172' ' ' TRP . 19.5 m -150.6 177.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.195 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -94.68 -11.17 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.44 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.82 136.25 46.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.823 0.344 . . . . 0.0 110.921 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.3 p -101.32 23.02 11.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.767 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.54 -167.97 2.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.02 109.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -28.38 8.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.42 -45.5 94.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.637 HG12 ' SG ' ' A' ' 174' ' ' CYS . 38.7 t -51.41 -32.56 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -42.9 59.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.761 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -45.35 74.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.43 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.3 pt-20 -75.96 -38.07 57.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -54.83 -45.04 74.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.472 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp -56.8 -42.42 79.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.3 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -42.47 95.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.344 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.4 t -66.26 -40.55 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.011 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.551 HD11 ' N ' ' A' ' 90' ' ' CYS . 1.5 mm? -52.08 -23.19 4.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.25 -50.23 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.536 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.434 ' CG ' ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.68 -22.48 66.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.553 -178.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -88.65 165.8 14.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.31 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -21.5 13.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -41.75 114.97 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.48 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 139.33 20.01 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.39 154.04 43.78 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.627 2.218 . . . . 0.0 112.789 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.945 HG21 HD11 ' A' ' 139' ' ' ILE . 3.4 p -110.97 170.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.55 ' H ' HG22 ' A' ' 117' ' ' VAL . 5.9 ttt85 -137.82 88.29 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.538 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.71 -150.94 5.53 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.739 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.648 HD23 ' C ' ' A' ' 83' ' ' PHE . 10.6 mt -123.04 151.22 42.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.487 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.532 ' CB ' ' CE1' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -99.04 106.88 19.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 129' ' ' ARG . 41.7 m-70 -71.57 63.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 194' ' ' ALA . 70.9 t -66.96 107.45 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.7 m -131.69 31.83 4.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.448 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 48.0 29.09 6.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.565 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' C ' HG22 ' A' ' 144' ' ' ILE . 24.0 t0 -140.97 -43.25 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.121 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -159.39 122.18 1.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.977 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.742 ' CD1' HD12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -73.04 82.98 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.76 0.314 . . . . 0.0 110.558 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 48.0 mtt85 -95.73 81.71 3.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.313 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 87' ' ' TYR . 2.0 p -73.55 88.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.21 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 132' ' ' ASP . 72.8 t -76.5 156.26 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.093 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -100.42 122.54 43.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.22 0.33 22.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.72 -32.21 8.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.5 p -119.82 -36.52 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.964 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 132' ' ' ASP . 0.9 OUTLIER 67.02 44.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -109.83 16.65 30.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.095 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 137' ' ' GLY . 6.9 tp 46.23 107.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.361 0.601 . . . . 0.0 111.673 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.945 HD11 HG21 ' A' ' 117' ' ' VAL . 32.4 mt -72.94 -61.62 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.908 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.2 t -104.58 97.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -98.92 71.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.18 172.67 12.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 145' ' ' GLU . 12.1 m -92.37 147.91 22.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.629 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.742 HD12 ' CD1' ' A' ' 128' ' ' LEU . 19.4 tt -81.12 -19.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.786 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.602 ' H ' HG22 ' A' ' 143' ' ' THR . 1.5 mt-10 -84.88 -36.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.212 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -43.17 14.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 148' ' ' SER . 10.4 p -46.03 164.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.314 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -70.85 -2.54 15.3 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 148' ' ' SER . 2.0 m-85 84.22 166.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.887 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 162' ' ' TYR . 29.0 p -87.43 -173.02 4.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.613 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 173.74 101.53 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.444 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 52.0 Cg_endo -69.65 129.79 18.33 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.594 2.196 . . . . 0.0 112.934 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -60.65 -150.34 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.209 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -107.97 19.66 19.73 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.625 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 156' ' ' HIS . 0.7 OUTLIER -55.77 -21.97 21.81 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.234 177.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' CB ' ' O ' ' A' ' 155' ' ' ASN . 4.0 t-80 90.49 -30.84 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.32 0.648 . . . . 0.0 111.47 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.06 71.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.706 0.288 . . . . 0.0 111.505 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.41 ' CD ' ' OD2' ' A' ' 182' ' ' ASP . 7.2 ptt180 167.82 -29.69 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.809 0.337 . . . . 0.0 111.225 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 160' ' ' PHE . . . -104.69 127.55 9.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.644 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 6.1 m-85 -139.06 177.64 7.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 p -175.3 125.78 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.756 ' OH ' HG21 ' A' ' 191' ' ' VAL . 4.9 m-30 -98.1 -171.75 2.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -156.97 155.18 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 22.9 p -146.12 143.22 29.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.952 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 79.34 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.061 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 168' ' ' THR . 37.9 t0 59.36 -88.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.761 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.98 -83.11 0.01 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.431 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 166' ' ' ASP . 1.8 m -139.72 22.34 2.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.793 0.33 . . . . 0.0 110.883 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 92.8 m -111.36 -82.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -158.03 -70.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.683 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -150.05 -155.51 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.977 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.622 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -65.46 76.23 0.06 Allowed 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -92.41 121.14 33.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.081 -177.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.637 ' SG ' HG12 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.16 142.54 28.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -114.49 118.7 34.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.998 0.428 . . . . 0.0 111.161 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' LEU . . . -115.45 151.88 18.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.833 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.829 ' HA ' HD13 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -178.62 176.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 111.956 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.28 139.82 35.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.153 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 187' ' ' LEU . . . -64.25 138.71 58.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 0.0 111.615 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 186' ' ' ARG . 21.9 mmtt -76.81 -27.78 55.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.656 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.41 ' OD2' ' CD ' ' A' ' 158' ' ' ARG . 1.4 t70 60.31 36.92 20.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.464 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.4 p -151.56 19.09 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.674 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.88 26.53 1.19 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.263 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.76 24.14 13.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.552 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -179.34 37.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.086 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 1.002 HD13 ' HB1' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -167.52 -52.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.469 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 160' ' ' PHE . 2.9 t -73.75 -66.64 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -52.41 -36.81 55.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.478 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.954 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.756 HG21 ' OH ' ' A' ' 162' ' ' TYR . 38.9 t -50.37 -48.86 25.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.994 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -52.03 -27.26 21.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.885 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.671 ' HB3' HG21 ' A' ' 76' ' ' VAL . 60.8 m -87.24 -28.32 22.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.94 0.4 . . . . 0.0 110.52 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.816 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -51.31 -51.31 55.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.461 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.712 ' O ' HD12 ' A' ' 199' ' ' LEU . 86.5 m-85 -55.06 -23.95 22.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.256 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -46.53 -49.88 18.0 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.856 0.36 . . . . 0.0 111.202 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 76' ' ' VAL . 86.2 t -58.75 -38.93 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 30.4 t -65.15 -30.78 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.201 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 195' ' ' PHE . 1.2 mp -130.32 57.4 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.296 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -48.22 -26.82 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -121.31 25.18 9.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.524 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.465 ' NZ ' HD11 ' B' ' 3' ' ' ILE . 1.7 mmtp 48.07 45.36 19.43 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.081 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -71.56 66.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.848 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.412 ' CG ' ' O ' ' A' ' 204' ' ' ARG . 0.3 OUTLIER -76.71 76.93 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.986 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -82.83 65.29 7.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.449 HG21 ' CA ' ' B' ' 7' ' ' LEU . 7.1 p -92.09 170.35 9.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -57.53 138.97 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 55.9 92.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -74.3 152.49 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.136 179.78 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -168.35 -87.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.723 ' HA ' HD13 ' B' ' 7' ' ' LEU . 28.7 mm -116.01 -51.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.867 0.365 . . . . 0.0 111.094 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 149' ' ' PHE . . . -50.98 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.361 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' B' ' 1' ' ' ALA . 32.3 Cg_exo -57.78 -34.41 98.19 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.567 2.178 . . . . 0.0 112.084 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.723 HD13 ' HA ' ' B' ' 3' ' ' ILE . 6.2 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.855 0.36 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.483 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 1.7 ptpt -137.69 47.32 1.63 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.357 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 65' ' ' LYS . 10.0 Cg_endo -51.18 -70.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.654 2.236 . . . . 0.0 112.189 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -136.74 -83.03 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.775 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.62 -28.78 65.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.759 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.424 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m0 -55.86 -46.41 78.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.07 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 2.0 pp0? -49.59 -33.48 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.004 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.33 -70.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.67 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 76' ' ' VAL . 11.5 m-20 -47.39 -32.04 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.489 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -65.21 -25.66 67.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.908 0.385 . . . . 0.0 110.959 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 73' ' ' GLU . 13.4 mt-10 -102.28 -35.91 8.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -53.91 -55.44 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 193' ' ' CYS . 28.7 m -55.14 -38.51 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -34.8 73.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 23.2 t -88.66 -12.13 43.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.198 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 78' ' ' SER . . . 75.28 73.16 0.09 Allowed 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.841 0.353 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -179.24 50.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -112.84 -179.35 3.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB2' HD11 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -174.15 122.69 0.3 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.503 0.668 . . . . 0.0 111.096 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -127.77 130.15 48.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.511 -177.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -60.68 160.41 9.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.935 ' HB ' HD21 ' A' ' 187' ' ' LEU . 7.5 p -177.77 159.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 111.923 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.518 ' N ' HG22 ' A' ' 85' ' ' VAL . 10.7 mttt -107.91 62.48 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.211 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.748 ' O ' HG12 ' A' ' 117' ' ' VAL . 31.6 t80 -55.6 119.86 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.472 -178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 109' ' ' LEU . 9.0 mp -60.83 -43.04 98.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.041 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 136.17 -159.02 24.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.975 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -115.51 145.8 42.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.023 0.44 . . . . 0.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -137.27 174.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.401 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.475 ' N ' HG13 ' A' ' 91' ' ' VAL . 2.8 pm0 -101.16 146.7 27.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.305 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 172' ' ' TRP . 4.5 m -144.55 163.85 13.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.027 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -84.79 -3.95 58.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.899 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG11 ' A' ' 101' ' ' VAL . 22.7 mm-40 -153.29 126.71 8.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.847 0.356 . . . . 0.0 110.912 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 3.0 p -95.72 27.08 3.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.604 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -151.03 149.46 29.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.0 -147.06 18.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.96 -46.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -26.93 15.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 95' ' ' GLU . 48.5 t -68.14 -36.73 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.782 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 53.7 m -67.95 -31.47 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -39.23 87.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.53 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 20.0 pt-20 -82.4 -34.09 28.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.29 13.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.678 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -49.4 -43.35 44.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.22 77.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.29 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.7 t -67.54 -43.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.917 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' A' ' 88' ' ' LEU . 3.1 mm? -53.14 -22.36 6.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -47.0 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.389 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -9.1 58.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.014 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -108.23 172.35 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.198 -179.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.37 6.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.666 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.648 ' HG3' HD13 ' A' ' 109' ' ' LEU . 2.4 mmt180 -43.18 113.38 0.48 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.441 ' CG ' ' HD2' ' A' ' 116' ' ' PRO . 60.8 ttt180 -118.66 144.97 36.53 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.321 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 115' ' ' ARG . 75.3 Cg_exo -50.34 155.39 4.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.813 2.342 . . . . 0.0 112.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 139' ' ' ILE . 10.7 p -126.39 109.55 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.252 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 133' ' ' ASP . 2.6 ttt180 -69.33 70.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.124 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.94 -165.26 11.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.232 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.625 HD13 ' C ' ' A' ' 120' ' ' LEU . 1.9 tm? -120.75 119.23 32.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.6 tp -77.38 83.7 3.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.075 0.464 . . . . 0.0 110.15 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.499 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -66.03 82.61 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.827 -178.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 81' ' ' CYS . 1.8 m -70.78 178.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 p -178.01 31.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.86 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.636 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 40.93 32.55 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.722 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -172.12 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.553 0.216 . . . . 0.0 111.398 -178.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -153.75 117.12 0.78 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.879 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.527 HD21 HD12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -90.13 130.02 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.748 0.309 . . . . 0.0 110.569 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.55 ' HB3' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -135.01 90.67 2.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.901 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 130' ' ' VAL . 3.9 p -72.72 102.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.0 t -91.96 135.91 25.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.36 137.59 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 118' ' ' ARG . 11.3 t0 -87.83 16.12 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -117.43 -35.0 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 43.3 p -119.26 -15.88 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.649 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.92 36.07 7.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.91 -164.79 24.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.873 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -122.5 132.01 54.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.846 HD11 HG21 ' A' ' 117' ' ' VAL . 4.3 mt -100.12 -23.52 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 140' ' ' VAL . 22.0 t -143.77 60.25 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.195 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.457 ' HB3' ' HG ' ' A' ' 138' ' ' LEU . 20.3 p-10 -67.74 73.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.484 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -145.13 151.37 38.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 111.407 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -60.62 179.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.746 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 126' ' ' ASP . 16.4 tt -108.07 -23.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -86.89 -24.18 24.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.879 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -94.76 21.33 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.0 OUTLIER -115.12 178.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.419 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.488 ' OG ' HD12 ' A' ' 163' ' ' ILE . 23.1 t -87.23 13.96 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 76.79 -177.61 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.771 0.319 . . . . 0.0 111.045 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 3.9 m -111.33 163.17 14.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.041 0.448 . . . . 0.0 111.281 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -174.75 98.45 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.866 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 34.1 Cg_endo -64.34 159.44 43.8 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.182 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 22.4 m-20 -78.33 57.3 1.88 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.43 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 153' ' ' ASP . 1.3 ttt180 82.02 6.43 1.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.023 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 40.39 30.68 0.08 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.78 0.324 . . . . 0.0 111.716 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.99 -15.17 52.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.796 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.68 29.23 2.14 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.473 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.0 OUTLIER 60.48 40.58 16.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.961 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.05 110.71 2.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.593 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.683 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 5.9 m-85 -91.82 170.28 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -164.18 107.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.786 ' OH ' HG11 ' A' ' 191' ' ' VAL . 4.0 m-30 -88.94 -179.5 5.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.325 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -159.32 148.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.404 ' HB3' ' CG1' ' A' ' 147' ' ' VAL . 19.6 p -139.21 157.84 45.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.752 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 87.32 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.885 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' THR . 3.1 p-10 47.62 26.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.169 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.72 80.04 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.417 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 166' ' ' ASP . 17.1 p 55.0 25.7 7.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.678 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -119.22 -78.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -158.79 -81.66 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 111.112 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -143.42 -148.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.891 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.638 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -66.76 74.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.452 ' HE3' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.29 118.1 27.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.352 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.42 168.08 17.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.091 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -140.58 90.54 2.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.783 0.325 . . . . 0.0 111.407 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -69.46 107.01 1.96 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -104.99 138.67 40.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 111.396 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 179' ' ' ALA . 2.8 tm? -135.37 108.4 7.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.388 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.683 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -44.88 145.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.713 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.02 -59.7 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -68.31 -27.44 66.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.525 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD1' HD21 ' A' ' 178' ' ' LEU . 0.5 OUTLIER 59.17 82.43 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.172 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.438 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 8.3 t -168.6 29.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 44.06 27.89 1.17 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.898 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.0 49.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.096 0.474 . . . . 0.0 110.79 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.55 ' C ' HD12 ' A' ' 187' ' ' LEU . 25.3 mmt180 -149.84 -46.5 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.486 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.935 HD21 ' HB ' ' A' ' 85' ' ' VAL . 2.6 mp -119.66 -36.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.122 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -58.42 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.65 -18.46 47.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.543 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 193' ' ' CYS . . . -87.83 -74.25 0.45 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.272 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 187' ' ' LEU . 3.4 p -52.09 -29.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.117 0.484 . . . . 0.0 110.119 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.13 -30.45 60.98 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.832 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -71.0 -32.04 68.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.139 0.495 . . . . 0.0 109.667 177.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.636 ' HB1' ' HA2' ' A' ' 125' ' ' GLY . . . -50.95 -33.6 25.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.564 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.785 ' O ' HD12 ' A' ' 199' ' ' LEU . 17.6 m-85 -61.45 -24.88 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.731 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.02 0.99 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.292 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.63 -34.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 31.9 t -52.16 -28.33 17.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.656 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -121.43 -38.41 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 201' ' ' ARG . 0.8 OUTLIER 63.2 105.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.043 -178.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.414 ' CB ' ' O ' ' A' ' 200' ' ' GLU . 1.1 ttt85 79.4 20.0 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.711 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm 47.45 47.89 16.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.322 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -58.56 -30.6 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.57 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.28 145.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.107 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -93.41 21.66 5.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.189 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' O ' ' B' ' 7' ' ' LEU . 7.7 p -85.52 -165.33 1.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.31 74.23 1.85 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.817 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -48.96 -45.06 41.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.217 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 48.9 39.67 14.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.169 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.037 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.428 ' C ' ' CG ' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.643 0.259 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.789 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER 178.43 -92.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.069 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.789 HD13 ' O ' ' B' ' 2' ' ' TYR . 5.1 mm -135.39 64.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.115 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.46 -78.63 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.457 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.4 ' HG2' ' HB1' ' B' ' 1' ' ' ALA . 75.9 Cg_exo -47.16 -42.22 26.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.531 2.154 . . . . 0.0 112.139 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.417 ' CD1' ' N ' ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' B' ' 7' ' ' LEU . 4.0 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.691 0.282 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 8.0 mtmt 51.8 51.07 9.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 110.765 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' LYS . 10.6 Cg_endo -53.37 -82.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.75 2.3 . . . . 0.0 112.241 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -141.62 -69.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 110.183 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.95 -28.91 40.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.081 0.467 . . . . 0.0 109.778 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.425 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 1.2 m0 -81.77 -33.9 30.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.168 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -24.13 65.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.965 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.66 -46.97 6.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.02 -46.04 65.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.08 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 69' ' ' TRP . 5.3 tt0 -50.57 -41.8 54.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.39 -23.23 35.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -63.57 -53.04 57.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.874 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -58.41 -43.64 87.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.266 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -53.42 -45.5 69.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.468 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 17.0 12.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.101 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 80' ' ' THR . . . 56.56 85.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.646 0.26 . . . . 0.0 111.303 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.639 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.6 t 174.24 51.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -119.81 166.7 12.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.763 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.914 ' HB3' HD21 ' A' ' 120' ' ' LEU . 2.0 m -166.48 160.21 15.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.048 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.469 ' CG ' ' O ' ' A' ' 82' ' ' SER . 21.2 m-85 -167.99 141.35 3.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 120' ' ' LEU . 8.2 t -59.37 158.74 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.893 ' HB ' HD21 ' A' ' 187' ' ' LEU . 14.9 p -175.47 160.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 111.952 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 85' ' ' VAL . 8.5 mttt -114.56 57.97 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.703 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.765 ' O ' HG22 ' A' ' 117' ' ' VAL . 26.7 t80 -47.67 134.38 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 109' ' ' LEU . 7.4 mp -79.21 -58.08 3.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.906 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.576 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 151.06 -155.34 26.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.543 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 20.0 p -121.26 144.03 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 109' ' ' LEU . 7.5 m -134.78 142.59 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.1 124.63 24.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 172' ' ' TRP . 15.4 m -127.25 176.92 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.985 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.22 2.9 53.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.886 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.5 mm-40 -153.85 164.97 37.49 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.974 0.416 . . . . 0.0 111.073 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.503 ' HG ' ' HE3' ' A' ' 172' ' ' TRP . 83.7 p -132.95 23.93 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.669 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.78 168.63 19.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.15 154.38 24.21 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -24.09 24.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -64.03 -42.5 97.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.044 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 45.5 t -64.73 -30.5 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -70.81 -58.08 3.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.037 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -48.27 -37.57 16.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.7 ' O ' HG23 ' A' ' 108' ' ' VAL . 12.3 pt-20 -83.86 -42.17 16.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.817 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 101' ' ' VAL . . . -50.4 -48.76 55.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HB3' ' NH1' ' A' ' 154' ' ' ARG . 0.3 OUTLIER -53.82 -51.47 63.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -51.11 -42.45 60.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.468 178.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -66.27 -35.67 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.119 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.627 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -53.76 -39.57 65.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -52.6 8.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.04 -36.33 28.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.045 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.04 -167.0 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 31.15 3.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.471 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -90.56 79.41 6.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.631 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -58.35 128.35 82.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.16 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.53 159.44 32.03 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.448 2.098 . . . . 0.0 112.435 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.933 HG11 HD11 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -104.88 -178.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.404 ' HG3' ' HE3' ' A' ' 86' ' ' LYS . 12.1 ttt180 -149.54 70.64 1.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.581 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.8 -130.09 2.66 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.721 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' A' ' 82' ' ' SER . 1.4 tp -136.77 139.44 41.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.936 0.398 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 85' ' ' VAL . 20.1 tp -92.93 124.66 37.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.392 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 129' ' ' ARG . 12.1 m170 -85.24 103.35 14.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.014 HG21 HG22 ' A' ' 191' ' ' VAL . 96.1 t -109.48 105.97 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -128.73 39.76 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.454 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 39.35 48.36 2.87 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.216 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.642 ' O ' HG22 ' A' ' 144' ' ' ILE . 4.4 t70 -160.62 -41.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.79 117.8 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.546 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.723 HD11 HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.6 133.78 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 0.0 110.97 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 14.5 mtm-85 -139.42 87.79 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.593 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.504 HG13 ' HB ' ' A' ' 139' ' ' ILE . 7.4 p -77.62 140.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.581 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 136' ' ' LYS . 5.2 t -135.26 152.7 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.478 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.5 t0 -95.82 149.49 21.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.781 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 5.8 t70 -91.77 19.96 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.351 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -127.27 -40.9 1.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 110.752 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 p -114.06 -19.59 11.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.125 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HA ' HG12 ' A' ' 131' ' ' VAL . 5.4 mmtp 59.3 22.34 10.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 110.784 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.38 120.21 5.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.423 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.456 ' CD2' ' HB2' ' A' ' 141' ' ' ASP . 2.0 tp -55.75 133.52 50.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.68 0.276 . . . . 0.0 110.608 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.933 HD11 HG11 ' A' ' 117' ' ' VAL . 6.0 mt -108.12 -43.25 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.08 86.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.529 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.456 ' HB2' ' CD2' ' A' ' 138' ' ' LEU . 26.8 t0 -98.09 69.44 2.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.758 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -124.54 179.12 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -91.82 171.67 8.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.649 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.723 HD12 HD11 ' A' ' 128' ' ' LEU . 10.1 tt -107.64 -16.7 8.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.404 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.94 -38.32 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 111.022 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -81.15 -24.79 37.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 163' ' ' ILE . 11.6 p -70.64 164.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.651 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.1 m -72.91 -2.19 19.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CB ' ' O ' ' A' ' 148' ' ' SER . 1.8 m-85 80.58 -167.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.1 p -129.8 -171.62 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.961 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB1' ' HG3' ' B' ' 5' ' ' PRO . . . -164.07 58.31 0.66 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.425 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 50.1 Cg_exo -52.87 113.41 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.361 2.041 . . . . 0.0 111.807 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -172.57 95.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 0.0 111.817 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 106' ' ' LEU . 8.4 ptt180 -179.37 111.38 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.587 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -72.33 -3.82 26.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.462 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -43.57 -65.56 0.48 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -157.15 40.76 0.32 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.828 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 60.55 62.7 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.732 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.83 147.6 17.19 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.541 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 1.5 m-85 -131.06 151.07 51.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.04 125.91 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.881 0.372 . . . . 0.0 111.689 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.669 ' O ' HG23 ' A' ' 163' ' ' ILE . 4.4 m-30 -94.94 -172.48 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.198 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -165.87 159.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.964 0.411 . . . . 0.0 111.379 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.47 ' HB3' HG23 ' A' ' 147' ' ' VAL . 24.0 p -157.56 157.66 34.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.514 ' HG3' ' CZ3' ' A' ' 172' ' ' TRP . 0.1 OUTLIER -116.03 85.09 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.3 p30 46.48 -163.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.76 -42.77 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.218 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.4 p -153.32 24.92 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.948 0.404 . . . . 0.0 110.734 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.68 -72.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.034 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.418 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER 179.81 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.759 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' MET . 6.2 ptt180 -131.05 -152.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.149 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 4.4 m95 -60.87 82.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -90.18 112.68 24.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.81 -177.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' A' ' 93' ' ' VAL . 1.2 m -82.29 171.41 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.974 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -146.3 118.83 8.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.92 0.391 . . . . 0.0 111.561 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 87' ' ' TYR . . . -92.32 124.19 7.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.74 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 4.7 m-85 -122.89 136.33 54.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.391 . . . . 0.0 111.327 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.79 108.59 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.438 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.597 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -50.1 134.38 22.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 111.177 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -60.38 3.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.79 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -57.6 -33.81 68.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.649 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.2 80.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.02 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.37 30.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.58 37.56 0.15 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 113.879 0.312 . . . . 0.0 113.879 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -147.58 49.4 1.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.019 0.438 . . . . 0.0 111.496 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.08 -42.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.0 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.893 HD21 ' HB ' ' A' ' 85' ' ' VAL . 5.7 mp -111.47 -44.47 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.4 p -53.9 -60.2 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -71.03 -28.1 64.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 186' ' ' ARG . . . -71.94 -68.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.865 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 1.014 HG22 HG21 ' A' ' 123' ' ' VAL . 2.7 t -60.6 -41.37 87.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.28 -39.85 36.37 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.782 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 1.7 m -76.13 -27.76 57.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.061 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.619 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -60.58 -41.96 95.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.542 ' CD2' HD11 ' A' ' 144' ' ' ILE . 42.4 m-85 -59.99 -35.51 75.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.493 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -51.45 -27.06 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.6 t -71.77 -31.6 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.45 ' HB3' HD23 ' A' ' 199' ' ' LEU . 38.9 t -48.25 -52.74 19.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.731 HD21 HG21 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -100.43 -33.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 5.2 tt0 45.62 35.3 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.674 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 178.69 34.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.25 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.432 ' HA ' HD12 ' A' ' 199' ' ' LEU . 2.2 mptp? 44.05 31.38 0.52 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.875 0.369 . . . . 0.0 111.267 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -59.56 -15.77 20.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.034 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.923 ' HD3' HG23 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -38.71 151.33 0.03 OUTLIER 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.589 0.356 . . . . 0.0 111.821 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 64.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.485 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 1.017 ' CG2' HD21 ' B' ' 7' ' ' LEU . 3.4 p -96.91 -48.91 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.241 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -148.22 118.87 7.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 55.51 167.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -145.71 99.26 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.043 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 117.938 -1.029 . . . . 0.0 111.149 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.736 0.303 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 179.77 74.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.923 HG23 ' HD3' ' A' ' 204' ' ' ARG . 4.8 mp 47.54 45.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.43 ' CA ' ' C ' ' B' ' 5' ' ' PRO . . . 127.44 87.65 0.59 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.514 ' HG3' ' HB1' ' A' ' 151' ' ' ALA . 41.3 Cg_exo -49.69 140.8 5.57 Favored 'Cis proline' 0 N--CA 1.482 0.801 0 CA-C-N 118.699 1.249 . . . . 0.0 114.922 6.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.458 ' C ' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 1.017 HD21 ' CG2' ' A' ' 206' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.843 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.84 0.352 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' CG ' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER 59.67 170.15 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 179.344 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 65' ' ' LYS . 37.5 Cg_endo -66.1 61.63 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.551 2.167 . . . . 0.0 112.393 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -148.5 -57.33 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.198 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.73 -46.83 9.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.009 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -58.97 -36.59 75.11 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.378 0.608 . . . . 0.0 110.05 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -13.68 40.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.232 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.79 -27.32 6.26 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 4.7 p30 -90.34 -25.92 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.662 0.267 . . . . 0.0 111.504 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 49.4 mt-10 -61.31 -27.0 68.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.976 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -102.04 -24.64 13.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.163 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' THR . . . -46.29 -37.6 7.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 194' ' ' ALA . 40.0 t -63.67 -50.47 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HA ' ' CG2' ' A' ' 197' ' ' VAL . 3.8 mtp180 -49.86 -48.63 51.12 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.107 0.479 . . . . 0.0 110.577 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.91 14.33 10.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.246 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 50.42 81.04 0.07 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.65 0.262 . . . . 0.0 111.116 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.8 t -171.96 29.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.586 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.57 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -97.59 157.87 15.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -171.43 144.81 2.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 54.1 m-85 -154.73 146.04 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.507 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -58.11 162.88 3.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.523 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.632 HG13 ' CD2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -159.63 172.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.208 0.528 . . . . 0.0 111.727 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.432 ' H ' HG12 ' A' ' 85' ' ' VAL . 4.4 mttt -125.42 42.4 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.965 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.496 ' N ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -38.98 122.33 1.18 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.388 -178.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.723 HD23 ' HB3' ' A' ' 109' ' ' LEU . 8.9 mp -67.59 -44.52 77.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.214 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.515 ' C ' HD11 ' A' ' 109' ' ' LEU . . . 145.37 -135.09 5.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.442 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.404 ' N ' HD11 ' A' ' 109' ' ' LEU . 25.3 p -139.65 148.75 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.865 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 174' ' ' CYS . 12.5 m -139.15 127.78 28.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.51 128.01 35.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.069 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 172' ' ' TRP . 32.9 m -126.15 -174.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.687 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.93 24.93 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.618 ' HB2' HG21 ' A' ' 101' ' ' VAL . 28.5 mp0 -141.96 -81.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.172 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m 60.36 22.73 12.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.783 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 24.89 2.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.49 -166.42 10.67 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.64 -39.35 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -59.54 -47.56 85.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.966 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' A' ' 95' ' ' GLU . 62.0 t -49.65 -26.67 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.07 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.6 m -66.88 -44.23 81.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.84 -53.81 43.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 pt-20 -76.81 -36.93 56.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.776 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.597 ' O ' HD23 ' A' ' 109' ' ' LEU . . . -48.9 -25.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tt -81.8 -43.54 18.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.07 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 6.8 pttt -60.76 -35.18 75.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.023 0.44 . . . . 0.0 110.321 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -68.16 -35.69 72.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.583 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.723 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -54.37 -27.82 38.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -47.39 6.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.079 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -23.48 5.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.795 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.73 177.95 4.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -12.7 58.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.303 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.702 ' HG2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -43.23 108.91 0.12 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 0.0 111.537 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.2 ptt180 -98.92 144.76 28.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.8 160.37 12.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.461 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.984 HG21 HD11 ' A' ' 139' ' ' ILE . 1.6 p -115.92 176.18 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.599 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -147.69 79.88 1.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.12 5.35 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.008 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 120' ' ' LEU . 3.4 mt -121.1 131.19 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.475 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -88.04 104.89 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -72.09 69.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.261 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.849 HG21 HG22 ' A' ' 191' ' ' VAL . 93.9 t -77.84 97.28 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.371 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 24.9 p -119.62 42.62 2.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.459 ' HA2' ' CA ' ' A' ' 194' ' ' ALA . . . 42.99 41.91 4.83 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.708 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.764 ' O ' HG22 ' A' ' 144' ' ' ILE . 9.8 t0 -163.39 -43.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.613 0.244 . . . . 0.0 111.286 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -148.14 127.56 2.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.283 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 191' ' ' VAL . 0.2 OUTLIER -87.03 71.41 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.667 0.27 . . . . 0.0 110.886 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -87.48 89.84 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.8 0.334 . . . . 0.0 111.176 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.864 HG13 ' HB ' ' A' ' 139' ' ' ILE . 5.8 p -85.93 90.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.952 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 132' ' ' ASP . 7.2 p -86.2 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -99.62 147.68 25.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -100.66 14.41 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.676 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.89 -43.77 3.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 58.7 p -111.31 -19.96 12.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.754 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 38.45 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.049 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.41 139.99 15.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.103 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 139' ' ' ILE . 2.6 tp -73.39 110.81 7.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.984 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 117' ' ' VAL . 38.2 mt -68.38 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.31 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 138' ' ' LEU . 66.2 t -110.28 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.075 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.442 ' HA ' HD21 ' A' ' 138' ' ' LEU . 26.6 t70 -93.89 73.25 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.497 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.2 170.37 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 145' ' ' GLU . 87.9 m -103.64 141.8 35.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.545 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.889 HD11 ' CE1' ' A' ' 195' ' ' PHE . 13.0 tt -70.66 -27.09 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.014 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.68 ' H ' HG22 ' A' ' 143' ' ' THR . 0.4 OUTLIER -81.79 -30.92 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.772 178.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -91.42 -41.7 10.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.943 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 163' ' ' ILE . 14.3 p -47.4 161.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.074 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.536 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.4 m -52.7 -50.95 62.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 1.061 ' CE1' HD11 ' A' ' 163' ' ' ILE . 3.0 p90 150.75 -176.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.673 0.789 . . . . 0.0 109.971 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 15.9 p -114.91 151.48 33.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.425 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -177.05 102.09 0.23 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.129 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 45.5 Cg_endo -67.31 159.11 53.82 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.332 2.022 . . . . 0.0 111.963 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.63 -59.82 2.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.28 33.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.197 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 41.56 30.97 0.16 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.662 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.415 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 15.1 t60 -104.88 16.58 25.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.588 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -169.8 29.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.671 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.409 ' CD ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER 53.2 26.12 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.73 0.3 . . . . 0.0 111.232 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -110.81 154.14 16.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.594 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 0.3 OUTLIER -139.29 -175.46 4.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.75 0.309 . . . . 0.0 110.728 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.6 t -177.31 136.02 0.2 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.878 0.37 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.645 ' OH ' HG11 ' A' ' 191' ' ' VAL . 60.5 m-85 -105.06 -171.49 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.365 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.061 HD11 ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -165.31 142.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 111.474 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 20.0 p -132.98 142.58 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.466 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 172' ' ' TRP . 4.5 ptt180 -108.51 83.07 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.429 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 170' ' ' ARG . 2.9 p30 45.45 -162.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.415 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.52 -64.06 4.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.664 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -44.35 5.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.353 . . . . 0.0 111.127 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 79.9 m -86.18 -88.29 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.91 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 166' ' ' ASP . 18.2 mmm180 -154.81 -81.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 110.372 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 173' ' ' MET . 3.3 ptp180 -127.59 -152.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.492 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.804 ' O ' HG22 ' A' ' 93' ' ' VAL . 19.5 m95 -67.3 71.53 0.11 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -88.39 119.01 28.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.596 ' SG ' HG11 ' A' ' 93' ' ' VAL . 15.2 m -89.19 157.9 18.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.333 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -135.62 99.11 4.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 111.649 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -94.28 134.1 11.89 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.92 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.5 p90 -154.93 148.74 25.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 111.482 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.537 HD11 ' OD2' ' A' ' 182' ' ' ASP . 8.2 tp -118.52 132.7 56.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.396 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -49.29 140.43 9.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -61.35 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.685 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -68.21 -32.84 73.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.537 ' OD2' HD11 ' A' ' 178' ' ' LEU . 10.6 t70 67.24 73.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.062 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.4 23.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.624 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 41.15 30.87 0.47 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.42 ' O ' ' NE ' ' A' ' 186' ' ' ARG . 2.0 mt-10 -136.92 41.43 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.669 0.271 . . . . 0.0 111.191 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.487 ' HD3' ' CE1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -154.64 -45.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.911 0.386 . . . . 0.0 110.768 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 191' ' ' VAL . 9.3 mp -113.54 -43.91 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.836 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.483 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 20.4 t -56.7 -61.16 2.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -67.3 -21.01 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.259 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.57 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -83.68 -60.92 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.176 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.849 HG22 HG21 ' A' ' 123' ' ' VAL . 2.2 t -66.74 -31.78 55.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.799 0.333 . . . . 0.0 110.553 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.21 -26.01 12.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.56 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 44.5 t -99.08 -23.02 15.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.439 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.619 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -50.07 -28.33 6.97 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.889 ' CE1' HD11 ' A' ' 144' ' ' ILE . 53.4 m-85 -84.87 -22.07 29.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 200' ' ' GLU . . . -60.61 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.774 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 77' ' ' ARG . 79.8 t -55.49 -39.09 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 34.9 t -57.61 -48.71 78.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.058 HD21 HG21 ' B' ' 3' ' ' ILE . 1.2 pt? -129.93 56.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.167 0.508 . . . . 0.0 110.754 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 196' ' ' ALA . 29.3 tt0 -45.1 -28.01 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.709 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -96.47 31.35 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 199' ' ' LEU . 6.0 mptt 47.84 35.08 4.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.005 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -69.65 65.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.432 ' HD2' ' CD1' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -127.16 45.42 2.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.19 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 51.83 25.56 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.82 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.4 t -116.9 103.62 10.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 65.79 133.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 61.58 49.33 5.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.237 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -168.49 35.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.247 -179.646 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.819 0.342 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.628 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -134.48 -78.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 1.058 HG21 HD21 ' A' ' 199' ' ' LEU . 8.1 mm -134.91 -42.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.21 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.03 -77.78 0.11 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.643 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' B' ' 7' ' ' LEU . 83.5 Cg_exo -47.34 140.86 14.73 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.683 2.256 . . . . 0.0 112.213 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.419 ' CD1' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' B' ' 5' ' ' PRO . 5.2 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.326 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.85 0.357 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 19.5 pttt -148.74 165.2 18.51 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.786 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 83.2 Cg_exo -45.59 161.93 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.458 2.105 . . . . 0.0 112.456 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' A' ' 66' ' ' PRO . 24.0 m-70 71.85 -68.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -69.1 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.739 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -32.6 67.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.699 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.14 -21.83 65.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.28 -62.84 1.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.408 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 3.9 p30 -53.14 -29.52 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.007 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.0 mm-40 -69.19 -36.0 76.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 0.0 110.522 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.8 -23.87 25.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.681 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.759 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -59.22 -57.37 13.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.677 HG13 ' HA ' ' A' ' 194' ' ' ALA . 1.2 t -50.59 -48.11 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.255 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -42.84 62.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.519 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.0 p -94.49 18.92 10.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.079 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.02 82.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -179.4 49.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.145 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -116.0 173.24 6.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.05 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 29.4 p 176.84 151.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' C ' HD23 ' A' ' 120' ' ' LEU . 53.3 m-85 -160.51 138.25 9.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.784 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.8 t -49.23 167.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.692 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 86' ' ' LYS . 8.5 p -174.48 162.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 111.993 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.526 ' N ' HG22 ' A' ' 85' ' ' VAL . 12.5 mtmm -111.96 56.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.617 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.616 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -47.7 176.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 116' ' ' PRO . 11.0 mt -137.48 -42.4 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.151 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.68 -144.67 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.485 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.5 m -136.58 155.93 49.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.586 HG13 HD13 ' A' ' 109' ' ' LEU . 2.8 m -134.61 128.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.873 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.67 124.28 20.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.852 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 172' ' ' TRP . 28.7 m -126.59 164.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -93.56 17.78 11.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.193 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HB2' HG21 ' A' ' 101' ' ' VAL . 38.3 mt-10 -159.0 114.38 2.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.05 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -93.62 21.35 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -151.84 130.9 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.63 130.34 3.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.457 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.43 ' HE1' ' O ' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -65.04 -32.81 74.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.751 0.31 . . . . 0.0 111.066 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -43.83 91.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 95' ' ' GLU . 59.6 t -61.98 -28.48 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.049 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.4 m -69.08 -48.02 63.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.013 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -52.41 -59.01 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.912 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -62.56 -30.78 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB1' ' HB3' ' A' ' 174' ' ' CYS . . . -62.96 -57.42 10.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.02 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -50.52 -44.44 56.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.528 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.79 -39.75 71.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.399 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 104' ' ' GLU . 15.0 t -64.24 -42.97 97.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.437 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.586 HD13 HG13 ' A' ' 91' ' ' VAL . 2.6 mm? -52.33 -22.42 4.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.228 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 -54.18 3.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.355 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 1.5 pp0? -61.16 -30.98 70.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.486 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -84.32 172.39 11.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -22.36 11.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HG3' HD13 ' A' ' 109' ' ' LEU . 1.1 mmt180 -45.26 102.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 141.36 24.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.714 ' HA ' HD23 ' A' ' 88' ' ' LEU . 36.2 Cg_exo -59.82 152.25 65.11 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.481 2.12 . . . . 0.0 112.441 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 118' ' ' ARG . 3.1 p -114.23 177.87 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.403 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.622 ' H ' HG22 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -146.19 74.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.454 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -128.57 -144.87 5.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.282 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -122.2 130.5 53.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.678 0.275 . . . . 0.0 111.281 -178.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.727 ' HG ' HG23 ' A' ' 123' ' ' VAL . 41.8 tp -84.97 100.01 11.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -73.61 87.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.684 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.954 HG21 HG22 ' A' ' 191' ' ' VAL . 94.0 t -101.87 112.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.91 42.73 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.576 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 47.19 25.0 2.48 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.718 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -174.38 27.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 156.43 121.92 0.72 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.14 -1.029 . . . . 0.0 113.468 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.922 HD13 ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -106.85 110.18 22.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 110.419 178.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -124.48 106.29 10.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 87' ' ' TYR . 10.2 p -86.98 112.45 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 136' ' ' LYS . 77.3 t -116.31 120.24 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -54.58 146.65 15.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -94.14 20.67 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -126.06 -42.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.66 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 39.8 p -110.45 -24.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.906 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.461 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER 68.43 25.27 6.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.38 123.41 6.22 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.364 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 141' ' ' ASP . 14.6 tp -63.48 118.37 8.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 0.0 111.02 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' A' ' 130' ' ' VAL . 3.7 mt -92.67 -50.63 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.41 HG21 ' OH ' ' A' ' 87' ' ' TYR . 11.7 t -120.09 123.08 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.529 ' HB3' HD21 ' A' ' 138' ' ' LEU . 2.2 p-10 -116.94 65.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.169 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.27 165.55 11.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.683 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.81 ' O ' HG22 ' A' ' 144' ' ' ILE . 1.9 t -111.28 2.75 17.87 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.857 HD12 HD21 ' A' ' 128' ' ' LEU . 3.1 tt 72.63 -3.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.403 ' HB3' HG23 ' A' ' 143' ' ' THR . 25.9 tt0 -110.86 -37.53 5.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -30.69 27.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.574 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 148' ' ' SER . 10.7 p -51.46 164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.915 ' CB ' HD12 ' A' ' 163' ' ' ILE . 66.1 m -53.01 -53.91 43.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.323 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 163' ' ' ILE . 0.1 OUTLIER 155.84 -15.3 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.862 0.726 . . . . 0.0 112.212 178.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 0.5 OUTLIER 90.75 172.2 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.292 0.637 . . . . 0.0 111.097 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 166.55 107.0 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.114 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 46.0 Cg_endo -68.49 140.33 47.51 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.364 2.043 . . . . 0.0 112.089 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.43 ' O ' ' HE1' ' A' ' 99' ' ' MET . 0.1 OUTLIER -44.95 -85.29 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.361 -179.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -149.76 22.43 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.3 m120 45.82 34.48 1.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.295 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -91.28 -18.41 24.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.409 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -142.47 15.8 2.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.703 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.26 51.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.321 . . . . 0.0 110.891 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -129.54 146.31 17.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.567 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 177' ' ' PHE . 2.0 m-85 -111.63 -176.31 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.702 0.287 . . . . 0.0 110.718 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.429 ' OG ' HD12 ' A' ' 106' ' ' LEU . 1.7 m -168.41 106.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.893 0.378 . . . . 0.0 111.276 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.922 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 42.8 m-85 -85.12 -173.16 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.915 HD12 ' CB ' ' A' ' 148' ' ' SER . 0.0 OUTLIER -167.09 132.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.478 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 38.5 t -131.42 156.69 45.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.859 0.361 . . . . 0.0 111.033 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -113.99 80.53 1.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.001 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 t0 52.47 -161.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 168' ' ' THR . . . 100.21 -22.28 40.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.325 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 167' ' ' GLY . 18.9 p -161.75 -42.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -75.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.05 -42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 173' ' ' MET . 2.1 ptp85 -166.67 -150.78 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.954 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.739 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.27 74.42 0.09 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 171' ' ' ARG . 71.0 mmm -89.19 117.9 28.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.651 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.54 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 0.8 OUTLIER -79.68 165.05 23.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.713 177.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -131.89 120.87 23.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 111.29 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.411 ' HA2' ' HG ' ' A' ' 106' ' ' LEU . . . -116.3 113.68 2.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.432 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.571 ' CZ ' ' CE2' ' A' ' 162' ' ' TYR . 1.0 OUTLIER -143.65 162.2 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -137.53 131.15 31.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.983 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 187' ' ' LEU . . . -47.85 138.94 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.375 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -56.41 11.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.885 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.21 -33.67 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 110.455 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.9 t70 66.17 69.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.28 25.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.901 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 35.18 37.81 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 113.985 0.354 . . . . 0.0 113.985 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -148.69 23.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.846 0.323 . . . . 0.0 111.585 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -155.74 21.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.394 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.912 ' O ' HG23 ' A' ' 191' ' ' VAL . 0.6 OUTLIER 179.59 -38.92 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.539 ' N ' HD23 ' A' ' 187' ' ' LEU . 70.5 m -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.482 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -55.81 -28.13 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.093 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 76' ' ' VAL . . . -59.0 -49.75 76.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.534 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.954 HG22 HG21 ' A' ' 123' ' ' VAL . 2.5 t -73.74 -38.82 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.531 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.09 -40.95 45.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.951 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -79.23 -29.53 42.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.288 178.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.677 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -56.84 -43.02 80.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.519 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 144' ' ' ILE . 6.8 m-85 -58.09 -28.37 64.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.212 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -51.14 47.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.013 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 64.7 t -50.78 -37.71 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.867 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.1 t -61.8 -35.97 79.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.576 HD11 HD11 ' B' ' 3' ' ' ILE . 1.2 pt? -140.13 64.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.295 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 196' ' ' ALA . 1.3 pt-20 -50.29 -30.09 11.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.469 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.73 24.94 3.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.039 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.53 33.97 11.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.44 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -67.74 82.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.268 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -106.02 17.44 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.117 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -23.53 14.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.744 0.307 . . . . 0.0 111.069 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.562 HG23 HD21 ' B' ' 7' ' ' LEU . 5.1 t -48.03 167.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.232 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.23 -75.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.298 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.37 169.87 10.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.349 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 64.12 168.87 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.174 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.971 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.699 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -161.34 -96.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' B' ' 2' ' ' TYR . 4.8 mp -102.71 -47.67 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.456 ' HA2' ' CD1' ' A' ' 149' ' ' PHE . . . -51.09 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' B' ' 1' ' ' ALA . 16.2 Cg_exo -68.59 161.2 46.17 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.692 2.262 . . . . 0.0 111.61 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.407 ' CD1' ' N ' ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 206' ' ' THR . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -129.12 150.62 75.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.54 159.8 28.69 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.632 2.221 . . . . 0.0 112.626 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' TRP . 12.6 m80 63.1 112.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.149 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.66 -73.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.201 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.417 ' N ' ' O ' ' A' ' 67' ' ' HIS . 3.1 m0 -46.3 -34.45 4.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.201 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -62.92 -34.8 78.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.633 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.27 -55.84 4.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.129 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 15.9 t70 -49.42 -49.17 46.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -49.69 -41.58 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -86.21 -23.38 26.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.764 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB1' HG23 ' A' ' 80' ' ' THR . . . -72.7 -66.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 110.709 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.653 ' CG2' ' HB2' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -48.27 -37.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.832 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -45.68 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.038 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -90.78 18.57 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.411 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 55.71 96.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.835 0.35 . . . . 0.0 111.103 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.574 HG23 ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -178.8 -30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.92 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.571 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 0.7 OUTLIER -41.12 158.21 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 111.278 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 175.49 145.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.103 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' CD1' ' HG2' ' A' ' 186' ' ' ARG . 89.6 m-85 -160.59 148.01 15.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 120' ' ' LEU . 32.3 t -47.32 166.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.615 ' HB ' HD11 ' A' ' 187' ' ' LEU . 8.8 p -173.9 159.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.979 0.418 . . . . 0.0 111.724 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.441 ' N ' HG22 ' A' ' 85' ' ' VAL . 32.0 mttm -121.18 65.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.754 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.489 ' HB3' HG12 ' A' ' 117' ' ' VAL . 14.6 t80 -56.68 121.13 9.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.269 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.66 -41.21 94.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.474 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . . . 141.9 -178.43 20.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.231 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.41 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 38.1 m -100.86 142.57 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.453 ' O ' ' HE1' ' A' ' 173' ' ' MET . 0.4 OUTLIER -136.51 172.42 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.893 -178.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' CG ' ' HD2' ' A' ' 171' ' ' ARG . 4.0 tt0 -109.83 148.43 31.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.165 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 172' ' ' TRP . 12.9 m -148.73 173.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.426 ' O ' ' CD1' ' A' ' 172' ' ' TRP . 22.5 m-85 -87.94 -24.07 23.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.658 ' HB2' HG21 ' A' ' 101' ' ' VAL . 4.5 mp0 -133.09 145.36 50.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 111.197 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 25.31 5.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.47 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.406 ' HG2' ' HD3' ' A' ' 165' ' ' ARG . 28.3 mtm180 -136.97 24.15 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.89 128.47 4.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.478 ' HG3' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -57.92 -37.89 74.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.842 0.353 . . . . 0.0 110.962 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -55.12 -34.4 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 95' ' ' GLU . 82.2 t -64.86 -30.78 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.884 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 91.8 m -66.39 -43.68 85.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.21 -46.73 79.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.8 pt-20 -76.03 -32.14 59.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.984 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' O ' HD23 ' A' ' 109' ' ' LEU . . . -63.08 -59.79 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.507 HD13 ' OD2' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -46.31 -36.18 6.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -40.58 88.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.4 t -67.49 -32.42 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.615 HD13 ' HG3' ' A' ' 114' ' ' ARG . 4.0 mm? -60.36 -18.63 51.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.086 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -97.17 -45.31 6.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -64.35 -30.42 71.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.73 171.99 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -21.61 14.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD13 ' A' ' 109' ' ' LEU . 4.7 mmt180 -45.43 114.21 0.71 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.6 ptt-85 -124.51 148.15 57.74 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.292 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.1 156.64 2.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.785 2.324 . . . . 0.0 112.632 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 117' ' ' VAL . 10.6 p -129.08 114.34 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.907 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.97 63.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.681 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -117.65 -139.29 6.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.478 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.834 HD23 ' CD2' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -144.27 137.79 27.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.985 0.421 . . . . 0.0 111.2 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.623 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -88.8 104.0 16.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.486 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.834 ' CD2' HD23 ' A' ' 120' ' ' LEU . 15.8 m-70 -72.01 117.16 13.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.785 HG21 HG22 ' A' ' 191' ' ' VAL . 65.8 t -131.65 88.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.416 ' HB3' ' N ' ' A' ' 80' ' ' THR . 5.5 m -119.26 46.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.89 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 197' ' ' VAL . . . 35.23 61.37 0.66 Allowed Glycine 0 CA--C 1.521 0.456 0 O-C-N 123.415 0.447 . . . . 0.0 113.855 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.708 ' C ' HG22 ' A' ' 144' ' ' ILE . 6.2 t70 -178.94 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.65 122.35 0.95 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.56 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 162' ' ' TYR . 12.8 mt -78.78 146.44 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 122' ' ' HIS . 29.4 mtt180 -154.16 96.17 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.737 HG13 ' HB ' ' A' ' 139' ' ' ILE . 3.5 p -86.89 115.46 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.707 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.16 136.22 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 42.1 t0 -68.5 152.64 45.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 7.0 t0 -97.4 21.55 9.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.23 -46.12 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 110.654 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.3 p -102.17 -25.37 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 66.02 32.09 8.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.03 124.42 8.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.353 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 141' ' ' ASP . 11.7 tp -55.89 118.17 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.737 ' HB ' HG13 ' A' ' 130' ' ' VAL . 8.6 mt -87.81 -50.51 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.262 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.496 HG23 ' CG1' ' A' ' 130' ' ' VAL . 57.3 t -112.69 79.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.147 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.452 ' HB3' ' CD2' ' A' ' 138' ' ' LEU . 9.3 p-10 -82.74 68.91 9.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -174.33 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.5 m -105.48 169.86 8.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.708 HG22 ' C ' ' A' ' 126' ' ' ASP . 11.5 tt -99.62 -26.04 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.9 -42.32 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -45.65 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 163' ' ' ILE . 14.7 p -48.04 164.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -80.67 7.84 9.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.449 ' H ' HG13 ' A' ' 147' ' ' VAL . 1.5 m-85 80.58 -161.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 110.933 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.48 ' HB3' ' CD1' ' A' ' 162' ' ' TYR . 28.3 p -143.75 163.46 33.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.936 0.398 . . . . 0.0 111.214 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 99' ' ' MET . . . -154.91 110.3 2.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.707 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 151' ' ' ALA . 25.5 Cg_endo -61.68 132.32 39.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.268 1.979 . . . . 0.0 112.1 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.507 ' OD2' HD13 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -43.31 -54.56 4.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.277 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 177.99 35.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.261 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 42.15 35.26 0.56 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.455 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -78.35 -13.82 59.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.884 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.04 24.48 0.13 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.894 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 64.0 48.07 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 111.045 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.59 128.13 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.326 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -113.78 174.89 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.931 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 t -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.831 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.623 ' OH ' HD11 ' A' ' 121' ' ' LEU . 4.5 m-30 -93.82 -178.15 4.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.625 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.6 pt -163.93 136.97 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.13 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.513 ' SG ' HG23 ' A' ' 147' ' ' VAL . 3.0 m -131.22 160.15 35.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.411 ' HB2' ' NH1' ' A' ' 165' ' ' ARG . 23.5 mtm105 -119.28 85.1 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.075 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.4 p30 46.58 -161.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.26 -82.24 1.06 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.304 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 24.13 11.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.332 . . . . 0.0 111.015 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.9 -82.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.248 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.5 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.428 ' HD2' ' CG ' ' A' ' 92' ' ' GLU . 4.6 ptp180 -133.27 -151.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.125 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.51 ' O ' HG22 ' A' ' 93' ' ' VAL . 12.2 m95 -63.15 82.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.453 ' HE1' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -86.68 121.09 28.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.559 -178.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 155.09 17.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.067 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -137.16 123.21 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.757 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -98.69 112.04 4.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.532 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.476 ' CE2' ' CD2' ' A' ' 162' ' ' TYR . 22.0 m-85 -109.0 158.7 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.751 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 178' ' ' LEU . 0.4 OUTLIER -149.84 99.29 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.299 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 85' ' ' VAL . . . -42.32 141.23 0.99 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.436 ' HB2' ' N ' ' A' ' 85' ' ' VAL . 34.7 t -63.94 -66.22 0.57 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.308 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -29.38 49.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.138 0.494 . . . . 0.0 109.907 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.76 75.19 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.223 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.06 30.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.428 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.454 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 39.1 30.25 0.12 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.421 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -133.71 49.63 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.502 ' HG2' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 169.71 -32.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.673 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.615 HD11 ' HB ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER -112.11 -30.33 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.905 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.454 ' CB ' ' HA2' ' A' ' 184' ' ' GLY . 11.1 t -87.65 -66.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.149 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -30.34 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.571 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -68.04 -68.87 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.996 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.785 HG22 HG21 ' A' ' 123' ' ' VAL . 29.7 t -52.87 -48.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.77 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.76 -35.18 23.27 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.716 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.413 ' HB3' HG11 ' A' ' 76' ' ' VAL . 14.5 t -86.46 -32.77 20.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.165 0.507 . . . . 0.0 109.884 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.653 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . . . -52.38 -33.85 45.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.894 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.525 ' CE1' ' CG1' ' A' ' 144' ' ' ILE . 32.6 m-85 -71.9 -18.86 62.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.104 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -44.85 -59.32 2.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.576 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 198' ' ' CYS . 34.4 m -50.47 -47.0 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.179 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.571 ' N ' HG23 ' A' ' 197' ' ' VAL . 41.0 t -54.41 -29.26 48.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 109.784 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.769 HD13 HG12 ' B' ' 3' ' ' ILE . 4.6 mp -123.28 43.29 2.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.521 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -44.93 -28.17 0.63 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.169 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 26.23 9.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 199' ' ' LEU . 15.8 mmtm 49.76 47.6 22.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -87.72 50.84 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.29 119.4 12.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.811 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -94.18 78.91 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.999 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.59 HG21 ' HB2' ' B' ' 7' ' ' LEU . 1.2 t -120.49 104.78 10.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.985 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 71.15 -63.96 0.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.071 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 209' ' ' ALA . . . -152.59 -84.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 208' ' ' ALA . . . 177.01 46.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.104 179.899 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.443 ' HB1' ' CE1' ' B' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.666 0.27 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.735 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -176.1 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.986 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.769 HG12 HD13 ' A' ' 199' ' ' LEU . 4.2 mp -140.24 54.09 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.163 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.486 ' N ' ' CD1' ' B' ' 7' ' ' LEU . . . -165.9 -67.1 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.418 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.24 1.88 8.55 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.139 2.56 . . . . 0.0 112.664 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.872 ' C ' HD22 ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.872 HD22 ' C ' ' B' ' 6' ' ' PTR . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.04 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.7 mttt 50.43 58.16 17.27 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.712 0.291 . . . . 0.0 111.067 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -44.38 -61.92 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.555 2.17 . . . . 0.0 112.474 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.89 -68.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.762 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -70.98 -23.59 62.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.598 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -33.26 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.006 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -67.31 -40.27 85.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.27 65.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.81 -41.02 94.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -30.47 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.597 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -87.84 -25.61 23.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.662 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -56.01 -50.21 71.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -61.12 -43.87 97.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.6 -179.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.8 83.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.448 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -95.05 19.85 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.046 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB1' ' CB ' ' A' ' 124' ' ' SER . . . 49.22 84.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.238 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 3.4 t 178.56 47.51 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.645 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 123' ' ' VAL . 9.7 t -120.83 114.27 21.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.434 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.89 142.79 51.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.866 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.489 ' HB2' HD11 ' A' ' 187' ' ' LEU . 49.0 m-85 -152.02 142.84 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.678 ' HA ' HD23 ' A' ' 120' ' ' LEU . 5.0 m -54.98 164.32 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 121' ' ' LEU . 4.8 p 176.6 161.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 85' ' ' VAL . 10.7 mtmm -113.11 79.33 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 139' ' ' ILE . 12.6 t80 -65.39 99.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.82 HD23 ' HG3' ' A' ' 116' ' ' PRO . 49.9 mt -46.47 -49.57 18.11 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA2' ' CE2' ' A' ' 87' ' ' TYR . . . 147.01 -169.18 28.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.228 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 21.1 p -123.96 129.25 50.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 110.962 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -117.88 147.24 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.999 -178.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.5 136.77 45.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 172' ' ' TRP . 27.4 m -132.76 178.92 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -116.48 26.87 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.674 ' CB ' HG21 ' A' ' 101' ' ' VAL . 3.9 mt-10 -145.0 -82.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.315 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.0 m 63.42 28.25 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 21.45 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.9 168.01 30.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.565 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -32.01 22.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.0 110.894 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -63.51 -17.02 62.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.326 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.674 HG21 ' CB ' ' A' ' 95' ' ' GLU . 25.8 t -87.5 -21.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.602 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.5 p -69.56 -37.0 76.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.62 -59.58 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.478 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.916 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.4 pt-20 -64.35 -32.92 74.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.611 ' HB1' ' CB ' ' A' ' 174' ' ' CYS . . . -67.63 -23.93 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.793 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.671 HD13 ' OD1' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -92.56 -24.14 18.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.874 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.412 ' C ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -81.61 -38.58 25.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.916 HG23 ' O ' ' A' ' 104' ' ' GLU . 70.9 t -53.14 -55.41 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.262 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.681 ' CD2' HG13 ' A' ' 91' ' ' VAL . 13.9 mt -56.45 -25.31 50.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -82.91 -27.57 30.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.459 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -89.87 -10.39 45.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.259 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.0 p -106.36 -165.67 1.11 Allowed 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -83.65 -21.95 32.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.865 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -48.36 91.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -84.77 159.62 57.48 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.202 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.82 ' HG3' HD23 ' A' ' 88' ' ' LEU . 4.4 Cg_exo -71.81 161.53 44.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.703 2.269 . . . . 0.0 111.962 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.736 HG12 ' HB3' ' A' ' 87' ' ' TYR . 9.6 p -117.64 118.19 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.44 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 64.93 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.349 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -122.34 -159.2 10.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.77 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' ' 84' ' ' SER . 5.3 mt -116.66 126.49 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.137 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.64 ' HB2' HG11 ' A' ' 85' ' ' VAL . 5.9 tp -86.82 100.36 12.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.436 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -76.45 103.61 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.538 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.59 HG21 HG22 ' A' ' 191' ' ' VAL . 58.6 t -104.5 133.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.456 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.461 ' CB ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -145.91 29.06 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.722 -178.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 48.08 23.62 2.83 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.596 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HA ' HG22 ' A' ' 144' ' ' ILE . 41.5 t0 -165.03 22.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 143' ' ' THR . . . 152.36 112.07 0.5 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' A' ' 162' ' ' TYR . 1.4 mt -91.88 101.41 13.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 110.523 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -104.49 89.88 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.689 HG13 ' HB ' ' A' ' 139' ' ' ILE . 7.6 p -83.69 112.96 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.67 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 137' ' ' GLY . 7.0 p -122.76 138.86 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.212 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 36.8 t0 -63.83 144.59 56.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 28.5 t70 -93.52 14.62 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.42 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -120.61 -39.28 2.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.778 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.7 p -104.85 -24.42 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.839 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.15 35.0 4.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -103.99 134.03 11.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.612 HD21 ' CG ' ' A' ' 141' ' ' ASP . 10.8 tp -67.02 120.95 14.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.398 . . . . 0.0 111.061 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.746 HG21 ' CE2' ' A' ' 87' ' ' TYR . 7.8 mt -90.55 -59.49 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.56 114.83 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.874 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.612 ' CG ' HD21 ' A' ' 138' ' ' LEU . 20.3 t0 -111.28 96.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -136.73 -163.93 1.49 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.682 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.816 ' O ' HG22 ' A' ' 144' ' ' ILE . 5.1 t -135.93 8.91 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 143' ' ' THR . 4.7 tt 65.59 7.01 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 143' ' ' THR . 0.7 OUTLIER -112.6 -36.23 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.132 0.491 . . . . 0.0 110.397 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -83.98 -19.85 33.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.37 177.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 148' ' ' SER . 8.3 p -66.62 164.0 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.784 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.53 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -85.75 16.27 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' A' ' 148' ' ' SER . 15.4 m-85 82.58 -179.45 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.871 0.367 . . . . 0.0 110.957 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 26.6 p -114.53 -178.76 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.456 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 150' ' ' CYS . . . 172.64 100.45 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.387 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' B' ' 5' ' ' PRO . 44.8 Cg_endo -68.9 143.83 56.52 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.507 2.138 . . . . 0.0 112.894 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.671 ' OD1' HD13 ' A' ' 106' ' ' LEU . 0.4 OUTLIER -66.43 -153.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.14 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -98.78 24.04 8.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.813 0.339 . . . . 0.0 110.683 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 156' ' ' HIS . 2.4 m120 -58.05 -18.83 27.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.574 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 155' ' ' ASN . 3.0 t60 86.19 -51.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.571 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -168.64 75.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 111.427 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER 165.72 -28.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 179.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -96.86 122.03 7.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.844 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.499 ' HB3' ' CE1' ' A' ' 177' ' ' PHE . 5.6 m-85 -134.61 159.64 40.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.3 t -159.88 138.24 10.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.44 . . . . 0.0 111.636 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.84 ' CE2' HD13 ' A' ' 128' ' ' LEU . 6.0 m-85 -105.69 -173.23 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 162' ' ' TYR . 1.1 pt -160.94 135.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.04 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 3.4 m -126.48 100.04 6.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.984 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 -65.04 80.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 168' ' ' THR . 34.4 t0 60.79 -87.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.747 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 49.06 -88.99 0.01 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.765 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 166' ' ' ASP . 2.6 m -116.54 -33.47 4.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.751 0.31 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 81.4 m -59.15 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.034 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 169' ' ' THR . 58.5 mtp180 -163.92 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -136.04 -154.72 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.762 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.75 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -64.27 78.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -99.71 120.96 40.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.153 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.611 ' CB ' ' HB1' ' A' ' 105' ' ' ALA . 86.5 m -91.26 159.22 16.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -129.95 94.67 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.305 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.64 126.32 8.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.366 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.527 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -149.29 152.95 36.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.819 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.464 HD21 ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -130.61 120.89 24.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -40.88 147.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.994 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -42.25 73.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.53 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -76.1 -34.68 59.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.498 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' HD21 ' A' ' 178' ' ' LEU . 3.9 m-20 67.07 64.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.332 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -162.22 24.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.584 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 42.33 27.81 0.5 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.257 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 1.9 mt-10 -125.4 43.4 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.889 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.584 ' C ' HD12 ' A' ' 187' ' ' LEU . 16.5 mmt-85 -158.51 -44.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 191' ' ' VAL . 4.3 mp -115.2 -36.11 4.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.734 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 12.3 t -58.92 -65.87 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 186' ' ' ARG . 10.5 p80 -61.29 -35.68 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.89 -73.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.016 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 187' ' ' LEU . 6.6 t -51.39 -43.57 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.631 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.65 -34.84 36.67 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.484 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 196' ' ' ALA . 56.5 m -91.14 -27.39 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.073 177.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.618 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -49.53 -45.47 47.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.99 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.603 ' O ' HD12 ' A' ' 199' ' ' LEU . 33.5 m-85 -57.2 -22.52 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.984 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 193' ' ' CYS . . . -50.24 -41.43 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.42 -34.38 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.819 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.97 -23.41 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.767 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 195' ' ' PHE . 5.3 mp -113.8 -45.73 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.824 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 201' ' ' ARG . 60.7 tt0 60.95 115.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.407 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.406 ' CB ' ' O ' ' A' ' 200' ' ' GLU . 3.8 ttm180 78.74 0.95 2.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.391 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.12 52.19 2.58 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.065 0.459 . . . . 0.0 110.961 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -76.97 59.92 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.817 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.473 ' HD2' HD11 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -68.73 104.56 2.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -73.86 61.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.0 t -154.78 38.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -145.16 -52.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -99.3 88.5 3.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.034 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -108.9 165.06 11.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.087 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.171 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER 174.73 87.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.897 0.38 . . . . 0.0 111.366 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.582 HG22 ' O ' ' B' ' 3' ' ' ILE . 4.1 mp 42.42 48.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.155 0.502 . . . . 0.0 111.753 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.17 86.27 1.7 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.853 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' B' ' 1' ' ' ALA . 32.5 Cg_exo -71.47 114.09 2.3 Favored 'Cis proline' 0 N--CA 1.481 0.793 0 CA-C-N 118.137 0.969 . . . . 0.0 114.041 4.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.418 ' HB3' ' O ' ' B' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.51 ' CD1' HG23 ' B' ' 3' ' ' ILE . 12.0 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.945 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 3.5 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.781 0.324 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -104.84 83.74 0.86 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.327 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 68' ' ' GLN . 58.6 Cg_endo -71.95 74.28 2.38 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.586 2.191 . . . . 0.0 112.521 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 64.34 -72.83 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.201 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -46.06 -39.24 8.96 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.488 ' CB ' ' HA ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -81.94 -31.32 31.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.478 179.128 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.79 -28.38 68.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -85.24 -37.33 20.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.863 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.561 ' O ' HG22 ' A' ' 76' ' ' VAL . 6.8 t0 -56.46 -49.65 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.66 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -58.15 4.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.354 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -29.15 53.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -51.16 -68.49 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.877 HG21 ' HB3' ' A' ' 193' ' ' CYS . 3.3 m -49.48 -27.43 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -52.14 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 m -95.37 15.94 18.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.152 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 61.97 84.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.69 0.281 . . . . 0.0 111.036 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.592 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.7 t 175.67 54.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.415 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.712 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 19.5 t -122.28 71.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.371 . . . . 0.0 110.65 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 122' ' ' HIS . 13.0 p -92.91 148.71 21.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.078 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.662 ' C ' HD12 ' A' ' 120' ' ' LEU . 29.4 m-85 -151.52 139.63 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -53.54 139.47 31.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 86' ' ' LYS . 11.9 p -151.68 159.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.55 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.527 ' N ' HG22 ' A' ' 85' ' ' VAL . 23.9 mtpp -114.81 61.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.797 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.543 ' HB3' HG12 ' A' ' 117' ' ' VAL . 23.3 t80 -47.55 119.22 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 109' ' ' LEU . 10.1 mp -56.49 -46.67 80.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.69 ' O ' HD11 ' A' ' 109' ' ' LEU . . . 148.64 -176.38 27.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.99 130.43 51.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 111.372 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.568 HG13 HD13 ' A' ' 109' ' ' LEU . 7.0 m -121.72 174.35 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.09 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 93' ' ' VAL . 2.9 pt-20 -105.7 154.41 20.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.087 0.47 . . . . 0.0 111.616 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.736 HG11 ' SG ' ' A' ' 174' ' ' CYS . 16.0 m -157.65 -175.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.25 20.02 2.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.602 0.239 . . . . 0.0 111.39 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HB2' HG21 ' A' ' 101' ' ' VAL . 1.2 mm-40 -115.76 -68.01 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.176 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 53.0 p 50.1 24.99 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.631 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -148.67 32.72 0.78 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.43 125.23 1.68 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.578 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -34.51 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -63.35 -25.97 68.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.695 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.659 HG21 ' HB2' ' A' ' 95' ' ' GLU . 43.3 t -62.67 -35.42 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -70.82 -34.88 72.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.48 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -64.18 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.2 pt-20 -85.14 -39.21 18.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.422 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.15 75.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.698 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 160' ' ' PHE . 33.0 tp -51.6 -33.48 33.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -43.47 28.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 104' ' ' GLU . 13.2 t -58.11 -33.31 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.69 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.7 OUTLIER -54.38 -31.07 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.215 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -50.43 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.539 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -54.09 -25.72 23.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.638 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.4 p -82.75 -177.85 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -3.73 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.407 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.433 ' HG3' ' CD1' ' A' ' 109' ' ' LEU . 11.9 mmp_? -48.54 177.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.774 0.321 . . . . 0.0 111.127 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.19 135.49 4.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.033 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 152.04 4.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.314 2.009 . . . . 0.0 112.099 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 139' ' ' ILE . 7.1 p -123.48 113.6 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.423 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 64.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.557 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -117.0 -150.17 9.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.91 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 83' ' ' PHE . 13.1 tp -137.42 128.21 27.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.773 0.321 . . . . 0.0 110.793 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -78.02 90.14 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -72.64 94.02 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.225 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.822 HG13 HD23 ' A' ' 128' ' ' LEU . 4.2 t -100.34 160.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.72 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -166.54 34.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.501 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 45.93 44.84 13.84 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.536 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -171.19 -43.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.679 0.276 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.53 114.4 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.286 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.918 HD13 ' CE2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -84.33 120.17 25.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 110.169 177.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -132.66 98.68 4.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.036 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 139' ' ' ILE . 5.7 p -83.26 129.45 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.846 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.499 HG23 ' H ' ' A' ' 138' ' ' LEU . 6.1 p -133.71 132.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.052 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.423 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 40.3 t0 -65.8 148.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.919 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -97.74 20.11 12.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -125.54 -42.15 1.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.616 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.3 p -104.27 -27.73 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.671 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tptm 49.35 49.9 18.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -113.69 14.03 22.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.076 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.736 HD12 ' H ' ' A' ' 139' ' ' ILE . 8.7 tp 59.36 148.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 111.248 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.996 HD11 HG21 ' A' ' 117' ' ' VAL . 3.3 mt -127.85 -51.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.493 ' O ' HD11 ' A' ' 138' ' ' LEU . 21.9 t -114.16 136.78 49.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.038 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -143.06 58.96 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -113.07 162.06 16.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.958 ' O ' HG23 ' A' ' 147' ' ' VAL . 63.4 m -97.67 122.73 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.603 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.94 HD11 ' CD1' ' A' ' 195' ' ' PHE . 7.3 tt -54.22 -31.4 21.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 143' ' ' THR . 24.3 tt0 -72.97 -25.25 60.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.444 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.2 OUTLIER -96.05 -39.55 9.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.499 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 143' ' ' THR . 17.8 t -49.76 144.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.272 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.476 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 9.1 m -50.51 -41.19 53.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.976 ' CE1' HD11 ' A' ' 163' ' ' ILE . 2.7 p90 155.77 -175.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.616 0.572 . . . . 0.0 110.074 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 195' ' ' PHE . 19.5 p -121.23 140.13 52.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.738 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -167.94 133.06 1.54 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.803 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.423 ' CB ' ' O ' ' A' ' 159' ' ' GLY . 98.3 Cg_endo -82.0 -96.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.482 2.122 . . . . 0.0 112.298 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -159.06 -62.83 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.874 0.369 . . . . 0.0 110.393 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -162.76 26.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.994 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 56.6 t30 45.18 48.69 9.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.284 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.98 -1.33 7.81 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.73 11.13 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.371 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HG2' ' CA ' ' A' ' 183' ' ' SER . 0.0 OUTLIER 58.84 37.17 24.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.029 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 152' ' ' PRO . . . -122.05 141.3 14.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.569 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.473 ' O ' HD13 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -105.51 -163.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 0.0 110.83 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.8 t 172.5 129.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.736 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.918 ' CE2' HD13 ' A' ' 128' ' ' LEU . 3.9 m-30 -110.86 -179.56 3.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.976 HD11 ' CE1' ' A' ' 149' ' ' PHE . 1.6 pt -163.83 143.24 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.446 ' HB3' HG13 ' A' ' 147' ' ' VAL . 1.8 p -169.1 133.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.579 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.502 ' HG3' ' CZ2' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -67.63 84.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.979 177.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 169' ' ' THR . 97.8 m-20 -66.6 110.13 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.5 -20.72 59.64 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.467 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -48.56 3.33 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.473 ' CB ' ' HB3' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -50.2 -64.19 0.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.374 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 171' ' ' ARG . 53.7 mtp180 -164.54 -46.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.108 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 165.0 -145.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.502 ' CZ2' ' HG3' ' A' ' 165' ' ' ARG . 1.7 m-90 -64.17 81.7 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.489 ' HE2' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.81 134.9 39.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.333 0.587 . . . . 0.0 111.764 -176.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.736 ' SG ' HG11 ' A' ' 93' ' ' VAL . 1.2 m -101.89 169.03 9.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.978 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 39.8 m-70 -146.79 123.42 11.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 111.549 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -101.76 114.6 5.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.877 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.424 ' HD1' HG21 ' A' ' 85' ' ' VAL . 6.8 m-85 -104.96 146.04 29.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.124 0.488 . . . . 0.0 111.623 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.706 HD13 ' O ' ' A' ' 179' ' ' ALA . 3.1 tm? -145.76 110.46 5.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.706 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -42.39 143.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.858 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.8 t -71.91 -48.67 43.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.801 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -78.57 -25.13 45.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.99 77.84 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.462 ' CA ' ' HG2' ' A' ' 158' ' ' ARG . 39.9 t -169.9 28.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.503 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 40.05 34.99 0.62 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.144 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -136.21 47.54 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.546 ' CB ' HD13 ' A' ' 187' ' ' LEU . 1.6 mpt_? -153.47 -57.74 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.131 0.491 . . . . 0.0 110.158 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.49 -0.97 4.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.867 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.428 ' HA ' ' CE2' ' A' ' 160' ' ' PHE . 70.1 m -80.44 -44.08 19.87 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.076 0.465 . . . . 0.0 110.228 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CG ' ' CZ2' ' A' ' 69' ' ' TRP . 2.1 t-80 -94.84 -18.86 20.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.67 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.712 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -78.74 -63.07 1.5 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.539 HG21 ' OH ' ' A' ' 162' ' ' TYR . 54.4 t -48.41 -46.52 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -58.8 -24.22 57.2 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.792 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.877 ' HB3' HG21 ' A' ' 76' ' ' VAL . 56.1 m -85.84 -31.3 22.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.497 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.547 ' HB2' HG11 ' A' ' 123' ' ' VAL . . . -52.68 -42.39 64.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.94 ' CD1' HD11 ' A' ' 144' ' ' ILE . 45.3 m-85 -65.44 -25.88 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.876 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -43.44 -42.05 4.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 194' ' ' ALA . 0.5 OUTLIER -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.908 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.607 ' HB3' HD23 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -43.03 -46.4 5.56 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.811 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 202' ' ' LYS . 0.2 OUTLIER -106.67 -27.28 10.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.096 177.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 72.84 -63.54 0.43 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.139 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -90.55 29.95 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.757 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.695 ' HA ' HD12 ' A' ' 199' ' ' LEU . 3.7 mmmt 45.95 36.42 2.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.147 0.498 . . . . 0.0 110.388 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -102.59 73.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.473 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.653 ' HG2' HD12 ' B' ' 7' ' ' LEU . 0.1 OUTLIER -86.4 -73.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.321 178.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.64 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.922 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.434 HG23 HD23 ' B' ' 7' ' ' LEU . 0.0 OUTLIER -167.24 108.62 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.971 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -74.82 160.59 30.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.09 98.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.06 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -175.3 -75.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.05 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.074 -179.948 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.95 ' HB3' ' HG3' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 2' ' ' TYR . 0.0 OUTLIER -157.41 68.44 0.53 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.209 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.678 HD12 ' N ' ' B' ' 3' ' ' ILE . 2.0 mp 66.41 -65.19 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.353 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 149' ' ' PHE . . . -40.49 -61.91 1.72 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.398 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.95 ' HG3' ' HB3' ' B' ' 1' ' ' ALA . 85.2 Cg_endo -76.43 -23.46 11.5 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.908 2.405 . . . . 0.0 112.533 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . 0.722 ' C ' HD13 ' B' ' 7' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.722 HD13 ' C ' ' B' ' 6' ' ' PTR . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.711 0.291 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -153.79 146.54 17.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.046 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.07 41.2 0.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.866 2.377 . . . . 0.0 112.8 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -138.95 -63.53 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.49 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -79.26 -56.4 4.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.057 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -58.94 -38.6 79.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.155 0.503 . . . . 0.0 109.89 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -53.16 -24.42 10.61 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.332 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.57 23.1 13.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.994 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -131.45 -48.19 0.98 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.064 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.01 -37.97 22.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.899 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.08 -26.08 39.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . -52.01 -65.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 197' ' ' VAL . 2.7 m -51.45 -31.58 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -47.78 73.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.758 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -94.04 21.56 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.006 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 124' ' ' SER . . . 49.06 85.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.174 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -176.8 41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -109.2 161.84 14.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.899 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' PHE . 78.7 p 178.66 155.16 0.42 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' SER . 49.5 m-85 -164.69 141.61 6.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 t -51.84 149.92 4.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.352 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 187' ' ' LEU . 1.7 t -146.66 167.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.231 0.539 . . . . 0.0 112.324 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' H ' HG12 ' A' ' 85' ' ' VAL . 17.7 mmtt -121.52 48.07 1.75 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.995 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.936 ' CB ' HG12 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -38.8 150.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.066 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 116' ' ' PRO . 75.1 mt -106.54 -38.82 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.643 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.43 169.52 12.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.192 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 9.2 p -101.58 144.3 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.411 . . . . 0.0 110.914 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -127.32 176.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.873 -178.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.5 ' N ' HG13 ' A' ' 91' ' ' VAL . 2.5 pt-20 -95.92 145.57 25.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.909 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 172' ' ' TRP . 13.6 m -146.0 166.91 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.87 0.367 . . . . 0.0 111.274 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -93.61 20.65 7.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.307 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 94' ' ' PHE . 9.9 mt-10 -167.2 150.05 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.031 0.443 . . . . 0.0 110.906 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 96.3 p -125.32 20.61 8.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.16 74.19 1.02 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.785 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -164.56 117.6 0.76 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.444 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.642 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -56.9 -26.76 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -27.98 36.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.416 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 58.4 t -62.11 -48.3 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.779 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.1 m -60.57 -37.63 81.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.633 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.43 -42.31 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.0 pt-20 -79.45 -35.53 40.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.503 ' O ' HD22 ' A' ' 109' ' ' LEU . . . -55.44 -53.22 58.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.453 ' CD1' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -47.18 -46.2 23.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.906 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -42.68 86.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 104' ' ' GLU . 25.2 t -57.66 -47.52 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.808 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.572 HD13 ' HG3' ' A' ' 114' ' ' ARG . 2.7 mm? -53.15 -23.31 7.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.92 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -59.99 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.408 ' HG2' ' HA ' ' A' ' 108' ' ' VAL . 1.3 pp0? -53.15 -31.18 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -85.04 -171.96 3.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.955 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 25.44 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.572 ' HG3' HD13 ' A' ' 109' ' ' LEU . 8.5 mmt180 -65.04 76.53 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.41 135.07 5.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.508 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.708 ' HB3' HD23 ' A' ' 88' ' ' LEU . 92.8 Cg_endo -82.4 164.93 16.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.574 2.183 . . . . 0.0 112.068 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.936 HG12 ' CB ' ' A' ' 87' ' ' TYR . 1.5 p -114.56 176.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.014 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.58 ' H ' HG22 ' A' ' 117' ' ' VAL . 3.0 ttt180 -152.65 89.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.455 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -149.59 -137.73 2.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.846 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -122.75 121.72 36.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.646 0.26 . . . . 0.0 111.219 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.636 ' HB2' HG21 ' A' ' 85' ' ' VAL . 8.6 tp -87.61 104.21 16.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.437 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -74.22 110.75 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.717 ' CG1' ' HB2' ' A' ' 194' ' ' ALA . 68.3 t -114.04 105.75 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 1.2 p -118.17 16.13 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.739 ' HA2' ' HB1' ' A' ' 194' ' ' ALA . . . 62.09 11.49 32.39 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.964 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -149.33 16.13 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.698 0.249 . . . . 0.0 111.282 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 161.06 96.88 0.11 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.812 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.867 HD13 ' CE2' ' A' ' 162' ' ' TYR . 1.6 mt -77.03 111.7 12.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.695 0.283 . . . . 0.0 110.501 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.35 86.76 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.312 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 139' ' ' ILE . 6.2 p -77.93 100.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.602 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 132' ' ' ASP . 65.2 t -99.72 154.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.562 ' OD2' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -91.85 139.49 30.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.634 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.425 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 38.7 t70 -87.82 14.33 8.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.524 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.4 OUTLIER -111.44 -30.62 7.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.05 0.452 . . . . 0.0 110.526 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.435 ' N ' ' HG3' ' A' ' 134' ' ' GLU . 67.0 p -139.12 8.64 2.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.512 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER 42.02 44.15 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.484 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.12 143.61 15.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.096 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.43 112.06 12.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.87 0.367 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.799 HD11 HG21 ' A' ' 117' ' ' VAL . 10.2 mt -81.18 -51.47 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.438 ' HB ' HG12 ' A' ' 130' ' ' VAL . 58.8 t -120.12 101.29 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -95.54 90.85 5.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.178 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 147' ' ' VAL . 19.2 mt-30 -142.13 161.36 38.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.65 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.702 ' O ' HG22 ' A' ' 144' ' ' ILE . 2.0 t -100.21 5.54 44.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 143' ' ' THR . 2.1 tt 84.66 -39.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.122 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -86.45 -25.16 25.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.918 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -78.59 -18.43 54.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.257 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.957 HG12 ' O ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -79.08 -177.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.607 ' HB3' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -98.01 22.3 9.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.38 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.436 ' CB ' ' O ' ' A' ' 148' ' ' SER . 18.5 m-85 85.62 -171.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 20.4 p -134.4 168.05 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.733 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.642 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -175.49 110.44 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HB3' ' CD1' ' A' ' 160' ' ' PHE . 25.8 Cg_endo -62.14 158.95 36.81 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.462 2.108 . . . . 0.0 112.919 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 26.6 t0 -95.9 53.56 1.41 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.036 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER 88.65 93.66 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.985 -178.238 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -52.66 -20.85 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.368 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 -23.49 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.685 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -109.92 1.14 18.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.466 -0.493 . . . . 0.0 112.214 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 70.33 50.96 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.702 0.287 . . . . 0.0 111.073 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.06 129.5 5.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.799 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 177' ' ' PHE . 0.5 OUTLIER -104.77 -174.53 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 110.591 178.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER 179.68 126.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 111.426 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.867 ' CE2' HD13 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -97.77 -173.78 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.61 179.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.957 ' O ' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -159.07 133.36 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.622 ' HB2' HG13 ' A' ' 147' ' ' VAL . 35.4 t -131.5 152.45 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.009 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.89 96.93 5.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.03 -166.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.719 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.76 -86.74 1.2 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.68 29.73 6.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.683 0.277 . . . . 0.0 110.883 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 -84.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 173' ' ' MET . 9.3 ptm180 -179.21 -47.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -150.45 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.99 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.623 ' O ' HG22 ' A' ' 93' ' ' VAL . 5.7 m95 -68.31 72.86 0.21 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.468 ' HE3' ' O ' ' A' ' 91' ' ' VAL . 75.3 mmm -89.23 118.02 28.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.293 0.568 . . . . 0.0 111.772 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 161.64 26.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.135 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -133.64 109.52 9.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.42 125.8 7.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 162' ' ' TYR . 1.7 p90 -144.5 144.6 31.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.642 HD12 ' OD2' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -110.34 140.51 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.841 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 182' ' ' ASP . . . -62.51 140.47 58.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.149 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.39 -62.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -74.8 -26.7 59.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.642 ' OD2' HD12 ' A' ' 178' ' ' LEU . 0.3 OUTLIER 62.48 81.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.088 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.52 33.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.447 ' HA2' ' CB ' ' A' ' 188' ' ' SER . . . 46.15 39.66 9.58 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.594 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.84 4.58 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.574 ' CB ' HD13 ' A' ' 187' ' ' LEU . 14.1 mmt180 -114.76 -64.51 1.3 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.81 0.338 . . . . 0.0 110.743 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.844 HD12 HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -143.37 15.77 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.652 178.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.476 ' O ' ' CE1' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -96.38 -34.26 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 178.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.39 -21.42 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.52 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.18 -58.76 3.08 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 123' ' ' VAL . 33.2 t -49.73 -49.75 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.106 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.38 -33.89 12.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.354 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 2.9 t -76.41 -28.56 56.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.544 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.739 ' HB1' ' HA2' ' A' ' 125' ' ' GLY . . . -57.92 -47.02 84.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.787 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -53.56 -26.63 22.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 193' ' ' CYS . . . -50.37 -29.07 9.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 76' ' ' VAL . 86.5 t -84.97 -31.32 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.505 ' HB3' HD23 ' A' ' 199' ' ' LEU . 11.5 t -53.94 -48.0 70.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.325 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 198' ' ' CYS . 0.1 OUTLIER -95.65 -24.5 16.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER 53.57 120.76 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.287 0.565 . . . . 0.0 111.733 179.077 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER 78.07 25.39 0.63 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.905 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 204' ' ' ARG . 8.8 mmmt 49.85 44.31 25.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.231 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -66.49 70.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.78 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.949 ' HG3' HD21 ' B' ' 7' ' ' LEU . 0.2 OUTLIER -66.3 112.47 4.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.191 -179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.505 ' H ' HD13 ' B' ' 7' ' ' LEU . 0.0 OUTLIER -77.11 106.01 8.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.977 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 33.7 p -154.4 64.82 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -57.23 10.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.057 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 60.77 82.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.039 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.27 79.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.002 -0.999 . . . . 0.0 111.082 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.742 ' HB3' ' CG ' ' B' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.47 ' HB2' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -130.65 -82.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.928 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.839 HG23 HD11 ' B' ' 7' ' ' LEU . 3.7 mp -132.23 -58.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' B' ' 5' ' ' PRO . . . -45.59 -50.48 10.81 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.742 ' CG ' ' HB3' ' B' ' 1' ' ' ALA . 52.5 Cg_endo -88.02 -28.83 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.332 2.688 . . . . 0.0 112.732 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.949 HD21 ' HG3' ' A' ' 204' ' ' ARG . 11.8 mt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.357 -178.805 . . . . . . . . 1 1 . 1 stop_ save_